Investigating the effects of oxygen tension and electrospun nanofibre topography on the adhesion of embryonic stem cells by Kumar, Deepak
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is protected by copyright and other intellectual property rights and 
duplication or sale of all or part is not permitted, except that material may be 
duplicated by you for research, private study, criticism/review or educational 
purposes. Electronic or print copies are for your own personal, non-
commercial use and shall not be passed to any other individual. No quotation 
may be published without proper acknowledgement. For any other use, or to 
quote extensively from the work, permission must be obtained from the 
copyright holder/s. 
 
  
Investigating the effects of oxygen tension  
and electrospun nanofibre topography on the  
adhesion of embryonic stem cells  
 
 
Deepak Kumar 
 
 
 
 
School of Postgraduate Medicine 
Institute for Science and Technology in Medicine 
Keele University 
 
Thesis submitted to Keele University for the Degree of 
Doctor of Philosophy 
 
September 2013 
 
 
I 
 
Abstract 
Human embryonic stem cells (hESCs) have the potential to differentiate into all cell types 
of the three germ layers. However, various limitations hinder their use in the clinic, 
including possibilities of teratoma formation, xenogenic exposure through the use of 
Matrigel™ and feeder layers, along with poor attachment and expansion rates and inability 
to transport hESCs into an in vivo site. 
 
This thesis has aimed to overcome the above limitations. Electrospun nanofibrous 
substrates from a purely synthetic FDA approved material have been developed and 
investigated for the novel use in the expansion of undifferentiated hESCs. Synergistic 
effects between the oxygen environment and nanofibre technology were revealed which 
demonstrated the expansion of pluripotent hESCs in physiological normoxia (2% O2) on 
these substrates, with retention of differentiation capacity. However, in hyperoxia (21% 
O2), hESCs cultured on these substrates dictated embryoid body formation. A range of 
polymers (PCL, PLLA and PLGA) were tested (aligned and random conformations) where 
the optimal polymer (PCL) was further investigated at 2% O2 at various fibre diameters to 
reveal its impact on hESC clonogenicity. 
 
Exploring integrin expression levels and patterns within hESCs in 2% and 21% O2 
revealed significantly up regulated integrin’s/sub-units in 2% O2 in comparison to 21% O2. 
In 2% O2 (αVβ5 and α6) and in 21% O2 (CD44), specifically influenced hESC stemness 
and their initial attachment to Matrigel™. This data was further cross-validated by proving 
the adsorption of corresponding ECM proteins from MEF conditioned media to the 
substrates for the identified integrins/sub-units. Spectral similarities in protein adsorption 
 
II 
 
from pure proteins to conditioned media were witnessed. Critical amino acid fragments 
(exposed at a higher intensity) were identified on these nanofibrous substrates and thus 
may play a critical role for mediating hESC attachment. In conclusion, a novel substrate 
has been developed for the expansion of undifferentiated hESCs, which eliminates 
xenogenic contamination and provides a suitable carrier for transporting differentiated 
hESCs to a clinical setting. 
 
Keywords: Human embryonic stem cells, Electrospun nanofibres, Biodegradable 
Polymers, Physiological normoxia, Integrins, Protein Adsorption, Clonogenicity. 
 
III 
 
Contents  
Abstract  I 
List of Figures  VII 
List of Tables  XI 
Abbreviations  XIII 
Publications and 
Presentations 
 XV 
Acknowledgements  XVII 
   
1 Introduction 1 
1.1 Overview of Stem Cells 1 
1.1.1 Different Types of Stem Cells 3 
1.2 Human Embryonic Stem Cells 6 
1.2.1 Derivation & Isolation of Embryonic Stem Cells 6 
1.2.2 Embryonic Stem Cell Characteristics 9 
1.2.2.1 Plasticity of Embryonic Stem Cells 9 
1.2.2.2 Embryonic Stem Cell Molecular Markers 11 
1.2.3 In Vitro Culture Methods 12 
1.2.3.1 Feeder Method 12 
1.2.3.2 Feeder-Free Method 12 
1.3 Integrins 15 
1.3.1 Structure and Function 15 
1.3.2 Bidirectional Signalling and Signalling Pathways 17 
1.3.3 Integrin-related Proteins 19 
1.3.4 Factors Affecting Integrin Expression 21 
1.3.5 Embryonic Stem Cell Associated Integrins 23 
1.3.6 ECM Proteins and Corresponding Integrin Interactions 
Mediating hESC Activity Using Matrigel™ and Feeder 
Cells 
24 
1.3.6.1 Laminin 24 
1.3.6.2 Fibronectin 26 
1.3.6.3 Vitronectin 26 
1.3.6.4 Collagen IV 28 
1.3.6.5 Heparin Sulphate Proteoglycans 30 
1.4 Physiological normoxia and Intracellular Pathways for 
Embryonic Stem Cells 
31 
1.5 ECM Proteins for In Vitro hESC Expansion 37 
1.6 Tissue Engineering and Regenerative Medicine Strategies 42 
1.6.1 Naturally-derived Polymer Scaffolds 45 
1.6.2 Synthetic Polymer Scaffolds 47 
1.6.3 Protein Adsorption 53 
1.6.4 Nanotechnology 58 
1.6.4.1 Applications of Nanotechnology in Tissue Engineering and 
Human Embryonic Stem Cells 
59 
1.7 Electrospinning 63 
1.7.1 Electrospinning Method 63 
1.7.2 Electrospining Parameters 64 
1.7.2.1 Polymer Solution Parameter 65 
 
IV 
 
1.7.2.1.1 Viscosity, Concentration, Surface Tension and Solution 
Conductivity 
65 
1.7.2.2 Processing Parameters 68 
1.7.2.2.1 Voltage 68 
1.7.2.2.2 Flow Rate 70 
1.7.2.2.3 Working Distance 70 
1.7.2.2.4 Effect of Collector 71 
1.7.2.3 Environmental Parameters 73 
1.7.3 Applications of Electrospun Nanofibre Scaffolds with Stem 
Cells 
73 
1.8 Thesis Aims and Objectives 81 
   
2 Materials and Methods 82 
2.1 Electrospinning and Scaffold Fabrication 82 
2.1.1 Electrospinning Set-up 82 
2.1.2 Preparation of Polymer Solutions 82 
2.1.3 Fabrication of Random Electrospun Nanofibres 85 
2.1.4 Fabrication of Aligned Electrospun Nanofibres 85 
2.1.5 Reinforcement of Electrospun Nanofibrous Scaffolds 86 
2.1.6 Sterilisation Process of Nanofibrous Scaffolds 87 
2.2 Human Embryonic Stem Cell Culture 87 
2.2.1 Extraction and Isolation of Mouse Embryonic Fibroblasts 87 
2.2.2 Conditioning Embryonic Stem Cell Media using Mouse 
Embryonic Fibroblasts 
88 
2.2.3 Expansion of Human Embryonic Stem Cell Line SHEF 1 89 
2.3 Human Embryonic Stem Cell Culture on Nanofibres 89 
2.3.1 Pluripotent Colony-Forming Unit Assay 90 
2.3.1.1 Giemsa Staining 90 
2.3.1.2 Alkaline Phosphatase Staining 91 
2.3.2 Embryoid Body Formation 91 
2.3.3 Differentiation of Human Embryonic Stem Cells 92 
2.3.3.1 Spontaneous Differentiation 92 
2.3.3.1.1 RT-PCR 92 
2.3.3.1.2 RNA Extraction and Quantification 93 
2.3.3.1.3 One-Step Reverse Transcriptase Polymer Chain Reaction 94 
2.3.3.1.4 Electrophoresis Gel 95 
2.3.3.2 Mesodermal Germ Layer Lineage Differentiation 96 
2.3.3.2.1 Adipogenic Differentiation 96 
2.3.3.2.2 Chondrogenic Differentiation 96 
2.3.3.2.3 Osteogenic Differentiation 96 
2.3.3.3 Histological Evaluation 97 
2.3.3.3.1 Oil Red O Staining of Lipids 97 
2.3.3.3.2 Alcian Blue Staining of Glycosaminoglycans 97 
2.3.3.3.3 Alizarin Red Staining of Ca
2+
 ions 97 
2.4  Antibody Blocking of Human Embryonic Stem Cell 
Receptors 
98 
2.4.1 In silico Microarray Analysis of hESCs Integrin Expression 98 
2.4.2 Antibody blocking of Integrins and Surface Adhesion 98 
 
V 
 
Molecules 
2.4.2.1 Matrigel™ 98 
2.4.2.2 Electrospun Nanofibrous Substrates 99 
2.4.2.3 Quantification Cell Number Post-Antibody Treatment 100 
2.4.3 Immunoflourescent Staining 100 
2.4.3.1 αVβ5 Integrin and CD44 Expression in hESCs 100 
2.4.3.2 Pluripotent hESC Markers on Matrigel™ and Electrospun 
Nanofibre Substrates 
100 
2.4.3.3 Flourescent Activated Cell Sorting (FACS) 101 
2.5 Materials Related Characterising Techniques 102 
2.5.1 Field Emission Scanning Electron Microscope 102 
2.5.2 Water Contact Angle Analysis 102 
2.5.3 Time of Flight Secondary Ion Mass Spectrometry 104 
2.5.3.1 Sample Preparation 104 
2.5.3.2 Protein Adsorption to Substrates Experiment 105 
2.5.3.3 Specimen Analysis Using Tof-SIMS 105 
2.5.4 Nano Orange® Flourometric Assay 106 
2.6 Statistical Analysis 109 
   
3 Self-Renewal of hESCs on Electrospun Nanofibrous 
Substrates 
110 
3.1 Introduction 110 
3.2 Aims and Objectives 113 
3.3 Materials and Methods 115 
3.4 Results 116 
3.4.1 Characterisation of Optimised Electrospun Nanofibrous 
Substrates 
116 
3.4.2 Optimisation of hESC Seeding Density 122 
3.4.3 Characterisation and Quantification of hESC CFUs on 
Nanofibrous Substrates in 2% O2 and 21% O2 
124 
3.4.4 Pluripotency of hESCs Cultured on Electrospun Nanofibrous 
Substrates 
132 
3.4.5 Differentiation Capacity of hESCs on Electrospun 
Nanofibrous Substrates 
137 
3.4.6 The effect of Fibre Diameter on the Recovery and Expansion 
of hESC-CFUs in Physiological Normoxia (2% O2) 
142 
3.5 Discussion 145 
3.6 Conclusion 153 
   
4 Identification of Adhesion Determining Molecules in 
hESCs 
155 
4.1 Introduction 155 
4.2 Aims and Objectives 158 
4.3 Materials and Methods 160 
4.4 Results 162 
4.4.1 In Silico Microarray Analysis 162 
4.4.2 hESC Attachment after Post-Antibody Treatment 168 
4.4.3 Characterisation and Quantification of αVβ5 and CD44 171 
 
VI 
 
Receptor 
4.4.4 Pluripotent Marker Expression of hESCs with blocked αVβ5 
and CD44 receptors 
175 
4.4.5 Effect of blocking αVβ5 Integrin Receptor in hESCs 
Cultured on Nanofibrous Substrates in Physiological 
Normoxia 
179 
4.5 Discussion 181 
4.6 Conclusion 189 
   
5 Characterisation of Protein Adsorption Activity on 
Electrospun Nanofibrous Substrates to Support hESC 
Attachment 
191 
5.1 Introduction 191 
5.2 Aims and Objectives 199 
5.3 Materials and Methods 200 
5.4 Results 202 
5.4.1 Characterisation of PCL Electrospun Nanofibrous Substrates 202 
5.4.2 Quantification of Protein Adsorption on PCL Electrospun 
Nanofibrous Substrates 
203 
5.4.3 Tof-SIMS Analysis of Protein Adsorption on PCL 
Electrospun Nanofibrous Substrates in Physiological 
Normoxia (2% O2) 
204 
5.5 Discussion 229 
5.6 Conclusion 238 
   
6 General Discussion, Future Work and Conclusions 239 
6.1 Discussion 239 
6.2 Future Work 249 
6.3 Concluding Remarks 250 
   
7 References 251 
   
Appendix  271 
  
 
VII 
 
List of Figures 
Figure Title  
Figure 1.1….. Process involved in the derivation and isolation of pluripotent ESCs 
from the inner cell mass (ICM) of a blastocyst. 
7 
Figure 1.2….. Timeline illustrating the essential milestones during embryonic 
stem cell culture development. 
9 
Figure 1.3….. Demonstrating the in vitro differentiation capacity of ESCs into 
specialised cell types of the three somatic germ layers; Ectoderm, 
Endoderm and Mesoderm. 
12 
Figure 1.4….. Structure of an integrin, demonstrating both α and β sub-units 
during an inactive and active state 
17 
Figure 1.5….. Essential intracellular proteins which mediate integrin interaction 22 
Figure 1.6...... Schematic representing the connection between ECM proteins and 
intracellular components proteins through integrins 
32 
Figure 1.7….. A schematic describing the Vromann effect 56 
Figure 1.8….. Nano-scale topography and architecture influence on cell 
attachment abilities 
62 
Figure 1.9….. A schematic of a basic electrospinning set-up 65 
   
Figure 2.1….. Image of the electrospinning set-up. 84 
Figure 2.2….. Flow diagram representing the experiments performed with each 
electrospun polymer solution. 
85 
Figure 2.3….. Photograph illustrating the contact angle set-up. 102 
Figure 2.4...... Photograph illustrating the Tof-SIMS instrument set-up 105 
Figure 2.5….. Standard curve for BSA 107 
Figure 2.6….. Standard curve for Collagen I 108 
Figure 2.7….. Standard curve for Fibronectin 108 
Figure 2.8….. Standard curve for Laminin 109 
Figure 2.9….. Standard curve for Vitronectin 109 
   
Figure 3.1...... Optical microscopy images of optimised electrospun nanofibrous 
substrates fabricated from 12.5% PCL, 7% PLGA and 2% PLLA in 
both aligned and random conformations. 
118 
Figure 3.2...... FESEM images of electrospun nanofibres fabricated from PCL, 
PLGA and PLLA, in both aligned and random conformations. 
119 
Figure 3.3...... Graph representing the average fibre diameters of both aligned and 
random electrospun nanofibres made from PCL, PLGA and PLLA. 
120 
Figure 3.4...... Method of calculating water contact angle. 122 
   
 
VIII 
 
Figure 3.5...... Water contact angle analysis. Measurements for both aligned and 
random electrospun nanofibrous substrates. 
122 
Figure 3.6...... Optimisation of hESC seeding density to form CFUs on Matrigel™ 
coated 6-well plates, cultured for 21 days with ES conditioned 
media and in physiological normoxia and hyperoxia stained using 
Giemsa and Alkaline phosphatase. Quantification of Giemsa 
stained hESC colony count on Matrigel™ when seeded at different 
seeding densities 
124 
Figure 3.7...... Macroscopic evaluation of hESC expansion. 127 
Figure 3.8...... hESC morphology within a colny formed under physiological 
normoxia on various substrates. 
128 
Figure 3.9...... Quantification of CFUs on Matrigel™ and nanofibrous substrates 131 
Figure 3.10.... Quantification of colony size of ES colonies formed on positive 
control (Matrigel™) and nanofibrous substrates in physiological 
normoxia (2% O2). 
132 
Figure 3.11.... Immunostaining of pluripotent gene expression in hESCs cultured 
on Matrigel™ in physiological normoxia. 
133 
Figure 3.12.... Immunostaining of ALP in hESCs cultured on electrospun 
nanofibrous substrates. 
135 
Figure 3.13.... Immunostaining of Nanog in hESCs cultured on electrospun 
nanofibrous substrates. 
136 
Figure 3.14.... Immunostaining of Oct 3/4 in hESCs cultured on electrospun 
nanofibrous substrates. 
137 
Figure 3.15.... Optical microscopy images of hESC-CFUs (expanded for 21 days 
with ES conditioned media) and spontaneously differentiated 
hESC-CFUs for a further 21 days using spontaneously 
differentiation media, formed on Matrigel™ and electrospun 
nanofibrous substrates in physiological normoxia. 
139 
Figure 3.16.... RT-PCR ran on 2% Agarose gel electrophoresis to evidently 
illustrate the presence and expression levels of various genes, on 
both aligned and random nanofiber substrates including positive 
control (Matrigel™). 
140 
Figure 3.17.... Representative optical images of respective histology stain of 
differentiated hESC CFUs into skeletal lineages (Adipogenesis, 
Chondrogenesis and Osteogenesis). 
142 
Figure 3.18.... Scanning electron microscopy images of electrospun PCL 
nanofibrous substrates with varying diameter. 
143 
Figure 3.19.... Graph representing the average fibre dimaeters of both aligned and 
random electrospun naofibers fabricated from PCL with varying 
fiber diameter. 
144 
Figure 3.20.... Relationship between PCL aligned and random nanfibrous 
substrates at various diameters and hESC CFU ability. 
145 
Figure 3.21.... Graphs representing relationship between hESC and hMSC CFU 
fibre diameter. 
152 
   
Figure 4.1...... Schematic demonstrating the protocol used for antibody blocking 
of hESCs for cell adhesion investigations. 
161 
 
IX 
 
Figure 4.2...... Selected relative expression levels of integrin sub-units in hESCs. 167 
Figure 4.3...... Effects of integrin blocking on attachment of hESCs to Matrigel™. 170 
Figure 4.4...... Normalised cell attachment values (%) of hESCs treated with anti-
integrin antibodies at 1 µg/ml and 25 µg/ml concentrations, to the 
relevant control values for each integrin. 
171 
Figure 4.5...... Representative immunostained images of αVβ5 integrin and CD44 
receptor expression in hESCs cultured in both physiological 
normoxia and hyperoxia on Matrigel™ substrates. 
173 
Figure 4.6...... FACS analysis of αVβ5 expression in hESCs cultured in both 
physiological normoxia (2% O2) and hyperoxia (21% O2) 
conditions. 
174 
Figure 4.7...... Quantitative analysis of FACS data. 175 
Figure 4.8...... Evaluation of pluripotent marker expression in hESCs treated with 
αVβ5 blocking antibody (25 µg/ml) and cultured in physiological 
normoxia (2% O2). 
177 
Figure 4.9...... Evaluation of pluripotent marker expression in hESCs treated 
CD44 blocking antibody (25 µg/ml) and cultured in physiological 
normoxia (21% O2). 
178 
Figure 4.10.... Oct-3/4 and Nanog nuclear localisation quantification. 179 
Figure 4.11.... Characterisation of hESC-CFU’s expanded on Matrigel
TM
 and PCL 
nanofibrous substrates (aligned and random) with and without anti-
αVβ5 antibody blocking treatment. 
180 
Figure 4.12.... Quantification of colonies formed after the treatment of hESCs 
with and without anti-αVβ5 antibody blocking solution and 
cultured on nanofibrous substrates or Matrigel™ in physiological 
normoxia for 21 days. 
182 
Figure 4.13.... Flow diagram representing the speculative mechanisms that may 
occur as a result of blocking αVβ5 in physiological normoxia and 
CD44 receptor in hyperoxia 
188 
   
Figure 5.1...... Schematic demonstrating the Tof-SIMS instrument set-up 199 
Figure 5.2….. Protein adsorption protocol 202 
Figure 5.3...... Representative FESEM images of PCL electrospun nanofibres in 
both aligned and random conformations, at various different fibre 
diameters. 
203 
Figure 5.4...... Quantification of protein adsorption from ES conditioned media 
(CM) and pure protein solutions on PCL nanofibrous substrates. 
205 
Figure 5.5….. Score plots on the first two multivariate axes from PCA of the 
positive ions data of the Tof-SIMS spectra of all substrates 
207 
Figure 5.6….. Score plots on the first two multivariate axes from PCA of the 
positive ions data of proteins adsorbed on smaller fibre diameter 
substrates 
209 
Figure 5.7….. Score plots on the first two multivariate axes from PCA of the 
positive ions data of proteins adsorbed on larger fibre diameter 
substrates 
210 
 
X 
 
Figure 5.8….. Loading plots for PC1 and PC2 of positive ions spectra 212 
Figure 5.9….. Normalised intensity value calculation method 214 
Figure 5.10… Normalised intensity values of detected positive protein fragments 
on nanofibrous substrates 
217 
Figure 5.11… PCA score plots of Tof-SIMS spectra of all substrates (negative 
ions) 
220 
Figure 5.12… PCA score plots of Tof-SIMS spectra for small fibre diameter 
substrates only 
221 
Figure 5.13… PCA score plots of Tof-SIMS spectra for large fibre diameter 
substrates only 
222 
Figure 5.14… Loading plots from PCA of negative ions spectra 224 
Figure 5.15… Normalised intensity values of negative ion mass peaks of protein 
fragments from conditioned media and all pure protein solutions on 
all substrates 
228 
Figure 6.1….. An overriding schematic which describes the key, novel findings 
identified in this thesis, collating together the results from Chapter 
3, 4 (Integrin mechanisms) and 5 (Protein adsorption to nanofibrous 
substrates).  
240 
 
  
 
XI 
 
List of Tables 
Table Title  
Table 1.1……. Stem cells with varying potency and the locations where they can 
be found 
3 
Table 1.2……. Different sources for attaining ASCs and their plasticity 5 
Table 1.3……. Structure and function of integrin binding adaptor proteins 23 
Table 1.4……. A summary of the critical integrins and interactive ECM ligands 
which promote the adhesion and undifferentiated expansion of 
hESCs 
31 
Table 1.5……. Effects of  physiological normoxia (2% O2) on hESCs and 
hMSCs cultured in vitro 
37 
Table 1.6……. A summary of studies which investigated the potential of purified 
ECM proteins as substrates for the attachment and expansion of 
hESCs during in vitro culture. 
40 
Table 1.7……. A summary of synthetic substrates used to culture and expand, 
undifferentiated hESCs 
50 
Table 1.8……. Molecular structure and properties of commonly used synthetic 
biodegradable polymers in tissue engineering 
53 
Table 1.9…..... Relationship between wettability dictating parameters; contact 
angle and adhesion tension 
57 
Table 1.10…... Available techniques for fabricating nanofibrous substrates 63 
Table 1.11…... A summary of various modified methods of electrospinning to 
attain aligned nanofibrous substrates 
72 
Table 1.12…... A summary of environmental parameters that have an impact on 
the electrospinning process 
74 
Table 1.13…... A summary of electrospun nanofibrous substrates fabricated from 
various synthetic polymers to culture, expand and differentiate 
ESCs 
80 
   
Table 2.1……. Polymer solutions and the concentration at which they were 
prepared using solvents at specific ratio’s 
85 
Table 2.2……. Electrospinning parameters used to attain random nanofibres for 
each polymer type 
86 
Table 2.3……. Electrospinning parameters used to attain aligned nanofibres for 
each polymer type. 
87 
Table 2.4……. One-Step RT-PCR. Gene type investigated and their forward and 
reverse primers plus annealing temperatures. 
96 
   
Table 4.1……. Normalised signal intensity values from microarray analysis for 
all integrins expressed in hESCs cultured in physiological 
normoxia and hyperoxia 
165 
Table 5.1……. A summary of various available techniques currently used to 
analyse and characterise protein adsorption. 
196 
Table 5.2……. Summary of the advantages and disadvantages associated with 
using ToF-SIMS. 
199 
 
XII 
 
Table 5.3……. Amino Acid Fragments identified by To-SIMS on PCL 
Electrospun nanofibrous substrates 
211 
Table 5.4……. Positive ion amino acid fragments identified from loading plots 
from PCA 
213 
Table 5.5……. Positive ion mass peaks detected at a higher normalised intensity 
value on each substrate type from pure protein solution relative to 
conditioned media 
218 
Table 5.6……. Definition of clusters observed for protein fragments on all 
substrates for negative ion data 
223 
Table 5.7……. Negative ion amino acid fragments identified from loading plots 
from PCA and the samples on which detected at the highest 
normalised intensity 
225 
Table 5.8……. Negative ion mass peaks detected at a higher normalised intensity 
value on each substrate type from each pure protein solution 
relative to conditioned media 
229 
 
  
 
XIII 
 
Abbreviations 
Ø Diameter ECM Extracellular matrix 
21% O2 Physiological normoxia ESC Embryonic stem cells 
2% O2 Hyperoxia FC Final concentration 
2D Two-dimensional FA Focal adhesion 
3D  Three-dimensional FACS Flourescent Activated Cell 
Sorting 
ALP Alkaline phosphatase FAK Focal adhesion kinase 
AP-1 Activator protein 1 FBS Fetal bovine serum 
bFGF Basic fibroblastic growth 
factor 
FC Fold-change 
BSA Bovine serum albumin FDA Food and drug administration 
CFUs  Colony forming units FESEM Field Emission Scanning 
Electron Microscopy 
CHL Chloroform FGF-2  Fibroblastic growth factor-2 
CM Conditioned media Fn Fibronectin 
Coll I Collagen type I G Gauge 
DCM Dichloromethane GAGs Glycosaminoglycans 
DMF Dimethylformamide GAPDH Glyceraldehyde-3-phosphate 
dehydrogenase 
E Young’s modulus GFs Growth factors 
EBs Embryoid bodies HA Hyaluronic acid 
 
XIV 
 
HIF Hypoxia inducible factor PBS Phosphate buffer solution 
hMSC Human mesenchymal stem 
cells 
PC1 Principle component 1 
HSPGs Heparin sulphate 
proteoglycans 
PC2 Principle component 2 
hTERT Human telomerase reverse 
transcriptase 
PCA Principle component analysis 
IC Initial concentration PCL Poly-ɛ-caprolactone 
ICM Inner cell mass PE-TCPS Oxygen plasma etched tissue 
culture polystyrene 
IMS Industrial methylated spirit PFA Paraformaldehyde 
ILK Interleukin kinase PLGA Poly-lactide-co-glycolic acid 
IPA isopropyl alcohol PLLA Poly-L-lactic acid 
KO-SR Knock-out serum 
replacement 
PS Penicillin and streptomycin 
kV Voltage RNA Ribonucleic acid 
L-Glut L-glutamine RT-PCR Reverse Transcriptase-
polymer chain reaction 
LIF Leukemia inhibitory factor TA-EDTA Tris Acetate-
Ethylenediaminetetraacetic 
acid 
Ln Laminin TCP Tissue culture plastic 
MAPK Mitogen-activated protein 
kinase 
Tof-SIMS Time of flight secondary ion 
mass spectrometry 
MEFs Mouse embryonic fibroblasts UV Ultra-violet 
NEAA Non-essential amino acid Vn Vitronectin 
  
 
XV 
 
Publications and Presentations 
Patents 
Kumar D, Yang Y and Forsyth NR. Stem Cell Culture Method: UK Patent # 
GB1214704.7; filed August 2012. 
Kumar D, Yang Y and Forsyth NR. Stem Cell Culture Method: US Patent # US13/800325; 
filed March 2013.  
 
Associated research publications 
Kumar D, Wimpenny I, Dale T, Yang Y and Forsyth NR. Self-Renewal of Human 
Embryonic Stem Cells using Nanofibres as Non-Biological Supports. (Submitted) 
 
Kumar D, Gupta S, Yang Y and Forsyth NR. αVβ5, α6 and CD44 are Oxygen-Regulated 
Human Embryonic Stem Cell Attachment Factors. (Submitted) 
 
Kumar D, Roach P, Forsyth NR and Yang Y. Study of Adsorbed Proteins on Nanofibrous 
Substrates. (In Preparation) 
 
Non-associated research publications 
Pijanka JK, Kumar D, Dale T, Yousef I, Parkes G, Untereiner V, Yang Y, Dumas P, 
Collins D, Manfait M, Sockalingum GD, Forsyth NR and Sule-Suso J. Vibrational 
Spectroscopy Differentiates between Multipotent and Pluripotent Stem Cells. Analyst 
(2010), 135: 3126-3132. 
Kumar D, Gittings JP, Turner IG, Bowen CR, Bastida-Hidalgo A and Cartmell SH. 
Polarization of Hydroxyapatite: Influence on Osteoblast Cell Proliferation. Acta 
Biomaterialia (2009), 6: 1549-1554. 
Fouriki A, Kumar D, Forsyth NR and Dobson J. Nanomagnetic Gene Transfection for 
Non-Viral Gene Delivery in Human Embryonic Stem Cells. (Accepted; Gene Therapy). 
Kumar D, Rutter AV, Pijanka JK, Sandt C, Cinque G, Dumas P, Yang Y, Forsyth NR and 
Sule-Suso J. Lipids as a Potential Human Embryonic Stem Cell Biomarker for Cell 
Differentiation. (In Preparation) 
 
XVI 
 
Akram KM, Kumar D, Spiteri MA and Forsyth NR. Expansion of Bone Marrow Derived 
Mesenchymal Stem Cells in Hypoxia Enhances their Differentiation when Cultured in 
Normoxia. (In Preparation). 
 
Published poster presentations  
Kumar D, Roach P, Forsyth NR and Yang Y. Study of Adsorbed Proteins to Nanofibrous 
Substrates. TERMIS World Congress, Vienna (September 2012).  
Kumar D, Gupta S, Yang Y and Forsyth NR. αVβ5, α6 and CD44 are Oxygen-Regulated 
Human Embryonic Stem Cell Attachment Factors. BIRAX Conference Israel (2011) 
Kumar D, Gupta S, Yang Y and Forsyth NR. Integrin Expression and Reliance are Oxygen 
Concentration Dependant in Human Embryonic Stem Cells. European Cells and Materials 
(TCES Leeds, 2011), 22 (3): 31. 
Kumar D, Wilson SL, Forsyth NR and Yang Y. Investigating the Relationship between 
Surface Properties of Polymers and Protein Adsorption. European Cells and Materials 
(TCES Manchester, 2011), 22 (2): 60. 
Kumar D, Gupta, Wilson SL, Forsyth NR and Yang Y. Investigating the Relationship 
between Surface Topography of Polymers and Protein Adsorption. (ExperTissues, 
Portugal; 2010) 
 
Conference Oral Presentations 
Kumar D, Forsyth NR and Yang L. Intervertebral Disc Tissue Engineering through Design 
of Injectable Scaffolds and Physiologically Informed Bioreactors. TERMIS World 
Congress, Vienna (September 2012).  
  
 
XVII 
 
Acknowledgements  
Thank you to His Holiness “Shri Ashutosh Maharaaj”, for his blessings 
“Dedicated to my granddad Late Mohinder Pal” 
 
A deep hearted thank you to both of my supervisors without whom this thesis would not 
have been possible. I feel very lucky to have had a supervisor like Dr Nick Forsyth who 
has guided me constantly throughout my PhD, pushed me too boundaries which I never 
thought I could reach and for constantly giving me the drive to push myself to the 
extremes. I feel like I have learned so much from you; skills which will “no doubt” be 
useful for the rest of my career. Also, a thank you to Dr Ying Yang for her useful 
contributions and lifting my spirits up during the low points. The classic phrase of “I 
believe this should happen” always managed to convince me that an experiment must work 
and it was “my bad” for not making it happen. Ying you have truly challenged my stamina 
and patience. I would also like to thank Dr Paul Roach for a collaboration that has resulted 
in valuable data. More importantly, for his unlimited availability, support and 
encouragement when I needed to “hang tough”. Paul, you have a massive heart and will 
always value your support and good nature. A big “gracias” to Dr Josep Sule-Suso who has 
been a great character; I always enjoy having our awesome “non-work related convo’s” 
and looking at your holiday photo’s with a cuppa!! 
 
Just as importantly, I would like to thank the greatest parents in the world. This thesis and 
achievement is dedicated to you. I will always appreciate and never forget the sacrifice, 
continuous support (in everything and anything I can possibly think of, and more), 
encouragement and the pillar of strength that you have been for more. You have definitely 
raised the bar for being amazing parents – which I feel I will never be able to achieve. 
 
XVIII 
 
Mum-Star, your constant words of “you can always do better”, comparisons to others and 
constantly challenging me, have all no doubt contributed to achieving this thesis. Thanks 
Supz for taking care of everything whilst I have been trying to get through this; knowing 
that you had everything under control back home gave me the peace of mind to carry on. 
Thanks for your sacrifice; part of this achievement is defo down to you (hurry up and 
become a Lyer…. I mean a Lawyer). Thanks Raj (aka Pinky) for your contributions; you 
may be bigger than me, but I defo have the bigger brains, Boom!! Also thank you to Ashok 
(Godfather, you defo have swagger like a Godfather, which I still need to work on, 
classy!!), Asha, Rakesh, Ravi (Beast in body and mind) and Ramma, who have all made 
priceless contributions.  
 
Good work by the BRO-TEAM. Firstly Sid (Soul bro who’s a pro), Meeta and Calvin 
“Klein”. Am privileged to have the most amazing mate and bro in the world. An abso 
legend who ticks all the boxes that I have ever wanted in a bro. “Bro’s 4 life” is a solid 
statement. Thanks Whomps, nice 1 blud for your priceless help, support and words of 
wisdom when the going got tough. You have contributed in helping me power through this 
bizzle (“wiggle wiggle wiggle, yeah”). Thanks to all the other boys in the team, Jizzatastic 
Jazz, DJ Shayan, Mo-Star, Manu, Jamie (Dodga), Shiraz, Indi and Si. Nights out have 
always been “memories”, no matter what life has thrown at us……….Brrraaapppppp!!! 
 
A special thanks to the Cypriat Villager-Hari; I don’t have the words to thank you enough 
for everything that you have done for me over the last few years – you have a massive 
heart. You are a total pillar of strength and a legend. A big hug to Sammy (aka Blonde 
Kutti) and Angeliki, we have truly powered through stuff as a team, lifting each other up 
through high’s and lows. Nice work Sammy with the random raving in labs, courtesy of 
 
XIX 
 
Radio 1 (especially F Cotts) and the sexy time images for my thesis. Good work SG, for 
proof reading this boring thesis and for your words of wisdom. Finally, I would also like to 
thank some of the people I have worked with over the years including, Abbie (Abzypoo), 
JP, Cass the Bat, Halil-iano, Vaselinee Vas, Alex, Kizza, Khondokey, Mikey Spikey, SR, 
Tin Tin, Neeni and J-Glo. We have defo had some good jokes and great laughs. Girlies at 
reception, you have been great help; particularly Annie Anne – you’re truly a character and 
a half and so are you my Maria-mou (Dr Hoody). 
 
 
“High achievement always takes place in the framework of high expectation” 
Introduction 
Chapter 1 
 
 
1 
 
1. Introduction 
1.1 Overview of Stem Cells 
Currently there is high interest and research into the unspecialised cells known as stem 
cells for use in tissue engineering and regenerative medicine applications. These cells can 
be used individually by injecting them into defect (injury) sites or can be incorporated into 
tissue engineering strategies and constructs to repair or regenerate tissue in vitro or in vivo 
[Finkemeier, 2002]. 
 
A stem cell has three important properties; 
 Self-renewal: via symmetrical division (where a parental cell divides to give two 
daughter cells that retain the potentiality of its parental cell known as mitosis; this 
increases the pool of stem cells), or by asymmetric division (whereby a stem cell 
divides to give one daughter cell that retains its stem cell properties and another 
daughter cell which commits to a differentiation lineage by becoming a progenitor 
cell) [Howell and Yoder, 2003; Trounson, 2006; Wagers and Weissman, 2004]. 
 Differentiation capacity: the ability to differentiate into a specialised mature cell 
type. Stem cells can be further classified depending on their differentiation capacity 
in terms of the various specialised cells/tissues/organs that they can form and can 
be termed as either totipotent, pluripotent or multipotent (for definitions, see Table 
1.1) [Howell and Yoder, 2003]. 
 In vivo reconstitution of a given tissue: Stem cells should able to divide 
symmetrically to maintain a population of stem cells and differentiate into the cells 
required to generate the tissue in which they are situated [Howell and Yoder, 2003]. 
Introduction 
Chapter 1 
 
 
2 
 
The stem cell niche plays an important part in maintaining the undifferentiated state of a 
stem cell and can be defined as the 3D microenvironment which controls gene expression 
and the properties of stem cells through signalling molecules, inter-cellular contact and 
stem cell- extracellular matrix (ECM) interactions. The ECM is the chemical and 
mechanical structure required for development and for responses to (patho)-physiological 
signals. Stiffness and composition of the ECM considerably influence cell behaviour 
[Kruegel and Miosge, 2010]. Cells are sensitive to applied mechanical forces as well as the 
mechanical properties of its environment such as elasticity which is directly affected by the 
composition of ECM (as structural proteins such as collagen provide strength to tissues, 
whereas elastin and proteoglycans provide matrix resiliency). Substrate stiffness strongly 
influences several factors such as how strongly cells can adhere to a substrate, the amount 
of force they can exert, the degree of spreading, the rate of proliferation (which has known 
to be faster on stiffer substrates compared to softer ones), and cell differentiation. For 
example; stiffer substrates have demonstrated to induce differentiation of hMSCs towards 
myocytes and osteoblasts whereas softer substrates induced their differentiation to neurons 
[Engler et al., 2006]. On softer substrates, hESCs enhanced their attachment and 
proliferation rate whereas stiffer substrates induced their differentiation towards an 
osteogenic lineage [Evans et al., 2009]. 
 
Furthermore, the stem cell niche also influences “stem cell plasticity/stem cell fate” 
(flexibility to differentiate into mature cell types giving rise to cell types of the certain 
microenvironments in which they have been placed) and exerts restrictions on its 
differentiation capabilities [Bajada et al., 2008b]. 
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Table 1.1 Stem cells with varying potency and the locations where they can be found  
[Wagers and Weissman, 2004] 
Level of 
Potency 
Definition Example of Source 
Totipotent Able to give rise to all embryonic and extra-
embryonic cell types 
Zygote (Oocyte)  
Pluripotent Able to differentiate into all cell types of the 
embryo apart from placental cells 
Inner cell mass (ICM) of a 
blastocyst 
Multipotent Ability to differentiate into a few specialised 
cell lineages 
Marrow Stroma 
 
 
1.1.1 Different Types of Stem Cells 
Stem cells can be broadly classified into two types; embryonic stem cells (ESCs) and adult 
stem cells (ASCs). ESCs are pluripotent which enables them to give rise to all specialised, 
mature cell types of the three somatic germ layers (Ectoderm, Endoderm and Mesoderm) 
but not the extraembryonic tissues. ASCs are traditionally considered to be multipotent and 
have less plasticity in comparison to ESCs. However, this dogma has recently been 
questioned where current literature states that ASCs may actually have a greater plasticity 
than originally thought. It has been demonstrated that ASCs are able to differentiate into 
other cell types rather than the tissue from which it originates from, in response to its 
surrounding microenvironment [Bajada et al., 2008a]. For example, neural stem cells 
which traditionally were thought to only differentiate into various nerve cells in the adult 
brain, have now also been shown to differentiate into hematopoietic cells [Lakshmipathy 
and Verfaillie, 2005]. Another example includes, human neuronal stem cells co-cultured 
with muscle cells resulting in neuronal stem cell differentiation into skeletal muscle [Galli 
et al., 2000]. Bone marrow stromal cells have been demonstrated differentiation towards 
lung, liver and gut tissues [Jiang et al., 2002]. Possibility of greater plasticity of ASCs has 
triggered a keen interest by stem cell biologists due to their great therapeutic potential. 
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Various types of ASCs exist including: Amniotic-fluid derived stem cells (AFDSCs), 
umbilical cord derived stem cells (UCDSCs; derived from the cord lining or cord blood), 
fat-derived stem cells and bone marrow derived mesenchymal stem cells (BM-MSCs). 
Their characteristics and properties are described briefly in Table 1.2. 
   
 
Table 1.2 Different sources for attaining ASCs and their plasticity  
Different types of ASCs Location Differentiation Capacity 
Tissue -specific stem cells Within specific 
tissues and 
organs such as 
adipose 
Able to differentiate into the mature 
cell type of the tissue/organ it is located 
within. Eg. Cardiac stem cells support 
myocardial regeneration [Beltrami et 
al., 2003] and limbal stem cells support 
cornea regeneration [Dua and Azuara-
Blanco, 2000].  
Haematopoietic stem cells Bone marrow Able to differentiate into all lineages of 
mature blood cell types and blood 
components [Spangrude et al., 1988]. 
Amniotic fluid derived 
stem cells 
Amniotic fluid Multipotent stem cells which also 
express some ESC markers. 
Demonstrated differentiation towards 
functional cells of each of the three 
embryonic germ layers [De Coppi et 
al., 2007]. 
Umbilical cord/placental 
tissue derived syem cells 
Umbilical cord Source for both pluripotent stem cells 
(from umbilical cord blood) [Kogler et 
al., 2005] and mulitpotent stem cells 
(umbilical cord matrix) [Mitchell et al., 
2003].  
Adipose-derived stem cells Fat tissue Ability to differentiate into 
chondrocytes [Erickson et al., 2002], 
osteocytes [Halvorsen et al., 2001], 
adipocytes, hepatocytes [Seo et al., 
2005] and neurogenic lineages [Safford 
et al., 2002]. 
Mesenchymal stem cells Bone Marrow Mesenchymal lineages including; 
skeletal muscle, bone, cartilage, tendon, 
fat [Pittenger et al., 1999]. 
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ASCs with typical multipotent characteristics include; haematopoietic stem cells (HSCs; 
able to differentiate to give rise to all mature blood cell types including vessels) and 
mesenchymal stem cells (MSCs) [Trounson, 2006]. MSCs can be sourced from the bone 
marrow and extracted via the iliac crest, for instance. Within bone marrow stromal cells; a 
subpopulation of approximately 0.001 – 0.01% are multipotent MSCs (first isolated by 
Friedenstein and collegaues in the 1960s) [Friedenstein et al., 1987]. 
 
hMSCs can be separated from the rest of the bone marrow which contains HSCs and non-
adherent cells by their adherent properties . During in vitro culture, hMSCs expand with a 
fibroblastic-like morphology and demonstrate the ability to produce colony forming units 
(CFU), which are a typical feature of undifferentiated stem cell expansion. The surface 
antigen expression profile of hMSCs include; SH2, SH3, CD29
+
, CD44
+
, CD71
+
, CD90
+
, 
CD106
+
, CD120a
+
, CD124
+
, STRO-1
+
, VCAM-1
+
, CD14
-
, CD34
-
 and CD45
-
 [Pittenger et 
al., 1999; Young and Black, 2004]. 
 
hMSCs are also immune-privileged [Rose and Oreffo, 2002] demonstrated by their ability 
to inhibit critical immune effector cells such as CD4
+
, CD8
+
, NK cells, B cells and 
monocytes during culture in combination with transforming growth factor (TGF-β), 
hepatocyte-growth factor (HGF), prostaglandin (PG)E2 and interferon-gamma (IFN-γ) 
[Krampera et al., 2006].  
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1.2 Human Embryonic Stem Cells 
1.2.1 Derivation & Isolation of Embryonic Stem Cells 
When the male gamete (sperm cell) fertilises the female gamete (ovum) this produces a 
diploid zygote cell, which is the earliest developmental stage of the embryo. At this stage 
and up to the eight-cell stage of the morula it is possible to produce an entire organism 
including the placenta as the cells are totipotent and thus can differentiate into any cell 
type. After this stage, ongoing development results in the formation of a pre-implantation 
blastocyst; comprised of an outer layer of trophoblast cells and an inner cell mass (ICM) of 
undifferentiated cells from which ESCs are isolated between day 3-5. Characteristics of 
cells from ICM explants plated out onto tissue culture plastic (TCP) and cultured in vitro 
have a rounded morphology and expand as tightly packed adherent colonies [Thomson et 
al., 1998]. 
 
 
Figure 1.1 Process involved in the derivation and isolation of pluripotent ESCs from the 
inner cell mass (ICM) of a blastocyst. Adapted from Wobus et al., 2005. 
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The ability to isolate and culture undifferentiated hESCs in vitro, is a recent development 
and the key milestones associated with ESC culture development are summarised in Figure 
1.2. However, several ethical concerns still surround the use of ESCs where several 
countries do not permit embryo research (Austria, Denmark, Poland, Slovakia, Malta and 
France where as some countries permit embryo research under specific legislation 
(Finland, Belgium, Spain and UK). 
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Figure 1.2 Timeline illustrating the essential milestones during embryonic stem cell culture development [Axelrod, 1984; Thomson et al., 
1998; Gearhart and Mintz., 1974; Xu et al., 2001; Xu et al., 2005]. 
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1.2.2 Embryonic Stem Cell Characteristics  
ESCs display unlimited self-renew and are immortal in vitro. This is attributed to ESCs 
having high telomerase activity (a ribonucleoprotein enzyme which maintains telomere 
length by adding repeats to chromosome ends), providing long-term proliferative potential 
[Thomson et al., 1998] and preventing senescence, which usually occurs during tissue 
culture after a population doubling between 50-80 [Odorico et al., 2001]. During 
expansion in vitro, ESCs have a high nucleus to cytoplasmic ratio with prominent nucleoli 
[Thomson et al., 1998]. Furthermore, as pluripotent hESCs proliferate (population 
doubling time of 36 hours) [Amit et al., 2000], they form flat, compact colonies that are 
tightly adherent (more so in hESCs, relative to mouse embryonic stem cells; mESCs), 
whereas differentiated ESCs aggregate together in suspension to form embryoid bodies 
(EBs) in vitro or teratoma’s in vivo, resulting in tumorigenicity [Thomson et al., 1998].  
 
1.2.2.1 Plasticity of Embryonic Stem Cells  
ESCs are pluripotent with the potential to differentiate into all mature cell types of the 3 
somatic germ layers; endoderm, ectoderm and mesoderm (Figure 1.3), including the male 
and female germ cells [Thomson et al., 1998] with the exception of placental cells in vitro. 
Therefore, the use of ESCs have great potential for a wide range of therapeutic applications 
as they provide an unlimited source of several different cell types for tissue replacement 
and regeneration [Xu et al., 2001]. Certain growth factors can direct the differentiation of 
hESCs into specific germ layers; for example endoderm lineages can be stimulated using 
hepatocyte growth factor, mesoderm lineages can be encouraged using BMP-4 and TGF-β 
and ectoderm lineages using nerve growth factor and retinoic acid [Trounson, 2006].  
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During embryo development ESCs within the ICM of a blastocyst spontaneously 
differentiate and give rise to the entire organism. Theoretically, isolated ESCs should have 
the same plasticity in vitro; however establishing supportive chemical cues and 
environment is crucial in directing their differentiation to become functional, specialised 
cell types. Examples of in vitro differentiation of hESCs include; oligodendrocytes, 
(induced using bFGF, epidermal GF and retinoic acid, [Nistor et al., 2005], the 
haematopoietic lineage (using a cocktail of haematopoietic cytokines SCF, Flt3L, IL-3, IL-
6, G-CSF and BMP-4 [Chadwick et al., 2003]), cardiomyocytes (when co-cultured with 
mouse visceral endoderm gave rise to beating heart muscle colonies that expressed 
cardiomyocyte markers, α-myosin heavy chain and cardiac troponins) and hepatocytes 
(which expressed markers, albumin, α-1-anti-trypsin and cytokeratin 8 and 18) [Mummery 
et al., 2003]. Examples of in vitro hESC differentiation into mesodermal lineages include: 
chondrogenesis (confirmed by expression of proteoglycans, Col2a1, Sox9 and Col10a1) 
[Koay et al., 2007], osteogenesis (confirmed by expression of osteoblastic markers; 
alkaline phosphatase, osteocalcin and collagen type II) [Karner et al., 2007] and 
adipogenesis (confirmed by expression of Adiponectin, Leptin, Adipophilin and Perilipin) 
[Olivier et al., 2006]. hESCs were cultured in relevant chemical media for each of the 
lineages.  
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Figure 1.3 In vitro differentiation capacity of ESCs into specialised cell types of the three 
somatic germ layers; Ectoderm, Endoderm and Mesoderm.  
 
1.2.2.2 Embryonic Stem Cell Molecular Markers 
Surface antigens which are frequently employed to determine hESC ‘stemness’ include 
stage specific embryonic surface antigens (SSEA)-3, SSEA-4 and high molecular weight 
glycoproteins TRA-1-60 and TRA-1-81. However, mESCs express SSEA-1 (hESCs do 
not) and not the SSEA-3/SSEA-4 antigens and also require leukemia inhibitory factor 
(LIF; a soluble glycoprotein belonging to the interleukin-6 family of cytokines that 
activates the gp130 signalling pathway) in their media during pluripotent proliferation. 
High alkaline phosphatase activity is also demonstrated by hESCs as well as the expression 
of the transcriptional factors; Oct 3/4 (POU5-F1), Nanog and SOX-2 [Thomson et al., 
1998].  
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1.2.3 In Vitro Culture Methods 
Current techniques for culturing pluripotent hESCs in vitro can involve either direct or 
indirect feeder layer methods. However the underlying mechanisms which support their 
proliferation in an undifferentiated state remain largely unresolved.  
 
1.2.3.1 Feeder Method 
The feeder method involves the co-culture of hESCs with a layer of mitotically inactivated 
mouse embryonic fibroblasts (MEFs). Recent modifications to this include the use of 
alternative feeder layers such as; human embryonic fibroblasts, adult Fallopian tube 
epithelium [Richards et al., 2002] or human foreskin fibroblasts (with the ability to expand 
up to 42 passages) [Amit et al., 2003], human muscle or skin and postnatal mitotically 
inactivated human bone marrow stromal cells [Conley et al., 2004]. All of which claim to 
support the expansion of undifferentiated hESCs with retained morphology and expression 
of pluripotent hESC markers [Conley et al., 2004]. 
 
1.2.3.2 Feeder-Free Method   
The feeder-free method uses pre hESC-conditioned media from MEFs (where cytokines 
and other growth factors are secreted) and is further supplemented with basic fibroblastic 
growth factor (bFGF; known to enhance cloning efficiency during hESC expansion in 
vitro) [Odorico et al., 2001], in combination with a biological substrate such as Matrigel
TM 
[Thomson et al., 1998; Xu et al., 2001]. This method supported the expansion of 
undifferentiated hESCs in vitro for up to 130 population doublings [Xu et al., 2001] with 
karyotype and phenotype characteristic retention and gave rise to more tightly packed 
colonies in comparison to MEF feeder layers. 
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Matrigel
TM
 is a commercially available, loosely defined gel, sourced from Engelbreth-
Holm-Swarm tumours. Matrigel
TM
 is comprised of extracellular matrix (ECM) proteins 
including; laminen-111, collagen IV, heparin sulphate proteoglycans, entactin/nidogen, 
fibronectin, growth factors, matrix-degrading enzymes and their inhibitors; and other 
proteins yet to be defined [Meng et al., 2010; Xu et al., 2001]. Matrigel
TM
 functions to 
artificially mimic the ESC ECM niche environment and provides the required chemical 
cues during for the expansion of hESCs in a pluripotent state, whilst inhibiting 
differentiation. Recent improvements related to this method have included eliminating 
animal based serum and replacing it with Knock-out™ serum replacement; whose 
components are kept confidential but is known to contain better-defined growth 
supplements [Price et al., 1998]. Further developments to completely eliminate any 
xenogenic contaminations have included designing a medium which is totally serum and 
xeno–free; TeSR contains bFGF, TGF β1, Human Insulin, Human Holo-Transferrin, 
Human Serum Albumin and Glutathione in DMEM/F12 and retain the undifferentiated 
state of hESCs when used in combination with Matrigel™ [Ludwig et al., 2006]. Despite 
various recent modifications to enhance hESC scale-up in vitro whilst retaining their 
pluripotency, feeder layers (MEFs) and Matrigel™ still provides the best performance and 
are the conventional methods for hESC expansion [Fadeev and Melkoumian, 2011]. 
 
Other limitations associated with the current technique of culturing hESCs using 
Matrigel
TM
 include; batch to batch variability of MEFs, xenogenic contamination and 
expression of foreign oligosaccharide residues, and issues associated with scale-up [Meng 
et al., 2010]. Feeder layers also carry the risk of retroviral infections [Braam et al., 2008; 
Martin et al., 2005]. Sialic acid (Neu5Gc) has been identified on the surface of hESCs; this 
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molecule is not of human origin and therefore may potentially elicit an immune response 
during transplantation. Originally it had been speculated that the Neu5Gc molecule was 
derived from MEFs but now its origin appears to have been from serum replacement 
[Mallon et al., 2006]. 
 
The underlying mechanisms associated with Matrigel™ which support the attachment and 
undifferentiated expansion of hESCs are yet to be fully defined. Investigating these 
pathways would be important to help in understanding the associated pathways and 
proteins and perhaps mimic this phenomenon by using novel substrates that would 
eliminate the use of xenogenic materials and increase the efficiency of hESC numbers 
during routine culture. 
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1.3 Integrins 
1.3.1 Structure and Function 
Integrins are heterodimeric, transmembrane glycoproteins situated in the plasma membrane 
of a cell. There are 18 -subunits and 8 -subunits, which are able to construct 24 distinct 
heterodimer arrangements. An individual receptor is a combination of an α-subunit and a 
β-subunit (non-covalently linked) and each unique integrin heterodimer is able to recognise 
and connect to a specific ECM ligand and determines subsequent signal transduction [Gao 
et al., 2010; Humphries et al., 2006; Hynes, 2002; Wiesner et al., 2005; Wong and 
Bernstein, 2010]. For example; the 1 subunit is able to form heterodimers with at least 12 
distinct  chains and these integrins have been identified on cells derived from all three 
somatic germ layers. The β subunits can be further classified into three sub-categories 
which are β1, β2 and β3 sub-units; however it is the β1 sub-units in combination with a 
variety of interacting proteins (such as Talin and α-actinin) which primarily mediate the 
connection between the cytoplasm of a cell and its ECM. β-tails are also vital in promoting 
subcellular localisation, the activation of signalling pathways and more importantly in 
regulating the affinity of integrins towards ECM-ligands. Integrin function is further 
strengthened by the α-subunits which support integrin regulation [Liu et al., 2000; Meng et 
al., 2010]. 
 
A large section of the integrin sub-units are situated in the ECM region and are globular in 
shape, whereas the cytoplasmic domains are shorter and in the shape of a tail. The β sub-
unit tails act to transduce signals to the cell [Wiesner et al., 2005]. During the change from 
an “inactive state” to an “active state” of an integrin, conformational changes occur upon 
binding of the integrin to its corresponding ECM ligand; these conformational changes are 
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largely regulated by the intramolecular interaction between α and β cytoplasmic domains 
[Schwartz, 2001]. Basically in a low affinity state, the tail of an integrin is in a closed form 
and the ECM section is bent; upon activation the integrins have a high affinity for their 
corresponding ligand and is characterised by a dissociated tail and erect ECM region 
(Figure 1.4) [Hynes, 2002].  
 
 
Figure 1.4 Structure of an integrin, demonstrating both α and β sub-units during an 
“inactive” and “active” state. Adapted from Humphries et al., 2006.   
 
The primary biological function of integrins is to provide a mechanically sound interaction 
between the cell and its surrounding ECM by specifically binding to basement membrane 
proteins [Wiesner et al., 2005]. Other integrin functions include; facilitating cell-cell and 
cell-ECM interaction and aiding in various cell activities. These include: the initial 
settlement of cells to their niche, mediating bidirectional signalling and exchange of vital 
information between the cells’ cytoskeleton and its surrounding ECM effectively, retaining 
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the cell-niche environment (regulation of matrix secretion and degradation) and also the 
advancement in the architecture of the cell-niche [Ellis and Tanentzapf, 2010]. As a result, 
integrins are able to detect physical and chemical changes in the ECM and transmit 
external environmental signals to intracellular regions of the cell or vice versa, triggering a 
cascade of intracellular pathways impacting cell motility, behaviour, morphology, 
proliferation and differentiation. However, binding of integrins to soluble ECM ligands or 
their overexpression can also have a negative effect resulting in the inhibition of 
proliferation leading to apoptosis [Wiesner et al., 2005]. 
 
In some cases, deactivation of integrins is also important; particularly during mitosis where 
a cell needs to lose its adhesiveness to divide and also during cell migration where 
integrins within cells require deactivation in areas where they have already adhered and be 
activated in sites where adhesion needs to take place to permit cell movement within an 
ECM environment. 
 
1.3.2 Bidirectional Signalling and Signalling Pathways 
Bidirectional signalling of integrins permits “inside-out” and “outside-in” signalling within 
cells. “Inside-out” signalling are the signalling mechanisms which regulate components 
related to integrin-ECM ligand binding activities and encourage adhesion [Coppolino and 
Dedhar, 2000]. Integrin activity is affected by two main mechanisms; changes in avidity 
and changes in affinity. Changes in avidity (multiple integrin interactions resulting in 
combined strength) is associated with the re-arrangement of integrins across the plasma 
membrane. When integrins group together they form a cluster known as focal adhesion 
points resulting in an attraction of matrix adhesion proteins towards these integrin clusters 
Introduction 
Chapter 1 
 
 
18 
 
and providing a strong connection between the cell and ECM ligand sites. Several clusters 
can result in multiple interactions with ECM ligands as well as permitting rebinding 
activities [Coppolino and Dedhar, 2000]. However, ECM proteins are also dynamic and 
are constantly changing resulting in changes in integrin activity. Phosphorylation (addition 
of PO4
3- 
to a protein), GTP-GDP and phospholipid metabolism are all known to also 
enhance integrin avidity. Changes in affinity are also known to have an impact on integrin 
activity.  During its “inactive form”, integrins are expressed on the cell surface; they have a 
low binding efficiency to their corresponding ligands as they are in a low affinity state. The 
activation of an integrin to a “high affinity state” is attributed to intracellular signals and 
agonists within the cell which require energy and result in the conformational change of an 
integrin within the cytoplasmic region through to the extracellular protein binding region 
allowing the receptor to bind to its corresponding protein. 
 
“Outside-in” signalling is crucial in determining cell fate/survival; the absence of 
appropriate integrin-ECM interaction results in cell apoptosis (programmed cell death) in 
adherent cell types. Furthermore, “outside in” signalling of integrins allows the 
transduction of signals which stimulate cytoskeletal re-organisation and expression of 
specific genes [Liu et al., 2000]. Soluble factors and ECM proteins situated within the 
ECM transduce biochemical signals to the cells via integrins which influence cellular 
processes such as promotion of cell proliferation and inhibition of cell apoptosis as well as 
activation of a number of growth factor pathways such as Platelet derived growth factor 
(PDGF; [Sundberg and Rubin, 1996]), Vascular endothelial growth factor (VEGF; [Wang 
et al., 2006]) and Epidermal growth factor (EGF; [Moro et al., 1998]). Self-
phosphorylation of growth factors can also lead to a cascade of signalling events resulting 
in an alternative route to integrin activation. Intracellular biochemical signals activated as a 
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result of integrin activation are known to cause elevation of intracellular calcium, 
activation of the Nα/H anti-porter, phosphorylation of cytoplasmic proteins, accumulation 
of GTP-bound P21
ras
 and phosphoinositide 3-OH kinase. This further triggers a network of 
signalling pathways essentially through the MAPK (Mitogen-activated protein kinase) 
pathway involving the Cyclins, Cyclin-Dependent Kinases and cell cycle inhibitors which 
regulate cell cycle progression and encourage cell adhesion. Cell survival has also been 
demonstrated to be influenced by a key molecule (bcl-2) whose expression is upregulated 
through integrin α5β1 (fibronectin receptor) signalling; this protein interacts with BAX 
(promotes cell apoptosis) and the ratio between these two molecules is crucial in 
determining cell-survival [Coppolino and Dedhar, 2000; Zhang et al., 1995]. 
 
1.3.3 Integrin-related Proteins 
The exact mechanisms associated with the transduction of information from cytoplasmic 
integrin regions to intracellular molecules are yet to be fully defined. However, two other 
types of proteins identified within the membrane-region forming direct contacts with 
integrins are; integrin associated protein (IAP; CD47, a member of the immunoglobulin 
superfamily) (with a size of 46kDa) is known to be an important factor for regulating 
calcium influx in endothelial cells during αVβ3 attachment to fibronectin or vitronectin. 
The other types of proteins are CD9, CD63 and CD81 (which belong to the 
transmembrane-4 superfamily); these have also shown to have an effect on intracellular 
calcium and have been suggested to function as ion channels [Schwartz, 2001]. 
 
Important intracellular proteins essential for integrin function include interacting adaptor 
(also referred as effector) proteins. Integrins lack enzymatic activity and it is therefore 
Introduction 
Chapter 1 
 
 
20 
 
essential for integrins to associate with these proteins to activate and transmit a signal, in 
either direction [Liu et al., 2000]. Specifically, the cytoplasmic region of the integrin binds 
directly to the cytoskeletal associated adaptor proteins and completes the physical 
connection pathway which ultimately targets the actin cytoskeleton region of a cell 
[Wiesner et al., 2005]. Examples of effector proteins include: α-actinin, Filamin, Focal 
Adhesion Kinase (FAK), Paxillin, Talin, Vinculin and others whose structure and function 
are stated in Table 1.3. [Liu et al., 2000].  
 
A plaque of these adaptor proteins combine to form a focal adhesion (FA) complex where 
each individual protein has specific binding properties. The FA complex permits the 
connection between the ECM and cytoskeleton of a cell to transmit vital signals; acting as 
contacts, these allow the attachment of actin filaments (also referred to as filamentous 
actin; F-actin) to the membrane region of a cell (Figure 1.5). Actin filaments are a network 
of stress fibres which complete the physical connection between the cell and its ECM. 
Once a connection is made, actin filaments are able to control cell retraction and cell body 
stiffness; actin filaments are able to create tension which affects the assembly and 
organisation of the ECM which ultimately influences cell behaviour such as proliferation 
and differentiation [Schoenwaelder and Burridge, 1999]. Actin filaments also permit the 
protrusion of cell membranes allowing the formation of features such as lamellipodia and 
filopodia. These are generated by an extensively dense, branched network of actin 
filaments against the cell membrane which occurs by an autocatalytic process using the 
seven-polypeptide Arp 2/3 complex [Le Clainche and Carlier, 2008]. Fibrillar adhesions 
also have a similar role but are particularly formed by cells that bind to fibronectin through 
the α5β1 receptor; this mediates the organisation of ECM fibronectin fibrils in a parallel 
direction to the actin stress fibres [Danen et al., 2002]. 
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Figure 1.5 Essential intracellular proteins which mediate integrin interaction. Adapted from 
Humphries et al., 2006. 
 
1.3.4 Factors Affecting Integrin Expression 
There are several factors that can determine the activation and expression of integrins 
including the availability of ECM ligands, the ability of integrins to recognise 
corresponding ECM ligands, matrix stiffness, mechanotransduction and oxygen 
concentration [Forsyth et al., 2008; Millward-Sadler and Salter, 2004]. The overall effect 
of these parameters affects specific cell types differently. These parameters may also play 
an important role in mediating the expansion of hESCs both in vivo and in vitro; any 
incremental changes can lead to changes in integrin expression subsequently determining 
the adhesion, proliferation and pluripotency of hESCs [Forsyth and McWhir, 2008]. 
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Table 1.3 Structure and function of integrin binding adaptor proteins. 
Integrin Binding 
Proteins 
Structure and Function Reference 
α-actinin A modular protein which has the ability to bind and cross-link F-actin. Also has an additional number of 
binding partners which involve actin-binding proteins such as vinculin, zyxin and p85 subunit of 
phosphatidylinositol-3-kinase (PI3K). α-actinin is able to co-localise with integrins within focal adhesion 
complexes as well as along cytoskeletal stress fibres (actin filaments). 
[Otey et al., 
1990] 
Filamin Has a size of 280 kDa and is comprised of 24-immunoglobulin-like repeats; Filamin interacts with a number 
of signalling proteins and is able to bind to F-actin Binding sites for Actin are situated in the N-terminal 
region. Filamin localises to the cortical region of the actin cytoskeleton and any mechanical stress encourages 
the localisation of Filamin towards β1 which stimulates the recruitment of F-actin. 
[van der Flier 
and 
Sonnenberg, 
2001] 
Focal Adhesion 
Kinase (FAK) 
Also referred as pp125
FAK
 is a tyrosine kinase but functions in non-specific binding. Due to lack of enzymatic 
activity within integrins, FAKs function as enzymes which transfer a phosphate group from ATP to a tyrosine 
residue in a protein resulting in tyrosine phosphorylation of Paxillin, Talin and Tenascin which is vital for the 
transduction of signalling.  
[Liu et al., 
2000; Parsons, 
2003; Schaller 
et al., 1995] 
Interleukin Kinase 
(ILK) 
ILK is another non-receptor serine/threonine kinase which binds to crucial adaptor proteins such as Paxillin to 
connect to the β-tails of an integrin. 
 
[Schlaepfer 
and Hunter, 
1996] 
Paxillin Paxillin mediates matrix adhesion assembly, the turnover of matrix and matrix signalling and is the only 
protein known to have the ability to bind to the α4 sub-unit.  
[Schaller et al., 
1995] 
Talin Has a size of 270 kDa and plays a key role in integrin activation and initiates matrix adhesion formation by 
connecting integrin receptors to the actin cytoskeleton (F-actin) via the formation of focal complexes. The 
head region of Talin contains a binding site for FAK and PIP2.A reduction in the expression of Talin has been 
proven to disrupt the expression of integrins on the cell surface resulting in the prevention of creating focal 
adhesion complexes.  
[Goldmann, 
2000; Horwitz 
et al., 1986; 
Liu et al., 
2000] 
Vinculin An actin binding protein which promotes and stabilises the clustering of integrins.  [Franco et al., 
2004] 
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1.3.5 Embryonic Stem Cell Associated Integrins 
The difficulty in expanding large numbers of hESCs in vitro, is attributed to the lack of 
understanding of the key mechanisms which promote the adhesion and expansion of 
hESCs whilst retaining their pluripotency. As mentioned earlier, the current standard 
method for culturing hESCs in vitro is using Matrigel
TM
; this permits good initial recovery 
and attachment of hESCs and retains their undifferentiated state with a typical 
morphology. Although the exact composition of Matrigel
TM
 is unknown, the crucial 
proteins which are known to play an important role in hESC adhesion and pluripotent 
expansion have been identified as; Laminin, Fibronectin, Vitronectin, Collagen IV and 
Heparin Sulphate Proteoglycans. However, the concentration of these proteins in respect to 
each other varies and whether or not this influences hESC adhesion is yet to be 
investigated.  
 
Partial elucidation of proteins in Matrigel
TM
 has encouraged the identification of some of 
the important corresponding integrins expressed on the surface of hESCs. These integrins 
permit the successful connection resulting in their ability to adhere to ECM proteins, attach 
and proliferate in a typical pluripotent manner by forming colony-forming units (Young 
and Carpenter 2001). This results in “inside-out” integrin signalling where integrin-
mediated signalling determines the type of ECM protein secreted and control how they are 
organised in the ECM binding surface of cells to encourage pluripotent expansion [Streuli 
and Akhtar, 2009]. Therefore, understanding the hESC integrin profile will help improve 
current technology by creating novel substrates that would promote hESC adhesion via 
those integrins resulting in an increased yield of initial hESC adhesion and allowing an 
efficient expansion rate of undifferentiated cells. With sufficient numbers this would 
permit the use of hESCs for clinical trials [Fadeev and Melkoumian, 2011]. 
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1.3.6 ECM Proteins and Corresponding Integrin Interactions Mediating hESC 
Activity Using Matrigel
TM
 and Feeder Cells 
 
1.3.6.1 Laminin 
During embryonic development, Laminin is the first basement membrane (BM) component 
of the ECM to be laid down [Mostafavi-Pour et al., 2012]. BM’s function as structural 
barriers and act as substrates for cellular behaviours including; cell polarity, proliferation, 
differentiation, migration and chemotaxis [Poschl et al., 2004]. Therefore, BMs allow the 
isolation of cells whilst at the same time connect them to their interstitial matrix. Examples 
of BM’s include: perlecan, collagen IV and nidogen [Kruegel and Miosge, 2010]. 
 
Laminin is a heterotrimeric glycoprotein with three chains consisting of α, β and γ which 
can able to give rise to 16 different isoform types of laminin, which all help regulate tissue 
structure and the behaviour of cells [Kruegel and Miosge, 2010]. During embryonic 
development, the key laminin isoforms that are involved include laminin-111 and laminin-
511, which are also expressed by hESC lines; although on Matrigel™ substrate, laminin-
111 is the isoform that is present [Rodin et al., 2012]. However, in vitro investigations 
have also shown the ability of recombinant laminin-511 to promote hESC self-renewal and 
to be more effective in mediating hESC adhesion, expressing standard hESC markers, 
maintaining a reasonable proliferation rate, and retention of pluripotency (up to 20 
passages) relative to other laminin isoforms such as laminin-111 and laminin-332. 
Furthermore, the extensive use of laminin-511 has included its ability to support derivation 
of new hESC lines simply by plating ICM’s onto laminin-511 which permitted ICM 
attachment and the outgrowth of hESCs [Azarin and Palecek, 2010].   
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Recent investigations have confirmed the ability of laminin to support hESC growth 
similar to Matrigel™ during in vitro culture [Young and Carpentar, 2002]. Thus, laminin is 
considered to be an essential protein in promoting cell adhesion, migration, spreading and 
stimulating the proliferation of hESCs whilst retaining their undifferentiated state 
[Mostafavi-Pour et al., 2012]. Many interacting integrin receptors for laminin have been 
identified and include: α1β1, α2β1, α2β2, α3β1, α6β1, α6β4, α7β1, α9β1, α10β1 and αVβ1; 
these are able to give rise to heterodimers specific for adhesion to other ECM proteins 
including fibronectin, vitronectin and collagen IV [Prowse et al., 2011]. 
 
However, for laminin, α6β1 is considered to play a crucial role in hESC adhesion and is a 
highly expressed surface receptor [Humphries et al., 2006; Kruegel and Miosge, 2010; 
Young and Carpentar, 2002]. Specifically, there are two isoforms of the α6 sub-unit, α6A 
and α6B with the differences visible in the cytoplasmic domains but in undifferentiated 
hESCs the α6B isoform is expressed. 
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1.3.6.2 Fibronectin 
Fibronectin is an omnipresent, structural glycoprotein with a high molecular weight, 
consisting of peptide sub-units which comprise three types of repeats including type I, II 
and III. Fibronectin contains binding sites for various ECM proteins including: collagen, 
fibrin, fibronectin itself and heparin. Functions of fibronectin include; organising the ECM, 
therefore it plays a vital role in matrix assembly, cell adhesion, spreading, migration, 
morphology and organisation of the cytoskeleton. Within the cell, fibronectin is initially 
synthesised as a monomer but is instantly dimerised inside the endoplasmic reticulum and 
secreted into the ECM as a disulphide-bonded dimer in an inactive form; upon binding to 
its interacting integrin (α5β1) [Mostafavi-Pour et al., 2012], this extends the fibronectin 
dimer via the RGD (Arg-Gly-Asp) peptide binding sequence [Coppolino and Dedhar, 
2000] resulting in its activation and subsequent fibrillar network formation [Labat-Robert, 
2012]. Furthermore, out of the 24 integrin heterodimers, 8 of these integrins have been 
identified to be able to bind to the RGD peptide sequence [Labat-Robert, 2012].  
 
During hESC culture, fibronectin is secreted by feeder cells (MEFs) into ES conditioned 
media but is also present as a component of Matrigel
TM
; hESCs cultured on Matrigel™ in 
combination with ESC conditioned media express corresponding interacting integrins for 
fibronectin, specifically α5β1 . 
 
 
1.3.6.3 Vitronectin 
Vitronectin (molecular weight of ~ 75kDa) is a multi-functional glycoprotein and can be 
found in blood, plasma (concentration of 200µg/ml) and ECM; it has the ability to bind 
and anchor onto proteins such as glycosaminoglycans (GAGs), collagen, plasminogen as 
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well as the urokinase receptor. Major biological functions of vitronectin include: 
fibrinolysis, hemostasis, immune defence and more relevant functions with respect to cell 
behaviour. These include; cell adhesion, spreading, ECM anchoring (to collagen and 
GAGs), proliferation, proteolytic degradation of matrix and cell migration when coupled 
with interacting cell integrins and growth factors, which together have a synergistic effect 
on cell growth [Schvartz et al., 1999]. 
 
Cell adhesion, spreading and migration are primarily mediated via the RGD peptide within 
vitronectin; in vitro the RGD peptide has demonstrated its ability to bind to and interact 
with several integrins such as; αVβ3, αVβ5, αVβ1, αVβ6, and αVβ8 resulting in 
subsequent protein phosphorylation triggering the activation of the MAPK pathway 
[Braam et al., 2008; Schvartz et al., 1999]. However, recent studies have reported the 
αVβ5 vitronectin receptor to be important in mediating hESC adhesion and pluripotent 
expansion when cultured using Matrigel
TM
 or Vitronectin substrates
 
[Braam et al., 2008] 
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1.3.6.4 Collagen IV 
Collagen IV is another type of BM protein that is present in all BMs including Matrigel™ 
[Poschl et al., 2004]. It is comprised of 6 different alpha chains that are able to assemble 
into 3 different heterotrimers.  Collagen IV is unique compared to other types of collagen. 
As a basement membrane, collagen IV has an important role in mediating cell adhesion, 
migration and differentiation by acting as a scaffold which provides mechanical stability, 
structural integrity and central cohesiveness to BMs in situations where greater mechanical 
stability is required and there is an increase in mechanical forces [Poschl et al., 2004]. The 
network of collagen IV fibres functions as a foundation scaffold with the ability to form a 
complex arrangement by the incorporation of other components such as Laminin, Nidogen-
1 and 2 (mediate the formation of ternary complexes between Laminin and collagen IV in 
vitro) and Perlecan. Together, this combination of proteins produces a highly 
supramolecular architecture that form sheet-like BM complex structures [Poschl et al., 
2004]. 
 
Collagen IV contains binding sites for numerous cell types including: platelets, 
hepatocytes, keratinocytes, endothelial/pancreatic cells and hESCs [Kruegel and Miosge, 
2010]. There are many interacting integrins that can bind to collagen IV including; α1β1, 
α2β1, α3β1, α6β1, α10β1, α11β1 and αVβ5 [Kruegel and Miosge, 2010]. However, the 
collagen receptor identified in playing a major role in adhesion of hESCs to Matrigel
TM
 
specifically includes α2β1 [Mostafavi-Pour et al., 2012] and α9β1, which is a receptor not 
only for collagen IV but also laminin and VCAM-1 [Lee et al., 2010]. 
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1.3.6.5 Heparin Sulphate Proteoglycans 
Heparin sulphate protegolycans (HSPGs) are cell surface and ECM proteins; containing a 
core protein they are surrounded by covalently linked glycosaminoglycan (GAG) chains. 
Based on the core protein of HSPGs, they can be classified into 3 types; perlecan, glypican 
(disulfide-stabilised globular core protein linked to the plasma membrane) and syndecan 
(transmembrane protein which can also bind chondroitin sulphate), the latter two having a 
greater importance in cell surface HSPGs [Lin, 2004]. HSPGs are able to incorporate into a 
network of other BM proteins including Laminin and Collagen IV. Other critical functions 
of HSPGs in relation to BMs include; retaining BM integrity, BM filtration functions and 
the ability of BMs to lock storage of growth factors [Poschl et al., 2004]. HSPGs are able 
to manage GFs, but also function as GFs themselves and more importantly, they are able to 
facilitate the interaction of GFs with the extracellular matrix [Symes et al., 2010]. HSPGs 
play an important role in regulating the formation of signalling pathways such as Wnt, 
Hedgehog, TGF-β and specifically bFGF. bFGF receptor activation is known to mediate 
hESC pluripotency and is also strongly linked with integrin signalling pathways [Braam et 
al., 2008]. 
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Table 1.4 Summary of the critical integrins and interactive ECM ligands which promote 
the adhesion and undifferentiated expansion of hESCs [Meng et al., 2010; Mostafavi-Pour 
et al., 2012 Rowland et al., 2010] 
Integrin Integrin Function Corresponding ECM 
Protein (Ligand) 
Reference 
α6β1 Maintain hESC stemness Laminin Meng et al., 2010, 
Mostafavi-Pour et 
al., 2012. 
α5β1 Maintain hESC stemness Fibronectin Rowland et al., 
2010, Mostafavi-
Pour et al., 2012. 
αVβ5 Mediates hESC adhesion and 
maintenance of pluripotency 
Vitronectin Rowland et al., 
2010 
α2β1 Major role in hESC adhesion 
to Matrigel™ 
Collagen IV  Meng et al., 2010 
 
 
In summary, numerous ECM proteins are present in Matrigel
TM 
and are also secreted by 
hESCs. These proteins play a crucial role in mediating hESC attachment and proliferation 
when cultured in vitro (Figure 1.6). There are various integrin receptors located on the 
membrane of hESCs which mediate the connection to these proteins and support the bi-
directional talk between the cytoplasmic region of a cell and its extracellular matrix. The 
critical integrins that have been identified in mediating hESC attachment and proliferation 
whilst retaining pluripotency are summarised in Table 1.4. Furthermore, the impact of 
ECM protein availability, concentration and corresponding hESC surface integrin 
expression on hESC differentiation is not fully understood and yet to be fully elucidated. 
This would help to determine the exact integrin-protein interactions which induce hESC 
differentiation. However, the key interactions involved in hESC adhesion have partially 
been identified. 
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Figure 1.6 Schematic representing the connection between ECM proteins and intracellular 
components proteins through integrins. Adapted from Humphries et al., 2006.  
 
1.4 Physiological Normoxia and Intracellular Pathways for Embryonic Stem Cells 
 
Several factors can affect the expression of integrins and growth factors including; 
chemical cues, mechanotransduction, the substrate on which cells are cultured, ECM 
proteins and oxygen concentration. As a result, integrins and growth factors ultimately 
affect the intracellular pathways, which in turn influence pluripotency and differentiation 
of hESCs. The dominating signalling cascades that are involved in controlling 
differentiation of hESCs include; bone morphogenetic, Wnt, Hedgehog and Notch [Zachar 
et al., 2010].  
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One essential component of the stem cell microenvironment is the oxygen concentration 
[Csete, 2005], which also plays a central role in oxidative metabolism, cell signal 
transduction pathways as well as tissue and organ morphogenesis [De Filippis and Delia, 
2011]. Various stem cells have performed better during expansion in in vitro physiological 
normoxic (also referred as hypoxia; defined as low oxygen levels; 2% - 8% O2) culture 
conditions in comparison to hyperoxia (21% O2) and have particularly shown to retain 
their stemness and undifferentiated state [Szablowska-Gadomska et al., 2011; Zuk et al., 
2002]. Examples include; Hematopoietic stem cells (HSCs) which were shown to express a 
significantly greater number of long-term colony initiating cells (LTC-ICS), relative to 
HSCs cultured in 21% O2 [Ivanović et al., 2000]. The bone marrow is also a 
physiologically normoxic environment, hence mimicking this environment in vitro further 
supported an increase in the number and frequency of colony forming units (CFU) of 
undifferentiated hMSCs [Grayson et al., 2006], amongst other beneficial changes, 
summarised in Table 1.6.  
 
The oxygen environment has also shown to have an influence on the intracellular pathways 
of hESCs. Oxygen is known to function as a signalling, bioactive molecule in conjunction 
with other regulatory factors [Zachar et al., 2010] which can determine hESC survival, 
proliferation and differentiation, by providing a metabolic substrate for cells in a 3D spatial 
environment [Griffith and Swartz, 2006]. As mentioned earlier, hESCs are derived from 
the ICM of a blastocyst; the blastocyst is surrounded by a trophoblast shell which excludes 
oxygenated maternal blood, hence forming an hypoxic environment until vascularisation 
occurs at a later stage [Rodesch et al., 1992]. Furthermore, the oxygen environment within 
the uterine environment is between 2.5% - 5% O2, to which human embryos are exposed to 
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and experience a physiological normoxic environment [Chen et al., 2010; Szablowska-
Gadomska et al., 2011]. Therefore, hypoxia is typically considered to be the physiological 
norm for hESCs and thus creating a hypoxic environment in vitro would be beneficial to 
mimic this physiological environment [Chen et al., 2010]. 
 
Recent studies have demonstrated that the effects of physiological normoxia on in vitro 
culture of hESCs improves their ability to retain typical undifferentiated morphological 
characteristics effectively (appear significantly smaller and less granular relative to hESCs 
cultured in 21% O2 [Forsyth et al., 2006], for longer periods of time [Zachar et al., 2010]. 
hESCs at 5% O2, have shown stimulated proliferation, enhanced phenotypic 
characteristics, a greater capacity to differentiate into all 3 germ layers and many other 
encouraging changes summarised in Table 1.5). Essentially, hESCs cultured in 
physiological normoxia maintain their pluripotency [Forsyth et al., 2008] and demonstrate 
an enhanced expression of pluripotent markers including Oct-3/4, Nanog and Notch-
1(heavily involved in hESC differentiation) [Zachar et al., 2010], due to physiological 
normoxia activating signalling pathways such as FGF, TGF-β/GMP in hESCs as well as 
increased expression of P-Smad 2/3 [Chen et al., 2010]. Up regulation of Nanog, 
significantly increases hESC proliferation by binding to interacting regions of CDK6 and 
CDC25A, which are important cell cycle molecules [Forristal et al., 2010]. Transcriptional 
fingerprint analysis has demonstrated the up regulation of 302 genes and the down 
regulation of 56 genes in hESCs cultured in physiological normoxia [Forsyth et al., 2008]. 
Furthermore, oxygen levels of 20% O2 causes the down regulation of LEFTY2 in 
comparison to hESCs cultured in physiological normoxia; LEFTY2 is a key gene which 
prevents the spontaneous differentiation of hESCs along mesoderm and endoderm lineages 
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and its down regulation causes the destabilisation of a network of genes that maintain ES 
pluripotency [Westfall et al., 2008]. However, oxygen concentrations any lower than 1% 
O2 decrease the proliferation rate of hESCs but still retain their pluripotent state; this 
suggests the apparent ability of oxygen to modulate proliferation and quiescence of stem 
cells [Ezashi et al., 2005; Mohyeldin et al., 2010]. 
 
Recently, pluripotency of hESCs has been proven to be primarily regulated by a family of 
hypoxia inducible factors (HIFs) which can be expressed by decreasing the oxygen 
environment, but can also be activated by various growth factors, cytokines, vascular 
hormones and viral proteins [Szablowska-Gadomska et al., 2011]. HIFs are heterodimeric, 
environment sensing [Mohyeldin et al., 2010], transcriptional factors and are comprised of 
α and β sub-units. There are three oxygen dependant isoforms of the α-subunit which are 
HIF-1α (120 kDa), HIF-2α (EPASI) and HIF-3α; these can bind to two types of β sub-units 
which are HIF-1β and HIF-2β [Forristal et al., 2010; Szablowska-Gadomska et al., 2011]. 
The expression of HIFs influences the promotion and suppression of several genes that are 
associated with cell survival, oxygen homeostasis, cell proliferation, angiogenesis, glucose 
metabolism and cell apoptosis [Szablowska-Gadomska et al., 2011]. Specifically, this is 
mediated by the direct interaction of HIFs with other important transcriptional factors that 
have a critical function in several cellular processes including mediating Notch signalling 
by binding to its intracellular domain which contribute in maintaining pluripotency. These 
include; NF-kB, Activator protein-1 (AP-1), p53 and c-Myc. NF-kB has known to play an 
important role in inflammatory response and the immune system, AP-1 has an involvement 
in proliferation and cell apoptosis; c-Myc is known to mediate cell growth, proliferation, 
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promotion of angiogenesis and the inhibition of cell differentiation [Szablowska-
Gadomska et al., 2011]. 
 
HIF-A has been recognised as the main oxygen sensing sub-unit controlling glycolytic 
genes [Forristal et al., 2010]. In 21% O2 proteosomal degradation (through the 26S 
proteasome) of HIF-1α occurs, whereas in physiological normoxia (2% O2) HIF-1α in 
combination with HIF-2α and HIF-1β expression, activates the expression of several hESC 
pluripotent markers [Szablowska-Gadomska et al., 2011]. The stable presence of HIF-1 
supported by physiological normoxia (2% O2) contributes to maintaining the 
undifferentiated phenotype of hESCs [Zachar et al., 2010]; blockage of prolyl 
hydroxylation proteins (PHD) and factor inhibiting factor (FHIF) which further stabilises 
HIF-α and initiates activation of nuclear localisation signals (NLSs), particularly the C-
terminal section of the transactivation domain (TAD) causing the dimerization of HIF-α 
with HIF-β and the translocation of HIF-1α into the nucleus resulting in subsequent 
activation of more than 60 genes all of which are particularly involved in glycolysis, 
angiogenesis and cell cycle and survival [Szablowska-Gadomska et al., 2011]. However, in  
hyperoxia (21% O2), PHDs are activated causing subsequent proteosomal degradation of 
HIFs, which is further mediated by the Von Hippel-Lindau (VHL) protein preventing its 
translocation and activation of several genes [Forristal et al., 2010].  
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Table 1.5 Effects of physiological normoxia (2% O2) on hESCs and hMSCs cultured in 
vitro.  
hESC Activity in vitro 
Maintain pluripotency [Forsyth et al., 2008]  
Minimise spontaneous differentiation [Ezashi et al., 2005; Forristal et al., 2010; 
Forsyth et al., 2008] 
Improve establishment of mouse ESCs  [Wang et al., 2006] 
Enhance clonal recovery (reported to have a 6-fold increase in 2% O2, relative to 21 
% O2) [Forsyth et al., 2006]  
Reduce Chromosomal abnormalities [Forristal et al., 2010; Forsyth et al., 2008] 
Decreased morphological differentiation phenotype [Ma et al., 2009] 
Produce lower amounts of chorionic Gonadotropin and progesterone [Ezashi et al., 
2005] 
Enhanced EB formation as a result of down regulation in the expression of SOX-17, 
Desmin, GATA4, Brachyury and cdx2 [Chen et al., 2010]. 
Direct ESC differentiation [Bauwens et al., 2005] 
Enhanced proliferation demonstrated by significantly larger colonies [Ezashi et al., 
2005] 
Enhanced differentiation into skeletal lineages such as Osteogenesis [Zachar et al., 
2010] 
hMSC Activity in vitro 
Greater colony forming unit potential [Ren et al., 2006] 
Faster and prolonged proliferation [Ren et al., 2006] 
Maintenance of undifferentiated state [D'Ippolito et al., 2004] 
 
Essentially, HIF-1α plays a crucial role in the initial adaptation of cells to the physiological 
normoxic environment; as HIF-1α is only applicable for a short term [Zachar et al., 2010], 
its expression is lost after 48 hours and instead HIF-3α is expressed and transferred to the 
nucleus. Upon entering the nucleus, this activates the up regulation of HIF-2α; the 
expression of HIF-2α results in the up regulation of crucial transcriptional factors such as 
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Oct-3/4 (POU5-F1), Sox-2, SSEA-4 and Nanog, all of which maintain the pluripotency of 
hESCs [Ezashi et al., 2005; Szablowska-Gadomska et al., 2011]. However, there are 
concerns involved in attempting to mimic the hypoxic environment for cells in vitro. Issues 
include the speculation of reoxygenation which can occur when attempting to create a 
constant hypoxic environment. It is apparent that reoxygenation triggers the generation of 
reactive oxygen species and the up regulation of a number of genes which have subsequent 
deleterious effects, such as DNA damage [Mohyeldin et al., 2010; Zachar et al., 2010]. 
 
1.5 ECM Proteins for In Vitro hESC Expansion 
The realisation of many limitations associated with the in vitro expansion of hESCs using 
Matrigel™ has driven researchers to explore other alternatives. Partial elucidation of the 
composition of Matrigel™ has identified the presence of various ECM proteins including 
fibronectin, laminin and collagen. This has encouraged the investigation of the ability of 
various ECM proteins to support the in vitro expansion of undifferentiated hESCs. ECM 
proteins investigated have included: vitronectin, fibronectin, laminin, collagen type I and 
IV and hyaluronic acid; a summary of various studies is shown in Table 1.6. These 
proteins have been coated onto typical tissue culture plastic surfaces and cultured with 
MEF-conditioned media or more defined ESC media’s that are commercially available. 
 
Despite extensive research suggesting the possible use of ECM proteins for the in vitro 
expansion of hESCs, the scale up of hESCs using ECM proteins as their growth substrates 
is not as straightforward, as previously thought. Limitations associated with using 
recombinant proteins include; highly expensive to produce and purify, batch-to-batch 
variability, issues of coating during an aseptic environment, the possibility of degradation 
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and denaturation once dehydrated, an undefined thickness threshold to provide similar 
attachment and proliferation to Matrigel
TM
 and the inefficiency in protein coating as more 
than 50% remains in the solution. As a result of these limitations, Matrigel
TM 
still remains 
the gold standard and desirable substrate to culture and expand undifferentiated hESCs in 
vitro [Jones et al., 2010]. 
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Table 1.6 A summary of studies which have investigated the potential of purified ECM proteins as substrates for the attachment and expansion of human embryonic stem 
cells during in vitro culture. 
ECM Protein 
Substrate 
Substrate details hESC Line Observations Reference 
Collagen Type I 
 
Biomatrix (10 µg/cm
2
) H1 and H9 hESCs expanded on Collagen I substrate 
with conditioned media from human 
embryonic germ-cell-derived cells had a 
population doubling time similar to hESCs 
expanded on Matrigel
TM 
with ES 
conditioned media. hESC expressed typical 
pluripotent markers (Oct-4, Nanog and Tra-
1-60) 
[Jones et al., 2010] 
 
 
 
Substrate coating on flask HUES-1 and 
SHEF-1 
hESCs were expanded with KO-DMEM/SR 
and defined media (HESF8). Both media’s 
in combination with Type I Collagen 
substrate demonstrated stable expression of 
pluripotent markers (Oct-3/4, Nanog, 
SSEA-1 and 3) as well as maintaining their 
differentiation capacity 
[Furue et al., 2008] 
Collagen Type 
IV 
Substrate coating onto 96-well 
plate 
HUES-1, HES2, 
HESC-NL3 
Supported undifferentiated expansion of 
hESCs with MEF conditioned media, 
however in defined media (mTESR) 
proliferation was not as effective 
[Braam et al., 2008] 
Vitronectin Human purified and 
Recombinant Vitronectin 
coating onto 96-well plate 
HUES-1, HES2, 
HESC-NL3 
hESCs were expanded on Vitronectin with 
mTESR-1 media or MEF-conditioned 
media; mTESR-1 supported better hESC 
growth with retained pluripotency; although 
in both media’s, vitronectin supported the 
greatest proliferation of hESCs, in 
comparison to laminin + entactin, collagen 
IV and fibronectin 
[Braam et al., 2008] 
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Substrate coating hES1 hESCs were cultured in combination with 
StemPro media 
[Prowse et al., 2011] 
Substrate coating 
 
H9 Good proliferation and retained 
pluripotency 
[Rowland et al., 
2010] 
Laminin  Various recombinant laminins 
(511, 411, 332, 211 and 111) 
KhES-1, KhES-2 
and KhES-3 
hESCs were cultured with MEF 
conditioned media and observed a 
inconsistent cell attachment with laminin 
332 showing  better results. 
[Miyazaki et al., 
2008] 
Laminin 511 coating HS420, HS207, 
HS401 
Good attachment and proliferation with 
retention of pluripotency. 
[Rodin et al., 2012] 
Substrate coating H1 and h9 hESCs expanded with MEF conditioned 
media. hESCs maintained a normal 
karyotype, stable proliferation rate and high 
telomerase activity. Expressed Oct-4, 
hTERT, ALP and surface markers such as 
SSEA-4, Tra 1-60 and Tra 1-81 
[Xu et al., 2001] 
. 
Laminin + 
Entactin 
Substrate coating onto 96-well 
plate 
HUES-1, HES2, 
HESC-NL3 
Supported the proliferation of 
undifferentiated hESCs; however 
proliferation activity was the lowest on this 
substrate, relative to Collagen IV, 
Vitronectin, Fibronectin and Matrigel
TM
 
[Braam et al., 2008] 
Fibronectin 
 
Human plasma fibronectin 
(Fn) coating 
HUES-1 Supported hESC colony expansion with 
retained pluripotency when expanded in 
MEF-conditioned media. Proliferation rate 
was lower in comparison to hESCs grown 
on collagen IV and vitronectin.  
[Braam et al., 2008] 
 
Three types of fibronectin 
investigated: bovine Fn 
(bovine, human plasma and 
human cellular),  
I-3, I-6 and H9 hESCs cultured on all 3 types of fibronectin 
coated substrates with media (plus 15% SR 
and a combination of TGF-β1, LiF and 
bFGF were suitable for the undifferentiated 
hESC proliferation for more than 50 
passages. 
[Amit et al., 2004] 
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Hyaluronic Acid 
(HA) and dextran 
hydrogels  
3D Hydrogel, 
modified with  photoinitiator 
groups and photoinitiator 
cross-linked by UV curing for 
10 mins HA hydrogels (Ø 3 
mm and 2 mm thickness) 
H1, H9 and H13 hESCs were encapsulated into HA hydrogel 
and cultured in MEF conditioned ES media. 
hESCs retained their metabolic activity, 
supported their proliferation whilst 
retaining their pluripotency and capacity to 
differentiate for up to 20 days in culture. 
Dextran hydrogels supported EB formation 
instead. 
[Gerecht et al., 2007] 
Hyaluronic Acid 
surface 
functionalised 
with ECM 
proteins/peptides 
Layer-by-layer self-assembled 
surface of HA functionalised 
with various ECM proteins 
using a cross-linking agent 
 
MEL1 and MEL2 hESC attachment observations after 2 hours 
showed no attachment of hESCs to HA 
without any biofunctionalisation of proteins 
to its surface and that functionalization of 
recombinant Fn to HA enhanced hESC 
attachment. hESCs were cultured on these 
substrates using defined culture media. 
[Doran et al., 2010] 
E-cadherin Human E-cadherin coating  H1 and H9 hESCs maintained a typical morphology 
and retained a similar proliferation rate to 
hESCs grown on Matrigel
TM
 
[Nagaoka et al., 
2010] 
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1.6 Tissue Engineering and Regenerative Medicine Strategies 
Major limitations of Matrigel
TM 
include batch-to-batch variability, reproducibility, scale-up 
issues, xenogenic contaminations (such as Neu5Gc and lactate dehydrogenase elevating 
virus; LDEV) [Nagaoka et al., 2010] and cost cause great concern for their clinical 
therapeutic use [Li et al., 2010]. In addition to the limitations of using ECM proteins as 
alternatives, this has driven researchers to attempt to overcome these limitations and 
increase their applicability for clinical therapeutics. Currently, there are four main 
therapeutic approaches using stem cells: direct administration of adult stem cells (currently 
in clinical use), regeneration by stimulation of endogenous stem cells, implantation of 
differentiated stem cells and tissue engineering [Polak and Bishop, 2006]. Improved scale 
up of hESCs would have many beneficial implications such as the in vivo clinical 
application use with the elimination of any xenogenic contact and applications relating to 
tissue engineering and regenerative medicine applications.  
 
The ultimate goal of regenerative medicine and tissue engineering is “to replace or 
regenerate cells, tissues or organs, to restore, improve or create normal function” [Mason 
and Dunnill, 2008]. This field is highly interdisciplinary and applies the knowledge and 
principles of engineering, materials science, medicine, biology and life science towards the 
development of biological substitutes. A tissue engineering strategy involves a 
combinatory use of cells, engineering materials and biochemical factors; [Agarwal et al., 
2008; Godier et al., 2008; Liao et al., 2008]. The native stem cell ECM is an 
environmental structure to anchor and support cells and provides a template for tissue 
growth in 3D [Polak and Bishop, 2006]. It is made of several fibrous proteins such as 
collagen, fibronectin, glycoproteins, proteoglycans, growth factors, bioactive molecules 
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that maintain cell adhesion and growth [Ramakrishna et al., 2006] including chemical 
ligands which are able to interact with surface receptors on cells with mechanical stability 
[Toh et al., 2006] Biomaterial scaffolds are temporary, artificial substrates which 
fundamentally aim to provide a 3D environment (physically, chemically and biologically) 
[Slaughter et al., 2009] to mimic this native ECM. Fundamental aims of scaffolds are to 
support and encourage cell proliferation and differentiation, allow the isolation and 
expansion of cells, function as a drug delivery system, growth factor delivery systems and 
to maintain the spatial environment to encourage the regeneration of tissue [Rose and 
Oreffo, 2002]. The more similar the structure and the ability of the scaffold to mimic the 
extracellular matrix, the better the end result of tissue engineering and its function. Specific 
to hESCs, biomaterials endeavour to simulate the stem cell microenvironment and niche 
which would hope to help maintain the typical stem cell phenotype expression whilst also 
retaining their plasticity and differentiation function by providing the appropriate 
biochemical signals.  
 
Incorporating the use of biomaterial scaffolds with stem cell therapy would provide the 
ability to expand a sufficient number of undifferentiated hESCs in a shorter time period. 
hESCs would be suitable for clinical therapies and expand with a greater homogeneity of 
undifferentiated hESCs that can be directed to differentiate into various specialised 
cell/tissue lineages. More importantly, scaffolds would able to act as a portable carrier to 
permit in vivo transplantation for the use of hESCs in in vivo clinical implantations. 
[Higuchi et al., 2012] 
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The composition, topography and architecture of scaffolds allow cellular interaction and 
can influence behaviour and even modify the response of cells [Howard et al., 2008]. 
Scaffolds must have several important characteristics which enable them to function 
appropriately. Essentially, a scaffold must be “biocompatible” and hence must not elicit a 
host response and be non-toxic to the cell [Rose and Oreffo, 2002; Slaughter et al., 2009]. 
Therefore, many substrates are fabricated from materials that are already FDA approved, 
which permits their use for in vivo implantation [Rose and Oreffo, 2002]. 
“Biodegradability”, is also an important consideration; a substrates main function would be 
to act as a carrier for implantation of expanded stem cells to an in vivo injured site. Upon 
arrival, the rate of scaffold breakdown should correlate with sufficient amount of matrix 
deposition. If the degradation rate is too slow, this will impede neotissue formation, on the 
contrary, if the degradation rate is too fast this reduces the mechanical properties of the 
scaffold which are important for the initial support to cells. Furthermore, degraded by-
products via hydrolysis must be non-toxic to the cells or the host whilst in vivo 
implantation and biodegradability of substrate prevents the need for secondary surgical 
intervention [Sill and von Recum, 2008]. A scaffold must also be “bioactive”, which 
allows a better interaction with the biological environment and is able to support cellular 
functions [Sill and von Recum, 2008]. Furthermore, the ease of a scaffold to be easily 
processed into complicated shapes with appropriate porosity is also essential [Gunatillake 
and Adhikari, 2003].  
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1.6.1 Naturally-derived Polymer Scaffolds 
Polymers are a primary choice for biomaterials as they possess functional properties and 
flexibility in design. Broadly, there are two types of polymers which are natural and 
synthetic polymers; naturally-derived polymers include popular examples such as collagen, 
gelatin, chitin, chitosan and cellulose. Advantages of using natural polymers includes: 
precise mimicking of the native ECM structure, available recognition sites which provide 
multiple cell attachment opportunities and therefore giving the substrate good adhesion 
properties which support subsequent cell growth and better interaction between the 
substrate and cells due to the bioactive nature of the substrate. Natural polymer hydrogels 
are also biocompatible, allow cell dependant degradability, inherent cellular interaction and 
eliminate the limitations of 2D flat culture using tissue culture plastic surfaces [Higuchi et 
al., 2012]. However, limitations associated with the use of natural polymers as scaffolds 
includes: the dangers of eliciting an immune response, batch to batch variability with a 
limited range of mechanical properties, rapid degradation rate and weak mechanical 
properties (though these limitations can be overcome by cross-linking), lack of consistency 
and structural malleability [Polak and Bishop, 2006].  
 
Currently, there are a limited number of studies which have investigated the use of natural 
polymer scaffolds to support the expansion of hESCs. A 3D porous chitosan scaffold (Ø 13 
mm and 2mm thickness, with 95% porosity and 65% average pore size) with mechanical 
properties (compressive E of 8.1 MPa and tensile E of 0.8 MPa) has been reported to 
support the expansion of hESCs in vitro where hESCs retained their pluripotency 
(confirmed by ALP and SSEA-4 expression) and retained typical hESC morphology. 
Further investigations included in vivo transplantation into an immunodeficient mouse 
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where observations included hESCs populating the scaffold. Pluripotency was not 
maintained for longer than 30 days [Li et al., 2009].  
 
Complex investigations have included the fabrication of hydrogels. Hydrogels are 3D 
networks formed from hydrophilic homopolymers, copolymers or macromers cross-linked 
to form insoluble polymer matrices [Slaughter et al., 2009]. Properties such as 
biocompatibility, flexible method of formation, anticipated physical characteristics, the 
provision of structural integrity to tissue constructs, the essential structural and 
compositional similarities to ECM and an extensive framework which provides cellular 
proliferation and survival [Slaughter et al., 2009] makes them the ideal candidates for 
hESCs. Hydrogels fabricated from natural polymers have been demonstrated to 
successfully culture stem cells [Benoit et al., 2008; Brännvall et al., 2007] although issues 
exist in terms of controlling mechanical and degradation properties, which could be 
eliminated using synthetic hydrogels due to superior control over chemical composition 
and architecture. Hydrogels have the potential to mimic the 3D environment that hESCs 
are exposed to including: biological, chemical, physical and mechanical cues during 
embryogenesis, within the inner cell mass whilst embedded in a 3D matrix, which controls 
their self-renewal and differentiation. hESCs have been encapsulated within calcium 
alginate hydrogels and expanded in typical hESC media; it was apparent that after 260 
days of culture, hESCs retained their pluripotency (expression of Oct-4, Nanog and SSEA-
4) with the capacity to differentiate into all three germ layers. Furthermore hESCs were 
arranged in typical closely packed colonies. This study showed promising results and 
eliminated any xenogenic contamination [Siti-Ismail et al., 2008]. Hyaluronic acid (HA) 
hydrogels (Ø 3 mm and 2 mm thickness) fabricated by UV cross-linking were 
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demonstrated to support the expansion of undifferentiated hESCs for up to 20 days in 
culture, while dextran hydrogels caused EB formation and subsequent differentiation 
[Gerecht et al., 2007]. Biofunctionality of HA with ECM proteins/peptides, especially 
fibronectin improved and enhanced initial hESC attachment rates [Doran et al., 2010].  
 
1.6.2 Synthetic Polymer Scaffolds 
Synthetic polymers are man-made polymers that have great potential in tissue engineering 
due to biodegradation and mechanical property [Dhandayuthapani et al., 2011]. Several 
advantages of using synthetic polymers for scaffolds include biocompatibility, their 
chemistry being versatile, able to incorporate mimicking biological properties and the 
ability to tailor scaffolds’ mechanical properties (including porosity, spatial arrangement, 
strength and degradation rate to suit various applications) [Polak and Bishop, 2006]. 
Synthetic polymers are also cheaper, can be produced in large uniform numbers with a 
long shelf life, can be designed to show similar physicochemical and mechanical properties 
to biological tissue with reproducible mechanical properties such as tensile strength and 
elastic modulus. With regards to hESCs, synthetic polymers can contribute to the 
development of feeder-free cultures with the ability to offer reproducible culture 
conditions. Furthermore, they can minimise the cost of hESC expansion and eliminate their 
contact with xenogenic contaminants. These contributions as a result of utlilising synthetic 
polymers for stem cell culture would increase the potential clinical applications of 
differentiated hESCs [Higuchi et al., 2012].  
 
However, synthetic polymers lack biological function and require physical or chemical 
modification for cells to function appropriately. An example of simple modifications has 
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included treatment of typical polystyrene flasks including, plasma etching and plasma-
deposited gradients of octadiene to acrylic acid which have demonstrated to support the 
expansion of ESCs whilst retaining pluripotency. The same modification technique has 
been used for modification of the surface chemistry of scaffolds (via charged gas plasma 
polymerisation deposition) which allows the ability to enhance the adherence properties of 
cells to a scaffold [Howard et al., 2008]. However, although synthetic polymers such as 
(polyethylene glycol) PEG/PLGA have properties such as the ease to control and 
reproduce, the surfaces have to be modified to enhance cell adhesion as they lack 
biological signalling in comparison to natural polymers [Godier et al., 2008]. As a result, 
more complex modifications have included the biofunctionalisation of synthetic materials 
using ECM/natural proteins; for example, ECM molecules/peptides have been deposited 
onto various substrates including Hyaluronic acid and chitosan using methods such as 
layer-by-layer self-assembly and covalent bonding to enhance ESC adhesion properties. 
[Derda et al., 2007; Doran et al., 2010; Nur-E-Kamal et al., 2006]. A summary of various 
synthetic polymer substrates that have demonstrated to show the ability to expand 
undifferentiated hESCs are stated in Table 1.7. However, limitations associated with many 
of these substrates include: flat 2D surfaces such as oxygen plasma treatment to typical 
tissue culture plastic surfaces, which do not fully mimic the typical 3D ECM structure and 
environment; there is batch to batch variability with limited mechanical properties, many 
of the polymers are not FDA approved (such as PMVE-Alt-Ma and PGSA) and the 
possibility of causing genotoxicity through UV photo cross-linked curing polymers 
[Brafman et al., 2010; Irwin et al., 2011].  
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Table 1.7 A summary of synthetic substrates used to culture and expand, undifferentiated 
hESCs. 
Synthetic 
Substrates 
 
Scaffold Properties hESC Line Observations Reference 
Oxygen 
plasma etched 
tissue culture 
polystyrene 
2D synthetic culture 
surface stable at room 
temperature for atleast a 
year. 
HUES7 and 
NOTT1 
hESCs cultured with 
MEF conditioned 
media and retained 
typical hESC 
morphology for up to 
10-14 passages. 
Expressed typical 
pluripotent markers 
(Oct-4, TRA1-60 and 
SSEA-4). 
[Mahlstedt et 
al., 2010] 
Poly(ethylene 
terephthalate) 
PET 
Porous membranes. 1-4 
x 10
6
 pores/cm
2
 (0.291-
0.345 GPa). 
 
Information 
not 
available 
Pore density of 4 x 
10
6
 supported the 
greatest number of 
hESC colonies, 
increased cell 
proliferation and 
maintained uniform 
and undifferentiated 
hESCs. 
[Lee et al., 
2011] 
Poly(ethylene 
terephthalate) 
PET 
Porous membranes with 
different pore sizes (1, 3 
and 8 µm). 
CHA-
hESC3 
Feeder layers at the 
bottom of the trans-
well inserts whilst 
hESCs were seeded 
on top of the porous 
membranes. 3 µm 
pore size 
demonstrated 
optimal results with 
greatest number of 
hESC colonies 
formed, prevented 
direct interaction 
with feeder cells and 
helped retain 
undifferentiated state 
for up to 25 
passages. 
[Kim et al., 
2007] 
Amino-
propylmethacr
ylate 
hydrochloride 
(APMAAm) 
Hydrogel photointiated 
using UV light.  
H1 and H9 In combination with 
chemically defined 
media (mTESR1). 
hESCs demonstrated 
pluripotent 
expansion similar to 
hESCs expanded on 
Matrigel
TM
 for over 
[Irwin et al., 
2011] 
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20 passages.  
PLGA/PLA Porous sponges, 
fabricated via salt 
leaching with 
dimensions; 5 x 4 x 1 
mm
3
 coated with either 
Matrigel
TM
 or 
fibronectin [50 µg/ml] 
for 1 hour at room 
temperature. Pore size 
250-500µm.  
H9 hESC expanded in 
media with various 
growth factors (TGF-
β1, Activin-A, 
Insulin-like growth 
factor and retinoic 
acid) specific for 
various 
differentiation 
lineages such as 
neural tissues and  
cartilage. Showed 
good attachment and 
2-week survival of 
differentiated EBs 
[Levenberg 
et al., 2003] 
Poly (methyl 
vinyl ether-
Alt-maleic 
anhydride) 
PMVE-Alt-
MA 
Various polymers 
including PMVE-Alt-
MA were deposited onto 
acrylamide gel coated 
slides in a spot (Ø150 – 
200 µm) 
HUES1 
HUES9 
 
1 x 10
6
 cells seeded 
per array slide (10-20 
cells/polymer spot) 
and cultured. 
Supported long-term 
proliferation and 
self-renewal of 
hESCs (Oct-4 and 
Sox-2) with 
differentiation 
capacity to form all 3 
germ layers 
[Brafman et 
al., 2010] 
Poly(glycerolc
o-sebacate)-
acrylate 
PGSA 
PGSA polymerisation 
using a photoinitiator 
and UV. Macropore size 
(~85-86 µM) and 
Youngs modulus (42.3-
59.9 kPa) 
H9 and 
H13 
Encapsulated hESCs 
within PGSA 
scaffolds 
demonstrated 
organisation into 
colonies within the 
macropores after 1 
day of culture. After 
7 days, cells 
proliferated and 
formed EBs where 
cells expressed 
markers for all 3 
germ layers 
[Gerecht et 
al., 2007] 
Poly [2-
(methacryloyl
oxy) ethyl 
dimethyl-(3-
sulfopropyl) 
ammonium 
hydroxide] 
PMEDSAH 
PMEDSAH coated onto 
typical tissue culture 
plastic dishes 
BG01 and 
H9 
hESCs cultured long-
term up to passage 
15 with defined 
media including 
Stem-Pro and 
mTeSR. hESCs 
stained positive for 
pluripotent markers 
and all 3 germ layers 
[Ross et al., 
2012] 
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Many FDA approved, biodegradable synthetic polymers are used in tissue engineering and 
belong to the polyester family [Gunatillake and Adhikari, 2003]; popular examples 
include: poly-lactic acid (PLA), poly-glycolic acid (PGA), poly-lactic-co-glycolic acid 
(PLGA) and poly-ɛ-caprolactone (PCL). PLA, PGA and PLGA are poly-α-hydroxy acids 
that have bulk degradation properties and thus are able to breakdown by hydrolysis of ester 
linkages which results in non-toxic by-products that can be resorbed through the metabolic 
pathways and thus do not elicit an immune response. For example; PGA breaks down into 
glycolic acid (a natural metabolite) and PLA degrades into lactic acid which enters the 
tricarboxylic acid cycle and excreted as water and carbon dioxide [Gunatillake and 
Adhikari, 2003; Howard et al., 2008].   
 
PLA has two isoforms, “D” and “L”; PDLA has a higher degradation rate than PLLA, 
although PLLA has better biocompatibility. However, as PGA is more hydrophilic, it has a 
faster degradation rate (in vivo and in vitro) than PLA resulting in subsequent lower 
mechanical strength than PLA. A combined polymer of PGA and PLA results in poly-
lactide-co-glycolic acid (PLGA) and has a degradation rate which can be manipulated 
depending on the ratio between PLA and PGA. On the other hand, PCL has a much slower 
degradation rate than both PGA and PLA as a result of being more hydrophobic. 
Degradation rates of commonly used synthetic biodegradable polymers are stated in Table 
1.8  
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Table 1.8 Molecular structure and properties of commonly used synthetic biodegradable 
polymers in tissue engineering [Gunatillake and Adhikari, 2003]. 
 
Limitations concerning the use of biodegradable synthetic polymers are that they have 
weak mechanical properties, batch to batch variability, lack biomimetic function and thus 
do not have recognisable attachment sites for cells. The natural ECM environment is 
hydrophilic in nature with a 3D network of nanofibres at the micro- and nano-scale 
[Slaughter et al., 2009] and therefore it is important for the polymer substrates to support 
cell attachment, proliferation and differentiation and enhance their biocompatibility for 
these cell activities. As mentioned previously, many studies have attempted to enhance the 
Biodegradable 
polymer 
Properties Degradation 
rate 
(months) 
Molecular structure 
Poly Glycolic 
acid (PGA) 
 Rigid thermoplastic material 
 High crystallinity (46-50 %) 
 Glass Transition temperature = 36 ᵒC 
 Melting temperature = 225 ᵒC 
 Approximate strength 7.0 GPa 
 Degradation products into glycolic 
acid 
 Tensile modulus: 6-7 GPa 
 Tensile strength: 60-100 MPa 
6-12 
 
Poly-L-Lactic 
Acid (PLA) 
 Semi-crystalline solid 
 Melting temperature 173 – 178 ᵒC 
 Glass transition temperature 60-65 
ᵒC 
 Approximate strength 2.7 GPa 
 Degradation products into lactic acid 
 Tensile modulus: 3-4 GPa 
 Tensile strength: 50-70 MPa 
>24 
 
Poly-ɛ-
caprolactone 
(PCL) 
 Semi-crystalline 
 Glass transition temperature = - 60 
ᵒC 
 Low melting temperature 59 – 64 ᵒC 
 Approximate strength 0.4 GPa. 
 Degradation product in caproic acid 
 Tensile modulus: 200-400 MPa 
 Tensile strength: 20-42 MPa 
>24 
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adhesive properties of substrates, either by surface treatment, e.g. altering the surface 
energy properties via presenting charged particles or by functionalising natural ECM 
proteins to synthetic substrates which provide recognisable attachment sites for cells. 
 
1.6.3 Protein Adsorption 
It is important to select the appropriate polymer to function as a tissue engineering scaffold 
or substrate which makes it highly biocompatible and thus support activities such as cell 
attachment. Cell attachment and interaction to a biomaterial and its biocompatibility is a 
subsequent result of protein adsorption (process where molecules adhere to a solid surface) 
[Kasemo, 2002] to the surface of a biomaterial which is a fundamental process taking place 
during the initial stages of implantation in vivo [Kasemo, 1998]. The surface of an 
implant/scaffold is a dynamic area where protein adsorption activity is continuously 
changing. Initially, highly abundant serum proteins with low molecular weight adhere to 
the surface and are gradually replaced by less abundant, high molecular weight, cell 
adhesive proteins such as fibronectin with time; this is known as the Vroman effect 
[Vroman, 1962] (shown in Figure 1.7). The ability of proteins to adsorb to substrate 
surfaces from media is highly dependent on its wettability (which can be evaluated by 
contact angle. Contact angle is defined as the angle of liquid to a solid in the presence of 
gas; [Roach, 2005]), which is ultimately dependant on numerous factors including: surface 
chemistry, [Roach et al., 2005; Roach et al., 2006] shape, charge, topography [Roach et 
al., 2006], surface roughness and surface energy; changes in these factors can enhance 
protein adsorption which subsequently influence cell behaviour such as adhesion and 
proliferation [Roach et al., 2005]. These physical and chemical modifications of the 
surface can have an influence in the quantity, density, conformation and orientation of the 
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adsorbed proteins [Taborelli et al., 1995]. Adsorption of proteins to substrates occurs 
through various interactions including; van der Waals, hydrophobic and electrostatic 
interactions, and hydrogen bonding [Roach et al., 2005]. If the surface is hydrophobic 
(non-wettable and opposes contact with water due to cohesive forces causing the liquid to 
ball up), it produces a less water dense region with an open hydrogen-bonded network and 
has a pure water adhesion tension (τᵒ) of <30 dyn/cm [Vogler, 1998]. Adsorption of 
proteins is even more energetically favourable on hydrophobic surfaces compared to 
hydrophilic (wettable surface; a dense water region that has a pure water adhesion tension 
(τᵒ) of >30 dyn/cm; [Vogler, 1998] surfaces) and also bind more stubbornly [Roach et al., 
2005]. 
 
Contact angle is a method through which wettability of a material substrate can be 
characterised. A high water contact angle (≥90ᵒ) means that water is unable to spread over 
a surface and therefore is defined as hydrophobic. Whereas on hydrophilic surfaces, water 
is able to spread over its surface resulting in a high solid water interface and a contact 
angle of ≤90ᵒ [Roach, 2005]. Furthermore, it has been demonstrated that measuring the 
water contact angle from a direction perpendicular to the anisotropic topography of 
grooves is a more accurate indicator of water contact angle as supposed to taking a 
measurement from a parallel direction [McHale et al., 2004; Yang et al., 2009]. Generally 
cells prefer a substrate which is neither too hydrophobic nor too hydrophilic and thus have 
moderate wettability [Horbett et al., 1985; van Wachem et al., 1987]. Furthermore 
different cells prefer a different surface type in terms of wettability. For example, 
endothelial cells prefer a surface with a contact angle of 70ᵒ [Zhu et al., 2002] whereas 
chondrocytes prefer a surface with a contact angle of 76ᵒ. It was apparent that reducing the 
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water contact angle to 65ᵒ (increasing the hydrophilicity) resulted in decreased attachment 
and proliferation of chondrocytes [Ma, 2003]. In agreement, it has also been stated that 
hydrophobic materials with a τᵒ < 30 dyn/cm permit good cell attachment. The relationship 
between contact angle and water adhesion tension τᵒ is summarised in Table 1.9. 
 
 
Figure 1.7 A schematic describing the Vroman effect. Adapted from Roach et al., 2006. 
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Table 1.9 Relationship between wettability dictating parameters; contact angle and 
adhesion tension [Ma et al., 2007]. 
Wettability Contact Angle (θ) Water Adhesion Tension (τᵒ) 
Hydrophobic High contact angle (≥90ᵒ) Low adhesion tension (<30 
dyn/cm) 
Hydrophilic Low contact angle (≤90ᵒ) High adhesion tension (>30 
dyn/cm) 
 
Proteins are amphipathic in nature as they have hydrophobic residues in the interior and 
hydrophilic polar and charged amino acids in the exterior. Each protein has a unique 
primary structure (made up of an amino acid sequence) and can directly affect the 
interaction of the protein with the surface. There are 20 amino acids and each amino acid 
differs in its chemical nature in terms of its side chain which give rise to various 
physicochemical properties, which also play a role in the overall properties of the protein 
itself. Charged amino acids are hydrophilic and are usually located on the outside of 
proteins and hence are available for direct interaction with surfaces [Dee et al., 2003; 
Patthy, 1999]. Charge and the distribution of charge on these proteins can also affect the 
ability of protein adsorption. In addition, size of the protein can also play a major role, 
where larger molecules have a greater number of contact sites with the surface; molecules 
close to their isoelectric point (the pH at which the molecule exhibits zero charge) also 
adsorb more willingly as at this point there is reduced electrostatic repulsion between 
uncharged adsorbing molecules. This also permits a greater number of proteins to bind 
[Dee et al., 2003]. Conformational changes of proteins also lead to alterations in the 
protein structure resulting in a change in the charge of amino acids; unfolding of proteins 
reveals more sites available for surface attachment/contact and so substrates which induce 
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and enhance the rate of unfolding can result in greater surface adhesion of proteins [Roach 
et al., 2006]. Furthermore, proteins that are able to unfold better and expose more sites for 
attachment to surfaces are those which have an unstable structural stability due to less 
intramolecular cross-linking which allows greater and more ease of unfolding. As a 
consequence of protein unfolding this can change the type of amino acids exposed on the 
protein surface such as unveiling hydrophobic amino acids to the protein surface for 
interaction with a surface [Dee et al., 2003].  
 
As well as protein properties, the properties of the biomaterial surfaces are also just as 
important. Surface properties can be generalised broadly into three categories; electrical, 
chemical and geometric. Surface potential of the biomaterial can determine counter-ions 
from the electrolyte solution attracted to the surface; this also results in isotropically 
dispersed water molecules to become ordered [Dee et al., 2003]. The overall result is 
combinatory of water ions, molecules and net surface charge which regulate interaction 
with proteins. For example, it has been demonstrated that polarised hydroxyapatite 
scaffolds enhanced MC3T3 cell proliferation in comparison to non-polarised scaffolds 
[Kumar et al., 2010]. Chemical composition of the surface depicts the available functional 
species for interaction with proteins. For example, metallic biomaterials whose surfaces are 
oxidised expose metal and oxygen ions, as do ceramics and glass; polymer materials have 
functional groups present such as amino, carbonyl, carboxyl and aromatic groups. The 
presence of particular functional groups can determine the affinity of specific proteins or 
even a specific region of a protein to a biomaterial surface. Topographical features such as 
nanofibres expose a greater surface area for the adsorption of proteins [Roach et al., 2006; 
Scopelliti et al., 2010]; this can result in an increase of a local protein concentration at the 
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biomaterial surface up to 1,000 times greater than in the bulk solution. Furthermore it has 
been demonstrated that introducing topography through increasing surface curvature on 
smaller substrates at the nano-scale, increased affinity of BSA and fibrinogen and lowered 
their saturation constants. Additionally, wettability also had an effect on protein adsorption 
ability; on flat surfaces BSA adsorbed in greater quantities on hydrophilic surfaces in 
comparison to hydrophobic surfaces [Roach et al., 2006]. 
 
1.6.4 Nanotechnology 
Nanotechnology is a field that has become popular and gained keen interest by many 
researchers from many fields. It was first introduced by Richard Feynman in 1959 who 
defined nanotechnology as “the understanding and control of matter at dimensions of 1-
100nm (in at least one of their dimensions) where unique phenomena allow novel 
applications”.  The development of materials, devices and constructs within this size range 
is also regarded as nanotechnology [Khademhosseini et al., 2007]. Fabrication approaches 
of nano-scale materials and devices are possible via two routes which are commonly 
known as top-down and bottom-down approaches. Nanostructures fabricated from a build-
up of atoms or molecules in a controlled manner generally are considered as the bottom-up 
approach, whereas top-down approaches utilise micro-technologies to fabricate these 
nanostructures [Khademhosseini et al., 2007]. Nanotechnology has an important role in 
numerous applications including: energy storage, healthcare, biotechnology, environmental 
engineering, and defense and security [Ramakrishna et al., 2006].  
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1.6.4.1 Applications of Nanotechnology in Tissue Engineering and Human Embryonic 
Stem cells 
Nanotechnology in tissue engineering aims to create structures at the atomic and molecular 
levels with a size range of 10-500 nm [Prabhakaran et al., 2012]. The natural 3D stem cell 
niche and ECM at the nano-scale level is very dynamic and has a complex mixture of 
pores, pits and a network of intricate nanofibres composed from various structural proteins 
including collagen fibrils which all provide fundamental cues at the cellular level that 
support and regulate various cell functions and activity as a consequence of topographical 
features [Prabhakaran et al., 2012]. 
 
Cells are highly sensitive to the local nanoscale ECM patterns and topography and can 
probe these features using their filopodia which can strongly encourage the retention of 
cell shape or induce changes resulting in subsequent differentiation via cytoskeletal 
arrangement modification [Howard et al., 2008; Prabhakaran et al., 2012; Stevens and 
George, 2005]. Typically, cells are tens of micrometers in diameter but have components 
such as cytoskeletal elements and transmembrane proteins that are nano-sized. 
Furthermore, it has been stated that stem cells have the ability to react with features as 
small as 5 nm and thus are highly sensitive to nanotopography [Biggs et al., 2010]. 
Anisotropic topography is also considered important at the nanoscale level in ECM where 
cells in tissues such as nerve, cardiac and tendon require to be highly organised which 
directs secreted ECM and tissues structure organisation from nanoscale through to 
macroscale levels [Lim and Mao, 2009]. With relevance to tissue engineering applications, 
this architecture provides an important model for the design of artificial synthetic scaffolds 
which can support, instruct and guide the behaviour of cells [Liao et al., 2008; Stevens and 
George, 2005]. 
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Nanotechnology enables to provide artificial templates which are able to mimic the 
architecture and topographical structure of the native ECM as closely and accurately as 
possible. This enables the expectation of a cell response and behaviour to be similar to as it 
would react or perform in vivo, in its natural environment. Scaffolds fabricated with a 
nanotexture such as nanofibres, whose topography can also be controlled are able to mimic 
this natural ECM architecture and provide a high surface area to volume ratio with a 
microporous structure [Vasita and Katti, 2006]. This has known to enhance cell adhesion 
and biomimetic properties, in turn attract stem cells, support stem cell activities such as 
proliferation, differentiation and also provide appropriate functioning of tissues (Figure 
1.8) [Liao et al., 2008; Prabhakaran et al., 2012]. Various techniques are available to 
fabricate nanofibres including template synthesis, drawing, self-assembly, phase separation 
and electrospinning; the pros and cons of these methods are summarised in Table 1.10.  
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Figure 1.8 Nano-scale topography and architecture influence on cell attachment abilities. 
Adapted from Stevens and George., 2005. 
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Table 1.10 Available techniques for fabricating nanofibrous substrates [Ramakrishna et al., 
2005]. 
Nanofibre 
Fabrication 
Technology 
Description of Technique Reference 
Self-Assembly  Method: Autonomous organisation of individual constituents in 
an organised structure or pattern without human intervention. 
This occurs through non-covalent forces such as hydrogen 
bonding, electrostatic forces, or hydrophobic forces. 
Advantages: Extremely fine nanofibres. 
Disadvantages: Limited amphiphilic materials, random/very 
short nanofibres and questionable ability for large-scale 
production of consistent fibre dimensions. 
[Liao et al., 
2008; 
Prabhakaran et 
al., 2012] 
Phase 
Separation 
Method: Two different phases of materials are combined and 
mixed together; after solidification process of this mixture the 
removal of one phase (solvent) leaves the remaining phase 
material with pores. 
Advantages: Simple set-up polymer adjustable properties which 
allows a production of microporous substrates only.  
Disadvantages: Time consuming, only applicable to a limited 
number of polymers that produces inconsistent fibre dimensions.   
Usually used for the production of microfibrous substrates. 
[Ma and 
Zhang, 1999] 
Template 
Synthesis 
Method: Template with certain dimensions used through which 
a material is extruded into another non-interacting material.  
Advantages: Able to produce fibres with variable length and 
size from a variety of polymers 
Disadvantages: A complicated process that has the inability to 
produce fibres that are continuous and feasible for small scale 
production 
[Feng et al., 
2002] 
Drawing Method: Micropipette used to extrude out a fibre from a 
polymer droplet 
Advantages: A simple set-up which allows the production of 
fine fibres possible 
Disadvantages: Can only use viscoelastic materials, which are 
able to resist shear stresses applied on the material. Inconsistent 
production of fibres 
[Nain et al., 
2006] 
Electrospinning Method: Use of an electrode which polarises a polymer solution 
drawn through a needle and deposited onto an oppositely 
polarised or ground electrode collector. 
Advantages: Simple system, versatile, affordable and cost-
effective. Long fibres can be fabricated from various materials 
including natural, synthetic and composite polymers from nano 
to micro-scale. Precise control of fibre diameter and allows 
large-scale production of tissue engineering scaffolds on an 
industrial level. 
Disadvantages: fibre production rate, although considered to be 
faster than other production methods mentioned above. Difficult 
to control steadiness of the jet causing subsequent changes in 
fibre morphology 
[Prabhakaran 
et al., 2012] 
 
[Ramakrishn
a et al., 2005] 
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1.7 Electrospinning  
Nanofibres have great implications for tissue engineering, in both research and industrial 
settings. Specifically, electrospinning has attracted great attention by the regenerative 
medicine field, in both academia and industry due to its unique ability to generate 
nanofibres from a variety of materials (including synthetic biodegradable and natural 
polymers). Electrospinning has the ability to form various fibrous structures that are able to 
provide an excellent supportive, framework for stem cell adhesion, proliferation and 
differentiation [Prabhakaran et al., 2012; Ramakrishna et al., 2006]. Other benefits of 
electrospinning include: high production rate of nanofibrous substrates, can be fabricated 
to fill any anatomical defect shape, a simple set-up and versatile procedure, architecture 
provides appropriate mechanical properties to support various cell activities, formation of 
highly porous mesh’, production of fibres from micro to nano-scales and their large surface 
area to volume ratio (100 m
2
/g). High surface area to volume ratio provides the ability to 
enhance protein adsorption activity onto the surface of these nanofibrous substrates 
causing subsequent enhancement in cell adhesion properties thus providing an availability 
of recognition sites for cells to attach, spread and expand. 
 
1.7.1 Electrospinning Method 
The electrospinning process utilises a polymer solution which is charged up using high 
voltage electrodes which allows the polymer to be drawn from a needle (nozzle) and is 
accelerated towards an oppositely charged or grounded collecting substrate [Toh et al., 
2006]. During flight from the needle to the collector, the intensity of the electric field pulls 
the polymer solution by forming a Taylor cone from the needle. Once the electric field 
over powers the surface tension of the polymer, this results in the formation of an instable 
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jet which during flight undergoes whipping and solvent evaporation causing the deposition 
of finer fibres on the collecting substrate [Toh et al., 2006]. A schematic of a basic 
electrospinning set-up is shown in Figure 1.9. 
 
Figure 1.9 A schematic of a basic electrospinning set-up. Adapted from Ramakrishna et 
al., 2006. 
 
 
 
1.7.2 Electrospinning Parameters 
Properties of electrospun nanofibres such as fibre diameter and morphology can be 
controlled by manipulating a range of electrospinning parameters, broadly categorised as 
solution, operating and environmental parameters.   
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1.7.2.1 Polymer solution Parameters 
These parameters are perhaps the most important and have a significant effect and 
influence on the overall electrospinning system. Polymer solution parameters can have a 
direct influence on the morphology of the nanofibres. 
 
1.7.2.1.1 Viscosity, Concentration, Surface Tension and Solution Conductivity 
Higher the number of monomers (single unit) within a polymer results in a higher 
molecular weight (Mw) and length of the polymer. Increasing the Mw and length causes a 
subsequent increase in viscosity due to an increase in the number of entanglements 
between the polymer chains. It is a necessity for the polymer solution to be of adequate Mw 
and sufficient viscosity, otherwise upon exposure to an intense electric field, if there are 
not enough entanglements between the molecule chains to resist the electrostatic repulsion 
force, this results in the extrusion jet to break up and not maintain a continuous jet 
resulting in the formation of shorter length fibres with inconsistency in fibre diameter and 
beaded morphology. Extreme consequences would result in electrospraying with little or 
no deposition of fibres on the collector [Sill and von Recum, 2008]. 
 
Alternatively, the polymer concentration can also increase the viscosity; this enables 
greater entanglements between the polymer chains within the solution which during 
electrospinning prevents the jet breaking up and remains continuously intact. The 
concentration of a polymer at lower Mw can determine the spinnability of the solution as 
well as the viscosity and surface tension [Sill and von Recum, 2008]. For example, 
Introduction 
Chapter 1 
 
 
66 
 
changing the polymer concentration of PCL (Mw = 80,000) from 13% to 10% resulted in 
change in fibre morphology from uniform fibres to beaded fibres [Lee et al., 2003]. 
 
On the contrary, if the viscosity of the polymer is too high, this increases the number of 
polymer chain entanglements to such an extent that it becomes difficult to produce a high 
enough electric field intensity that overcomes the surface tension causing prevention of the 
polymer solution to be drawn out of the needle tip. However, suitable viscosity is 
desirable, as when charge is applied to the solution this results in more polymer chain 
entanglements and thus is able to extrude better as well as allowing distribution of solvent 
molecules amongst the polymer chains thus presenting a lower surface tension 
[Ramakrishna et al., 2005]. Furthermore, it has been demonstrated that increasing the 
viscosity or concentration subsequently increases the fibre diameter as a result of increased 
number of entanglements giving a greater resistance to the polymer solution to be stretched 
by the electrostatic force. As viscosity can be increased as a result of an increase in 
concentration, this can decrease the amount of bending instability thus reducing the 
polymer path to the collector [Greiner and Wendorff, 2007]. 
 
Electrospinning is initiated if the charged jet of polymer solution is greater than its surface 
attractive force to the surface of the capillary; this is referred to as surface tension. 
Depending on polymer solution properties, surface tension can sometimes cause the jet to 
form beads in within the nanofibres. This is a result of surface tension which aims to 
decrease the surface area per unit mass of a fluid. Bead-like fibres form in situations where 
the polymer solution is of a low viscosity, or where there a high number of solvent 
molecules that are free to move and have not been distributed well over the entangled 
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polymer molecules. These solvent molecules instead prefer to congregate together and 
adapt a spherical shape due to surface tension [Ramakrishna et al., 2005]. On the hand, 
where the viscosity of the polymer solution is higher, there is better distribution of the 
solvent molecules amongst the polymer molecule chains and thus during extrusion force, 
this reduces the chances of the solvent molecules accumulating together thus preventing 
the increase in surface tension. Surface tension can also be decreased by using a solvent 
with appropriate properties. 
 
Polymer solution is able to be drawn out during electrospinning as a result of charges at the 
surface repelling each other. Therefore, increasing the charge number carried by the jet 
causes a subsequent increase in its conductivity. The incorporation of additional ions to the 
polymer solution through salts or a polyelectrolyte provide increased solution conductivity 
which permits a better extrusion force, resulting in much smoother, thinner fibres and 
prevention beaded morphology which occur due to insufficient stretching of the polymer 
solution [Keun Kwon et al., 2005; Zuo et al., 2005]. Furthermore, this also decreases the 
critical voltage at which the jet needs to be initiated and electrospun. However, increasing 
solution conductivity can result in bending instability of the jet giving rise to a larger fibre 
deposition area on the collector. Bending stability increases the pathway of the jet resulting 
in fibres with a smaller diameter [Zuo et al., 2005]. Various solvents are used to increase 
conductivity [Fong et al., 1999] including: dimethylformamide (1.090 mS/m), methanol 
(0.1207 mS/m) and ethanol (0.0554 mS/m).  
 
Solvent properties can also have an impact on the production of nanofibres via 
electrospinning. An important property is the dielectric constant which is the ratio of the 
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permittivity of a substance to the permittivity of free space. An increase in dielectric 
constant can increase the electric flux density in the substance and can prevent the 
formation of beads. Addtionally, it can also encourage the reduction in fibre diameter. 
However, at the same time increasing dielectric property increases bending instability, the 
jet pathway and thus resulting in a greater deposition area of the fibres on the collector 
[Zuo et al., 2005]. For example, dimethylformamide has a high dielectric constant (36.71) 
in comparison to acetic acid (6.15) and chloroform (4.80) [Ramakrishna et al., 2005].  
 
1.7.2.2 Processing Parameters 
Electrospinning has many processing parameters which are important to control and can 
influence the characteristics of the fibres produced. 
 
1.7.2.2.1 Voltage 
The polymer solution jet is initiated by the voltage supply which stimulates the charges 
present in the solution; by the use of an external electric field this results in the electrostatic 
repulsion force to become greater than the solutions surface tension. Whether positive or 
negative, an applied high voltage causes the drop of polymer solution located at the needle 
tip to stretch and distort into a shape referred to as the Taylor cone, once the 
electrospinning jet has been established. A sufficient and adequate voltage supply will 
provide a stable Taylor cone and the electrostatic repulsion forces in the jet then become 
greater than the viscoelastic force and surface tension resulting in the ejection of the 
polymer solution from the Taylor cone [Taylor, 1964]. Increasing the voltage increases the 
amount of charge, which subsequently provides a faster ejection of the polymer solution 
from the needle tip. However, increasing the voltage can also unstable and reduce the 
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Taylor cone. Increased voltage and the resultant electric field both have an effect on the 
stretching and speed of the jet which in turn has an influence on fibre morphology, as a 
result of voltage increasing the energy carried by the charge which provides a greater 
columbic repulsive forces in the jet and a more intense electric field due to a greater 
potential difference [Beachley and Wen, 2009].  
 
At higher voltages, the polymer jet undergoes greater stretching, subsequently resulting in 
a reduction in fibre diameter and accelerated solvent evaporation giving rise to drier fibres. 
This is particularly the case with low viscosity polymers where secondary jets are visible 
resulting in thinner fibres. Alternatively, thinner fibres can be generated by reducing the 
voltage which causes deceleration of the jet and thus increasing the jet path flight time; an 
increase in jet path time allows the polymer jet to stretch and elongate for a longer time 
and thus giving rise to fibres with a reduced fibre diameter [Beachley and Wen, 2009]. 
However, high voltages on high viscosity polymers increases the bending instability due to 
the movement of the Taylor cone into the needle resulting in greater bead density within 
fibres which can at extremely high voltages even merge together and produce thicker 
beads; as voltage can directly have an effect on the shape of the Taylor cone this can 
therefore dictate the morphology of the electrospun fibres. Other effects of increasing 
voltage also include the electrostatic field encouraging a more ordered alignment of the 
polymer molecules causing changes in crystallinity properties of the formulated polymer 
fibres on the collector. Electric field induced through applied voltage effects are sinusoidal 
and hence there is an optimum range for a specific polymer solvent system, which above or 
below this optimum range can result in beaded fibres [Sill and von Recum, 2008]. 
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1.7.2.2.2 Flow Rate 
Flow rate is defined as the volume of polymer solution which passes through the needle 
per unit time. It is imperative to identify and match the correct voltage and flow rate to 
maintain a stable Taylor cone throughout the process. However, should the flow rate be 
increased with a constant voltage this can result in thicker fibres or greater bead size due to 
a greater volume of polymer solution being extruded from the needle tip at one time 
[Ramakrishna et al., 2005]. It is generally preferred to keep the flow rate slow to allow 
sufficient evaporation of the solvents and increases the jet pathway time to obtain drier 
fibres [Greiner and Wendorff, 2007; Sill and von Recum, 2008]. 
 
1.7.2.2.3 Working Distance 
Working distance is defined as the jet pathway distance from the needle tip to the collector; 
this also has a direct effect on the jet pathway time as well as the strength of the electric 
field. Increasing the working distance subsequently increases the jet pathway time as well 
as decreasing the electric field strength. On the contrary, decreasing the working distance 
reduces the jet pathway but also increases the electric field intensity which accelerates the 
jet (allowing less time for solvent evaporation). Therefore, it is apparent that either 
decreasing the working distance or increasing the voltage both has the same effect which is 
to increase the strength of the electric field [Ramakrishna et al., 2005]. Working distance 
can influence the diameter of the fibres; fibre diameter can be decreased by increasing the 
polymer jet pathway which increases the time for it to be stretched and elongated before 
deposition onto the collector [Beachley and Wen, 2009]. 
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1.7.2.2.4 Effect of Collector 
Electrospun fibres are deposited onto a collector which is either oppositely charged to the 
ejection site at the needle tip or is grounded. The collector is electrically conductive and is 
usually covered with aluminium foil to maintain a potential difference. Furthermore, 
conductive collectors allow charge dissipation thus yielding a greater number of fibres 
closer together rather a non-conducting collector where charge accumulates causing 
repulsion of fibres resulting in a lower yield of fibres [Ramakrishna et al., 2005]. The type 
of collector can determine the type of fibres attained; a simple change such as a static 
collector versus a moving collector can have dramatic effects. Generally, a static collector 
allows the production of random nanofibres whereas moving collectors allow the 
production of aligned nanofibres that are also drier as rotation increases evaporation time. 
There are various methods by which aligned nanofibres can be attained including: rotating 
mandrel, knife-edge disk, auxillary electrode and parallel conducting collector; these 
techniques are summarised in Table 1.11 
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Table 1.11 A summary of various modified methods of electrospinning to attain aligned 
nanofibrous substrates. 
Method Schematic Description Reference 
Rotating mandrel 
 
A simple set-up where a 
mandrel is attached to a 
motor which allows rotation 
at high speed (1000 rpm) 
resulting in the accumulation 
of fibres around the 
circumference. A large area 
of aligned fibres can be 
fabricated and the degree of 
alignment can varied 
depending on rotation speed 
[Ashammakhi et 
al., 2009; Boland 
et al., 2004; 
Matthews et al., 
2002] 
Disc collector  A simple set-up where a 
rotating disc with a small 
deposition area is used. 
Allows the fabrication of 
highly aligned fibres. 
However, difficult to 
maintain high alignment of 
fibres as deposition becomes 
thicker. Only a small area of 
deposition. 
[Zussman et al., 
2003] 
Rotating tube 
collector with 
knife-edge 
electrodes 
 
Knife-edged blades attached 
to a negative high electrode 
and a rotating mandrel 
directly in front is used to 
attain highly aligned 
nanofibres which cover the 
whole mandrel. This allows a 
thicker layer of aligned fibres 
and the rotating tube has to 
be of small diameter. 
[Teo and 
Ramakrishna, 
2006] 
Parallel 
conducting 
collector  
 
A static simple set-up where 
two parallel conducting 
electrodes are placed with a 
gap between them. This 
allows easy fabrication of 
highly aligned fibres which 
can also be transferrable to 
another substrate. However, 
limitations of this method 
include a limit in the length 
of the aligned fibres 
 
 
[Ashammakhi et 
al., 2009; Teo and 
Ramakrishna, 
2005] 
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1.7.2.3 Environmental Parameters 
Polymer solution and processing parameters have the greatest impact and effect on fibre 
morphology and diameter; however, environmental parameters can also have an influence. 
Environmental parameters include: humidity, temperature, type of atmosphere and 
pressure; these have been summarised in Table 1.12. 
 
Table 1.12 A summary of environmental parameters that have an impact on the 
electrospinning process. Adapted from [Ramakrishna et al., 2005] 
Environmental 
Parameter 
Effects on Electrospinning Process 
Humidity Determines amount of water that condenses onto the polymer fibre surfaces 
which can disrupt the rate of solvent evaporation. High humidity results in 
slower evaporation of the solvent whereas low humidity would speed up 
evaporation thus providing drier fibres. 
Temperature Two major effects can occur as a result of increased temperature; 
evaporation rate of solvent is increased thus producing drier and more 
uniform fibres, and also reduces the viscosity of the polymer solution which 
is able to provide a greater extrusion force as the polymer molecules are 
more mobile thus allowing the jet to stretch greater resulting in thinner 
fibres. 
Type of atmosphere Air is made of various gases including oxygen and nitrogen which can also 
influence the electrospinning process. The electric field has an effect on the 
gases themselves; an example is Helium which can breakdown under high 
electrostatic fields allowing the process to proceed.  
Pressure The correct pressure is also important during electrospinning; if the 
surrounding pressure of the jet is lower than the atmosphere pressure this 
will cause the solution to be unstable and just seep out without proper jet 
initiation.  
 
 
 
1.7.3 Applications of Electrospun Nanofibre Scaffolds with Stem cells 
Many studies have investigated the ability to expand and culture various stem cells on 
synthetic polymer electrospun nanofibrous substrates. Aligned electrospun nanofibres 
fabricated from polymers such as PLLA, PLAGA, PCL and PCL/collagen blends have all 
demonstrated to induce the differentiation of neural stem cells towards nerve cells. 
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Alignment and topography are particularly important parameters for the application of 
neural tissue engineering where the anisotropic organisation of the fibres encourages and 
increases neurite outgrowth in the direction parallel to the fibres when compared to random 
nanofibres and controls (flat surfaces without topography) Other factors which were also 
identified to increase neurite outgrowth in terms of topography included fibres with a 
narrower diameter and increased anisotropy of fibres which also resulted in increased cell 
attachment and differentiation [Schnell et al., 2007]. Human cord-blood derived somatic 
stem cells have also been cultured on electrospun PCL random nanofibres; in this study 
stem cells were successfully differentiated in vitro towards hepatocyte-like cells using 
inducing factor media for 6 weeks. Typical endoderm hepatic markers (albumin, glycogen 
storage and α-fetoprotein) were expressed positively via immunostaining expression 
markers were positively stained via immunostaining [Hashemi et al., 2009].  
 
hMSCs are a popular source of stem cells due to their potential to differentiate into various 
skeletal lineages, availability and immunoprivilige [Rose and Oreffo, 2002]. Introducing 
topography via electrospun nanofibres from various polymer including: PLDLA, PLGA, 
PCL and poly vinyl alchohol induced the differentiation of hMSCs towards osteogenesis, 
chondrogenesis and adipogenesis after 21 days of culture in relevant chemical 
supplements. Histological staining via von kossa and alizarin red (bone), alcian blue 
(cartilage) and oil red O (fat) confirmed hMSC differentiation which was cross-vailidated 
by PCR analysis of specific markers for each tissue type [Li et al., 2005; Wimpenny et al., 
2010]. 
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Current limitations associated with stem cells include; efficiency of expansion and 
adequate numbers suitable for clinical therapeutic use. To overcome this limitation, many 
researchers have attempted to expand stem cells using nanofibrous substrates. Bone 
marrow-derived hematopoietic stem cells have non-adherent properties and their current 
conventional culture methods have several limitations including maintaining cell 
localisation. The use of electrospun nanofibres have displayed promising results to 
overcome these limitations where collagen I blended PLGA nanofibres were able to 
significantly increase stem cell capture and enhance their proliferation activity [Ma et al., 
2008]. Undifferentiated umbilical cord stem cells have successfully been expanded on 
electrospun polyethersulfone (PES) nanofibres (Ø 627 nm). PES is generally hydrophobic 
and thus through surface treatment and collagen grafting, this improved its 
biocompatibility resulting in subsequent provision of attachment sites to enhance cell 
adhesion. This resulted in cell attachment and infiltration of the stem cells into the scaffold 
whilst retaining its typical cell phenotype morphology [Shabani et al., 2009].  
 
Electrospun, ultra-fine fibres (Ø 500-800nm) fabricated from PLGA with a tensile modulus 
of 323.145 MPa and an ultimate tensile stress of 22.67 MPa had a similar morphology to 
fibres found in the natural ECM. This substrate supported the successful adhesion and 
proliferation of hMSCs (up to day 10), whilst maintaining their typical phenotypic 
morphology and multipotency [Li et al., 2002]. hMSCs can also expand whilst retaining 
their stemness on electrospun silk fibroin–based fibre matrices (Ø 700 nm). These fibres 
demonstrated suitable biocompatibility adequate to support hMSC adhesion and 
proliferation up to 14 days of culture [Jin et al., 2004]. However, many of the above 
studies have investigated hMSCs that have been already recovered from bone marrow 
aspirate, isolated and expanded on TCP before seeding and culturing onto alternative 
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substrates such as electrospun nanofibres. An improved one-step direct method of hMSC 
recovery and isolation from bone marrow aspirate has been successfully performed by our 
research group, previously. Here, bone marrow aspirate was directly seeded onto 
electrospun PLDLA (Ø 478 – 645 nm), PLGA (Ø 96.3 – 2000 nm) and PCL (Ø 222 – 275 
nm) nano to sub-micron fibre scaffolds in both aligned and random conformations and 
expanded for 3 weeks in either 2% or 21% O2 to recover undifferentiated hMSCs. Results 
demonstrated, overall a greater number of hMSC colony recovery in 2% O2 rather than 
21% O2, on all substrates. Furthermore, aligned nanofibres supported greater hMSC colony 
recovery relative to their random counterparts; overall, PLGA and PCL aligned substrates 
which also had the smallest fibre diameter provided the best performance [Wimpenny et 
al., 2010]. Early adhesive efficiency of hMSCs has also been enhanced through 
nanotopography on collagen-coated P(LLA-CL) electrospun nanofibres, where topography 
demonstrated to significantly improve hMSC attachment after 30 minutes of seeding onto 
the substrates, relative to flat collagen or gelatin coated coverslips [Chan et al., 2009]. 
Thus, it is apparent that topography (such as aligned nanofibres) is not only effective for 
inducing the differentiation of stem cells towards various lineages but can also enhance 
stem cell adhesion and proliferative properties whilst retaining their stemness. 
Additionally, it appears that fibre diameter also influences the adhesion and expansion 
ability of stem cells, where the narrower fibres are accurately mimicking the native ECM 
nanofibrils. 
  
With regards to embryonic stem cells, a limited number of investigations have explored the 
ability of electrospun nanofibrous scaffolds to support their activity including attachment, 
proliferation and differentiation and hence is still a very much unexplored area. Perhaps, 
the reason for this is due to various complications associated with the complex 
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conventional culture of expanding ESCs and the partial understanding of the exact 
mechanisms associated with controlling embryonic stem cell behaviour. For this reason, 
many studies have found it easier to differentiate embryonic stem cells towards countless 
lineages, as they have potential to transform into specialised cell types of all three germ 
layers. For example, PLLA nanofibres were able to successfully differentiate mESCs 
towards the osteogenic lineage and expressed bone specific markers such as calcium and 
osteocalcin [Smith et al., 2009]. Considerable attention has been given to the application of 
electrospun nanofibres for nerve regeneration, as electrospinning provides the ability to 
generate nanofibres with great degree of anisotropy and alignment which provides 
topographical cues to induce and direct the differentiation of ESCs towards nerve cells 
[Prabhakaran et al., 2012]. Electrospun polyurethane nanofibrous scaffolds (150 µm 
thickness, 84 % porosity and 360 nm fibre Ø) supported the initial adhesion and 
undifferentiated expansion of hESCs, which were then differentiated towards neurones by 
culturing in neurobasal A basal media supplemented with 1% B27, 1% N2, epidermal 
growth factor (EGF) and bFGF for up to 47 days [Carlberg et al., 2009]. Similarly, 
neurospheres generated from hESCs were cultured onto PLDLA electrospun nanofibrous 
3D scaffolds (thin structures of 2-3 fibre thickness; thick structures of >10 fibre thickness); 
observations here included enhanced neuron growth on the thicker scaffolds relative to 
thinner scaffolds. Cells had a typical morphology for neuronal cells and followed fibre 
orientation [Yla-Outinen et al., 2010]. Due to the difficulty of hESCs adhering to synthetic 
substrates, alternative methods have included inducing embryoid body formation and then 
seeding these embryoid bodies onto electrospun nanofibrous substrates in combination 
with biochemical cues to induce their differentiation into specific lineages. Examples 
include electropsun nanofibre scaffolds from PLA which supported the differentiation of 
hESC-derived EB cells in the presence of osteogenic media towards osteogenesis and 
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implanted subcutaneously to the back of immunodeficient mice for 5 weeks. Observations 
included discrete mineralisation expression of typical bone markers including osteocalcin 
[Bielby et al., 2004]. PCL aligned and random electrospun nanofibres have successfully 
supported the differentiation of hESC-derived EBs into neural progenitors in the presence 
of neurobasal media (supplemented with B27); aligned nanofibres particularly enhanced 
the neurite outgrowth which was directed parallel to the orientation of the nanofibres [Xie 
et al., 2009].  
 
However, there are a limited number of studies that have attempted to culture and expand 
undifferentiated embryonic stem cells (mouse and human origin) on electrospun synthetic 
nanofibrous substrates, specifically of human origin. A few attempts have been made using 
synthetic biodegradable polymers such as PCL, polyurethane and polyamide. Furthermore, 
composite polymers where natural polymers such as collagen and gelatin have been 
electrospun with synthetic polymers such as PCL have successfully enhanced the adhesion 
properties of the nanofibres resulting in attachment and expansion of undifferentiated 
ESCs. It has also been identified that the geometry and topography of the electrospun 
nanofibres alone was sufficient to support of significantly larger colonies of 
undifferentiated ESCs in comparison to controls such as glass coverlips and relative 
polymer films [Nur-E-Kamal et al., 2006]. A summary of studies which have attempted to 
culture ESCs on electrospun nanofibrous substrates is stated in Table 1.13.  
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Table 1.13 A summary of electrospun nanorfibrous substrates fabricated from various 
synthetic polymers to culture, expand and differentiate embryonic stem cells. 
Synthetic 
Nanofibrous 
Substrates 
Substrate 
properties 
hESC 
Line 
Observations Reference 
Polyurethane 150 µm 
thickness 
Exhibited high 
porosity 84 % 
Pore size 5-6 
and 1 µm 
Fibre Ø 360 
nm 
SA002 Undifferentiated hESCs were 
cultured and expanded on scaffolds 
(in hESC media for 5-7 days) and 
then induced to differentiate (using 
neurobasal media supplemented with 
1 % B27 and 1 % N2) towards 
neurones for up to 47 days. 
Differentiation confirmed by positive 
immunostaining of dopaminergic 
tyrosine hydroxylase 
[Carlberg et 
al., 2009] 
PCL Random and 
aligned 
nanofibres on 
coverslips 
Fibre Ø 250 
nm 
mESCs ESCs induced to form embryoid 
bodies which were seeded onto the 
nanofibrous substrates and induced to 
differentiate towards neurons using 
retinoic acid and neural basal media. 
After 14 days expression of neuron 
marker Tuj1 was visible. 
 
Direct seeding of ESCs without 
forming EBs displayed that using 
retinoic acid and culturing in neural 
basal media with B27 supplement 
ESCs formed aggregates on both 
aligned and random nanofibrous 
substrates 
[Xie et al., 
2009] 
PCL/collagen 
and 
PCL/gelatin 
Random 
topography 
nanofibrous 
substrates. 
PCL/collagen 
(Ø 275 nm) 
and 
PCL/gelatin 
(Ø 283 nm) 
fibre diameters 
 
HES3 hESCs were grown in the presence of 
MEFs. Larger hESC colonies were 
supported on both substrates with 
increased cell growth by 47.58% and 
40.18% for (PCL/collagen and PCL 
/gelatin, respectively) in comparison 
to their control (hESCs on MEFs 
only). Colonies generated on 
substrates retained stemness 
characteristics. On aligned substrates 
cell migrated away from the EB an 
along the axis of the aligned fibres 
[Gauthama
n et al., 
2009] 
PCL and 
calcium 
deficient 
hydroxyapatite 
Electrospun 
nanohybrid 
mats (non-
woven 
architecture) 
2 and 55 wt.% 
of calcium 
hydroxyapatite 
content 
mESCs mESC response to nanohybrid PCL 
and calcium deficient hydroxyapatite 
substrates and neat PCL was 
evaluated. mESCs were able to 
adhere (although 45 % efficiency 
relative to control), expand in an 
undifferentiated, pluripotent state 
(Nanog and β-Tubilin) in a typical 
way 
[Bianco et 
al., 2009] 
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Average fibre 
size 1.5 m, 
porosity 80-90 
% and specific 
surface area 
16m
2
g
-1 
PCL Thickness of 
scaffold 200 
µm. Porosity 
of ~ 88 %, 
Pore size 30 
µm and 
average fibre 
diameter 691 
nm 
mESCs mESCs differentiated towards 
adipogenesis using a 3D culture 
system. mESCs seeded into PCL 
matrices. mESCs seeded into PCL 
matrices sealed into transwell inserts 
with membrane removed and 
expanded for 2 days  before 4-day 
treatment with RA, insulin and T3 
induction. Upon inducing 
differentiation morphology changed 
from fibroblastic to a spherical with 
evidence of lipid accumulation (Oil-
red-O-staining) with confirmation 
using PPAR-γ marker. Migration and 
penetration of differentiated mESCs 
40 µm deep into substrate 
[Kang et 
al., 2007] 
Polyamide A 3D Ultra-
thin 
nanofibrous 
substrate 
mESCs Ultra-web nanofibrous substrates 
fabricated from polyamide 
demonstrated to support the 
expansion of significantly larger 
colonies of undifferentiated mESCs 
compared to glass coverslips and 
relative polymer film controls. 
[Nur-E-
Kamal et 
al., 2006] 
 
Despite the recent attempt to culture and expand hESCs on synthetic nanofibrous 
substrates; the use of purely synthetic FDA approved polymers such as PCL, PLGA and 
PLLA electrospun into aligned and random conformations are yet to be investigated with 
the combined effects of oxygen tension on the attachment and expansion of hESCs. 
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1.8 Thesis Aims and Objectives 
Electrospinning offers great potential in the field of tissue engineering to generate nano-
scale scaffolds for many applications. By merging biomaterial technology with embryonic 
stem cell biology this may drive their potential use in clinical therapeutics by enhancing 
and improving the expansion capabilities of hESCs by the elimination of current associated 
limitations including retaining pluripotency, slow expansion rate and the use of xenogenic 
agents in culture.  
 
The aims of this thesis are to: 
 Develop a synthetic substrate of electrospun nanofibrous scaffolds from FDA 
approved polymers with different topographical conformations. 
 Investigate the potential of these substrates to support the attachment and 
undifferentiated expansion and differentiation capacity of hESCs in combination 
with different oxygen tension exposures to identify the optimal materials related 
and culture environment related parameters suitable for hESC expansion. 
 Characterise the underlying integrin mechanisms within hESCs that regulates their 
attachment to electrospun nanofibrous substrates. 
 Identify proteins in relatively undefined ESC media which specifically interact with 
electrospun nanofibrous substrates and encourage their attachment.  
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2. Materials and Methods 
2.1 Electrospinning and Scaffold Fabrication 
2.1.1 Electrospinning Set-up  
All electrospinning was performed within a fume cupboard in accordance with local Health 
and Safety regulations and included interlocks and a voltage dissipater. The fundamental 
components of the electrospinner included, two high voltage power supplies (HVPS; 
Spellman HV, Pulborough, UK) which were connected in master-slave configuration 
(allowing an adjustment of voltage between 0 – 60kV and current between 0 – 5mA); a 
calibrated syringe pump (KR Analytical, Sandbach, UK) to which a glass syringe with a 
stainless steel needle is attached and a negatively charged copper collection plate. An 
image of the electrospinning equipment is shown in Figure 2.1 
 
2.1.2 Preparation of Polymer solutions 
Electrospinning polymer solutions were prepared from Poly-L-lactic acid (PLA), poly-l,d 
lactic-glycolic acid (96L/4D; L:G 80/20 PLGA; Purac BV, Netherlands) and Poly-ɛ-
caprolactone (PCL, Mw 80,000), purchased from Sigma, Poole, UK; Purac BV, 
Netherlands and Sigma, Poole, UK, respectively. Polymer solutions were prepared by 
initially dissolving each polymer (w/v) in chloroform (CHL) or dichloromethane (DCM) 
followed by the addition of electric charge using dimethylformamide (DMF). A summary 
of the concentration of polymer solutions and the solvents used to make those solutions are 
stated in Table 2.1. Outline of experiments performed using each of the polymers is briefly 
described in Figure 2.2. 
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Figure 2.1 Image of the electrospinning set-up. (A) Showing the basic components of the electrospinner; (1) Adjusting platform, (2) Syringe 
pump, (3) Glass syringe with metal needle attached, (4) Copper plate collector, (5) Safety interlock and (6) External high voltage power supply; 
(B) Illustrates the electrospinning set-up for attaining random electrospun fibres and (C) demonstrates the rotating mandrel set-up for attaining 
aligned electrospun fibres. 
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Table 2.1 Polymer solutions and the concentration at which they were prepared using 
solvents at specific ratios.  
Polymer Solution  Solvent Ratio 
12.5% PCL CHL and DMF 7:3 
15% PCL DCM and DMF 7:3 
2% PLGA  CHL and DMF 7:3 
7% PLLA CHL and DMF 9:1 
 
 
Figure 2.2 Flow diagram representing the experiments performed with each electrospun 
polymer solution. 
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2.1.3 Fabrication of Random Electrospun Fibres 
Electrospun random fibres were attained using the basic set-up as shown in Figure 2.1A 
and B. Polymer solutions were loaded into the glass syringe and spun using the parameters 
stated in Table 2.2. The copper plate was pre-covered with aluminium foil; 24 mm x 24 
mm glass coverslips were attached to the collector directly opposite the syringe and fibres 
were spun and collected onto these coverslips.  
 
Table 2.2 Electrospinning parameters used to attain random fibres for each polymer type 
 
Polymer 
Parameter 
Needle Flow Rate 
ml/min 
Working 
Distance (cm) 
Voltage (kV) 
12.5% PCL 22G  0.01 15 4 
15% PCL 18G 0.025 15 5 
2% PLGA 22G  0.01 20 4 
7% PLLA 18G  0.025 15 6 
 
2.1.4 Fabrication of Aligned Electrospun Fibres 
Electrospun aligned fibres were fabricated using the rotating mandrel method and the 
parameters for each polymer as stated in Table 2.3. This required a brief modification to 
the basic set-up as demonstrated in Figure 2.1C. A 10 mm aluminium rod functioned as an 
axle for the mandrel; the mandrel itself was a drink can (22 cm aluminium), sealed drum 
(0.95 mm diameter to ensure a firm fixation to the aluminium axle) which was drilled in 
the centre at both ends of the drum and fixated over the axle. A motor was connected to the 
axle using a modified plastic eppendorf and parafilm to ensure a tight, firm fit preventing 
the axle from slipping from the axle connector. A DC sourced voltage transformer with 
variable voltage (3-12 volts) was connected to the motor with ca. 5,250 rpm. The distal end 
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of the axle was firmly fixed using another eppendorf attached with a small hole in the 
conical end held in place with a smooth metal needle, preventing low friction during 
rotation of the mandrel. Finally, the whole rotating mandrel was held together and fixed in 
position using clamp stands. 
 
Table 2.3 Electrospinning parameters used to attain aligned fibres for each polymer type. 
 
Polymer 
Parameter 
Needle Flow Rate 
ml/min 
Working 
Distance (cm) 
Voltage (kV) 
12.5% PCL 22G  0.01 20 4.5 
15% PCL 18G 0.025 20 6 
2% PLGA 22G  0.01 20 3.5 
7% PLLA 18G  0.025 20 7 
 
2.1.5 Reinforcement of Electrospun Fibrous Scaffolds 
Electrospun fibrous scaffold attachment on glass coverslips was further reinforced with 
silicone rubber strips (Silex Ltd, Borden, UK). These strips were adhered using silicone 
glue (RS Scientific, Corby, UK). Scaffolds were allowed to dry for 3-4 hours before 
sterilisation and cell seeding. 
 
2.1.6 Sterilisation Process of Electrospun Fibrous Scaffolds 
All electrospun fibrous scaffolds and controls were sterilised by immersion in 70% 
industrial methylated spirit (IMS) for at least one hour. After this, IMS was aspirated off 
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and the scaffolds were air-dried in non-adherent petri dishes for one hour (Sterilin, 
Newport, UK). 
  
2.2 Human Embryonic Stem Cell Culture 
All experiments carried out in this thesis used human embryonic stem cells which were 
cultured using the feeder-free method as described below. Specifically, the cell line 
Sheffield 1 (SHEF1) was used for all experiments in this thesis 
 
2.2.1 Extraction and Isolation of Mouse Embryonic Fibroblasts 
Female mice at day 12.5-13.5 of pregnancy were first sacrificed before having the 
abdomen area sterilised using 70% ethanol and dissection performed using tools pre-
swabbed in ethanol. Briefly, skin was removed from the stomach and an incision was made 
across the body (proximal to the legs) ensuring to slice on the skin layer. The skin layer 
was pulled back and a “V” shape cut was made towards the head in order to expose the 
internal regions. The uterine horn was removed with the filled purple sacs attached, and 
was cut open in order to detach the embryo’s using sterile blunt forceps. After removing 
the heads, the bodies were placed in tubes containing Phosphate Buffer Saline (PBS) and 
Penicillin and Streptomycin (PS).  
 
Within a sterile biological safety cabinet the embryos were removed from PBS + PS and 
placed onto a sterile petri dish lid. The viscera (red matter) was removed and the remaining 
material washed with a series of three PBS wash bath’s in petri dishes. Each embryo was 
placed into a bijou containing 1% Trypsin and EDTA solution and incubated at 37 ºC for 5 
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minutes, vortexed and placed into the incubator at 37 ºC for 5 minutes again. After 
vortexing, 3 ml of MEF medium (DMEM, 10% Fetal Bovine Serum, 1% L-Glutamine and 
1% Non-essential amino acids) was added and the top 3 ml were removed and plated into a 
T75 flask with 12-15 ml of MEF media. Flasks were placed in incubators (37 ºC) overnight, 
after which a media change was performed. 
 
MEFs were allowed to expand with a MEF media change every 3-4 days until a confluent 
monolayer of cells was achieved. MEFs were then trypsinised and cryopreserved in freeze 
media (90 % FBS + 10 % DMSO) until required. Briefly, a flask of cells were spun down 
to a pellet, resuspended in 1 ml of freeze media, transferred to cryovials and stored in a Mr 
Frosty overnight at -80 ºC before storing in liquid nitrogen.  
 
2.2.2 Conditioning Embryonic Stem Cell Media using Mouse Embryonic Fibroblasts 
MEFs were resuscitated and expanded using MEF media until 50% confluence, after 
which point hESC media was conditioned. This comprised Knock-out DMEM (Gibco-
Invitrogen, Paisley, UK) supplemented with 20% Knock-out Serum Replacement (Gibco-
Invitrogen, UK), 1% L-glut (Lonza, Slough, UK), 1% NEAA (Lonza, Slough, UK), 4 
ng/ml basic fibroblastic growth factor (bFGF; Lonza, Slough, UK) and 0.1 mM 
mercaptoethanol (Gibco-Invitrogen, UK). hESC media was conditioned overnight, 
collected, further supplemented with 4 ng/ml of bFGF, and sterile filtered (Millipore, 
Watford, UK) before use [Xu et al., 2001]. 
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2.2.3 Expansion of Human Embryonic Stem Cell Line SHEF 1 
hESCs (SHEF 1) were resuscitated (Passage 32) and cultured on Matrigel™ coated flasks 
(BD Biosciences, Oxford, UK) and hESC conditioned culture media prepared as described 
previously and above in section 2.1.2 [Forsyth et al., 2008]. T25 Flasks were coated with 
Matrigel™ (thawed from -20 º C to -4 º C) diluted at 1:100 using KO-DMEM and chilled 
stripettes (Gibco-Invitrogen, UK) for 1 hour at room temperature and then aspirated off. 
Media was changed daily and hESCs were generally passaged at a ratio of 1:2 every two-
three days after reaching 90% confluence using a brief 0.25% Trypsin/EDTA treatment 
[Xu et al., 2001] 
 
hESCs were cultured and expanded in two different oxygen tensions; 2% O2 (using a 
modular modification of a Galaxy R
+
 incubator; RS Biotech, Irvine, UK, and 21% O2 
(Heraeus Cytoperm 2 incubator; Thermo Electron Corporation, UK). 
 
2.3 Human Embryonic Stem Cell Culture on Electrospun Fibres  
Electrospun scaffolds and controls (positive control; Matrigel
TM
 coated coverslips and 
negative control; non-coated coverslips) were placed in non-adherent petri dishes (60 mm 
diameter; Corning, UK) and seeded with hESCs (SHEF 1, Passage 42-56), cultured and 
expanded in either 2% O2 or 21% O2 conditions. Cell density was 1700 cells/cm
2
 per 
scaffold/control sample; this was determined to be the optimum by an experiment 
performed examining hESC Colony forming units (CFU) on Matrigel
TM
 during a three 
week time period of culture at different seeding densities. hESCs were seeded in 500 l of 
MEF conditioned hESC media, which was pipetted directly onto the nanofibre scaffold or 
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control coverslips. All samples were incubated in their relevant oxygen levels (2% O2 or 
21% O2) overnight, after which, each petri dish was flooded with 6 ml of MEF-conditioned 
hESC media and colonies were recovered over a 21 day period without a change of media. 
For each sample type (controls and scaffolds), at each oxygen tension, n=3 (three 
replicates) in 3 experimental repeats, unless stated otherwise. 
 
2.3.1 Pluripotent Colony-Forming Unit Assay 
An essential characteristic of stem cells expanding whilst maintaining their stemness is 
their ability to expand as colonies. A stem cell colony is an indication that a stem cell is 
able to self-renew whilst maintaining its undifferentiated state and expand in a tightly 
packed homogenous cluster [Thomson et al., 1998]. 
 
2.3.1.1 Giemsa Staining 
After 21 days of culture, formed hESC CFUs on electrospun fibrous scaffolds and 
Matrigel
TM
 substrates were washed twice with PBS, fixed in 95% methanol for 10 minutes 
and immersed in 100% Giemsa stain (Catalogue # G5637; Sigma-Aldrich, Gillingham, 
UK) and placed on a shaker (at low speed) for 30 minutes. All samples were washed 
thoroughly with water to remove background staining. Samples were then subsequently 
air-dried and colonies visually recorded by placing a dot with a marker pen on the 
underside of the glass coverslip. 
2.3.1.2 Alkaline Phosphatase Staining 
hESCs were expanded at different cell densities (0, 1, 10, 100, 1000 and 10 000 cells/well), 
in 6-well plates coated with Matrigel
TM
, in either 2% O2 or 21% O2 for 21 days using 
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MEF-conditioned media. hESCs were washed once with PBS and fixed in 4% 
paraformaldehyde (prepared in PBS) for 1-2 minutes (any longer causes deactivation of 
alkaline phosphatase within the cells). Fixed hESCs were further rinsed using Tris-buffered 
Saline Tween-20; TBST) rinse buffer and treated with 500 l/sample of alkaline 
phosphatase staining solution prepared using three components; Fast Red Violet, Naphthol 
AS-B1 Phosphate (4 mg/ml) in  2-Amino-2-methyl-1,3-propanediol buffer (AMPD; 2 
mol/L at pH 9.5) and distilled water at a ratio of 2:1:1 as per manufacturer’s instructions 
(Millipore, Catalogue # SCR004). Samples were incubated in the dark at room temperature 
for 15 minutes, washed with rinse buffer and stored in PBS for optical microscopy 
imaging. 
 
2.3.2 Embryoid Body Formation 
hESCs were expanded in a T25 flask until confluence, trypsinised and seeded into a non-
adherent 60 mm petri dish. hESCs were flooded in with 10 ml of ES conditioned media 
and incubated overnight in order to allow hESCs to aggregate together. hESC aggregates 
and media were collected and transferred into a centrifuge tube and allowed to stand for 10 
minutes; ES conditioned media was removed carefully and replaced with 10 ml of basic 
media composed of; DMEM, 10% FBS, % L-glut and 1% NEAA. Aggregates and media 
were transferred into a non-adherent petri dish and incubated for 5 days without changing 
media. After 5 days, EBs were transferred into gelatin coated adherent petri dishes with 
fresh spontaneous differentiation media. After 21 days of expansion, media was removed 
and EBs fixed in 10% Formalin for 10 minutes before being immersed in 100% Giemsa 
stain for 30 minutes. EBs were washed thoroughly with water to remove background 
staining and air-dried before imaging.  
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2.3.3 Differentiation of Human Embryonic Stem Cells 
For all differentiation studies, hESCs were cultured for a period of 21 days on electrospun 
PCL nanofibre substrates and Matrigel
TM
 coated glass coverslips, in physiological 
normoxia (2% O2); hESC colonies were then induced to differentiate into specialised 
mesodermal germ layer lineages (Adipogenesis, Chondrogenesis and Osteogenesis) using 
chemical cues in the form of supplemented media for respective differentiation lineages, 
for a further 21 days in physiological normoxic (2% O2) conditions. MEF-conditioned 
media was removed from all samples, washed with PBS and immersed in corresponding 
differentiating media’s where media changes took place every three days.  
 
2.3.3.1 Spontaneous Differentiation 
Spontaneous differentiation media was composed of knock-out DMEM, 10% FBS, 1% L-
Glut, 1% NEAA and 0.1 mM -mercaptoethanol.  
 
2.3.3.1.1 RT-PCR 
After 21 days of hESC culture on electrospun nanofibre substrates and Matrigel
TM
 
controls, in physiological normoxic conditions and spontaneous differentiation media; cell 
lysis was performed in situ at 0, 5, 10 and 20 days of culture in spontaneous media for 
subsequent RNA extraction. Cell lysates were prepared and homogenised as per 
manufacturer’s protocol (RNeasy, Qiagen, Crawley, UK). Briefly, cells were lysed in 
350µl RLT buffer (prepared in 70% ethanol) and 10 l/ml of -mercaptoethanol, 
centrifuged for 2 minutes at full power and stored at -80 °C until RNA extraction is 
required. 
Materials and Methods 
Chapter 2 
 
 
93 
 
2.3.3.1.2 RNA Extraction and Quantification  
Cell lysates were removed from -80 °C and thawed on ice. Lysates volume samples 
underwent a series of centrifugation steps and washes in RW
1
 and RPE buffer, and water as 
provided by the RNAeasy Mini Kit (Qiagen, Crawley) according to manufacturer’s 
instructions. Samples placed in eppendorfs were centrifuged and homogenised for 7 
seconds (at full speed), immersed in 350 l of 70% ethanol and transferred to RNeasy mini 
spin columns. Samples were again centrifuged for a further 15 seconds (at full speed, 4 °C) 
and the supernatant discarded. 700 l of RW1 buffer was added to samples and centrifuged 
(full speed for15 seconds). RW
1 
buffer was removed and samples centrifuged with RPE 
buffer (500 l, 15 seconds at full power); this step was repeated twice. Second time, 
samples were centrifuged for 2 minutes at full power and then transferred to sterile 
eppendorfs, where 10 l of H2O was added to the centre of the RNeasy mini spin column 
and allowed to soak through for 1 minute before centrifugation (full speed, 1 minute). 10 
l H2O containing RNA was extracted and replaced within RNeasy mini spin column to be 
centrifuged for a final time (full speed, 1 minute). Finally, eppendorfs, with pure RNA 
content were labelled appropriately and ready for quantification using the Nanodrop 
spectrophotometer (ND1000; Thermo Scientific, Dorset, UK). 
 
2.3.3.1.3 One-Step Reverse Transcriptase Polymer Chain Reaction 
RT-PCR analysis was performed on RNA samples for hESCs cultured on all substrate 
types (Matrigel
TM
 coated glass coverslips, PCL Aligned nanofibres and PCL Random 
nanofibres) at all time points (0, 5, 10, 20 days), in physiological normoxic conditions (2% 
O2). All RNA samples were used at a working concentration of 5 ng/l and one-step RT-
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PCR was performed using the SuperScript® III One-Step RT-PCR system with Platinum® 
Taq DNA Polymerase (Invitrogen, Paisley, UK) according to manufacturer’s instructions.  
 
Briefly all primers were designed using the Primer3 Freeware [Rozen and Skaletsky, 
1999], primer sequences and the annealing temperatures for each gene are stated in Table 
2.4. Mastermix solutions were prepared which included; 6.25 l of 2X reaction mix, 1 µl 
Forward primer (10 M), 1 l Reverse primer (10M), 3 l of DNA/RNA free water and 
0.25 l of SuperScript III RT/Platinum Taq High Fidelity Enzyme, per 1 l of sample. All 
RT-PCR reactions consisted of 50 °C for 30 minutes, 94 °C for 2 minutes, 30 cycles: 94 °C 
for 15 seconds, primer specific annealing temperature (Table 2.4) for 30 seconds, and 68 
°C for one minute followed by a final extension of 68 °C for 5 minutes.  
 
GAPDH (a gene which codes for glyceraldehyde-3-phosphate dehydrogenase) was the 
housekeeping gene used alongside the genes of interest; POU5-F1 (pluripotency of 
hESCs), hTERT (Catalytic unit of telomerase), SOX-1 (mesodermal germ layer), ACTC-1 
(Cardiac actinin; Endodermal germ layer) [Wong and Bernstein, 2010] and AFP 
(Ectodermal germ layer) [Abeyta et al., 2004; Osafune et al., 2008]. GAPDH was selected 
as previous reports indicate that reducing oxygen tensions do not affect its expression 
[Barber et al., 2005]. 
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Table 2.4 One-Step RT-PCR. Gene type investigated and their forward and reverse primers 
plus annealing temperatures. 
Gene Type 
 
Forward Primer Reverse Primer Annealing 
Temperature 
(ºC) 
GAPDH 
(Housekeeping 
gene) 
5’TGAAGGTCGGAGT
CAACGGATTTGGT’3 
5’CATGTGGGCCATGA
GGTCCAC CAC’3 
56 
POU5F1 5’GCAATTTGCCAAG
CTCCTGAAGCAG’3 
5’CATAGC 
CTGGGGTACCAAAAT
GGGG’3 
56 
hTERT 5’GCAGCTCCCATTTC
ATCAGC’3 
5’CAGGATGGTCTTGA
AGTCTG’3 
58 
SOX-1 5’CCAGGAGAACCCC
AAGA GGC’3 
5’CGGCCAGCGAGTAC
TTGTCC’3 
56 
ACTC-1 5’CATCCTGACCCT 
GAAGTATCCCATC’3 
5’CCCTCATAGATGGG
GACATTGT GAG’3 
56 
AFP 5’CAGAAAAATGGCA
GCCACAGC’3 
5’TGGCAGCATTTCTCC
AACAGG’3 
54 
 
 
2.3.3.1.4 Electrophoresis Gel 
Gel electrophoresis was performed to confirm PCR product amplification. Agarose gel 
(Catalogue # BP1356; Fisher Scientific, USA) was prepared at 2% by dissolving the 
powder in 1X Tris Acetate-Ethylenediaminetetraacetic acid (TA-EDTA; catalogue # 
T9650-4L; Sigma-Aldrich, UK) at high heat. Agarose gel was further supplemented with 
6.25 l Ethidium Bromide (E1510-10 ml; Sigma-Aldrich, UK) and poured into a tray with 
a gel comb. Gel was allowed to set for 45 minutes after which the set gel was placed into 
the electrophoresis chamber containing 1X TA-EDTA buffer. 6l of PCR product were 
loaded with 2 l of loading buffer and 5 l of DNA ladder was also loaded along with a 
blank control (water plus loading buffer). Gel was run for 45 minutes at 100 V on constant 
mode from negative to positive. After completion of electrophoresis, gel was transferred to 
Genesnap where images were taken using a UV camera. 
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2.3.3.2 Mesodermal Germ Layer Lineage Differentiation 
2.3.3.2.1 Adipogenic Differentiation 
Adipogenic differentiation media was composed of DMEM supplemented with; 2% FBS, 
1% L-Glut, 1% NEAA, 0.5 mM Dexamethasone, 60 mM Indomethacin, 10 g/ml Insulin 
and 0.5 mM Isobutylmethylxanthine [Pittenger et al., 1999]. 
 
2.3.3.2.2 Chondrogenic Differentiation 
Chondrogenic differentiation media was comprised of supplementing DMEM/F12 with; 
1% L-Glut, 1% NEAA, 1% Sodium Pyruvate, 1% Insulin Transferin Sodium Selenite, 50 
g/ml Ascorbic acid, 50 g/ml L-proline, 0.1 M Dexamethasone, 10 ng/ml of 
Transforming growth factor (Peprotech, London, UK) [Mackay et al., 1998]. 
 
2.3.3.2.3 Osteogenic Differentiation 
Osteogenic differentiation media consisted of: DMEM with 2% FBS, 1% L-Glut, 1% 
NEAA, 0.1 M Dexamethasone, 10 mM Glycerophosphate and 50 M Ascorbic acid-2-
phosphate [Jaiswal et al., 1997]. 
 
2.3.3.3 Histological Evaluation 
After 21 days of culturing hESC CFU’s on PCL electrospun nanofibre scaffolds and 
Matrigel
TM
 using chemically induced differentiation media in hypoxic conditions; media 
was removed from all samples, washed with PBS and fixed with 10% Formalin for 10 
minutes. Samples were then histologically stained in correspondence to each lineage 
investigated using the following stains:  
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2.3.3.3.1 Oil Red O Staining of Lipids 
Samples were rinsed in distilled H2O and then in 60% isopropyl alcohol (IPA) before being 
stained with 0.18% Oil red ‘O’ (Sigma, UK) prepared in 60% IPA for 10 minutes 
[Pittenger et al., 1999]. Samples were rinsed in tap water to remove residual stains and air-
dried; lipids secreted appeared red. 
 
2.3.3.3.2 Alcian Blue Staining of Glycosaminoglycans 
0.1% Alcian Blue GX was prepared at pH 1.5 using 3% Acetic acid [Pittenger et al., 
1999]. Samples were immersed in the stain overnight at room temperature, after which 
they were rinsed in distilled water 3X in order to remove excess stain. GAGs secreted via 
hESCs differentiated into chondrocytes appeared blue. 
 
2.3.3.3.3 Alizarin Red Staining of Ca
2+
ions 
Alizarin Red stain was prepared at 1% in distilled H2O and paper filtered before use 
[Pittenger et al., 1999]. Samples were washed once with PBS, once with distilled H2O and 
treated with 200 l of Alizarin Red solution for 5 minutes at room temperature. Stain was 
removed and samples washed 3X with distilled H2O. Secreted calcium ions representing 
inorganic bone matrix secretion activity of an osteoblast appeared red. 
 
Light microscopy was performed on all histologically stained samples using a bright field 
Nikon Eclipse TS-100 light microscope equipped with a Canon EOS 400D digital SLR 
camera. Representative images were taken of various samples at x10, x20 and x40 
magnifications in different areas of the samples. 
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2.4 Antibody Blocking of Human Embryonic Stem Cell Receptors 
Monoclonal antibodies specific to integrin’s/sub-units were used in adhesion blocking 
experiments as well as characterising and quantifying these receptors in hESCs cultured in 
either 2% O2 (physiological normoxia) or 21% O2 (hyperoxia).  
 
2.4.1 In silico Microarray Analysis of hESCs Integrin Expression  
Sample file output for hESCs (cell lines; H1, H9, and RH1) cultured on Matrigel
TM
 until 
90% confluence was generated for both 21% O2 and 2% O2 cultured cells as previously 
described (Forsyth et al., 2008). Data was then sorted by gene name, relative expression 
values of <10 removed, and multiple probe hits deleted after generating averaged values.  
 
2.4.2 Antibody Blocking of Integrins and Surface Adhesion Molecules 
2.4.2.1 Matrigel™ 
hESCs (SHEF 1) used for these experiments were cultured and expanded in either; 2% O2 
or 21% O2 from P 34 to P 62. hESCs were pre-treated with blocking antibodies raised 
against integrin sub-units; anti-integrin V (R & D Biosystems, Abingdon, UK), anti-
integrin αVβ5 (Chemicon International, Watford, UK), anti-integrin β5 (R & D 
Biosystems, Abingdon, UK) anti-integrin αE (Lifespan Bioscience, Nottingham UK), anti-
integrin α6 (Autogen Bioclear, Calne, UK) and anti-CD44 (HCAM) (Santa Cruz 
Biotechnology, Heidelberg, Germany). hESCs were incubated with either 0, 1 or 25 g/ml 
concentrations of antibody (in PBS) in either 2% O2 or 21% O2 at 37
o
C for 30 minutes in 
KO-DMEM. Cells were then re-plated into Matrigel
TM
 coated 6-well plates at a density of 
4 x 10
5
 cells per well and incubated at either physiological normoxia (2% O2) or hyperoxia 
(21% O2) for 24 hours [Meng et al., 2010; Paikal et al., 2000]. 
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2.4.2.2 Electrospun Nanofibrous Substrates 
hESCs (SHEF 1) were cultured and expanded in 2% O2 from P 42 to P 46. hESCs were 
trypsinised and treated with primary antibody anti-αVβ5 at 25 µg/ml concentration and 
KO-DMEM for one hour at 37 ºC in hypoxia. The control groups were hESCs without any 
primary antibody anti-αVβ5 treatment. Cells were then resuspended in 500 µl of MEF-
conditioned media and seeded onto pre-sterilised PCL electrospun nanofibrous substrates 
(PCL; Aligned and Random) and Matrigel™ glass coverslip controls at a concentration 
1700 cells/cm
2 
and incubated overnight at 37 ºC physiological normoxia. Substrates were 
then flooded with MEF-conditioned media and continued to be cultured for 21 days in 
physiological normoxia.   
 
2.4.2.3 Quantification of Cell Number Post-Antibody Treatment  
After 24 hours, cells were trypsinised and counts recorded with a haemocytometer. Cell 
viability was determined by staining hESCs with Trypan Blue at a 1:1 ratio with cell 
solution. 
 
2.4.3 Immunoflourescent Staining 
2.4.3.1 αVβ5 Integrin and CD44 Expression in hESCs  
hESCs were cultured and expanded on Matrigel™ coated 24 – well plates to approximately 
70% confluence in both oxygen concentrations (21% O2 or 2% O2). Cells were fixed using 
4% paraformaldehyde (in PBS) for 40 minutes at room temperature and non-specific 
proteins were blocked with 3% bovine serum albumin (BSA; Gibco) for 1 hour at room 
temperature. Primary antibody treatment included; anti-integrin αVβ5 and anti-CD44 at 50 
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µg/ml concentration for one hour at 37 ºC in corresponding oxygen environments (2% O2 
or 21% O2). After treatment, cells were washed with PBS and visualised using a secondary 
antibody treatment with donkey anti-human IgG at 5 µg/ml for 2 hours at room 
temperature whilst wrapped in foil. 
 
2.4.3.2 Pluripotent hESC Markers on Matrigel™ and Electrospun Nanofibre Substrates 
hESCs were cultured and expanded on Matrigel™ coated 24 well plates and PCL 
electrospun nanofibres (Aligned and Random), in 2% O2 for a period of 21 days in MEF-
conditioned media. Media was removed, washed with PBS and fixed in 4% PFA (in PBS) 
for 40 minutes at room temperature. Cells were treated with 0.5% Triton-X for 5 minutes 
at room temperature, washed twice with PBS and non-specific proteins were blocked using 
3% BSA for 1 hour at room temperature. hESC colonies were then incubated with 1 µg/ 
100 µl working solution of primary anti-human monoclonal antibodies; mouse anti-
alkaline phosphatase, mouse anti-SSEA-1, mouse SSEA-4, goat anti-Nanog and goat anti-
Oct-3/4 overnight at 2-8 ºC. hESCs were washed three times with PBS; antibodies Nanog 
and Oct 3/4 were treated using secondary antibody donkey anti-goat IgG (NL003; R & D 
Biosystems); alkaline phosphatase and SSEA-4 were using secondary antibody; donkey 
anti-mouse IgG (NL557; R & D Biosystems) at 5 µg/ml for two hours at room 
temperature.  
 
All immunostained samples were further counterstained with DAPI (1:500, prepared in 
PBS (Sigma, UK) in order to visualise nuclei of cells and imaged using a fluorescent 
microscope (Nikon TZ1; Leica, Germany). 
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2.4.3.3 Flourescent Activated Cell Sorting (FACS) 
hESCs expanded in 2% O2 or 21% O2, were trypsinised off Matrigel™ coated flasks and 
resuspended to a cell density concentration of 100 000 cells/sample. At this density, hESCs 
were washed with PBS, centrifuged at 1200 rpm for 3 minutes and fixed in 4% 
paraformaldehyde (prepared in PBS) for 30 minutes at room temperature. Cells were 
washed twice in FACS buffer (0.5% FBS in PBS) and centrifuged before resuspending 
allocated samples for their primary antibody treatment in; 100 µl of 5 µg/10
6
 cells for 
αVβ5 antibody solution and 100 µl of 1.5 µg/106 cells for CD44. Incubation period was for 
2 hours at room temperature after which point, cells were micro-centrifuged, primary 
antibody solutions were removed, cells washed with FACS buffer and resuspended in 
secondary antibody; goat anti-mouse IgG secondary antibody (NL557; R&D Biosystems) 
at 5 µg/ml for a further 2 hours at room temperature and wrapped in foil. Cells were then 
washed in FACS buffer and transferred into FACS tubes. Samples were analysed on a 
FACSort flow cytometer (Beckton, Dickinson, Oxfordshire, UK). Data analysis was 
perfomed with the CellQuest Software package (BD Biosciences, UK). 
 
2.5 Materials Related Characterising Techniques 
2.5.1 Field Emission Scanning Electron Microscopy 
Field Emission Scanning Electron Microscopy (FESEM) samples were coated with gold 
using an Emscope 200 (Emscope, UK) sputter coater for two minutes prior to analysis. 
Samples were analysed using a Hitachi F4500, (Hitachi, UK) FESEM. FESEM images of 
electrospun fibres were analysed using Image J. Image J was calibrated according to the 
image magnification and the diameters of individual fibres were measured. Two separate 
fibre sub-samples were examined in a minimum of 3 different areas. Once the data for the 
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measurements was collected for each polymer/orientation, the average fibre diameter and 
standard deviations were calculated. 50-70 fibre diameter readings were taken for each 
substrate.  
 
2.5.2 Water Contact Angle analysis 
Determining the wettability of a substrate is important in terms of identifying its 
biocompatibility. Hydrophobic materials have high contact angles resulting in less 
wettability due to minimal spreading of the water droplet; in comparison to hydrophilic 
materials that have a low contact angle, demonstrating greater wettability as a result of 
spreading of the water droplet over time. In order to characterise the wettability of the 
electrospun fibrous substrates, contact angle measurements were taken using the sessile 
drop technique. Firstly, using a Hamilton syringe (Precision sampling corp. USA), 10 µl of 
ultra-pure H2O was placed onto substrates from a vertical distance of 5 mm. Conditions 
were set to 22 ºC and 35 % humidity before placing a droplet onto the substrate and 
imaged after 20 seconds using a CCD camera (XC-ST50CE, Sony, Japan) (Figure 2.3). 
Images were taken of 3 separate regions for each of the 3 samples of a substrate type. All 
electrospun fibrous substrates fabricated were compared to a blank glass coverslip control. 
The ‘LBADSA’ Image J plug-in [Stalder et al., 2006] was used to analyse the images in 
terms of its contact angle. 
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Figure 2.3 Photograph illustrating the contact angle set-up. (A) Hamilton syringe, (B) 
Substrate, (C) Adjusting platform, (D) Long working distance microscope is connected to a 
precision x,y translation stage, (E) CCD camera (Nikon, Japan) and (F) Image analysis 
system 
 
2.5.3 Time of Flight Secondary Ion Mass Spectrometry 
Time of flight secondary ion mass spectrometry (Tof-SIMS) consists of a liquid metal 
(LMIG) ion gun for spectroscopy and imaging purposes at a spatial resolution of closer to 
one micron during mode of operation in order to acquire high mass resolution data. Tof 
mass analyser has a mass resolution in excess of 7,000. The Tof-SIMS instrument is shown 
in Figure 2.4. 
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Figure 2.4 Photograph illustrating the Tof-SIMS instrument set-up. Courtesy of Dr David 
Scurr, Nottingham University. 
 
2.5.3.1 Sample Preparation 
PCL was electrospun into both aligned and random conformations at various different fibre 
diameters onto 13 mm circular glass coverslips. Parameters used to fabricate both random 
and aligned nanofibres are stated in Tables 2.2 and 2.3, respectively. 
 
 
2.5.3.2 Protein Adsorption to Substrates Experiment  
All substrates were placed into a 24 well plate, sterilised using UV for 90 seconds. Four 
different protein solutions; Collagen I (Rat tail; 3.4mg/ml BD Biosciences), Fibronectin 
(Human plasma 0.1% solution; Sigma, UK, 088K7537), and Laminin (Natural mouse; 
Invitrogen, 23017-015) and Vitronectin (Human plasma; Sigma-Aldrich, V8379) were 
prepared at 50 µg/ml in PBS, as well as MEF-conditioned hESC media. 50 µl of each 
prepared protein solution and MEF-conditioned media was placed onto separate samples 
and incubated at 2% O2 for 2 hours. Protein/media supernatant was collected (leaving a 
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negligible volume to prevent the disruption of the adsorbed protein layer meniscus) into 
eppendorfs and stored at 2-8 ºC, for protein quantification later. Substrates were rinsed 
with 50 µl of PBS three times and then 50 µl of ultrapure distilled water also three times 
(to remove salts from PBS) and then allowed to air dry. Samples were transported to 
Nottingham University in order to be analysed using ToF-SIMS.  
 
2.5.3.3 Specimen Analysis Using Tof-SIMS 
All samples were stored in nitrogen prior to sample loading into the Tof-SIMS specimen 
chamber for analysis. Sample analysis was conducted on a Tof-SIMS IV (ION-TOF 
GmbH of Műnster), with data acquisition and analysis performed using Surface-lab 6 
(IONTOF GmbH) software. A primary ion source (Bi3
+
) of 25 kV was established using a 
Bismuth liquid metal ion gun (LMIG) and a raster in random mode with a resolution of 
256 x 256. Positive and negative ion Tof-SIMS spectra were acquired over an area of 500 
× 500 µm and a pulsed electron flood gun (20 eV) was used for charge neutralisation for 
all samples in this study. Principle component analysis was performed using The 
Unscrambler. 
 
2.5.4 Nano Orange® Flourometric Assay 
The NanoOrange® assay (Molecular probes, N6666) is highly sensitive and allows the 
detection and quantification of proteins within solution between 10 ng/ml and 10 µg/ml. In 
aqueous solution the surfactant dye molecule is non-fluorescent but once bound to 
proteins, the surfactant dye is able to fluoresce at excitation peak 470 nm and emission 
peak 570 nm [Jones et al., 2010; Roach, 2005]. Protein/media supernatants were collected 
after incubation on electrospun nanofibrous substrates (12.5% PCL-Aligned, 12.5% PCL-
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Random; 15% PCL-Aligned, 15% PCL-Random) and controls (blank glass coverslip), in 
physiological normoxia for 2 hours at 37 ºC, as stated above in section 2.5.3.2. 100 µl of 
each sample (including standards) was plated into eppendorfs to which 100 µl of 1X 
NanoOrange working solution (prepared using 1X NanoOrange solution reagent diluted 
500-fold into a 1X protein quantification diluent which was further prepared by diluting 
10-fold in distilled water). Samples were then heated at 95ᵒC for 10 minutes and then 
allowed to cool down for a further 20 minutes. Finally, samples were analysed using a 
fluorescent plate reader. 485/590 nm (excitation/emission). Standard curve calibration 
plots were produced for protein concentration of each protein type investigated (collagen I, 
fibronectin, laminin, vitronectin), except MEF-conditioned media, for which a BSA 
standard curve was formulated. All samples were conducted in triplicates and the plots 
attained are demonstrated in Figures 2.6 to 2.10. 
 
Figure 2.5 Typical standard curve performed using dilutions of BSA ranging from 0 to 0.1 
µg/ml. 
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Figure 2.6 Typical standard curve performed using dilutions of Collagen I protein ranging 
from 0 to 0.35 µg/ml. 
 
Figure 2.7 Typical standard curve performed using dilutions of Fibronectin protein ranging 
from 0 to 10 µg/ml.  
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Figure 2.8 Typical standard curve performed using dilutions of Laminin protein ranging 
from 0 to 1 µg/ml.  
 
Figure 2.9 Typical standard curve performed using dilutions of Vitronectin protein ranging 
from 0 to 1 µg/ml.  
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2.6 Statistical Analysis 
Error bars on graphs indicate standard deviations (SD). Data were tested for normality and 
a 1-way ANOVA/Kruskall Wallis test or a 2-way ANOVA test was performed followed by 
an appropriate post hoc test (Tukey’s or Dunns, respectively) to determine the origins of 
significance. In this study significance levels are indicated according to the legend 
p<0.05*, p<0.01** and p<0.001***. 
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3. Self-Renewal of hESCs on Electrospun Nanofibrous Substrates 
3.1 Introduction 
Current methodology for expansion of hESCs is largely reliant on either the mitotically-
inactivated feeder cell method (using direct co-culture with embryonic or adult fibroblasts), 
or the feeder-free method, which utilises feeder cell, pre-conditioned media and a 
biological substrate, such as Matrigel
TM
 [Thomson et al., 1998; Xu et al., 2001]. The 
inherent limitation of the Matrigel
TM
-based feeder-free method is that it is unsuitable for 
incorporation into hESC-based clinical trials due to the risk of xenocontamination 
alongside the batch to batch variability of MEFs used to condition hESC media and the 
presence of a nonhuman sialic acid (Neu5Gc). Furthermore, Matrigel
TM
 limits hESC 
expansion to a two dimensional (2D) environment with subsequent interventions required 
prior to transplantation. Hence, innovative and novel tissue engineering strategies are 
urgently required to provide the opportunity of incorporating hESCs with synthetic, 
biomimetic substrates (scaffolds), with the potential to act as three dimensional (3D) 
carriers to facilitate ready transplantation into in vivo target sites and eliminate any 
xenogenic contaminations. 
 
Cells are sensitive to nano-scale topography [Toh et al., 2006]. A common method used 
for fabricating nano-scale tissue engineering scaffolds is electrospinning. Electrospinning 
provides the opportunity to produce nanofibrous scaffolds, of tailored dimensions, that are 
able to mimic the nano-architecture of native extracellular matrix [Matthews et al., 2002]. 
Nanofibres also provide a high surface area to volume ratio and high surface roughness 
resulting in an effective environment for cell adhesion due to increased focal adhesion 
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contact between the cells and the surrounding fibres [Agarwal et al., 2008; Yang et al., 
2005; Zhang et al., 2005]. This is an indication of effective interaction between the cell and 
the surrounding artificial ECM, which results in the potential transmission of guidance 
cues to the cells. Electrospun fibre meshes generally have poor mechanical strength, but 
are highly flexible, which can result in an environment where cells produce fewer stress 
fibres [Galbraith and Sheetz, 1998]. An involvement of nanotopographical features in the 
maintenance of undifferentiated ESCs has been previously proposed [Jacobson et al., 
2001]. 
 
Previous reports have detailed the biocompatibility of electrospun nanofibre scaffolds to 
support the attachment, proliferation and differentiation of human bone marrow-derived 
mesenchymal stem cells (hMSC), cord blood-derived somatic stem cells, neural stem cells, 
and haematopoietic stem cells [Bini et al., 2006; Chan et al., 2009; Hashemi et al., 2009; 
Ma et al., 2008; Schnell et al., 2007; Shih et al., 2006]. Many of these researchers used 
synthetic polymers such as PCL, poly-L-lactide acid (PLLA), poly(lactic-co-glycolic acid) 
(PLGA), as they are FDA approved and their bulk degradation properties are well 
characterised [Ramakrishna et al., 2005]. Recent observations have demonstrated aligned 
and random nanofibre scaffolds, fabricated using PCL, PLGA and poly-L/D-lactide acid 
(PLDLA) to function as a suitable, alternative substrate for the isolation and expansion of 
hMSCs directly from bone marrow aspirate while maintaining their multipotent state 
[Wimpenny et al., 2010].  
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Currently, studies performed regarding the culture and differentiation of hESCs on 
electrospun nanofibres is limited. However, recent attempts have included the 
differentiation of murine ESCs into mature neural cells using retinoic acid, via an 
embryoid body (EB) stage, when cultured on electrospun, oriented PCL nanofibre 
scaffolds [Xie et al., 2009]. Unfortunately, differentiation through the EB stage results in 
spontaneous differentiation and a heterogeneous population, hence only a small population 
of the specialised cell type of interest can be recovered. Attempts to culture hESCs on 
electrospun nanofibres have included: the use of composite polymer substrates such as 
PCL/collagen and PCL/gelatin; however hESCs co-cultured with MEFs on these substrates 
was the only method by which pluripotency could be maintained. Attempts have been 
made to culture hESCs on electrospun nanofibres from a purely synthetic material such as 
FDA-approved Polyurethane. In this case, neuronal differentiation was explored of hESCs 
cultured on polyurethane nanofibres in combination with .neuronal differentiation inducing 
media [Carlberg et al., 2009]. 
 
Though recent attempts have been made to culture hESCs on electrospun nanofibres, it is 
clear that hESCs display poor attachment to synthetic materials and subsequent 
proliferation is limited. Furthermore, expansion of pluripotent hESCs on purely synthetic 
nanofibres without the co-culture of MEFs still appears to be impossible and a challenging 
task. In this chapter, the use of electrospun nanofibres from FDA approved synthetic 
polymers are investigated for roles in encouraging the attachment and pluripotent 
expansion of hESCs without the use of Matrigel™. Furthermore, it is well documented that 
the use of physiological normoxia (2% O2) is thought to be a better environment for 
culturing hESCs. Hypoxia inducible factors (HIFs) are known to be expressed by 
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decreasing the oxygen environment; these are heterodimeric, environment sensing 
transcriptional factors and are comprised of α and β sub-units. The expression of HIFs 
influences the promotion and suppression of several genes that are associated with various 
cell activities. Investigations have revealed that hESCs cultured in physiological normoxia 
(2% O2) increases their clonogenicity whilst maintaining their undifferentiated state, 
amongst others (see section 1.4). This study investigates the synergistic effect of both 
nanofibre topography and physiological normoxic conditions for increased attachment and 
enhanced hESC expansion in an undifferentiated state. The final outcome would be to 
replace the conventional substrate (Matrigel™) with electrospun nanofibres for expansion 
of pluripotent hESCs without their exposure to xenogenic contaminations in identified 
optimal conditions. 
 
3.2 Aims and Objectives 
Several studies have documented the use of electrospun nanofibres in the support of 
activity of various stem cells including recovery, proliferation and differentiation into 
multiple lineages. An additional stem cell type which could also be supported by 
electrospun nanofibre scaffolds may include hESCs. Furthermore, by combining the effects 
of nanofibre topography (which mimics the topographical structure of native ECM at the 
nanoscale) and physiological normoxia (2% O2; suggested to enhance clonogenicity and 
retain pluripotency), it can be hypothesised that a novel, synthetic substrate may support 
the attachment and expansion of hESCs, though pending optimisation of several materials 
related and culture conditions. 
 
Self-Renewal of hESCs on Electrospun Fibrous Substrates 
Chapter 3 
 
 
114 
 
The aims of this chapter were as follows: 
 To optimise and characterise electrospun nanofibrous (<500 nm) and sub-micron 
fibrous substrates from three FDA approved synthetic polymers (PCL, PLGA and 
PLLA) in both aligned and random conformations. 
 Optimise materials related parameters (polymer type, fibre diameter and fibre 
orientation) in order to identify electrospun nanofibrous substrate to support hESC 
colony forming unit ability.  
 Compare the effects between physiological normoxia (2% O2) and hyperoxia (21% 
O2) in combination with electrospun nanofibrous substrates on hESC expansion. 
 Characterise the undifferentiated state and pluripotential differentiation capacity of 
hESCs recovered on electrospun nanofibrous substrates.   
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3.3 Materials and Methods 
All nanofibrous substrates were fabricated using electrospinning. Aligned fibres were 
attained using the rotating mandrel technique, whereas random fibres were produced using 
the static copper plate collector. The operating parameters used to attain both aligned and 
random fibres onto glass coverslips are stated in (Table 2.2-2.3, Chapter 2, section 2.1.3). 
Electrospun fibres on glass coverslips were further reinforced using silicone rubber strips 
and silicone glue to prevent their detachment whilst immersed in media. All electrospun 
fibrous substrates were sterilised using 70% IMS for at least 1 hour.  
 
Fibre morphology, orientation and diameter were characterised using field emission 
scanning electron microscopy (FESEM). Surface properties were characterised in terms of 
wettability using water contact angle analysis.  
 
hESCs were cultured and expanded on Matrigel™ in physiological normoxia (2% O2) and 
hyperoxia (21% O2) using MEF conditioned ESC media and seeded onto electrospun 
fibrous substrates at passage 35-42. hESC CFU recovery and hESC morphology within 
those colonies on electrospun fibrous substrates after 21 days of expansion in MEF 
conditioned ESC media was evaluated using Giemsa staining. Furthermore, the 
undifferentiated state of hESCs recovered on optimal (PCL) nanofibrous substrates in 
optimal oxygen conditions for 21 days was evaluated using immunoflourescent staining for 
pluripotent markers as well as Alkaline phosphatase staining. In addition the pluripotential 
differentiation capacity was investigated using RT-PCR.  
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3.4 Results 
 
3.4.1 Characterisation of Optimised Electrospun Fibrous Substrates 
 
Electrospinning is a versatile technique with several parameters that require optimisation to 
attain non-beaded and uniform nanofibres with the required diameter. Preliminary 
experiments included optimising polymer concentration of each polymer (PCL, PLGA and 
PLLA) in both aligned and random conformations to prevent the formation of beads and to 
provide consistency in fibre diameter. Linear and uniform electrospun fibres were achieved 
with concentrations of 12.5%, 2% and 7% for PCL, PLGA and PLLA respectively. The 
optimised concentration for each polymer was then electrospun at various working 
distances (10 cm, 15 cm and 20 cm), voltage (4 kV, 6 kV and 8 kV) and needle gauges 
(18G, 20G and 22G); for both aligned and random fibres deposited onto glass coverslips. 
The final parameters used to attain both aligned and random electrospun fibres from all 3 
polymers are stated in Table 2.2-2.3 (Chapter 2, section 2.1.3) Visualisation of the 
electrospun fibres using optical microscopy as shown in Figure 3.1 demonstrates the 
precise anisotropic direction of the aligned electrospun fibres and the complete 
disorganisation of the random electrospun fibres; whilst attaining linear fibres without 
beading. 
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Figure 3.1 Optical microscopy images of optimised electropsun fibrous scaffolds 
fabricated from 12.5% PCL, 7% PLGA and 2% PLLA in both aligned and random 
conformations. Red circle indicates the area magnified. Scale bar = 200 µm. 
 
To define the exact diameter of electrospun fibres and to visualise fibre morphology and 
overall surface topography, FESEM was performed (Figure 3.2). FESEM images allowed 
the direct analysis of fibre diameter; results demonstrated that PCL nanofibres had a 
smaller fibre diameter (aligned, 280 nm; random 318 nm) in comparison to PLLA (aligned 
2506 nm; random, 1028 nm) and PLGA (aligned, 769 nm; random 1229 nm) fibres. 
Furthermore, significant differences were apparent in the fibre diameters between aligned 
and random conformations within each polymer type when electrospun with the same 
concentration of the solution (Figure 3.3). Specifically, PCL-aligned nanofibres had a 
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significantly smaller fibre diameter in comparison to PCL-random nanofibres (p < 0.01); 
PLGA-A sub-micron fibres had a significantly greater fibre diameter in comparision to 
PLGA-R (p < 0.001) and PLLA-A sub-micron fibres also had a significantly greater fibre 
diameter when compared to the diameter of PLLA-R (p < 0.001) counterparts. 
 
 
Figure 3.2 FESEM images of electrospun fibrous substrates fabricated from: PCL, PLGA 
and PLLA, in both random and aligned conformations. Electrospun fibre diameters are 
presented under each image. An arrow indicates the predominant direction of aligned 
fibres. Scale bar = 3 µm. 
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Figure 3.3 Graph representing the average fibre diameters of both aligned and random 
electrospun fibres made from PCL, PLGA and PLLA. Values indicate mean fibre diameter 
and standard deviation of n=20; *p < 0.05, ***p < 0.001. 
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Surface roughness can be affected by several parameters including; polymer chemistry, 
fibre morphology, fibre diameter, and topography, and this can affect the biocompatibility 
and the wettability of a substrate which ultimately affects cell adhesion and proliferation. 
Wettability was evaluated using the water contact angle analysis method for all optimised 
electrospun fibrous substrates (PCL-A, PCL-R, PLGA-A, PLGA-R, PLLA-A and PLLA-
R) as well as a blank glass coverslip onto which the electrospun fibres were electrospun. 
Briefly, the water contact angle is measured by calculating the droplet angle made tangent 
to the liquid surface with the solid at the three phase boundary measured through the 
liquid, using image J, as shown in Figure 3.4A (Roach thesis; 2005) 
 
Water contact angle analysis demonstrated that PCL nanofibres (aligned, 83ᵒ; random, 
81.5ᵒ) were marginally more hydrophobic in comparison to fibres fabricated from PLGA 
(aligned, 79ᵒ; random, 77ᵒ) and PLLA (aligned, 77ᵒ; random, 79ᵒ) in both aligned and 
random conformations. PLGA and PLLA substrates had similar contact angle 
measurements, as shown in Figure 3.4B and 3.5. Interestingly Matrigel
TM
 (61ᵒ) and glass 
(65ᵒ) contact angle measurements were significantly more hydrophilic in comparison to all 
polymer contact angle measurements. 
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Figure 3.4 (A) Method of calculating water contact angle [Roach, 2005]. Various forces act 
at a solid-liquid interface (SV, solid-vapour; LV, liquid-vapour and SL, solid-liquid); these 
energetics dictate the droplet shape and thus wettable nature of the substrate. The angle 
contact angle made between the solid and liquid phase can be calculated using Image J. (B) 
Images representing water contact angles on electrospun fibrous substrates in both aligned 
and random conformations fabricated from: 12.5% PCL, 2% PLGA and 7% PLLA. 
 
Figure 3.5 Water contact angle analysis. Graph representing the water contact angle 
measurement for both aligned and random electrospun fibrous substrates fabricated from: 
12.5% PCL, 2% PLGA and 7% PLLA as well as naked glass and Matrigel
TM
. Values 
indicate mean contact angle measurement and standard deviation of n=3, ***p < 0.001.  
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3.4.2 Optimisation of hESC Seeding Density 
Before seeding human embryonic stem cells onto electrospun fibrous substrates it was 
important to optimise the seeding density at which the greatest number of hESC-CFUs 
could be recovered without the formation of a complete monolayer and the merging of 
colonies into each other after 21 days of culture with ES maintenance media in both 
physiological normoxia (2% O2) and hyperoxia (21% O2). A typical characteristic feature 
of hESC expansion in an undifferentiated state is their ability to form tightly adherent, 
compact colonies; the most vigorous environment to test the clonogenicity of hESCs, is to 
allow hESC expansion in ES conditioned media for 21 days with minimal disturbance. 
 
Matrigel™ coated 6-well plates were seeded with hESCs at 6 different seeding densities 
which were; 0, 1, 10, 100, 1000 and 10 000 cells per well resuspended in 500 µl of ES 
conditioned media and further immersed in 6 ml of ES conditioned media. After 21 days, 
hESC CFUs were fixed and Giemsa stained for colony morphological visualisation as well 
as morphological evaluation of single hESCs within a colony (Figure 3.6A). Results 
clearly demonstrated that in both 2% O2 and 21% O2 the greatest number of CFUs were 
formed when seeding hESCs at a density of 1000 cells (Figure 3.6B). For seeding 
densities; 100 and 1000 cells/well, a significantly greater number of hESC-CFUs were 
recovered in physiological normoxia (2% O2) relative to hyperoxia (21% O2), confirming 
that 2% O2 enhances the clonogenicity of hESCs, as demonstrated in Figure 3.6A. 
 
Furthermore, hESC CFUs produced were stained for alkaline phosphatase in order to 
evaluate their undifferentiated state. Pluripotent hESCs express alkaline phosphatase 
(ALP); as confirmed in Figure 3.6. A difference in stain intensity was noted as a 
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consequence of the change in oxygen environment in which the hESCs were cultured. It 
was clear that in physiological normoxia (2% O2) hESC CFUs expressed a greater intensity 
of ALP when compared to colonies expanded in hyperoxia (21 % O2).  
 
Figure 3.6 (A) Optimisation of hESC seeding density to form CFUs on Matrigel™ coated 
6-well plates, cultured for 21 days with ES conditioned media and in physiological 
normoxia (2% O2) and hyperoxia (21% O2) stained using Giemsa and Alkaline 
phosphatase. (B) Quantification of Giemsa stained hESC colony count on Matrigel™ when 
seeded at different seeding densities (0, 1, 10, 100, 1000 and 10 000 cells/ well) and 
cultured with ES conditioned media in physiological normoxia (2% O2) and hyperoxia 
(21% O2) for 21 days. Values indicate mean number of forming units and standard 
deviation of n=3, ***p < 0.001. 
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3.4.3 Characterisation and Quantification of hESC CFUs on Electrospun Fibrous 
Substrates in 2% O2 and 21% O2. 
To investigate the ability of electrospun fibrous substrates to support hESC expansion, 
electrospun fibrous substrates (aligned and random) fabricated from PCL, PLGA and 
PLLA and controls (positive control; Matrigel™ coated glass coverslip and negative 
control; non-Matrigel™ coated glass coverslip) were seeded with 1000 cells per 
scaffold/control. hESCs seeded on substrates were cultured in both; physiological 
normoxia (2% O2) and hyperoxia (21% O2) for 21 days. All substrates investigated were 
fixed and Giemsa stained; hESC-CFUs were only found to be present on positive controls 
with no colony recovery activity occurring on all electrospun fibrous substrates, regardless 
of oxygen environment in which they were cultured.  
 
The seeding density was increased to 10 000 cells/substrate (1700 cells/cm
2
) and all 
electrospun fibrous substrates including controls were seeded with hESCs and cultured in 
both oxygen environments (2% O2 and 21% O2) for 21 days. After fixing, Giemsa staining 
revealed the presence of hESC colonies on electrospun fibrous substrates. However, the 
oxygen environment highly influenced and determined whether or not hESCs were able to 
form colonies. As demonstrated in Figure 3.7, it was clear that physiological normoxia (2% 
O2) supported the expansion of tightly adherent, compact hESC colonies; broadly similar 
colony morphology was demonstrated on both PCL-Aligned and PCL-Random 
nanofibrous substrates (Figure 3.7C and Figure 3.7E, as an example) to the positive 
(Matrigel™) control (Figure 3.7A).  
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In hyperoxia (21% O2), despite maintaining all other conditions constant and only 
changing the oxygen environment, all electrospun fibrous substrates supported tightly 
packed, dense, adherent bodies of cells which resembled an adherent embryoid body (EB), 
to an extent, formation as demonstrated by PCL-Aligned (Figure 3.7D) and PCL-Random 
(Figure 3.7F) nanofibrous substrates, as an example. EB formation is typically induced by 
culturing hESCs on a substrate which prevents their initial attachment forcing them to 
group together into a clump of cells subsequently resulting in their spontaneous 
differentiation. Subsequently these EBs may be able to attach to a previously non-
permissive substrate as the expression of surface receptors changes with accompanying 
differentiation state. Characteristically, EBs have an “egg-like” morphology as 
demonstrated in Figure 3.7B; this feature appears similar to the cluster of hESCs formed 
on the same electrospun nanofibrous substrates but when cultured in hyperoxia (21 % O2) 
suggesting that these are also EBs that have formed. 
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Figure 3.7 Macroscopic evaluation of hESC expansion. Photographs of hESC expansion 
cultured in different oxygen environments: hESC-CFU formation in physiological 
normoxia (2% O2) on, (A) Matrigel™, (C) 12.5% PCL aligned nanofibrous substrate and 
(E) 12.5% PCL random nanofibrous substrate, whereas in hyperoxia (21% O2) hESC-
embryoid body formation on (B) gelatin, (D) 12.5% PCL aligned nanofibrous substrate and 
(F) 12.5% PCL random nanofibrous substrate. hESCs were cultured up to 21 days using 
ES conditioned media. (Scale bar = 12 mm for A and C-D but 200 µm for B) 
 
Evaluating the morphology of CFUs (microscopically) on electrospun fibrous substrates in 
physiological normoxia (2% O2) demonstrated similar morphology to hESCs expanded on 
Matrigel™. As expected, no colonies were visualised on a negative control (Figure 3.8A) 
but Matrigel™ substrates supported hESC-CFU formation in both 2% O2 (Figure 3.8B) 
and 21% O2. All colonies formed on all electropsun fibrous substrates (Figure 3.8C-F) in 2 
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% O2 displayed hESC morphology similar to that seen in recovered colonies on Matrigel™ 
control; however, hESC colonies recovered on PCL-Random (Figure 3.8C) appear to be 
more dense and compact when compared to its aligned counterpart (Figure 3.8D)  
 
Figure 3.8 hESC morphology within a colony formed under physiological normoxia (2% 
O2) on: (A) negative control (non-Matrigel™ coated glass coverslip; no colony formation), 
(B) positive control (Matrigel™ coated glass coverslip), (C) 12.5% PCL aligned 
nanofibrous substrate, (D) 12.5% PCL random nanofibrous substrate, (E) 2% PLGA 
aligned fibrous substrate and (F) 7% PLLA aligned fibrous substrate. hESC-CFUs were 
expanded for 21 days in ES conditioned media, fixed and Giemsa stained. Arrows indicate 
the predominant direction of the aligned fibres. Scale bar = 200 µm. 
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Quantification of colony forming units (CFU’s) demonstratesd that as anticipated, the 
Matrigel™-coated glass coverslips yielded significantly more hESC colonies than any 
other surface in both 2% O2 (5.9 CFUs) and 21% O2 (2 CFUs) conditions (Figure 3.9A). 
PCL nanofibrous substrates proved to be the most efficient polymer for the adherance and 
expansion of hESCs, particularly PCL-A (2.2 CFUs). However, it was strongly evident that 
the attachment of hESCs and their subsequent expansion into colonies was only possible in 
physiological normoxia (2% O2), as confirmed by colony appearance as well as the 
morphology of single hESCs within these formed colonies. The frequency of colony 
formation was broadly similar for PLGA (aligned, 0.5 CFUs; random, 0 CFUs) and PLLA 
(aligned, 0.2 CFUs; random, 0 CFUs) electrospun fibrous substrates irrespective of fibre 
orienatation; however PCL-A provided a 2-fold increase over its PCL-R counterpart 
(Figure 3.9A). 
 
The overall schema of colony formation and expansion in 2% O2 was as follows: positive 
control (5.9 CFUs) > PCL-A (2.2 CFUs) > PCL-R (1.2 CFUs) > PLGA-A (0.5 CFUs) > 
PLLA-A (0.2 CFUs) > PLGA-R ( 0 CFUs) = PLGA-R (0 CFUs). Interestingly, the 
isolation and expansion of hESC colonies could be performed on all aligned electrospun 
fibrous substrates and that irrespective of polymer, aligned electrospun fibres were 
preferable to their random counterparts. There was a significantly greater number of hESC 
CFUs on both PLGA-A and PLLA-A over their random counterparts (F(6,112) = 9.07, p< 
0.001); however, their was no significant difference found between orientation of PCL 
nanofibres. 
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In 21% O2, recovery of hESC colonies on electrospun fibrous substrates was not apparent 
but instead the attachment of tight, darkly stained, clusters of cells which had a 
morphological appearance similar to the mature EBs formed on gelatin-coated substrates 
(Figure 3.7B). The greatest number of these EB-like (EBL) cell clusters was seen on PCL 
nanofibres (aligned, 3 EBLs; random 3.8 EBLs) in comparison to all other polymer types. 
In particular, PCL-A supported the greatest number of EBL clusters with significantly 
greater number of EBL clusters than PLGA-A (F(5, 96) = 4.30, p< 0.05). EBL clusters were 
not observed on Matrigel™-coated coverslips in 21% O2 but instead the formation of an 
average of 2 CFU’s; however in 2% O2 a significantly greater of number of hESC CFUs 
were recovered relative to 21% O2 on Matrigel™-coated coverslips (F(1, 112) = 10.28, p< 
0.05) (Figure 3.9A). Overall schema for EBL clusters formation in 21% O2 was as follows: 
PCL-R (3.8) > PCL-A (3)> PLLA-R (1)> PLLA- A (0.8), PLGA-R (0) and PLGA-A (0) 
(Figure 3.9B). 
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Figure 3.9 (A) Quantification of CFUs on control (Matrigel™) and electrospun fibrous 
substrates under physiological normoxia (2%); (B) Embryoid body like clusters formed on 
fibrous surfaces in hyperoxia (21%). Values indicate mean number of forming units and 
standard deviation of n=9; *p < 0.05, **p < 0.01, ***p < 0.001. 
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Evaluation of the effect of electrospun fibrous substrates on the expansion of hESC CFUs 
in 2% O2 with regards to colony size was also investigated. Results demonstrated that, as 
anticipated significantly (p <0.001) larger sized colonies were recovered on Matrigel™ (5 
mm) relative to all electrospun fibrous substrates after 21 days of culture with ES 
conditioned media (Figure 3.10). Interestingly, amongst the electrospun fibrous substrates, 
PCL nanofibres appeared to be the overall preferential polymer type and in particular PCL-
A (2.5 mm) gave rise to significantly (p < 0.001) larger sized colonies in comparison to 
PLGA-R (0 mm), PLGA-A (0.5 mm), PLLA-R (0 mm) and PLLA-A (0.2 mm). In 
summary of these results it appears that overall PCL appeared to be the preferential 
polymer type in comparison to PLLA and PLGA for hESC colony formation and 
expansion in 2% O2 and EBL formation and expansion in 21% O2. 
 
Figure 3.10 Quantification of colony size of ES colonies formed on positive control and 
electrospun fibrous substrates in physiological normoxia (2% O2). Values indicate mean 
colony size and standard deviation of n=9; *p < 0.05, ***p < 0.001. 
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3.4.4 Pluripotency of hESCs Cultured on Electrospun Nanofibrous Substrates 
Using the conventional method of culturing hESCs in vitro, hESCs express pluripotent 
markers such as Alkaline Phosphatase (ALP), Nanog and Oct-3/4, where the former is a 
cytoplasmic marker and the latter two are intra-nuclear markers. Therefore it was 
important to investigate the pluripotency of hESCs cultured on Matrigel™ and PCL 
nanofibrous substrates (aligned and random) for 21 days with ES conditioned media in 
physiological normoxia (2% O2). As expected, results demonstrated that the expansion of 
hESC CFUs on Matrigel™ remained undifferentiated and expressed pluripotent markers: 
ALP, Nanog and Oct-3/4, as shown in Figure 3.11.  
Figure 3.11 Representative immunostained images of pluripotent gene expression (alkaline 
phosphatase, Nanog and Oct-3/4) in hESCs cultured on Matrigel
TM
 in physiological 
normoxia (2% O2) for 21 days with ES conditioned media. Scale Bar = 200 µm. 
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Despite colony morphology similarities it was important to confirm expression of 
pluripotency markers. PCL nanofibrous substrates were selected for pluripotency 
characterisation. hESCs-CFUs expanded in 2% O2, for 21 days with ES conditioned media 
on both PCL-aligned and PCL-random nanofibres expressed pluripotent markers: ALP 
(Figure 3.12), Nanog (Figure 3.13) and Oct-3/4 (Figure 3.14) as confirmed via 
immunostaining. Expression was similar on both aligned and random PCL nanofibrous 
substrates for ALP, Nanog and Oct-3/4 markers. 
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Figure 3.12 Representative immunostained images of alkaline phosphatase expression in 
hESCs cultured on electrospun nanofibrous substrates; PCL-random and PCL-aligned in 
physiological normoxia (2% O2) for 21 days. An arrow indicates the predominant direction 
of aligned fibres. Scale Bar = 200 µm.  
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Figure 3.13 Representative immunostained images of Nanog expression in hESCs cultured 
on electrospun nanofibrous substrates; PCL-random and PCL-aligned in physiological 
normoxia (2% O2) for 3 weeks. An arrow indicates the predominant direction of aligned 
fibres. Scale Bar = 200 µm. 
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Figure 314 Representative immunostained images of Oct-3/4 expression in hESCs cultured 
on electrospun nanofibrous substrates; PCL-random and PCL-aligned in physiological 
normoxia (2% O2) for 3 weeks. An arrow indicates the predominant direction of aligned 
fibres. Scale Bar = 200 µm. 
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3.4.5 Differentiation Capacity of hESCs on Electrospun Nanofibrous Substrates 
Though hESCs expanded on both PCL-aligned and PCL-random nanofibrous substrates 
with ES conditioned media in 2% O2 for 21 days expressed all typical undifferentiated 
markers (ALP, Nanog and Oct-3/4), as confirmed by immunostaining; the pluripotential 
differentiation capacity of these hESCs remained unconfirmed. hESCs are theoretically 
able to differentiate into cells of all three somatic germ layers (Ectoderm, Endoderm, and 
Mesoderm). 
 
Following recovery, hESC colonies on Matrigel™ and PCL (aligned and random) in 2% 
O2 were transferred into spontaneous differentiation media for a further 20 days. Optical 
images in Figure 3.15 demonstrate that hESC-CFUs cultured in spontaneous differentiation 
media begin to spontaneously differentiate into heterogeneous, random morphology 
populations with loss of hESC characteristics such as a high nucleus to cytoplasmic ratio. 
At day 21 of hESCs cultured in spontaneous differentiation media, cells appear much 
larger and different in shape on all three substrates: Matrigel™, PCL-A and PCL-R 
nanofibrous substrates. As expected, differentiating hESCs begin to migrate out of their 
colonies and become more spaced out, particularly on PCL-A and PCL-R nanofibrous 
substrates demonstrated in Figure 3.15. 
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Figure 3.15 Representative optical microscopy images of hESC CFUs (expanded for 21 
days with ES conditioned media) and spontaneously differentiated hESC-CFUs for a 
further 21 days using spontaneously differentiating media, formed on Matrigel™, PCL 
aligned and PCL random nanofibrous substrates in physiological normoxia (2% O2). Scale 
bar = 200 µm. 
 
Gene expression analysis of spontaneously differentiated hESC demonstrated that gradual 
down regulation of POU5F1 (Oct-3/4) and human Telomerase reverse transcriptase 
(hTERT, associated with telomere lengthening resulting in immortaility of hESCs) was 
immediately apparent on Matrigel™-coated and PCL-A coated coverslips and less so on 
PCL-R (Figure 3.16). The retention of pluripotential differentiation capacity was evidenced 
by the expression of transcription factors associated with the three germ layers; ectoderm 
(SOX1), endoderm (AFP), and mesoderm (ACTC1). SOX1 and ACTC1. However, there 
were slight differences in expression witnessed dependent on the substrate on which 
hESCs were cultured. SOX-1 expression was visible from day 0 to day 10 on Matrigel™, 
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whereas on PCL-R and PCL-A expression was evident from day 0 to day 20, although this 
was weaker expression compared to SOX-1 expression in hESCs cultured on Matrigel™. 
AFP expression was visible up to day 5 on Matrigel™ and up to day 10 for both PCL-A 
and PCL-R substrates. ACTC-1 expression was strong and visible from day 0 to day 20 on 
all three substrates (Matrigel™, PCL-A and PCL-R) 
 
 
Figure 3.16 RT-PCR ran on 2% Agarose Gel electrophoresis to evidently illustrate the 
presence and expression levels of various genes, on both PCL aligned and random 
nanofibrous substrates including positive control (Matrigel™). Qualitative gene expression 
was investigated at different time points during spontaneous differentiation. Genes 
investigated include: GAPDH (housekeeping gene), POU5F1 (pluripotent marker), TERT 
(immortality marker) SOX1 (ectoderm germ layer), ACTC1 (mesoderm germ layer) and 
AFP (endoderm germ layer). 
 
Having identified the differentiation capacity of hESCs towards all three somatic germ 
layers (ectoderm, endoderm and mesoderm) on PCL electrospun nanofibrous substrates in 
physiological normoxia (2% O2), the ability of hESCs to differentiate further into the 
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mesoderm lineage to become specialised cells of the skeletal lineages was also investigated 
on Matrigel™, PCL aligned and PCL random nanofibrous substrates. Expanded hESC-
CFUs on all three substrates for 21 days in physiological normoxia (2% O2) were 
differentiated into adipogenic, chondrogenic and osteogenic lineages using respective 
differentiation media’s for a further 21 days. Differentiated hESCs on all three substrates 
were fixed and stained using corresponding differentiation media’s; lipids (adipose tissue) 
were stained using oil red O, sulphated glycosaminoglycans (GAGs; cartilage tissue) were 
stained using alcian blue and calcium ions (bone tissue) were stained using alizarin red 
(Figure 3.17). Observations revealed that undifferentiated hESCs on all three substrates 
were negative for all three stains. All three substrates stained positive for lipids (indicated 
by red stain); greatest intensity of the stain was observed on Matrigel™ in comparison to 
PCL nanofibrous substrates (aligned and random). Chondrogenic differentiation of hESCs 
was evaluated by staining sulphated GAGs; though all three substrates stained positive for 
sulphated GAGs (indicated by blue stain), it was apparent that the nanofibres enhanced 
chondrogenic differentiation indicated by a greater secretion of GAGs in comparison to 
Matrigel™. Evaluation of hESC osteogenic differentiation was demonstrated by positive 
staining for secreted calcium ions (indicated by red stain). Despite similar intensity of 
staining on all three substrates, there was a visible difference in organisation of secreted 
calcium ions in the matrix; on PCL random nanofibres calcium ions were gathered in large 
rounded clumps in comparison to PCL aligned nanofibres where calcium ions within the 
secreted matrix were aligned parallel to the direction of the nanofibres. 
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Figure 3.17 Representative optical images of respective histology stains of differentiated hESC CFUs into skeletal lineages. hESCs were 
expanded on PCL aligned and random nanofibrous substrates using ES maintenance media for 21 days in physiological normoxia (2% O2); 
media was then switched to differentiation media specific for adipogenesis, chondrogenesis and osteogenesis for a further 21 days. Differentiated 
hESCs were fixed and stained for lipids (adipose tissue), sulphated glycosaminoglycans (cartilage tissue) and calcium ions (bone tissue) using 
relevant histological stains. Scale bar = 200 µm. 
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3.4.6 The effect of Fibre Diameter on the Recovery and Expansion of hESC-CFUs in 
Physiological Normoxia (2% O2) 
It has recently been documented that fibre diameter can influence the ability of cells to adhere, 
proliferate and differentiate [Badami et al., 2006]; however trends that occur are specific to both 
cell type and the substrate properties. PCL-A and PCL-R nanofibrous substrates were fabricated 
with two different fibre diameters for each fibre orientation. FESEM visualisation shows fibre 
morphology of the non-beaded PCL nanofibres as well as the difference in fibre diameter (Figure 
3.18). FESEM also further permitted fibre diameter analysis; in both cases for aligned and random 
nanofibres, the larger diameter nanofibres (PCL-A, 521 nm; PCL-R, 660 nm) were significantly (p 
< 0.01) greater than their smaller counterparts (PCL-A, 280 nm; PCL-R, 318 nm) as evaluated in 
Figure 3.19. 
 
Figure 3.18 Scanning Electron Microscopy images of electrospun PCL nanofibrous 
substrates (Aligned and Random) with varying fibre diameter. Scale Bar = 3 µm. 
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Figure 3.19 Graph representing the average fibre diameters of both aligned and random 
electrospun nanofibres fabricated from PCL with varying fibre diameter. Values indicate 
mean fibre diameter and standard deviation of n=20; **p < 0.01, 
 
hESCs were cultured on PCL-A and PCL-R nanofibrous substrates with large diameters   
(-A = 521 nm and –R= 660 nm) and small diameters (-A = 280 nm and –R = 318 nm) with 
ES conditioned media in physiological normoxia for 21 days. Giemsa staining of recovered 
colonies revealed as anticipated Matrigel™ surfaces to support significantly greater 
number of hESC CFUs than any nanofibrous substrate regardless of fibre orientation and 
diameter. Amongst the nanofibrous substrates, the smaller diameter nanofibres for both 
PCL-A and PCL-R recovered a greater number of hESC colonies compared to their larger 
diameter counterparts (Figure 3.20A). Morphological evaluation of recovered hESC 
colonies on each substrate was also visualised shown in Figure 3.20B. 
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Figure 3.20 Relationship between PCL aligned and random nanofibrous substrates at 
various diameters and hESC CFU ability. (A) Quantitative analysis of the number of hESC 
colonies formed on Matrigel™ PCL nanofibres where SD denotes for “small diameter (Ø 
280-318 nm)” and LD stands for “large diameter (Ø 521-660 nm)”. (B) Representative 
optical microscopy images of Giemsa stained optical microscopy images of hESC colonies 
on the various substrates investigated. Scale bar = 200 µm.  
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3.5 Discussion 
A novel substrate and culture conditions for hESCs have been identified and developed 
with the capacity to support the culture and expansion of hESCs whilst retaining their 
undifferentiated state, with scaleable opportunities sufficient for clinical therapies. 
However, the effectiveness of the substrate to support the expansion of hESCs is very 
much reliant on the oxygen environment. The novelty of the findings in this chapter 
demonstrates the synergistic effect of nanofibre and oxygen environment.  In combination 
they eliminate the use of Matrigel™ preventing xenocontamination exposure as well as 
providing basic foundations for a potential transportable and a transplantable substrate for 
the use of hESC-derived differentiated cells in clinical therapeutics including tissue 
engineering and regenerative medicine applications.  
 
hESCs expanded on electrospun fibrous substrates fabricated from FDA approved 
polymers (PCL, PLGA and PLLA) in both aligned and random conformations 
demonstrated their suitability for CFU expansion. PCL was then further exemplified as 
supportive of hESC culture through hESC morphology, CFU morphology, pluripotentcy 
marker expression, germ layer gene expression, and mesodermal differentiation capacity. 
However, this phenomenon was apparent in physiological normoxia (2% O2) only. These 
unique findings demonstrate several advantages over current attempts to culture hESCs on 
nanofibrous substrates; where many studies have shown to be reliant on either co-culture 
of MEFs (feeder layers) or the use of composite polymers (natural and synthetic) to 
encourage hESCs to recognise attachment sites for adhesion with the compromise of losing 
hESC pluripotency. This chapter is the first to demonstrate the use of purely synthetic 
polymers in both aligned and random conformations, in combination with the effects of 
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lower oxygen concentrations on the expansion of undifferentiated hESCs. However, 
limitations associated with this substrate include the lack of 3D structure (at the cellular 
level) of the substrate and the importance in maintaining the nano-architectural feature (at 
the cellular level) within a 3D construct. 
 
Of the polymers tested, PCL supported the recovery of the greatest number of hESC 
colonies. Colony Size, morphology, pluripotency and differentiation capacity were very 
similar between electrospun PCL nanofibres and positive controls (Matrigel™). The 
largest CFUs were observed on Matrigel™-coated and PCL-A nanofibre-coated coverslips. 
PCL belongs to the aliphatic polyester group of polymers and is considered to be semi-
crystalline with resorbable properties permitting a slow degradation rate as a result of its 
chemically stable and hydrophobic nature [Barnes et al., 2007; Kweon et al., 2003]. This 
data therefore suggests that degree of hydrophobicity and alignment may be suitable 
characteristics for hESC culture. PCL has FDA approval for use in medical devices due to 
its ready biodegradability into non-toxic by-products and its in vitro and in vivo 
biocompatibility. Previous cell-based studies have shown that electrospun PCL 
nanofibrous scaffolds can support numerous cell types including skeletal muscle cells 
[Choi et al., 2008], schwann cells [Schnell et al., 2007], fibroblasts [Chong et al., 2007], 
bone marrow derived-MSCs [Li et al., 2005], human cord-blood derived somatic stem 
cells [Hashemi et al., 2009], mouse ESCs [Xie et al., 2009] and hESCs [Gauthaman et al., 
2009].  
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The architectural structure of the extracellular matrix includes a network of nano- and 
micro fibres made up of structural, basement membrane proteins such as collagen and 
laminin. The attempt to mimic this native ECM architecture using synthetic electrospun 
nanofibres has encouraged the attachment and expansion of undifferentiated hESCs. This 
has been particularly demonstrated by the retention of the typical hESC morphology as 
small rounded cells with a high nucleus to cytoplasmic ratio,  and the maintainance of the 
characteristic feature of expanding in tightly adherent, compact colonies, between the 
expanded hESCs on PCL (aligned and random) nanofibrous substrates and Matrigel™. 
These observations were corroborated with the expression of pluripotent gene markers 
including Alkaline phosphatase, Oct-3/4 and Nanog at similar intensities between PCL and 
Matrigel™. Evaluation of the differentiation capacity of expanded hESCs on PCL 
substrates validated their ability to express gene markers for all three somatic germ layers 
(Ectoderm, Endoderm and Mesoderm).   
 
Wettability of the nanofibrous substrates was investigated using water contact angle 
analysis. Wettability can be affected by many factors including polymer chemistry, surface 
roughness, and topography. Increasing the hydrophilic nature of a substrate would result in 
greater wettability and increased adsorption of proteins from media with subsequent 
increase in cell attachment. Hence, increasing the hydrophilic nature of a substrate as 
demonstrated by a previous study where natural polymers (collagen and gelatin) were 
incorporated into PCL to fabricate nanofibrous substrates for culturing hESCs, improved 
their biocompatibility and thus cell affinity resulting in their attachment and proliferation. 
Water contact angle analysis demonstrated that all nanofibrous substrates investigated in 
this chapter had insignificant differences in terms of wettability regardless of polymer type 
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and orientation, although PCL is generally considered more hydrophobic in nature relative 
to PLGA and PLLA. 
 
Topography is also considered to have strong effects on cell activity [Badami et al., 2006], 
as it provides physical guidance, which is able to mimic native fibrillar ECM proteins, a 
key component of the stem cell niche [Ravichandran et al., 2009]. Cell adherence has been 
demonstrated to be directly under the influence of nanotopography (nanofibres) rather than 
the chemistry of the polymer itself [Schindler et al., 2005]. This was also demonstrated by 
preliminary data which revealed that polymer films (acting as a material control) fabricated 
from PCL, PLGA and PLLA, supported embryoid body-like cluster formation and no 
CFU’s, regardless of oxygen concentration. However, further work would be required to 
fully confirm this statement. Many studies have demonstrated the ability of electrospun 
nanofibrous substrates in combination with chemical cues to induce the differentiation of 
stem cells such as hMSCs/ESCs and other stem cells towards skeletal lineages such as 
adipose, bone and cartilage tissue [Bielby et al., 2004; Li et al., 2005; Smith et al., 2009; 
Wimpenny et al., 2010; Xie et al., 2009]which were confirmed by typical histological 
stains for specific ECM proteins and RT-PCR for transcriptional markers up regulated for 
each lineage. Furthermore, the substrates used in this chapter (electrospun PCL aligned and 
random nanofibrous substrates) supported hESC differentiation towards adipogenic, 
chondrogenic and osteogenic lineages as confirmed by histological stains for lipids, GAGs 
and calcium ions, respectively. Furthermore topography has also demonstrated to support 
the expansion of stem cells in an undifferentiated state; ESCs and hMSCs have been 
previously reported to expand on electrospun nanofibrous substrates while retaining their 
stemness, which further supports the data from this chapter [Chan et al., 2009; Jin et al., 
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2004; Li et al., 2005; Nur-E-Kamal et al., 2006]. However, in all of these cases, ESCs 
were reliant upon co-culture with other cells such as feeder layers or the combination of 
natural polymers electrospun with the synthetic polymer. None of these studies 
investigated the effects of purely synthetic polymers without the use of feeder layers for 
the attachment and expansion of undifferentiated hESCs. Nanofibres have an increased 
surface area to volume ratio which increases the number of focal adhesions sites a cell can 
form with numerous surrounding nanofibres. Increase in anisotropy is known to further 
increase the number of focal adhesion contacts from the cells to the surrounding fibres 
which may be the reason why aligned nanofibres support larger and greater number of 
CFU’s [Yang et al., 2005]. Anisotropy has shown to be particularly important during 
neural stem cell differentiation towards functional nerve cells with increased neurite 
outgrowth on aligned nanofibres and enhanced differentiation of hMSCs into mesoderm 
lineages [Pittenger et al., 1999; Schnell et al., 2007]. Findings from this chapter further 
demonstrate that anisotropy also plays an important role in stimulating cell proliferation of 
hESCs during culture in physiological normoxia (2% O2).  
 
It is important to note that different cell types behave differently and may prefer a certain 
type of substrate, dependant on hydrophilicity, topography and stiffness. PCL has modest 
bulk mechanical properties with a tensile modulus of 200-400MPa. When compared to 
other polymers used in this chapter (PLLA, up to 3-4 GPa; PGA, up to 6-7 GPa) , it is 
evident that PCL is less stiff and thus hESCs in particular may prefer a softer substrate for 
attachment and expansion [Mano et al., 2004]. Extensive studies investigating the 
relationship between stem cell fate and the stiffness of substrate matrix have demonstrated 
that with changing substrate modulus, hMSCs and ESCs can differentiate into various 
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lineages including bone, muscle and brain [Li et al., 2011]. Furthermore, softer hydrogels 
with a lower modulus increased the proliferation rate of hESCs [Lee et al., 2010], which 
also lies in agreement with observations by [Evans et al., 2009], where 
polydimethlysiloxane substrates with varying stiffness demonstrated to influence ESC 
proliferation and differentiation; in this study softer substrates enhanced cell attachment 
and proliferation rate whereas stiffer substrates induced their differentiation towards an 
osteogenic lineage [Evans et al., 2009].  
 
The impact of fibre diameter on cell activities including attachment and proliferation with 
various other cell types but not hESCs [Badami et al., 2006]. A study by Kwon et al., 2005 
described how fibres with a smaller diameter supported greater attachment and 
proliferation of human umbilical vein endothelial cells (HUVEC) [Keun Kwon et al., 
2005]. However, speculation still remains with regards to whether or not this is a generic 
trend or is influenced by several other factors including; degree of hydrophilicity, the cell 
type and the substrate stiffness. Nonetheless, data from this chapter supports the findings 
from [Keun Kwon et al., 2005]. PCL nanofibres were the thinnest fibres; Ø 280 nm and Ø 
318 nm for PCL-aligned and PCL-random, respectively; these fibres supported the greatest 
number of hESC-CFUs in contract to PLLA-A which were the thickest fibres (2506 nm) 
but yielded the smallest number of CFUs. These observations were further corroborated 
with colony size analysis which demonstrated that thinner nanofibres (PCL-aligned and 
PCL-random) supported greater proliferation represented by the formation of much larger 
colonies relative to thicker fibres such as PLLA-A. In depth investigations into the effect 
of fibre diameter on hESC expansion included electrospinning the preferential material 
PCL with tailored fibre diameters. Results demonstrated a similar trend where thinner 
fibres supported the greatest number of hESC-CFUs.  
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A similar trend was also determined by a previous study using hMSCs where nanofibrous 
scaffolds fabricated from 0.5% PLGA and 10% PCL had fibre diameters <280 nm but 
supported the greatest number of colonies in both physiological normoxia (2% O2) and 
hyperoxia (21% O2) (A combination of hMSC and hESC CFU recovery as a result of fibre 
diameter is demonstrated in Figure 3.21A). These observations have broad agreement 
across the field where fibre diameters of <500 nm generally promote cell adhesion and 
encourage greater cell attachment due to increased surface area to volume ratio with an 
associated increase in the probability of focal adhesion sites available for cell attachment 
[Ma et al., 2008; Ravichandran et al., 2009]. Fibre diameter may therefore play a pivotal 
role of more importance than the chemistry of the polymer itself (as preliminary data 
showed that polymer films supported the formation of embryoid body-like clusters rather 
than CFUs’). Furthermore, by tailoring the diameter of fibres electrospun from PLGA and 
PLLA, which under performed in comparison to PCL could enhance hESC CFU ability. 
Analysis of data also revealed the direct influence of fibre diameter on the size of CFUs 
recovered regardless of polymer chemistry. As shown in Figure 3.21, decreasing fibre 
diameter also resulted in an increase in colony size   
 
Figure 3.21 Graphs representing relationship between hESC and hMSC CFU phenomenon and 
fibre diameter; (A) number of colonies formed on various fibre diameters and (B) CFU size 
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influenced by fibre diameter on which they were cultured. Red circles indicate Matrigel
TM
 control 
values. 
 
The biocompatibility of a substrate dictates its ability to support cell activity such as 
attachment, proliferation and differentiation. In particular, the surface interface of the 
substrate is a dynamic environment and upon contact with biological fluid or media 
(during in vitro culture) initiates the adsorption of proteins to its surface and subsequent 
cell attachment. Protein adsorption is thus dependant on the availability of functional 
groups on the substrate, the polarity of the functional groups on the substrate as well as 
protein characteristics and their conformational changes. ECM proteins such as fibronectin, 
laminin and collagen IV are known to exist abundantly in hESC cultures; this leads to the 
speculation that there is a possibility in the difference of concentration of these proteins 
adsorbing to the various substrates investigated in this chapter resulting in a difference in 
cell attachment. Furthermore, the potential of PCL nanofibres to adsorb these ECM 
proteins and in turn for these proteins to have a high affinity for this substrate in an active 
conformational state result in more effective cell attachment in comparison to PLGA and 
PLLA. Physical entrapment of a greater number of proteins within thinner nanofibrous 
substrates may also enhance the concentration of crucial ECM proteins being present on 
PCL substrates allowing increased availability of recognised attachment sites for 
corresponding membrane receptors situated on hESCs. However, further investigations 
would be required to validate this hypothesis.  
 
It has been reported that selective adsorption of key ECM proteins on nanofibrous 
substrates can alter hESC cytoskeletal morphology on the fibres, consequently resulting in 
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the activation of Rac-AKT-JNK signalling pathways which maintain stem cell 
pluripotency [Nur-E-Kamal et al., 2006]. However, this cross-talk between cells and its 
surrounding ECM occurs through membrane receptors known as integrins, which permits 
the initial attachment of cells to their ECM and can influence several cellular activities. 
Integrins are able to interact with corresponding ECM ligands (such as fibronectin and 
laminin) that are initially adsorbed onto synthetic substrates depending on their 
conformation shape which determines their affinity for integrins. Additionally, integrins 
also become activated by ECM proteins permitting their initial adhesion and proliferation. 
As the results of this chapter have revealed a synergistic effect on hESC colony formation 
through combining physiological normoxia (2% O2) and nanofibrous substrate; this leads 
to the hypothesis that there may be a difference in integrin expression pattern dependant on 
the oxygen environment in which hESCs have been cultured which permits hESC 
attachment and proliferation on nanofibrous substrates to form undifferentiated hESC 
colonies under 2% O2 and EB-like structures under 21% O2.  
 
3.6 Conclusion 
A novel substrate for hESC expansion in the form of electrospun nanofibrous substrates 
fabricated from purely synthetic, FDA approved polymers demonstrated the ability to 
support the attachment and expansion of hESCs whilst retaining their undifferentiated 
state. However, a synergistic effect was apparent between nanofibres and oxygen 
concentration which supported this phenomenon; this was apparent in physiological 
normoxia (2% O2) only, as in 21% O2 hESCs demonstrated the expansion of embryoid 
bodies instead. As expected, Matrigel™ supported the greatest recovery of hESC colonies 
but the preferential synthetic material for hESC expansion in either oxygen environment 
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was PCL. Furthermore, aligned nanofibrous substrates significantly performed better over 
their random counterparts as demonstrated by CFU numbers and size. Overall, amongst the 
electrospun fibrous substrates, PCL-aligned significantly provided the optimal results. 
Characterisation of hESC expansion on optimal substrates (PCL nanofibres) in optimal 
oxygen conditions (2% O2) indicated that hESCs expressed undifferentiated markers such 
as alkaline phosphatase, Oct-3/4 and Nanog as well as hESCs cultured on Matrigel™. 
Additionally, pluripotential differentiation capacity evaluation of hESCs expanded on PCL 
nanofibrous substrates demonstrated the ability of expanded hESC colonies to express 
SOX1 (ectoderm germ layer), AFP (endoderm germ layer) and ACTC1 (mesoderm germ 
layer). Investigating the relationship between fibre diameter and expansion of hESC-CFUs 
in optimal conditions such as PCL-nanofibrous substrates and 2% O2 indicated that by 
tailoring fibres to a thinner diameter from Ø 521 – 660 nm to Ø 280 – 318 nm significantly 
increased the number of recovered hESC-CFUs. 
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4. Identification of Adhesion Determining Molecules in hESCs 
 
4.1 Introduction 
The previous chapter demonstrated the ability of FDA approved synthetic substrates to 
support the attachment, and expansion of hESCs in a defined environment dependent upon 
polymer type, fibre orientation, fibre diameter, and oxygen environment. The optimal 
conditions were identified as a PCL substrate, in aligned conformation, with fibre diameter 
in the range of 280 nm and physiological normoxic conditions (2% O2) for the expansion 
of undifferentiated hESCs with typical morphological characteristics, retention of 
pluripotential markers and differentiation capacity. However, these yielded a lower number 
of colonies in comparison to the conventional Matrigel
TM
 method, which remains as the 
optimal method for the expansion of undifferentiated hESCs in vitro. Minimal research has 
been performed to investigate the exact mechanisms which dictate the specificity of hESCs 
to adhere to substrates such as Matrigel
TM
.
 
 
 
Matrigel
TM 
is comprised of extracellular matrix (ECM) proteins including laminin-111, 
collagen IV, heparin sulphate proteoglycans, entactin, fibronectin, growth factors, matrix-
degrading enzymes and their inhibitors; and other undefined components [Xu et al., 2001]. 
Thus, Matrigel
TM
 is a broad-range substrate which, alongside medium provided 
components (i.e. FGF2), provides essential cues for hESC in vitro expansion. The ECM 
attachment of hESCs is primarily mediated by integrins (heterodimeric, transmembrane 
glycoproteins) and other surface receptors [Humphries et al., 2006]. Broadly, integrin 
functions include mediating cell-cell and cell-ECM interactions and bidirectional 
signalling between the cytoskeleton and ECM. As a result, integrins can detect and 
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transmit physical and chemical changes in the ECM to the intracellular regions of the cell 
or vice versa, triggering a cascade of intracellular pathways. The integrin family is 
comprised of 18 α-subunits and 8 β-subunits, with 24 recognised distinct heterodimer 
arrangements each with a specific set of functions [Humphries et al., 2006; Hynes, 2002; 
Wong and Bernstein, 2010]. For example, the β1 subunit can heterodimerise with, 
minimally, 12 distinct α chains to form integrin dimers found on cell types representative 
of the three germ layers [Meng et al., 2010].  
 
ECM proteins which are essential for hESC adhesion and pluripotency retention have been 
identified as laminin-111, collagen IV, fibronectin and vitronectin [Prowse et al., 2011]. 
Laminin, a key developmental, structural ECM protein, is an essential component of 
virtually all basement membranes [Cooper et al., 1991]. Critical roles of laminin include 
the mediation of cell adhesion, cell spreading, cell migration and proliferation. There are 
many associated integrin receptors for laminin including; αβαβandαβαβ1 is 
considered to be specific to laminin while the α6Bβ1 variant is expressed by pluripotent 
hESCs [Cooper et al., 1991]. Integrin subunits and heterodimers detected on the surface of 
hESCs include α2α3α5α6, α11βand αVβ5. These subunits can heterodimerise to 
form receptors specific to fibronectin (α5β1), vitronectin (αVβ5), collagen and laminin 
(α2β1) and laminin-111 (α6β1) Furthermore, α9β1 (integrin receptor for collagen, laminin 
and VCAM1) has also been recognised as an essential mediator for maintaining hESC 
pluripotency [Lee et al., 2010]. Fibronectin, bound by the α5β1 heterodimer, is one of the 
major substrate proteins found within MEF-conditioned media [Braam et al., 2008]. A 
recent study demonstrated that antibody-directed blockage of the α5β1 heterodimer 
impacted hESC attachment across a range of defined substrate coatings including collagen 
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IV, laminin and entactin, when cultured with MEF-conditioned media, suggesting that 
fibronectin is secreted by feeder cells which adsorbs onto surfaces thus promoting hESC 
adherence [Braam et al., 2008]. In defined media (mTeSR1), blocking α5β1 had no effect 
on hESC attachment to a vitronectin-coated substrate but hindered adhesion to all other 
ECM protein substrates (laminin, entactin, and collagen IV), suggesting that hESC 
substrate adhesion via αVβ5 is adequate for expansion of hESCs when cultured using 
defined media [Braam et al., 2008]. 
 
The oxygen environment has a direct influence on the intracellular pathways of stem cells, 
specifically hESCs. This occurs by a combinatory effect of oxygen (a bioactive signalling 
molecule) and other regulatory factors (integrins) that can influence a change in hESC 
activities including survival, proliferation and differentiation [Zachar et al., 2010]. hESCs 
are exposed to a physiological normoxic (2% O2) environment in vivo where the ICM of a 
blastocyst (from which they are derived) is surrounded by a trophoblast shell that prevents 
their exposure to oxygenated material blood. The pluripotency of hESCs has been proven 
to be primarily regulated by these hypoxia inducible factors (HIFs) which are expressed in 
decreased oxygen environments. HIFs are heterodimeric, environment sensing [Mohyeldin 
et al., 2010], transcriptional factors and are comprised of α and β sub-units. There are three 
oxygen dependant isoforms of the α-subunit which are HIF-1α (120 kDa), HIF-2α (EPASI) 
and HIF-3α; these can bind to two types of β sub-units which are HIF-1β and HIF-2β. 
[Forristal et al., 2010; Szablowska-Gadomska et al., 2011]. The expression of HIFs have 
known to have a direct influence on the up regulation and down regulation of several genes 
that are associated with cell survival, proliferation, angiogenesis, glucose metabolism and 
cell apoptosis [Szablowska-Gadomska et al., 2011]. Furthermore, previous studies on the 
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effects of reduced oxygen on hESC culture have demonstrated enhanced clonogenicity, 
decreased in vitro spontaneous differentiation, maintenance of pluripotency for prolonged 
periods, reduced chromosomal aberration frequency, improved consistency of embryoid 
body formation, significant transcriptional alterations, and permissive single-cell derived 
progenitor isolation [Ezashi et al., 2005; Forsyth et al., 2008; Forsyth et al., 2006; Hewitt 
et al., 2006; Westfall et al., 2008]. Further details of the effects of hypoxia on hESCs can 
be found in section 1.4, Chapter 1. 
 
Though recent attempts have been made to identify the critical interactions between hESC 
integrins and corresponding ECM adhesion proteins the key interactions remain to be fully 
elucidated and as a result Matrigel
TM
 still remains the gold standard for in vitro hESC 
expansion despite mediocre attachment, inconsistent proliferation and limitations including 
xenogenic contaminations. In this study, a detailed investigation is performed to determine 
the effects of a reduced oxygen environment on hESC integrin expression, seeking to 
understand and identify the mechanisms of action and critical interactions associated 
between specific integrins and ECM proteins with defined culture parameters which permit 
hESC attachment and undifferentiated expansion. These findings could help to drive the 
future development of novel substrates designed to improve the yield of hESC attachment, 
improve expansion efficiency, help retain a more homogenous population of 
undifferentiated hESCs, eliminate scale-up issues resulting in the elimination of 
Matrigel
TM 
and xenogenic contaminations. This would result in key implications of hESCs 
for clinical application coupled to in vivo post-transplantation modelling. 
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4.2 Aims and Objectives 
The oxygen environment can influence the attachment and proliferation of hESCs. 
Furthermore, reduced oxygen concentrations enhance hESC clonogenicity, minimise 
spontaneous differentiation, maintain pluripotency for prolonged in vitro cultures and 
reduce chromosomal aberrations. It can be hypothesised that due to improved 
clonogenicity as a result of change in oxygen environment, this suggests a potential for 
altered integrin expression resulting in enhanced colony formation through improved hESC 
attachment and expansion on Matrigel™. 
 
The aims of this chapter were as follows: 
 To evaluate the up regulation and down regulation of integrins between hESCs 
cultured in both physiological normoxia (2% O2) and hyperoxia (21% O2) 
 To identify the critical oxygen responsive integrins within hESCs cultured in both 
physiological normoxia (2% O2) and hyperoxia (21% O2) 
 Select the significant oxygen responsive integrins in hESCs and investigate their 
importance on cell attachment via antibody blocking adhesion assays. 
 Characterise and quantify the expression of significant oxygen responsive integrins 
in hESCs cultured in both physiological normoxia (2% O2) and hyperoxia (21% O2) 
 To investigate the effect of blocking the αVβ5 integrin receptor in hESCs on their 
ability to adhere to nanofibrous substrates when cultured in physiological normoxia 
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4.3 Materials and Methods 
Microarrays are a powerful, efficient technique which provides the ability to identify and 
quantify expression patterns of hundreds and thousands of genes in a short period, in 
parallel. DNA microarrays utilise cDNA or oligonucleotides as gene probes where 
amplified cDNA fragments in a high density pattern are identified on solid surface such as 
glass. [Kothapalli et al., 2002] Previous in silico Microarray experiments performed by our 
research group on hESCs cultured in both physiological normoxia (2% O2) and hyperoxia 
(21% O2) were reanalysed and statistically evaluated to identify oxygen-responsive 
integrin sub-units and determine changes in their expression levels. 
 
Integrin adhesion blocking assays were performed to investigate the effect of blocking 
significantly expressed integrins/sub-units on hESC attachment after 24 hours on 
Matrigel
TM
, cultured in either 2% O2 or 21% O2; the methodology is summarised in Figure 
4.1 below. A detailed protocol is stated in Section 2.4.2, Chapter 2. 
 
 
Figure 4.1 Schematic demonstrating the protocol used for antibody blocking of hESCs for 
cell adhesion investigations. 
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Immunocytochemistry analysis was used to visualise αVβ5 and CD44 expression and 
monitor changes in expression levels. hESCs cultured in both 2% and 21% O2 were fixed, 
BSA blocked and treated with primary antibodies specific to αVβ5 and CD44 receptors at 
50 µg/ml concentration for 24 hours and then treated with secondary antibody and 
counterstained with DAPI. Immunocytochemistry was used to characterise the expression 
of markers associated with pluripotency (Oct 3/4, Nanog, Alkaline Phosphatase and SSEA-
4) of hESCs after being blocked with αVβ5 and CD44 at 50 µg/ml for 24 hours in the 
relevant oxygen environments (2% O2 and 21% O2). A fluorescent microscope was then 
used to detect and visualise these fluorescently tagged markers within hESCs. Detailed 
protocol is stated in Section 2.4.3, Chapter 2 
 
Fluorescent-activated cell sorting (FACS) allows the quantification of cells that 
specifically express surface antigens that are recognised specifically by a fluorescently-
tagged antibody. FACS was used to quantify the expression of αVβ5 and CD44 in hESCs 
cultured in both physiological normoxia (2% O2) and hyperoxia (21% O2). Detailed 
protocol is described in Section 2.4.3.3, Chapter 2. 
 
hESCs were treated with and without anti-αVβ5 antibody solution before seeding and 
culturing them onto Matrigel™ and nanofibrous substrates (PCL aligned and random) in 
physiological normoxia for 21 days. Colonies were fixed and stained with Giemsa and 
counted for quantification.  
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4.4 Results 
4.4.1 In Silico Micro Array Analysis 
Previous reports have detailed widespread transcriptional alterations as a consequence of 
culturing hESCs in reduced oxygen environments [Forsyth et al., 2006; Westfall et al., 
2008]. The data set obtained previously by Forsyth et al was re-analysed to determine the 
integrin sub-units expression level in hESCs. Three hESC lines (H1, H9 and RH1) were 
investigated. Though these cell lines are different to the cell line used in this thesis (SHEF 
1), it has been reported that most hESC cell lines show broad equivalence of transcriptional 
protein expression and phosphorylation sites [Phanstiel et al., 2012]. Analysis of data 
revealed that integrin sub-units: β3 binding protein, β1 binding protein 1, β4 binding 
protein, α5, α6, α8, α9, αD, αE, αV, β1 and β5 were all expressed significantly higher in 
hESCs cultured in physiological normoxia (2% O2) when compared to hyperoxia (21% O2) 
as shown in Figure 4.1. Analysis of data revealed that the following integrin sub-units were 
expressed significantly higher in physiological normoxia (2% O2) relative to 21% O2: β1 
binding protein 1 (p < 7 x 10
-3
), αE (p < 3 x 10-4), β3 binding protein (p < 3 x 10-3), α6 (p < 
2 x 10
-4
), αV (p < 1.5 x 10-4), β5 (p < 1 x 10-3), α9 (p < 0.01), β4-binding protein (p < 
0.02), β1, (p < 0.03), α5 (p < 0.04) and αD (p < 0.05), , and. However, the order of relative 
intensity fold-change (FC) of these integrins with significance in 2% O2 over 21% O2 
culture was; D (2.25 FC), V (1.64 FC), 9 (1.54 FC), 5 (1.36 FC), 6 and E (1.31 
FC), β4 binding protein (1.26 FC), , 1 and β1 binding protein 1 (1.20 FC), 5 (1.16 FC) 
and β3 binding protein (1.09 FC), as shown in Table 4.1  
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Hyaluronic acid associated gene expression was also analysed in hESCs cultured in both 
physiological normoxia (2% O2) and hyperoxia (21% O2); these were investigated as  
Hyaluronic acid (HA) is known to promote hESC proliferation and associated intracellular 
pathways [Bourguignon et al., 2008; Gerecht et al., 2007] Significantly higher levels of 
expression were noted in 2% O2 cultured hESCs relative to hESCs cultured in 21% O2 for; 
Hyaluronan-mediated motility receptor, RHAMM (1.43 FC), Hyaluronoglucosaminidase 
(1.25 FC) and Hyaluronan and proteoglycan link protein-3 (0.90 FC), as stated in Table 4.1 
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Table 4.1 Expression units (relative) from microarray analysis for all integrins expressed in 
hESCs cultured in physiological normoxia (2% O2) and hyperoxia (21% O2). F/C indicates 
Fold Change (2% O2/21% O2) Integrins expressed significantly higher in hESCs cultured 
in 2% O2 relative to 21% O2 are highlighted in bold.  
Gene Symbol (Gene Name) 2% O2 21% O2 P Value Fold Change 
ITGB1BP2 (Integrin beta 1 binding 
protein 2) 
16.25 11.79 0.14 1.38 
AaeL-AAEL007077 (Integrin beta 
1 binding protein 1) 
212.15 177.21 7x10-3 1.20 
ITGB1BP3 (Integrin beta 1 binding 
protein 3) 
496.54 544.12 0.47 1.10 
ITGB3BP (Integrin beta 3 binding 
protein) 
595.30 545.43 3 x10-3 1.09 
LOC658655 (Integrin beta 4 
binding protein)  
1354.68 1074.23 0.02 1.26 
ITGA1 (Integrin alpha 1) 25.87 27.10 0.77 1.05 
ITGA10 (Integrin alpha 10) 39.93 34.89 0.43 1.14 
ITGA11 (Integrin alpha 11) 88.46 91.98 0.65 1.04 
ITGA2 (Integrin alpha 2) 21.55 28.47 0.24 1.32 
ITGA2B (Integrin alpha 2b) 64.27 67.22 0.63 1.05 
ITGA4 (Integrin alpha 4) 23.37 18.80 0.35 1.24 
ITGA5 (Integrin, alpha 5) 182.51 134.33 0.04 1.36 
ITGA6 (Integrin alpha 6) 1229.82 938.91 2 x10-4 1.31 
ITGA7 (Integrin alpha 7) 163.05 117.39 0.24 1.39 
ITGA8 (Integrin alpha 8) 34.53 43.15 0.09 1.25 
ITGA9 (Integrin alpha 9) 43.93 28.54 0.01 1.54 
ITGAD (Integrin alpha D) 25.82 11.50 0.05 2.25 
ITGAE (Integrin alpha E) 553.67 423.84 3 x10-4 1.31 
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ITGA11 (Integrin L) 16.06 15.69 0.88 1.02 
ITGAM (Integrin alpha M) 21.03 19.04 0.48 1.11 
ITGAV (Integrin alpha V) 851.72 524.89 1.5 x 10-4
 
1.64 
ITGB1 (Integrin beta 1) 4691.45 3910.88 0.03 1.20 
ITGB2 (Integrin beta 2) 47.30 51.05 0.53 1.08 
ITGB3 (Integrin beta 3) 45.74 36.88 0.25 1.24 
ITGB4 (Integrin beta 4) 51.26 46.43 0.26 1.10 
ITGB5 (Integrin beta 5) 1927.06 1662.95 1 x10-3 1.16 
ITGB6 (Integrin beta 6) 6.52 12.10 0.11 1.86 
ITGB7 (Integrin beta 7) 25.14 21.48 0.42 1.17 
ITGB8 (Integrin beta 8) 17.36 16.89 0.82 1.03 
ITGBL1 (Integrin beta-like 1) 36.32 34.09 0.39 1.07 
IIK (Integrin-linked kinase) 796.20 756.35 0.38 1.05 
IIKAP (Integrin-linked kinase-
associated serine/threonine 
phosphatise 2C) 
191.87 183.45 0.31 1.05 
CD44 molecule (Indian blood group) 54.08 42.64 0.37 1.27 
HAPLN3 (Hyaluronan and 
proteoglycan link protein 3) 
87.09 78.79 0.05 0.90 
HMMR (Hyaluronan-mediated 
motility receptor, RHAMM) 
269.57 385.62 3x10-5 1.43 
HYAL2 (Hyaluronoglucosaminidase 
2 
415.54 519.13 9x10-3 1.25 
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Integrin sub-units which displayed significantly higher levels of expression in hESCs 
cultured in physiological normoxia (2% O2) relative to hyperoxia (21% O2) are shown in 
Figure 4.2. Expression levels were split into three different categories; (high expression 
>1500; medium expression > 250 but < 1500 and low expression < 250). Integrin sub-units 
expressed significantly at the highest levels in physiological normoxia (2% O2) relative to 
hyperoxia (21% O2) was observed by β1 and β5 followed by medium expression of β4 
binding protein, α6, αV, β3 binding protein and αE, and low expression levels of β1 
binding protein 1, α4, α8, α9 and αD.  
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Figure 4.2 Selected relative expression levels of integrin subunits in hESCs. Microarray 
analysis of hESC cultured in both physiological normoxia (2% O2) and hyperoxia (21% 
O2) reveals significant expression differences for; AaeL-AAEL007077 (Integrin beta 1 
binding protein 1), ITGB3BP (Integrin beta 3 binding protein, beta3-endonexin), 
LOC658655 (Integrin beta 4 binding protein), ITGA4 (Integrin alpha 4, antigen CD49D, 
alpha 4 subunit of VLA-4), ITGA6 (Integrin alpha 6), ITGA8 (Integrin alpha 8), ITGA9 
(Integrin alpha 9), ITGAD (Integrin alpha D), ITGAE (Integrin alpha E), ITGAV (Integrin 
alpha V, vitronectin receptor, alpha polypeptide, antigen CD51), ITGB1 (Integrin beta 1, 
fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) and ITGB5 
(Integrin beta 5). No statistical significant difference was observed in CD44 gene 
expression between hESCs cultured in both 2% and 21% O2. Values indicate mean 
normalised signal intensity as an indicator of relative abundance. n=5; * p < 0.05, ** p < 
0.01, *** p < 0.001.  
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4.4.2 hESC Attachment after Post-Antibody Treatment 
Integrin sub-units, 6, E, V and 5 (including the integrin αVβ5) as well as CD44 
(Hyaluronan receptor; HA) which have the greatest significant change in expression 
between physiological normoxia (2% O2) and hyperoxia (21% O2), were selected for cell 
attachment studies. Receptor blocking using antibodies specific to the above integrin sub-
units at various concentrations (0, 1 and 25 µg/ml) was performed to determine the effect 
on hESC adhesion in both physiological normoxia (2% O2) and hyperoxia (21% O2) after 
24 hours, as demonstrated in Figure 4.3. Blocking of α6 sub-unit within hESCs expanded 
in both 2% O2 and 21% O2 demonstrated that with increasing antibody concentration there 
was a significant decrease in cell attachment when compared to the control (without 
antibody treatment) in 21% O2 no significant differences were observed as shown in Figure 
4.3A. Blocking of αE sub-unit demonstrated a decrease in cell attachment with increasing 
antibody concentration in both oxygen environments (2% O2 and 21% O2) as shown in 
Figure 4.3B. There were no significant differences observed in cell attachment when 
hESCs were blocked with αV or β5 sub-units in both oxygen concentrations (Figure 4.3C 
and 4.2D); the heterodimer αVβ5 demonstrated a significant decrease in cell attachment of 
hESCs in 2% O2 when treated with 25 µg/ml of antibody blocking solution, relative to the 
control (without antibody treatment) (Figure 4.3E). Blocking of CD44 receptor within 
hESCs cultured in 2% O2 or 21% O2 demonstrated a significant reduction in cell 
attachment with increasing antibody concentration relative to the control (without antibody 
treatment) only in 21%O2 (Figure 4.3F).  
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Figure 4.3 Effects of integrin blocking on the attachment of hESCs to Matrigel
TM
. hESCs 
were cultured in; physiological normoxia (2% O2) or hyperoxia (21% O2) and treated with 
the following antibodies; (A) Anti-Alpha 6 (ITGA6) antibody, (B) Anti-Alpha E (ITGAE) 
antibody (C) Anti-Alpha V (ITGAV) antibody, (D) Anti-Beta 5 (ITGB5) antibody, (E) 
Anti-Alpha V beta 5 antibody and (F) Anti-CD44 antibody. Values indicate mean 
percentage of cell attachment and error bars indicate standard deviations (n=6); * p < 0.05, 
** p < 0.01, *** p < 0.001. 
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Due to substantial cell attachment variability with Matrigel™ control (hESCs without 
antibody treatment) wells difficulties arose when making direct comparisons of cell 
attachments between different integrin sub-unit blocking, at various concentrations, in both 
2% O2 and 21% O2. To attempt to overcome this variation all integrin blocking data was 
normalised against the relevant Matrigel™ control (hESCs without antibody treatment), by 
dividing cell attachment value of treated samples by cell attachment value for that specific 
Matrigel™ control (hESCs without antibody treatment). Through this approach values 
greater than 1 indicated increased attachment whereas values less than 1 indicated reduced 
attachment (Figure 4.4).  
Figure 4.4 Normalised cell attachment values (%) of hESCs treated with anti-integrin 
antibodies at 1 g/ml and 25 g/ml concentrations, to the relevant control values for each 
integrin. Cell attachment evaluated after 24 hours of post-antibody treatment of hESCs 
cultured in either 2% O2 or 21% O2. Values indicate mean percentage of cell attachment 
(n=6); * p < 0.05, ** p < 0.01, *** p < 0.001. 
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4.4.3 Characterisation and Quantification of αVβ5 and CD44 Receptor Expression in 
hESCs 
As the blocking of CD44 receptor hindered attachment of hESCs in hyperoxia (21% O2) 
only and blocking of αVβ5 integrin and α6-subunit hindered attachment in physiological 
normoxia (2% O2) only; CD44 receptor and αVβ5 integrin expression was characterised to 
visualise differences in expression patterns. Positive immunocytochemistry staining of 
these receptors confirmed surface expression within hESCs cultured in either oxygen 
environments but with differing levels and patterns. The expression pattern of V5 in 
hESCs cultured in both 2% O2 and 21% O2 appeared broadly similar but with stronger 
staining being observed in 2% O2 (Figure 4.5A). The expression of CD44 appeared 
predominantly membrane-bound with higher expression at cell-cell junctions but also 
present in the cytoplasmic and nuclear regions in 21% O2 cultured hESCs (Figure 4.5B). 
Whereas, in 2% O2 cultured hESCs, expression was predominantly visible in cytoplasmic 
and nuclear regions and less intense at cell-cell junctions when compared to 21% O2 
(Figure 4.5B).  
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Figure 4.5 Representative immunostained images of (A) V5 integrin and (B) CD44 
receptor expression in hESCs cultured in both physiological normoxia (2% O2) and 
hyperoxia (21% O2) on Matrigel™ substrates. Scale bar = 100m. 
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Figure 4.6 FACS analysis of αVβ5 expression in hESCs cultured in both physiological 
normoxia (2% O2) and hyperoxia (21% O2) conditions; (A) control – no treatment, (B) 
primary antibody treatment but no secondary antibody treatment, (C) no primary antibody 
treatment but secondary antibody treatment, (D) αVβ5 expression in hESCs cultured in 2% 
O2, (E) αVβ5 expression in hESCs cultured in 21% O2, (F) CD44 expression in hESCs 
cultured in 2% O2 and (G) CD44 expression in 21% O2. 
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FACS analysis of αVβ5 and CD44 receptor expression in hESCs cultured in both 2% O2 
and 21% O2 provided quantitative evaluation of expression activity. αVβ5 expression in 
hESCs cultured in 2% O2 displayed a 2-fold increase (64.5 %) in expression levels vs. 21% 
O2 (32%) (p <0.029) (Figure 4.7A). Conversely, CD44 expression in hESCs cultured in 
21% O2 displayed a 1.38-fold increase (72.6%) in expression levels vs 2% O2 (52.7%) (p < 
0.037) (Figure 4.7B) 
 
 
Figure 4.7 Quantitative analysis of FACS data representing: (A) V5 integrin expression 
in hESCs cultured in both 2% and 21% O2 environments, (B) CD44 (HCAM) integrin 
expression in hESCs cultured in both 2% O2 and 21% O2 environments. Values indicate 
mean percentage of cells that express the integrins (n=5); * p < 0.05. 
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4.4.4 Pluripotent Marker Expression of hESCs with blocked αVβ5 and CD44 
Receptors  
Cultured hESCs which retained a substrate adhesion capacity 24 hours post-antibody 
blocking of the αVβ5 receptor were immunostained with a range of pluripotency markers. 
After αVβ5 blocking treatment (25 µg/ml), hESCs displayed a lack of nuclear localisation 
of Oct-3/4 and Nanog (Figure 4.8) and weak Alkaline phosphatase (ALP) and SSEA-4 
labelling, in comparison to unblocked hESCs. Furthermore, this was only experienced in 
2% O2 whereas little effect on pluripotent marker expression was observed in 21% O2. 
Additionally, CD44 receptor blocking (25 µg/ml) in hESCs cultured in 21% O2, also 
resulted in an absence of Oct-3/4, and Nanog nuclear localisation (Figure 4.9) weaker stain 
for pluripotent markers, in comparison to untreated hESCs., shown in Figure 4.9. No effect 
on pluripotent marker expression was observed when hESCs were blocked with CD44 and 
cultured in 2% O2 (Figure 4.9). 
 
Quantification of Oct-3/4 and Nanog nuclear localisation demonstrated a 4-fold and 3.6-
fold decrease respectively, relative to nuclear localisation in untreated hESCs after αVβ5 –
receptor blocking in 2% O2 only Additionally, blocking of the CD44 receptor in hESCs 
cultured in 21% O2 only, resulted in a 4.33-fold decrease (Oct-3/4) and a 3.22-fold 
decrease (Nanog) in nuclear localisation, as shown in Figure 4.10. 
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Figure 4.8 Evaluation of pluripotent marker (Oct 3/4, Nanog, ALP, SSEA-4) expression in hESCs treated with V5 blocking antibody (25 
µg/ml) and cultured in physiological normoxia (2% O2). Scale bar = 100 m.  
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Figure 4.9 Evaluation of pluripotent marker (Oct 3/4, Nanog, ALP, SSEA-4) expression in hESCs treated CD44 blocking antibody (25 µg/ml) 
and cultured in hyperoxia (21% O2). Scale bar = 100 m.
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Figure 4.10 Oct-3/4 and Nanog nuclear localisation quantification: (A) V5 (2% O2) and 
(B) CD44 (21% O2). Values indicate mean percentage of co-localisation of pluripotent 
genes expression; n=5, *** p < 0.001. 
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4.4.5 Effect of Blocking αVβ5 Integrin Receptor in hESCs Cultured on Nanofibrous 
Substrates in Physiological Normoxia (2% O2) 
In physiological normoxia (2% O2), αVβ5 was identified as a critical integrin receptor 
which hESCs utilised to adhere to Matrigel™ substrates. It was then hypothesised that the 
αVβ5 integrin may be the receptor through which hESCs are able to adhere to nanofibrous 
substrates when cultured in physiological normoxia.  
 
Figure 4.11 Characterisation of Giemsa stained hESC-CFU’s expanded on MatrigelTM and 
PCL nanofibrous substrates (aligned and random) with and without anti-αVβ5 antibody 
blocking treatment at 25 µg/ml of hESCs before seeding and culturing onto nanofibrous 
substrates for 21 days in physiological normoxia (2% O2). Scale Bar 200 µm.  
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hESCs were treated with and without 25 µg/ml of antibody αVβ5 blocking solution before 
seeding onto electrospun PCL nanofibrous substrates (aligned and random) and cultured 
for 21 days in physiological normoxia (2% O2). Characterisation of hESC CFUs formed 
without anti-αVβ5 treatment retained typical hESC colony morphology on Matrigel™, 
PCL-Aligned and PCL-Random nanofibrous substrates; shown by the dense, compact 
growth of hESCs together within a colony, in Figure 4.12. However, hESCs with anti-
αVβ5 antibody blocked prior to seeding onto nanofibrous substrates generated colonies 
which were less compact with single hESCs spread out, particularly on the nanofibrous 
substrates, relative to Matrigel™.  
 
Quantification of hESC CFUs recovered on nanofibrous substrates from hESCs treated 
with and without anti-αVβ5 antibody treatment revealed that Matrigel™ substrates 
supported significantly (p < 0.05) the greatest number of hESC colonies than any 
nanofibrous substrate (aligned and random) regardless of being treated with or without 
antibody blocking solution, before culturing onto these substrates Furthermore, there were 
significantly (p < 0.05) greater number of hESC CFUs recovered on non-treated 
Matrigel™ substrates compared to hESCs treated with αVβ5 antibody on Matrigel™ 
substrates. However, no significant differences were observed between untreated and 
treated hESCs cultured on PCL aligned and random nanofibrous substrates. 
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Figure 4.12 Quantification of colonies formed after the treatment of hESCs with and 
without anti-αVβ5 antibody blocking solution and cultured on nanofibrous substrates or 
Matrigel™ in physiological normoxia (2% O2) for 21 days. Values indicate average 
number of hESC colonies; n=3, * p < 0.05, ** p < 0.01. 
 
 
4.5 Discussion  
In the previous chapter, we demonstrated a synergistic effect between nanofibrous 
substrates and oxygen environment. This chapter investigated the specific effects of 
oxygen on the attachment of hESCs on conventional substrates such as Matrigel
TM
, 
cultured in physiological normoxia (2% O2) and hyperoxia (21% O2) to identify the critical 
integrins involved in the attachment of hESCs to Matrigel
TM
. This study is the first to 
identify oxygen-responsive integrins/sub-units critical for initial attachment of hESCs to 
Matrigel
TM
, followed by evaluation of pluripotency marker expression. These important 
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findings can potentially play a major role in the design and improvement of novel, 
synthetic substrates which would be tailored to support and interact with identified integrin 
receptors in hESCs, to enhance their attachment yield, scale up sufficient cell numbers for 
clinical applications and retention of pluripotency due to greater control on the mechanism 
pathways of hESCs leading to subsequent elimination of Matrigel
TM
 and any xenogenic 
contaminations driving hESCs into the regenerative medicine industry for the treatment of 
various diseases. 
 
Significant upregulation of specific integrins in hESCs cultured on Matrigel
TM
 under 
physiological normoxia (2% O2), relative to hyperoxia (21% O2) were noted. Antibody 
inhibition of selected integrins/sub-units in hESCs, in both 2% and 21% O2 was performed 
in order to evaluate their effects on initial attachment. Expression levels and patterns were 
characterised and quantified using immunostaining and FACS. The impact of blocking 
critical adhesion receptors in hESCs cultured in the most responsive oxygen environment 
was evaluated by testing the retention of pluripotent markers of hESCs that were able to 
adhere after post-antibody treatment.  
 
Many studies have utilised Microarrays to analyse and investigate changes in pluripotent 
and differentiation markers within various hESC lines [Cai et al., 2006; Lee et al., 2010] 
Our research group has specifically explored the effects of expanding hESCs in various 
oxygen environments (21% O2 and 2% O2) on the transcriptional fingerprint [Forsyth et 
al., 2008].This study analysed and detected changes in integrin expression levels and 
patterns in hESCs cultured in either 2% O2 or 21% O2, on Matrigel
TM
 substrates. 
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Microarray analysis identified; β3 binding protein, β1 binding protein 1, β4 binding 
protein, α5, α6, α8, α9, αD, αE, αV, β1 and β5 to be significantly up regulated in hESCs 
expanded in physiological normoxia (2% O2), relative to hESCs expanded in hyperoxia 
(21% O2). Interestingly, we also noted the significant upregulation of HA-associated 
genes; Hyaluronan and proteoglycan link protein 3, Hyaluronan-mediated motility receptor 
and Hyaluronoglucosaminidase 2 in hyperoxia (21% O2), instead of physiological 
normoxia (2% O2); numerical values are stated in Table 4.2. CD44 is also an essential 
specific receptor and mediator for an ECM protein called Hyaluronic acid (HA), which 
promotes hESC proliferation and associated intracellular pathways [Bourguignon et al., 
2008; Gerecht et al., 2007]. Similarly, a study by Saller et al., 2012, also observed 
alteration in integrin expression in hMSCs as a result of changing the oxygen environment 
in which they were cultured. hMSCs expanded on various substrates (polystyrene, collagen 
I, fibronectin and laminin) significantly increased expression of α3 and α6 (laminin 
receptors), α1 and α11 (collagen receptors), α5 and αV (fibronectin receptors) and β1 and 
β5 sub-units in physiological normoxia (2% O2), relative to normoxia (21% O2). However, 
significant increase in α2 expression was observed in normoxia (21% O2) relative to 
physiological normoxia (2% O2). Furthermore, hMSCs cultured in physiological normoxia 
provided a more homogenous population of stem cells with increased stemness and better 
migration ability [Saller et al., 2012]. 
 
Minimal research has been performed to identify and resolve which hESC integrin 
receptors mediate the initial attachment to Matrigel
TM
, whilst also retaining their 
pluripotent nature during expansion. Integrins expressed by hESCs are reported and 
confirmed for: laminin (61), vitronectin (V5) and fibronectin (V1, 51), collagen 
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and laminin (21), nidogen, laminin, collagen I and fibronectin (31), collagen (111) 
[Braam et al., 2008; Lee et al., 2010; Miyazaki et al., 2008]. These findings alongside the 
detection of oxygen-responsive integrins/sub-units encouraged the investigation of the 
effects in blocking integrin αVβ5 and sub-units; αV, β5, αE, α6 and CD44 receptor in 
hESCs cultured in both physiological normoxia (2% O2) and hyperoxia (21% O2) on their 
initial attachment to Matrigel
TM
. 
 
Receptor blocking using antibodies specific to the integrin sub-units was performed to 
determine the effect on hESC adhesion to Matrigel
TM 
in 2% O2 and 21% O2. Results 
demonstrated that blocking of αE significantly reduced hESC attachment in both 2% O2 
and 21% O2; interestingly inhibition of α6 and αVβ5 receptors significantly reduced hESC 
attachment in 2% O2.Though previous reports have detailed a reliance on αVβ5 and α6 
integrin sub-units for hESC attachment [Braam et al., 2008; Meng et al., 2010], these 
findings were observed in normal oxygen conditions only (21% O2) and thus differ from 
the observations in this chapter where significant alterations in integrin gene expression 
and attachment rates were specifically witnessed in 2% O2 only. Furthermore, blocking the 
CD44 receptor resulted in subsequent significant inhibition of hESC attachment in 21% O2 
conditions only. As mentioned earlier, CD44 is a specific receptor for HA. HA is secreted 
by MEFs into media at a concentration of approximately 840 ng/ml and plays a critical role 
in co-regulation of gene expression, signalling, proliferation, motility and adhesion of 
hESCs where levels are higher in undifferentiated hESCs and decrease with onset of 
differentiation [Bourguignon et al., 2008; Gerecht et al., 2007]. Our results provide 
validation and extension of recent reports in which antibody blocking of CD44 was 
described as reducing hESC clonogenicity in 21% O2 [Bourguignon et al., 2008; Gerecht 
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et al., 2007] Therefore, it is evident therefore that substantial redundancies exist across the 
signalling and cell-matrix interaction pathways that are associated with hESC adhesion and 
self-renewal. Taken together with our previous observations this collated data strongly 
suggests a strengthened statement that oxygen-signalling has a role in defining substrate 
adhesion mechanistic choice where a switch from CD44 reliance to V5 and 6 is 
identified. 
 
It is well documented that oxygen itself is a bioactive, signalling molecule which in 
conjunction with other regulatory factors can influence various cellular activities including 
cell attachment and proliferation as well as intracellular pathways which are involved in 
controlling stemness [Zachar et al., 2010]. The exposure of hESCs to hypoxic environment 
is of no surprise, as these conditions are typical in vivo, where the trophoblast excludes any 
oxygenated material blood contact to the ICM up to a certain point [Ma et al., 2009] and 
the uterine environment has oxygen levels reportedly in the range of 25 % - 5% O2 [Chen 
et al., 2010; Szablowska-Gadomska et al., 2011]. Reductions in oxygen concentration 
regulate the expression of hypoxia inducible factors (HIFs), which are transcriptional 
factors composed of α and β sub-units, which can in turn also trigger the activation of 
various growth factors, integrins, cytokines and viral proteins. Thus, it can be speculated 
that HIFs may play a critical role in the expression levels and patterns of surface integrins 
which mediate hESC attachment to Matrigel
TM
. Specifically, it is apparent that HIFs may 
be up regulating the expression of α6 and αVβ5 integrins in hESCs during hypoxic 
conditions and thus may be the mechanistic pathway for supporting hESC survival and 
attachment whilst retaining their pluripotency. 
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HIFs interact with integrins and growth factors signalling; interestingly growth factor and 
integrin pathways are also strongly interlinked and the activation of these pathways are 
crucial in maintaining the pluripotency of hESCs. Interference with substrate adhesion 
mechanisms had an immediate role upon maintenance of the undifferentiated state in 
hESCs. Antibody blockage of V5 (in 2% O2) and CD44 (in 21% O2), significantly 
decreased the nuclear localisation of Oct-3/4 and Nanog. In addition to these a substantial 
decrease in Alkaline Phosphatase and SSEA-4 expression was noted in both. The 
consistency of response indicates that either V5 and CD44 are signalling via similar 
pathways; for instance interfering with the FGF-2 signalling pathway resulting in 
inactivation of pathways MAPK/ERK, PI3/AKT kinase and NFKor through distinct, 
though mechanistically identical, self-renewal maintenance pathways [Armstrong et al., 
2006; Eiselleova et al., 2009]. More specifically, in 2% O2, HIFs are able to activate 
signalling pathways including FGF and Notch through up regulating the expression of 
transcriptional factors such as NFkB, Activator protein-1 (AP-1), p53 and c-Myc [Ma et 
al., 2009; Szablowska-Gadomska et al., 2011]. Therefore, it is apparent that the inhibition 
of receptors α6 and αVβ5 results in the outside-in signalling effect resulting in the 
inactivation of these intracellular pathways which cause the inactivation in the expression 
of pluripotent genes. Speculative mechanisms and the effects of blocking V5 (in 2% O2) 
and CD44 (in 21% O2), are illustrated in Figure 4.13  
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Figure 4.13 Flow diagram representing the speculative mechanisms that may occur as a 
result of blocking the αVβ5 receptor in physiological normoxia (2% O2) and CD44 
receptor in hyperoxia (21% O2) in hESCs cultured on Matrigel™. 
 
As the αVβ5 receptor was significantly up regulated in hESCs cultured in physiological 
normoxia (2% O2) and played a vital role in initial attachment to Matrigel™; it was 
hypothesised that the αVβ5 receptor may also play a crucial role in mediating the initial 
attachment of hESCs to nanofibrous substrates (PCL aligned and PCL random) when 
cultured in physiological normoxia (2% O2). It was apparent that a decrease in the number 
Identification of Adhesion Determining Molecules in hESCs 
Chapter 4 
 
 
188 
 
of colonies formed and a decrease in cell density within those colonies was a result of 
blocking the αVβ5 receptor in hESCs before seeding and culturing onto nanofibrous 
substrates in physiological normoxia (2% O2). Nanofibrous substrates can selectively 
adsorb ECM proteins from culture media onto their surfaces; hESC media contains many 
ECM proteins that are secreted by MEFs and hESCs which are able to adhere onto these 
substrates. However, the types of ECM proteins from hESC media which are able to 
adhere onto nanofibrous substrates (particularly PCL nanofibres) are relatively unknown. 
As blocking the αVβ5 integrin demonstrated a decrease in hESC CFU ability on PCL 
nanofibrous substrates in 2% O2, it can be hypothesised that hESCs are strongly reliant on 
this receptor for attachment to nanofibrous substrates and that the corresponding ECM 
ligand (vitronectin) for the αVβ5 integrin receptor is selectively adsorbed onto nanofibrous 
substrates, thus permitting the critical connection between hESCs and nanofibrous 
substrates resulting in subsequent activation of intracellular pathways which encourage 
hESC adhesion and proliferation whilst retaining their undifferentiated state. This further 
leads to the speculation that: polymer material, fibre orientation and fibre diameter may 
dictate and select the types and amount of specific hESC ECM proteins which are able to 
adsorb onto nanofibrous substrates; adsorbed proteins on the surface provide recognition 
sites for corresponding hESC integrin receptors in order to support subsequent attachment 
and expansion in a pluripotent state. Therefore a combination of increased expression of 
critical integrin receptors in hESCs, cultured in physiological normoxia (2% O2) and the 
selective ECM protein adsorption ability of nanofibrous substrates for corresponding 
ligands to these receptors provides a solid connection sufficient for hESC attachment and 
pluripotent expansion. 
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Tailoring substrates to have integrin specific ligands for critical integrin receptors in 
hESCs that are known to play a crucial role in adhesion has not yet been performed; on the 
other hand attempts have been made using mESCs where a synthetic hydrogel fabricated 
from branched poly (ethylene glycol) was cross-linked with matrix metalloproteinase-
sensitive peptides and functionalised with peptide adhesion ligands: RGDSP (specific for 
fibronectin and vitronectin), and TTSWSQ and AEIGIEL which were specific adhesion for 
integrins α5β1and αVβ5, α6β1 and α9β1 respectively. A combination of these peptide 
ligands on the synthetic hydrogel demonstrated the ability of mESCs to expand and form 
colonies and expressed key signal molecules that support stem cell self-renewal (β-catenin, 
smad-1/5/8 and Ant-1), expressed all pluripotent markers and encouraged the down 
regulation of differentiation markers [Lee et al., 2010]. This technique may be applied in 
the future to the nanofibrous substrates used this study, where both PCL aligned and PCL 
random nanofibrous substrates could be functionalised with an adhesion peptide ligand that 
is specific for the critical integrin identified in this chapter as αVβ5 for enhancing hESC 
attachment and proliferation on nanofibrous substrates, when cultured in physiological 
normoxia (2% O2). 
 
4.6 Conclusion 
This chapter has identified oxygen-responsive integrins/sub-units, which mediate the initial 
attachment of hESCs to Matrigel
TM 
coated substrates. In silico microarray data analysis 
revealed transcriptional level changes in a dozen oxygen-responsive integrin sub-units of 
which αV, β5, αE and α6 were significantly elevated in 2% O2 relative to 21% O2. 
Concomitantly, HA-related receptor genes showed increased expression levels in 21% O2, 
instead of 21% O2. Cell attachment studies demonstrated that blocking of an essential 
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ECM integrin αVβ5 and sub-unit α6 significantly hindered hESC attachment in 2% O2 
only and that CD44 inhibited cell attachment after 24 hours of post-antibody treatment, in 
21% O2 but not in 2% O2. Furthermore, immunofluorescence staining confirmed the 
expression of αVβ5 and CD44 in both 2% O2 and 21% O2; αVβ5 receptor stained much 
stronger in 2% O2 cultured hESCs, relative to 21% O2 and CD44 was more membrane-
bound and less predominant in cytoplasmic and nucleus regions in 21% O2 cultured hESCs 
in comparison to 2% O2. This was further confirmed by quantitative analysis by FACS 
which demonstrated a significantly higher percentage of αVβ5 expressing hESCs cultured 
in 2% O2, relative to hESCs cultured in 21% O2. Conversely, a greater number of 21% O2 
cultured hESCs expressed CD44; relative to 2% O2 cultured hESCs. The effect of blocking 
αVβ5 in hESCs cultured in physiological normoxia (2% O2) and blocking of CD44 (21% 
O2) in hESCs cultured in hyperoxia (21% O2) on hESC pluripotency was evaluated via 
immunofluorescence staining and demonstrated that upon blocking these receptors this 
decreased the expression of pluripotent markers such as Oct 3/4, Nanog, ALP and SSEA-4. 
Furthermore, blocking of the αVβ5 receptor in hESCs before seeding and culturing onto 
nanofibrous substrates in physiological normoxia revealed a decrease in the number of 
hESC colonies formed after 21 days; however no significant differences were found 
amongst the nanofibrous substrates although there was a significant difference found 
between hESC colonies formed from hESCs treated with or without anti-αVβ5 blocking 
solution and then cultured on Matrigel™ in physiological normoxia, for 21 days. 
 
Characterisation of Protein Adsorption Activity on Electrospun Nanofibrous Substrates to 
Support hESC Attachment 
Chapter 5 
 
191 
 
5. Characterisation of Protein Adsorption Activity on Electrospun Nanofibrous 
Substrates to Support hESC Attachment 
 
5.1 Introduction 
Current limitations associated with the use of human embryonic stem cells (hESCs) in 
clinical therapeutic applications includes: xenogenic exposure and the inability of large-
scale manufacture which would provide consistency and repeatability in the production of 
a homogenous and high quality population of undifferentiated hESCs [Fadeev and 
Melkoumian, 2011]. To overcome these issues, the discovery and identification of the 
proteins which promote and enhance hESC attachment and pluripotent expansion may 
prove essential. This would permit the design and modification of suitable, synthetic 
biomaterial substrates to improve hESC attachment and expansion.  
 
In this thesis, hESCs were cultured using the feeder-free method which involved 
Matrigel™ and MEF conditioned media. Matrigel™ is an ECM isolated from Engelbreth-
Holm-Swarm mouse sarcoma and is a complex gel comprised of many ECM proteins 
(collagen IV, laminin, fibronectin and heparin proteoglycans), amongst others. 
Furthermore, MEF conditioned media has also been identified to contain many secreted 
ECM proteins (by MEFs) including; collagen I, collagen IV, laminin, fibronectin, heparin 
proteoglycans, entactin and nidogen, amongst others which are yet to be identified [Fadeev 
and Melkoumian, 2011; Xu et al., 2001]. 
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ECM proteins are found in serum containing media and are critical in mediating a cells 
adhesion to a substrate (natural or synthetic). Ultimately this can dictate the 
biocompatibility of the substrate via formation of an interfacial layer of proteins that bridge 
materials and cells [Ma et al., 2007]. During contact between media and a synthetic 
substrate the, initial adsorption of proteins from media onto the superficial layer of the 
substrate provides natural recognition sites for corresponding cell membrane receptors. 
These include integrins. These initial attachments promote filopodia interactions and cell-
based secretion of proteins and carbohydrates essential for continued maintenance or 
modification of the interfacial layer [Ostuni et al., 1999].  
 
At lower protein solution concentrations, protein interaction with a biomaterial surface can 
be maximised (via orientation and unfolding), resulting in irreversible adsorption on the 
surface; at higher protein solution concentrations, there are less protein-surface interactions 
and hence are able to retain a stable conformation but can be easily detached [Nath et al., 
2004]. Proteins have a primary structure which is made up of a unique sequence of amino 
acids. In total, there are 20 amino acids and each amino acid differs in its chemical nature 
in terms of its side chain which gives rise to various physicochemical properties which also 
play a role in the overall properties of the protein itself [Patthy, 1999] 
 
Furthermore, the structure of the protein can also determine the protein adsorption ability 
and conformational integrity on substrate surfaces; “hard” proteins (lysozyme and RNAse) 
adsorb voluntarily to hydrophobic surfaces and cause minimal structural changes whereas 
“soft” proteins (BSA and IgG) are able to adsorb onto most surfaces with subsequent 
changes in conformation [Nath et al., 2004].The adsorbed protein interfacial layer (also 
referred as surface remodelling) is complex and dynamic, thus is constantly changing with 
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time. Initially, highly abundant serum proteins with low molecular weight adhere to the 
surface and are gradually replaced by less abundant, high molecular weight, cell adhesive 
proteins such as fibrinogen with time; this is known as the Vroman effect [Vroman, 1962]. 
Additionally, proteins that do adsorb onto substrate surfaces are likely to undergo 
unfolding at the surface with time resulting in subsequent alterations in conformation and 
thus changing the affinity status (wettability) of the biomaterial surface to permit cell 
attachment. 
 
The amount and type of protein that is able to adhere to a biomaterial substrate is 
determined by several factors which consequently determine cell attachment and the ability 
to function appropriately. These factors include; polymer substrate chemistry, surface 
charge, wettability (polarity of the surface), functional groups and topography, all of which 
are known to have an impact on protein adsorption and conformation state of the protein 
(which determines the affinity for cell attachment) [Roach et al., 2005; Stevens, 2008] 
Increasing surface roughness and introducing topography at the nanoscale with organised 
orientation enhanced cell attachment. Nanofibrous architecture through electrospun 
nanofibres is known to increase protein adsorption due to a greater surface area to volume 
ratio; essentially, nanofibrous architecture is able to closely mimic the natural ECM 
architecture resulting in a more desirable and recognisable environment for cell 
attachment. [Stevens and George, 2005; Woo et al., 2003]. Furthermore, surface 
topography has a two-fold effect on cell attachment; it provides contact guidance, where 
cell integrin receptors in focal contact transfer the variable degrees of tension or 
compression into the cytoskeleton resulting in its reorganisation in accordance to the 
surface topography. The second effect is to induce changes in surface free energy due to 
edges and disruption effects [Ma et al., 2007].  
Characterisation of Protein Adsorption Activity on Electrospun Nanofibrous Substrates to 
Support hESC Attachment 
Chapter 5 
 
194 
 
Current methods of detecting and characterising proteins that have adsorbed onto a surface 
as well as being able to define the surface chemical structure of a polymeric biomaterial 
substrate include: Quartz crystal microbalance (QCM), surface plasmon resonance (SPR), 
ellipsometry, attenuated total reflectance Fourier transform infrared spectroscopy (ATR-
FTIR), atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS). A brief 
description of how these techniques operate and any associated limitations are summarised 
in Table 5.1. These are very powerful techniques and most of them are able to reveal 
qualitative and quantitative analysis; amongst them ATR-FTIR and XPS are the most 
widely used spectroscopic techniques in order to reveal the chemical structure of polymeric 
biomaterials [Ma et al., 2007]. A critical parameter of a spectroscopic technique is surface 
sensitivity defined by the sampling depth which is important for interpreting results 
correctly [Ma et al., 2007]. However, many of these techniques have limitations including; 
limited surface types that can be analysed issues with adsorption, inconsistent monitoring 
of reorganisation and desorption of proteins, and the inability to differentiate between 
proteins (as there are many similarities between most proteins) [Roach et al., 2006; 
Wagner and Castner, 2001].  
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Table 5.1 A summary of various available techniques currently used to analyse and characterise 
protein adsorption. 
Technique Description  
Quartz crystal 
microbalance 
(QCM) 
Also known as the piezoelectric microbalance, allows the quantification 
of mass by measuring the change in frequency of a piezoelectric quartz 
crystal when it is disturbed by the addition of a tiny mass such as a 
protein. QCM measurements can be performed under vacuum and liquid 
environment, giving information regarding the approximate change in 
mass as well as the viscoelastic constant for the adsorbed layer of 
proteins on polymeric substrates by measuring frequency and dissipation 
(band width change or ring-down kinestics) respectively. [Ma et al., 
2007]  
Limitations: Measurements do not give direct information on adsorbing 
species – frequency and dissipation changes need to be modelled, giving 
only an indication of adsorbing species with errors brought into this 
dependant upon the validity of the model used.  
Ellipsometry  Ellipsometry allows the characterisation of the surface protein thickness. 
This method focuses on the measurement of the changes in polarisation 
state of a reflected light from its incident light. A smooth surface will 
reflect a monochromatic linear polarised light and upon doing so changes 
its polarisation state; the protein layer thickness absorbed on the substrate 
surface further induces a change in the polarisation state of the reflected 
light which can be calculated. [Ma et al., 2007] 
Limitations: Only limited to proteins adsorbed onto extremely smooth 
surfaces with strong reflective ability and with an obvious refractive 
index and hence is not practical for polymeric biomaterials surface 
analysis. [Ma et al., 2007] This technique also heavily relies on fitting 
experiments to models, and so the validity of the model to fit the 
conditions under investigation are paramount. 
Surface 
plasmon 
resonance 
(SPR) 
An optical technique used to investigate biological interactions such as 
protein adsorption processes being capable of real time analysis to define 
protein adsorption and desorption rates. Calculates the relationship 
between resonance energy and mass concentration of proteins adsorbed 
onto a thin metal film. [Ma et al., 2007]. Also a similar technique to 
ellipsometry. 
Limitations: as above with the model info 
Attenuated 
total 
reflectance 
Fourier 
transform 
infrared 
spectroscopy 
(ATR-FTIR) 
An evanescent wave (the incident radiation interacts with the sample 
with an exponentially decreasing penetration depth ranging from several 
nanometers to more than 1 µm, varying with respect to the wavelength. 
Limitations: a technique which does not allow a specific analysis of 
substrate surface as the signal is a combination of the surface and the 
substrate underneath. Is only practical for formed monomolecular layers 
on substrates such as silicate and inorganic crystals. Specifically for 
biodegradable polymers (PCL and PLA) bulk phase IR adsorption occurs 
therefore preventing the identification of immobilised proteins or 
polyacrylamide peaks. 
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Atomic force 
microscopy 
(AFM) 
A nano-scale resolution technique which requires no pre-preparation 
before imaging surface structure of insulating, semi-conductive or 
conductive samples. A sharp probe on a flexible lever allows the study of 
the structure of single biomolecules, native bio-membranes and the 
measurement of molecular forces at the single-molecule level. This 
technique has high force sensitivity, a high dynamic range (0.001-5000 
nN) and a high positional accuracy (0.01 nm) with ability to operate in a 
physiological environment [Lee et al., 2007]  
Limitations: AFM lacks the chemical specificity to identify adsorbed 
proteins unless the AFM tip is functionalised. [Wagner and Castner, 
2001] 
X-ray 
photoelectron 
spectroscopy 
(XPS) 
XPS can provide information such as coverage and thickness of adsorbed 
proteins; specifically XPS determines whether the adsorbed layer is 
continuous or exists as a patchy film and has a much smaller sampling 
depth (< 10 nm) in comparison to ATR-FTIR. Amount of immobilised 
proteins on biomaterial surface can be measured by radio labelling using 
I
125
 and is highly sensitive. 
Limitations: XPS gathers information under high vacuum and thus may 
not be a true representation of the actual liquid-solid biomaterials 
surface. [Ma et al., 2007] 
Electron 
paramagnetic 
resonance 
(EPR) 
Enables the evaluation in the behaviour of adsorbed proteins on 
biomaterial substrate surfaces. Adsorbed proteins are labelled with spin 
labels (nitroxide type); nitroxides have EPR spectra which especially 
sensitive to molecular mobility. By monitoring the changes in the EPR 
spectrum shape, one can clarify the behaviour of specific sites of proteins 
adsorbed on synthetic biomaterial surfaces. [Ma et al., 2007] 
Enzyme-
linked 
immune 
sorbent assay 
(ELISA) 
Allows the measurement and quantification of the bioactive state of 
immobilised proteins on biomaterials surfaces which can be 
characterised using a specific bio-recognition process between antibodies 
and antigens. [Ma et al., 2007]. A similar technique to ELISA is circular 
dichroism spectroscopy (CD) which specifically studies the protein 
conformation of the secondary structure.  
Limitations: CD poses intrinsic inconsistency problems in absolute 
secondary structure [Roach et al., 2006] 
 
Recent improvement in instrument development which can be used to analyse protein 
adsorption onto surfaces and eliminate limitations associated with current techniques is 
Time of flight secondary ion mass spectrometry (Tof-SIMS). Tof-SIMS can analyse the 
chemical composition (or any protein adsorption) of substrate surfaces. It combines the 
analytical technique of SIMS and the Tof mass analyser; the Tof mass analyser gives a 
detailed mass resolution compared to other SIMS set-ups which reveals the detection of all 
elements and isotopes including the provision of chemical information. Tof-SIMS uses a 
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pulsed ion beam (incident particles such as Bismuth 3 [Bi
3+
] cluster) to remove molecules 
from the very outermost surface of the substrate (10-20 Ǻ). The particles are removed from 
atomic monolayers on the surface (secondary ions; positive and negative ions) and tend to 
be molecular compounds or fragments which are characteristic of specific amino acids or 
larger organic macromolecules; these particles/fragments are then accelerated into a flight 
tube and their mass is determined by measuring the exact time at which they reach the 
detector. A schematic of the Tof-SIMS set-up is demonstrated in Figure 5.1.  
 
The advantages of using Tof-SIMS over existing tools is its extreme chemical specificity 
and high surface sensitivity, which provides specific molecular evaluation of composition, 
conformation, orientation and denaturation of proteins as well as being able to identify 
specific proteins adsorbed onto a substrate surface. Tof-SIMS provides greater chemical 
selection over XPS due to mass spectrometry and detailed molecular structure of the 
outermost layer (10-20 Ǻ) of proteins adsorbed onto a substrate surface, including the 
orientation and degree of conformational changes (determines what amino acid fragment is 
exposed and thus detected by Tof-SIMS) resulting in a large number of quantity of peaks 
[Ma et al., 2007]. A limitation with Tof-SIMS, is that the information obtained is under 
high vacuum and thus may not be a true representation of the actual liquid-solid 
biomaterials surface interface [Ma et al., 2007]. Table 5.2 summarises the advantages and 
disadvantages of using Tof-SIMS.  
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Figure 5.1 Schematic demonstrating the Tof-SIMS instrument set-up. Adapted from 
http://www.ion-tof.com/  
Table 5.2 Summary of the advantages and disadvantages associated with using Tof-SIMS. 
Advantages Disadvantages 
Allows the survey of all masses on substrate 
surfaces 
Mapping of elements and chemical groups 
on a sub-micron scale 
High mass resolution 
High sensitivity for trace 
elements/compounds 
Not qualitative but is semi-quantitative 
Limited optical capabilities  
Image shift during a change in collection 
mode from positive ion to negative ion data 
 
As synthetic substrates (PCL aligned and random nanofibrous) substrates support the 
attachment and expansion of undifferentiated hESCs. It remains unknown which ECM 
proteins can adhere to these nanofibrous substrates and form an interfacial layer with 
structure and composition that is specifically able to support the attachment of hESCs. This 
may be through integrin-binding sites which have been identified to be expressed on hESC 
membranes in the previous chapter. In this chapter, Tof-SIMS in combination with 
principle component analysis (PCA) is used to attempt to identify key ECM protein 
fragments adsorbed onto PCL electrospun nanofibrous (aligned and random) substrates 
from pure protein solutions and partially defined ESC conditioned media. 
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5.2 Aims and Objectives 
 
We have determined that hESCs displayed significantly elevated expression of the αVβ5 
receptor and α6 and αE sub-units when cultured in physiological normoxia (2% O2) vs 
hyperoxia (21% O2) and played a crucial role in attachment to Matrigel™ substrates. These 
data argue that ECM proteins associated with these hESC integrin/sub-units will adsorb 
onto PCL electrospun nanofibrous substrates (aligned and random) in an active 
conformation state that allows hESCs to attach, spread and proliferate. It can be 
hypothesised that these may include ECM proteins such as: vitronectin, fibronectin, 
collagen and laminin. We have also demonstrated that decreasing the fibre diameter 
enhanced hESC-CFU ability in physiological normoxia (2% O2); as smaller diameter fibres 
provides an increased surface area to volume ratio it can be hypothesised that this enhances 
the adsorption of proteins to the fibres with a subsequent increase in recognition sites for 
hESC integrin receptors. 
 
The objectives of this chapter seek to test the above hypothesis and are as follows: 
 Quantification of protein adsorption on PCL electrospun nanofibres (aligned and 
random) from pure protein solutions and MEF conditioned hESC media  
 Using Tof-SIMS and PCA to determine variation of serum proteins adsorbed from 
pure protein solutions and hESC conditioned media (from MEFs) onto PCL 
electrospun nanofibrous substrates in both aligned and random conformations.  
 To investigate the effect of varying fibre diameter of PCL nanofibrous substrates 
(aligned and random) on protein adsorption ability from pure protein solutions and 
hESC conditioned media. 
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5.3 Materials and Methods 
All nanofibrous substrates were fabricated using electrospinning. Aligned nanofibres were 
attained using the rotating mandrel technique, whereas random nanofibres were produced 
using the static copper plate collector. The operating parameters used to attain both aligned 
and random nanofibres onto 13 mm circular glass coverslips are stated in Table 2.2-2.3, 
Section 2.13-2.1.4, Chapter 2. Nanofibres on glass coverslips were further reinforced 
using silicone rubber strips and silicone glue to prevent their detachment whilst immersed 
in hESC conditioned media and pure protein solutions. All nanofibrous substrates were 
sterilised using 70% IMS for at least 1 hour. Fibre morphology, orientation and diameter 
were characterised using field emission scanning electron microscopy (FESEM). 
 
Pure protein solutions of collagen I (Coll I), fibronectin (Fn), laminin (Ln) and vitronectin 
(Vn) prepared in PBS at a concentration of 50 µg/ml and hESC conditioned media were 
placed onto individual PCL electrospun nanofibrous substrates (aligned and random) as 
well as blank glass coverslip controls at a volume of 50 µl. Samples with protein 
solutions/hESC conditioned media were incubated for 2 hours in physiological normoxia 
(2% O2). Substrates were then rinsed with PBS and water, dried and analysed using Tof-
SIMS Please refer to Section 2.5.3, Chapter 2, schematic is also visible in Figure 5.2. All 
Tof-SIMS screening of samples was performed by Dr David Scurr at the University of 
Nottingham; data analysis/treatment (including PCA) was performed by Dr Paul Roach.  
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Figure 5.2 Protein adsorption protocol. Proteins from single protein solutions (50 µg/ml) 
and hESC conditioned media were allowed to adsorb onto substrates (glass, PCL-A and 
PCL-R) for 2 hours at 37 ᵒC. Supernatant solution was removed; substrates were then 
washed with PBS and water, air dried and analysed using Tof-SIMS. 
 
Quantification of protein absorption was performed using the fluorometric assay, 
NanoOrange®. Briefly, 50 µl of pure protein solutions of Coll I, Fn, Ln and Vn at 50 
µg/ml, and hESC conditioned media were placed on PCL nanofibrous substrates/blank 
glass coverslips and incubated for 2 hours in physiological normoxia (2% O2). Protein 
solution/media supernatant was collected and quantified using NanoOrange® and then 
subtracted from initial concentration of proteins/media solutions in order to calculate the 
amount of protein adsorbed onto PCL electrospun nanofibrous substrates/blank glass 
coverslips. Detailed protocol stated in Section 2.5.4, Chapter 2. 
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5.4 Results 
 
5.4.1 Characterisation of PCL Electrospun Nanofibrous Substrates 
PCL was electrospun onto glass coverslips to attain nanofibres of large and small 
diameters, in both aligned and random conformations. Scanning electron microscopy 
(SEM) revealed nanofibrous substrate topography where all electrospun nanofibres had a 
similar morphology of uniform, linear fibres without any beading. SEM images allowed 
the measurement of fibre diameter (Figure 5.3); results demonstrated that 12.5% PCL 
provided smaller nanofibre diameters (aligned, 280 nm; random; 318 nm) whereas 15% 
PCL provided larger nanofibre diameters (aligned, 521 nm; random; 660 nm). 
 
Figure 5.3 Representative FESEM images of PCL electrospun nanofibres in both aligned and 
random conformations, at various different fibre diameters. Scale bar = 200 µm. 
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5.4.2 Quantification of Protein Adsorption on PCL Electrospun Nanofibrous 
Substrates in Physiological Normoxia (2% O2)  
A fluorometric assay, NanoOrange® was used to detect and quantify the amount of protein 
adsorbed/remained on PCL electrospun nanofibrous substrates (aligned and random) at the 
lower fibre diameter range. NanoOrange® is a highly sensitive assay which has the ability 
to detect small amounts (10 ng/ml) of proteins adsorbed on surfaces. PCL electrospun 
nanofibrous substrates (aligned and random) including blank glass coverslips (controls) 
were incubated with ES conditioned media (CM) as well as pure protein solutions of 
collagen I (Coll I), fibronectin (Fn), laminin (Ln) and vitronectin (Vn) at 50 µg/ml for 1 
hour in physiological normoxia (2% O2). After incubation, supernatant solutions of 
proteins and CM were collected and quantified using NanoOrange®; absorbance values 
were then deducted from initial protein solution/CM samples prior to placing on substrates, 
in order to calculate any adsorbed proteins onto substrates by mass balance. 
 
As shown in Figure 5.4, NanoOrange® revealed that proteins from pure protein solutions 
and CM were able to adsorb onto all three substrates; PCL-A, PCL-R and glass coverslips. 
Statistical analysis revealed that there was a significantly greater adsorption of CM (total 
protein) on PCL-A (6.6 µg/ml) compared to glass (CTL; 5.8 µg/ml) (p < 0.05) and also 
significantly greater adsorption of Vn on PCL-A (2.2 µg/ml) compared to glass (CTL; 1.8 
µg/ml) (p < 0.01). In other cases, despite differences in protein adsorption on nanofibrous 
substrates relative to glass (CTL) there was no real statistical differences between them.  
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Figure 5.4 Quantification of protein adsorption from ES conditioned media (CM) and pure 
protein solutions; collagen I (Coll I), fibronectin (Fn), laminin (Ln) and vitronectin (Vn) at 
50 µg/ml concentration, on PCL electrospun nanofibrous substrates in both aligned (A; 280 
± 122 nm) and random (R; 318 ± 151 nm) conformations as well as glass coverslips 
(control).∆ = Ic – Fc stands for the change in the initial protein concentration from final 
concentration. Values indicate mean adsorption of proteins and standard deviation of n=3; 
*p < 0.05, **p < 0.01. 
 
5.4.3 Tof SIMS Analysis of Protein Adsorption on PCL Electrospun Nanofibrous 
Substrates in Physiological Normoxia (2% O2) 
Electrospun PCL nanofibrous substrates were fabricated with both small (280-318 nm) and 
large (518-660 nm) fibre diameter dimensions in both aligned and random conformations. 
All nanofibrous substrates including blank glass coverslips (control; CTL) were immersed 
in MEF-conditioned hESC media and pure protein solutions (Coll I, Fn, Ln and Vn) and 
incubated at 37 ᵒC for 2 hours after which point media/protein solutions were removed and 
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samples analysed in terms of the amount adsorbed and the identification of the adsorbed 
layer by Tof SIMS. After data treatment and PCA; score plots for both media and all pure 
proteins on substrates (nanofibres and controls) revealed distinct groups belonging to each 
of the proteins on each substrate in the positive ion fragment data set, as shown in Figure 
5.5. PC1 and PC2 score plots of positive SIMS data indicated clustering of sample data 
into three distinct groups (cluster A, cluster B and cluster C; indicated by circles); 
however, a greater overlap between different samples were observed in cluster B and C 
particularly as shown in Figure 5.5 suggesting spectral similarities between several 
samples in terms of protein adsorption.  The samples within each cluster are specified in 
Table 5.3. 
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Figure 5.5 Scores plot on the first two multivariate axes from PCA of the Tof-SIMS spectra (positive ion data) of proteins adsorbed onto all 
electrospun nanofibrous substrates and control (blank glass coverslip). Definition of sample abbreviations: control (glass coverslip), A 
(aligned), R (random), Coll (collagen I), CM (conditioned media), Fn (fibronectin), Ln (laminin) and Vn (vitronectin). Circles indicating 
clustering of sample data with respect to PC1 and PC2.  
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PCA score plots of positive SIMS data, of samples separated in terms of fibre diameter; 
(small Ø, 280-318 nm; large Ø 521-660 nm) further demonstrated spectral similarities 
between several samples. In Figure 5.6, PCA score plots of smaller fibre diameter samples 
revealed overlapping and clustering of various samples in cluster A (indicated by a circle). 
Larger fibre diameter samples also revealed spectral similarities and thus overlapping of 
various samples into two distinct clusters A and B, as shown in Figure 5.6. However, it can 
be visualised greater overlapping and clustering of samples within smaller fibre diameter 
samples (Figure 5.5) in comparison to larger fibre diameter samples (Figure 5.6). The 
samples identified within each cluster for both Figure 5.5and 5.6 are stated in Table 5.3. 
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Figure 5.6 Scores plot on the first two multivariate axes from PCA of the Tof-SIMS spectra (positive ions data) of proteins adsorbed onto PCL 
nanofibrous substrates of smaller diameter (280 – 318 nm) and control (blank glass coverslip). Circles indicating clustering of sample data 
with respect to PC1 and PC2.  
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Figure 5.7 Scores plot on the first two multivariate axes from PCA of the Tof-SIMS spectra (positive ion data) of proteins adsorbed onto PCL 
nanofibrous substrates of larger diameter (521–660 nm) and control (blank glass coverslip). Circles indicating clustering of sample data with 
respect to PC1 and PC2. 
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Table 5.3 Definition of clusters observed in Figures 5.5-5.7 for protein fragments on all 
substrates for all positive ion data 
 Cluster Spectral similarities observed between proteins on various 
proteins (+ve SIMS) 
Figure 5.5 Cluster 
A 
CM-R (660 nm), Fn ctl, Ln ctl, and Vn-R (660 nm) 
Cluster 
B 
CM ctl, CM-A (280 nm), CM-A (521 nm), CM-R (318 nm), 
Coll-A (280 nm), Coll-R (318 nm), Coll-R (660 nm), Fn-A (280 
nm), Fn-R (318 nm) and Fn-R (660 nm), Ln-A (280 nm), Ln-A 
(521 nm), Vn ctl and Vn-R (318 nm) 
Cluster 
C 
Coll-R (660 nm), Vn-A (280 nm) and Vn-R (660 nm) 
Figure 5.6 Cluster 
A 
CM-R (660 nm), Fn ctl, Ln ctl, and Vn-R (660 nm) 
Figure 5.7 Cluster 
A 
Coll I-R (660 nm), Vn-R (660 nm), Vn-A (521 nm) 
Cluster 
B 
CM-A (521 nm), Fn-R (660 nm), Ln-A (521 nm) and Vn-A (521 
nm) 
 
The score plots for PCA provided visualisation of spectral similarities between 
multivariate data sets; they do not provide detailed information in terms of the original 
variables such as the Tof-SIMS ion mass intensities and the exact difference in peak 
intensities between the spectra of different proteins adsorbed onto various substrates. 
However, the loading plots do provide this information; loading plots for PC1 and PC2 
(Figure 5.8) for the positive ion fragments detected on substrates identified the following 
amino acid fragments to be expressed at a higher normalised intensity: C2H
+
, C2H5, 
CH4N
+
, C3H3
+
, CNO
-
, C2H5N, C2H6N
+
, C3H3O, C4H7
+
, C3H6N
+
, CH5N3, C4H6N
+
, C4H5O, 
C4H8N
+
, C6H6
+
, SO4
-
, C4H4NO2
+
, C4H10NS, C8H9NO
4
 and C13H9
+
. For each of the positive 
ion mass peaks identified, normalised intensity values were tabulated and categorised in 
terms of the media/pure protein solutions in which they were detected (positive ion mass 
tables; Table A1-A5 in  Appendix). Furthermore, these values enabled the identification of 
the samples on which normalised intensity peaks were the highest in terms of 
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media/protein type, substrate (glass, PCL-A, PCL-R) and fibre diameter (small Ø 280-318 
nm; large Ø 521-660 nm). This information is summarised in Table 5.4. 
 
Figure 5.8 Loading plots for PC1 and PC2 from PCA of positive ions spectra of proteins 
adsorbed from CM and pure protein solutions (Coll I, Fn, Ln, and Vn) onto glass (control), 
PCL-A and PCL-R substrates of both small (Ø 280-318 nm) and large (Ø 521-660 nm) 
fibre diameter. Red line indicates the threshold set above which mass peaks are considered 
to be expressed at high intensity (indicated in red). Thresholds for PC1 (positive, 0.018; 
negative, -0.01469) and PC2 (positive, 0.0108; negative, -0.01594) were set at these values 
due to an obvious difference (plots) in PC values from the baseline when displayed on the 
loading plots.  
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Table 5.4 Positive ion amino acid fragments identified from loading plots for PC1 and PC2 from PCA and 
the samples on which detected at the highest normalised intensity [Canavan et al., 2006; Mahlstedt et al., 
2010; Wagner and Castner, 2001; Wagner et al., 2002] 
m/z (+ve 
ions) 
Assignment Proteins and Substrates on which greatest normalised intensity 
observed 
25.9929 C2H
+ 
Coll I-A (521 nm), Vn-A (280 nm) 
27.9917 C2H3
+
 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (521 nm), Fn CTL 
(glass), Vn-A (280 nm), Vn-R (660 nm), Vn CTL (glass) 
29.0254 C2H5 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (280 nm), Fn-R (660 
nm) 
30.0112 CH4N
+
: Glycine 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (280 nm), Fn-R (660 
nm) 
39.7221 C3H3
+
 Vn-A (280 nm) 
41.0139 C3H5
+
 
Coll I-R (660 nm), Coll I-A (521 nm), Fn-A (521 nm), Vn-A (280 nm), 
Vn-A (521 nm), Vn-R (660 nm) 
41.7003 C3H5
+
 Coll I –R (660 nm), Coll I-A (521 nm), Fn-A (521 nm), Vn-A (521 nm) 
41.9932 
C2H4N: Alanine, 
Glycine 
Coll I-A (521 nm) 
42.9994 
CNO
-
; peptide 
backbone 
Vn-A (521 nm) 
43.0241 C2H5N 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (280 nm), Fn CTL 
(glass), Vn-R (318 nm), Vn CTL (glass) 
43.0421 C2H5N Coll I-R (660 nm), Coll I CTL (glass), Fn-R (660 nm) 
44.0371 
C2H6N
+ 
Alanine, Lysine, 
Asparagine 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (280 nm), Fn-R (660 
nm), Vn-R (318 nm), Vn CTL (glass) 
54.9998 
C3H3O 
Tyrosine 
Coll I-A (521 nm), Fn-A (521 nm), Vn-A (280 nm), Vn-R (318 nm), Vn-
A (521 nm), Vn-R (660 nm), Vn CTL (glass) 
55.0208 C4H7
+
 Coll I-R (660 nm), Coll I CTL (glass) 
56.0233 C3H6N
+
 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (280 nm), Fn-R (660 
nm) 
56.6144 C3H6N
+
 Vn-R (660 nm) 
59.0496 CH5N3; Arginine 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (280 nm), Fn-R (660 
nm), Vn-R (318 nm), Vn CTL (glass) 
68.0263 C4H6N
+
: Proline 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (280 nm), Fn-R (660 
nm) 
69.0374 C4H5O; Threonine Coll I-R (660 nm), Coll I CTL (glass), Fn-R (660 nm) 
70.0375 C4H8N
+
: Arginine 
Coll I-R (660 nm), Coll I CTL (glass), Coll I-A (270 nm), Fn-R (660 
nm) 
78.0441 C6H6
+
 
Coll I-R (660 nm), Coll I-A (521 nm), Fn-A (521 nm), Vn-A (280 nm), 
Vn-R (318 nm) 
96.8582 SO4
-
 Vn-A (521 nm), Vn-R (660 nm) 
98.1067 
C4H4NO2
+
; 
asparagine 
Coll I CTL (glass), Coll I-R (660 nm), Coll I-A (280 nm), Coll-A (521 
nm), Coll-R (318 nm) 
103.9236 
C4H10NS: 
Methionine 
Coll I CTL (glass), Fn-A (280 nm), Fn-R (660 nm), Vn-R (318 nm) 
124.9131 
C5H11N4: 
Arginine 
Fn CTL (glass) and Ln CTL (glass) 
164.857 C13H9
+
 Coll I-A (521 nm), Ln CTL (glass) 
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However,  of all positive ion mass peaks detected (stated in Table 5.4), the 11 positive ion 
fragments with the greatest normalised intensity values were selected as: 41.0139 (C3H5
+
), 
42.9994 (CNO
-
, peptide backbone), 43.0241 (C2H5N), 43.0421 (C2H5N), 44.0371 (C2H6N
+
; 
alanine, lysine or aspargine), 55.0208 (C4H7
+
), 56.0233 (C3H6N
+
), 59.0496 (CH5N3; 
arginine), 69.0374 (C4H5O; threonine), 70.0375 (C4H8N
+
; arginine) and 124.9131 
(C5H11N4; arginine). (A description of how normalised intensity values were calculated is 
shown in Figure 5.9) These mass ion fragments were then plotted in terms of substrate type 
in order to distinguish any patterns in the proteins that are adsorbed and specificity in 
protein adsorption to substrates in terms of fibre orientation and diameter, as shown in 
Figure 5.10. Mass peaks detected at a higher normalised intensity value on each substrate 
type from pure protein solutions than from conditioned media in order to confirm the 
adsorption of these individual ECM proteins and their existence in conditioned media as 
well as to assess patterns of protein adsorption and fragmentation pattern to nanofibrous 
substrates are stated in Table 5.5.  
 
Figure 5.9 (A) Normalised intensity value is calculated by dividing the intensity of a 
specific mass peak by the total intensity of the sum of all mass peaks (B) Graph illustrating 
the intensity of a specific peak in comparison to the sum of all peaks (total) which would 
be calculation CM, Coll I, Fn, Ln and Vn. 
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On glass coverslip substrates (control), many of the mass peaks with a higher intensity 
peak from pure protein solutions relative to conditioned media suggest that these amino 
acid fragments within these pure protein solutions are also present in conditioned media 
(Figure 5.10A and Table 5.5. However, it is apparent that Coll I is predominantly adsorbed 
onto glass coverslips. On PCL-A (280 nm) substrates, Coll I is also predominantly 
adsorbed onto these nanofibres, followed by Fn (Figure 5.10B). Interestingly by changing 
the fibre orientation; on PCL-R (318 nm) substrates, Coll I and Vn were predominantly 
being adsorbed instead (Figure 5.10C). By increasing the fibre diameter, PCL-A (521 nm) 
this changed the protein adsorption ability where in comparison to PCL-A (280 nm), not 
only did Coll I adsorb to the substrates but so did Fn and Ln (Figure 5.10D). On larger 
fibre diameter (660 nm) PCL-R substrates, Coll I, Fn and Ln were predominantly adsorbed 
with a greater number of mass peaks detected (Figure 5.10E). In terms of fibre diameter, 
there are less mass peaks detected at a higher intensity to conditioned media on smaller 
diameter fibres compared to larger fibres. 
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Figure 5.10 Normalised intensity values of  detected positive protein fragments from 
conditioned media (CM) and all pure protein solutions (Coll I, Fn, Ln and Vn) on: (A) 
glass coverslips (control), (B) PCL-A (280 nm), (C) PCL-R (318 nm), (D) PCL-A (521 
nm) and (E) PCL-R (660 nm). 
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Table 5.5 Positive ion mass peaks detected at a higher normalised intensity value on each 
substrate type from each pure protein solution relative to conditioned media. 
Substrate type Pure protein 
solution 
Positive ion fragments detected at a higher 
normalised intensity from pure protein 
solutions in comparison to conditioned media 
Glass (control) Coll I 43.0241, 43.0421, 55.0208, 56.0233, 59.0496, 
69.0374 and 70.0375 
Fn 69.0374 and 124.9131 
Ln 124.9131 
Vn 43.0241 and 59.0496 
PCL-A (280 
nm) 
Coll I 41.0139, 42.9994, 43.0421, 44.0371, 55.0208, 
56.0233, 59.0496 and 69.0374 
Fn 42.9994, 59.0496 and 69.0374 
Ln 59.0496 and 69.0374 
Vn Normalised intensity for all mass peaks 
equivalent to or less than conditioned media 
PCL-R (318 
nm) 
Coll I 41.0139 and 43.0241 
Fn 124.9131 
Ln Normalised intensity for all mass peaks 
equivalent to or less than conditioned media 
Vn 42.9994, 43.0241, 43.0421 and 59.0496 
PCL-A (521 
nm) 
Coll I 41.0139 and 42.9994 
Fn 41.139, 43.0241, 55.0208 and 69.0374 
Ln 43.0241, 43.0421, 440.371, 55.0208, 59.0496 and 
69.0374 
Vn Normalised intensity for all mass peaks 
equivalent to or less than conditioned media 
PCL-R (660 
nm) 
Coll I 41.0139, 43.0241, 43.0421, 44.0371, 55.0208, 
56.0233, 59.0496, 69.0374 and 70.0375 
Fn 43.0241, 43.0421, 44.0371, 55.0208, 56.0233, 
59.0496, 69.0374 and 70.0375 
Ln 43.0241, 43.0421, 44.0371, 55.0208, 56.0233, 
59.0496, 69. 0374, 70.0375 
Vn 43.0241 and 55.0208 
 
PCA analysis of the negative ion data set of media/pure protein solution adsorption on 
each substrate revealed distinct grouping of each data group, as shown in Figure 5.11. PC1 
and PC2 score plots of negative SIMS data indicated clustering of sample data into four 
distinct groups (cluster A, cluster B, cluster C and cluster D; indicated by circles); 
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however, a greater overlap between different samples was observed in cluster A and cluster 
B thus suggesting spectral similarities between various sample in terms of protein 
adsorption, as shown in Figure 5.11. The samples within each cluster are specified in Table 
5.6. 
 
PCA score plots of negative SIMS data, of samples separated in terms of fibre diameter; 
(small Ø, 280-318 nm; large Ø 521-660 nm) further demonstrated spectral similarities 
between several samples. In Figure 5.12, PCA score plots of smaller fibre diameter 
samples revealed overlapping and clustering of various samples in cluster A and cluster B. 
Larger fibre diameter samples revealed no spectral similarities, as shown in Figure 5.13. 
This suggests that smaller fibre diameters support a greater overlapping and clustering 
samples within smaller fibre diameter samples in comparison to larger fibre diameter 
samples. The samples identified within each cluster for Figure 5.12 are stated in Table 5.6.  
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Figure 5.11 Scores plot on the first two multivariate axes from PCA of the Tof-SIMS spectra (negative ion data) of proteins adsorbed onto all 
electrospun nanofibrous substrates and control (blank glass coverslip). Circles indicating clustering of sample data with respect to PC1 and 
PC2. 
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Figure 5.12 Scores plot on the first two multivariate axes from PCA of the Tof-SIMS spectra (negative ions data) of proteins adsorbed onto 
PCL nanofibrous substrates of smaller diameter (280 – 318 nm) and control (blank glass coverslip). Circles indicating clustering of sample 
data with respect to PC1 and PC2. 
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Figure 5.13 Scores plot on the first two multivariate axes from PCA of the Tof-SIMS spectra (negative ions data) of proteins adsorbed onto 
PCL nanofibrous substrates of smaller diameter (280 – 318 nm) and control (blank glass coverslip). Circles indicating clustering of sample 
data with respect to PC1 and PC2. 
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Table 5.6 Definition of clusters observed in Figures 5.11-5.13 for protein fragments on all 
substrates for all negative ion data. 
 Cluster Spectral similarities observed between proteins on various 
proteins 
Figure 
5.11 
Cluster 
A 
CM CTL, CM-A (280 nm), Coll I-R (318 nm), Fn CTL, Ln, CTL 
and Ln-A (280 nm) 
Cluster 
B 
CM CTL, CM-A (521 nm), CM-R (318 nm), Coll I-A (280 nm), 
Fn-R (660 nm), Ln-A (521 nm), Ln-R (318 nm), Ln-R (660 nm) 
and Vn CTL 
Cluster 
C 
CM-R (660 nm), Coll I-R (660 nm), Fn-R (660 nm), Vn-A (521 
nm), Vn-R (318 nm) 
Cluster 
D 
Coll I-A (521 nm), Vn-A (521 nm) and Vn-R (660 nm). 
Figure 
5.12 
Cluster 
A 
Coll I-R (660 nm), Vn-R (660 nm), Vn-A (521 nm) 
Cluster 
B 
CM-A (521 nm), Fn-R (660 nm), Ln-A (521 nm) and Vn-A (521 
nm) 
 
The score plots for PCA provided visualisation of spectral similarities between 
multivariate data sets; they do not provide detailed information in terms of the original 
variables such as the Tof-SIMS ion mass peaks and the exact difference in peak intensities 
between the spectra of different proteins adsorbed onto various substrates. However, the 
loading plots do provide this information; loading plots for PC1 and PC2 (Figure 5.14) for 
the negative ion fragments detected on substrates identified the following amino acid 
fragments to be expressed at a higher normalised intensity: CN
-
, SH
-
, C3H5
+
, CH3N2, 
C2H6NO, C2H5S, C3H8NO, C2H6NS, C4H6NO, C7H7
+
, C4H10N3 and C8H10NO. For each of 
the negative ion mass peaks identified, normalised intensity values were tabulated and 
categorised in terms of the media/pure protein solutions in which they were detected 
(negative ion mass tables; Table A6-A10, in Appendix). Furthermore, these values enabled 
the identification of the samples on which normalised intensity peaks were the highest in 
terms of media/protein type, substrate (glass, PCL-A, PCL-R) and fibre diameter (small Ø 
280-318 nm; large Ø 521-660 nm). This information is summarised in Table 5.7. 
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Figure 5.14 Loading plots for PC1 and PC2 from PCA of negative ions spectra of proteins 
adsorbed from CM and pure protein solutions (Coll I, Fn, Ln, and Vn) onto glass (control), 
PCL-A and PCL-R substrates of both small (Ø 280-318 nm) and large (Ø 521-660 nm) 
fibre diameter. Red line indicates the threshold set above which mass peaks are considered 
to be expressed at high intensity (indicated in red). Thresholds for PC1 (positive, 0.0265; 
negative, -0.0335) and PC2 (positive, 0.0294; negative, -0.0451) were set at these values 
due to an obvious difference (plots) in PC values from the baseline when display on the 
loading plots. 
Characterisation of Protein Adsorption Activity on Electrospun Nanofibrous Substrates to 
Support hESC Attachment 
Chapter 5 
 
224 
 
Table 5.7 Negative ion amino acid fragments identified from loading plots for PC1 and PC2 from PCA and 
the samples on which detected at the highest normalised intensity. [Canavan et al., 2006; Mahlstedt et al., 
2010; Wagner and Castner, 2001; Wagner et al., 2002] 
m/z (-ve 
ions) 
Assignment Proteins and Substrates on which greatest normalised 
intensity observed 
25.0094 
CN
-
; peptide 
backbone
 
Coll I-A (521 nm), Fn-A (521 nm), Vn-A (280 nm), Vn-R (660 
nm) 
34.9712 SH-; Cysteine 
Coll I CTL (glass), Coll-A (280 nm), Fn CTL (glass), Ln CTL 
(glass), Ln-R (660 nm) 
41.0453 C3H5
+ 
Coll I-R (660 nm), Fn-A (521 nm), Vn-A (280 nm), Vn-R (660 
nm) 
43.0017 
CH3N2: 
Arginine 
(Kaivosoja et 
al., 2012) 
Coll I-A (521 nm), Vn-A (280 nm), Vn-R (660 nm), Vn CTL 
(glass) 
59.9676 
C2H6NO: 
L-serine most 
prevalent in Fn 
Coll I-A (521 nm), Vn-A (280 nm), Vn-R (660 nm), Vn CTL 
(glass) 
62.9658 
C2H5S: 
Methionine 
most prevalent 
in Coll 
Coll I-A (521 nm), Vn-A (280 nm), Vn-R (660 nm) 
74.9971 
C3H8NO; 
Threonine most 
prevalent in Fn 
Ln-A (280 nm), Ln-A (521 nm), Ln-R (318 nm), Ln-R (660 nm) 
75.9611 
C2H6NS; 
cysteine most 
prevalent in Fn 
Coll I-A (521 nm), Vn-A (280 nm), Vn-R (660 nm) 
76.9699 
C2H6NS
+
; 
cysteine 
Coll I-A (521 nm), Vn-A (280 nm), Vn-R (660 nm) 
83.9729 
C4H6NO; 
glutamine 
Fn CTL (glass), Ln-A (280), Ln-A (521 nm) 
90.9943 
C7H7; 
Phenylalanine or 
Tyrosine 
Fn CTL (glass), Fn-A (280 nm), Ln-A (280 nm), Ln-A (521 nm), 
Ln-R (318 nm), Ln-R (660 nm) 
90.9992 
C7H7: 
Phenylalanine or 
Tyrosine 
Fn CTL (glass), Fn-A (280 nm), Ln-A (280 nm), Ln-A (521 nm), 
Ln-R (280 nm) 
99.9847 
C4H10N3; 
arginine 
Fn CTL (glass), Fn-A (280 nm), Ln CTL (glass), Ln-A (280 nm), 
Ln-R (318 nm), Ln-R (660 nm) 
127.9609 
C8H10NO; 
arginine 
Fn CTL (glass), Ln CTL (glass) 
136.9337 
C8H10NO; 
tyrosine 
Coll I-A (521 nm), Fn CTL (glass), Ln CTL (glass), Vn-A (280 
nm), Vn-R (660 nm) 
 
Of all the negative ion mass peaks detected (stated in Table 5.7), 6 negative ions with the 
greatest normalised intensity values were selected as: 31.9712 (SH
-
; cysteine), 62.9658 
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(C2H5S, methionine), 74.9971 (C3H3NO; threonine), 83.9729 (C4H6NO; glutamine), 
90.9943 (C7H7; phenylalanine/tyrosine) and 90.9992 (C7H7; phenylalanine/tyrosine). These 
mass ion fragments were plotted in terms of substrate type in order to distinguish any 
protein adsorption patterns and specificity in protein adsorption to substrates in terms of 
fibre orientation and diameter (Figure 5.14). Mass peaks detected at a higher normalised 
intensity value on each substrate type from pure protein solutions than from conditioned 
media are stated in Table 5.8. Assessment of the presence of protein ions from individual 
pure proteins adsorbed onto substrates with high normalised intensities has been performed 
and fragment patterns of these proteins on various substrates identified. When comparing 
these patterns to samples where proteins were adsorbed from conditioned media; those 
peaks (amino acid fragments) at the same m/z suggest having arised from the single protein 
with similar pattern of protein adsorption but does not definitely confirm which specific, 
individual protein the amino acid fragment is derived from (Figure 5.14A and Table 5.5). It 
was apparent that, Fn and Ln predominantly adsorbed onto glass coverslips, as evidently 
shown by similarities in spectral patterns for adsorption between Fn and Ln on glass 
coverslips (Cluster A, Figure 5.11). On PCL-A (280 nm) substrates, Fn and Ln again 
predominantly adsorbed onto these nanofibres (Figure 5.15B), further supported by 
similarities in protein adsorption. Interestingly by changing the fibre orientation; on PCL-R 
(318 nm) substrates, Coll I and Ln were predominantly being adsorbed instead (Figure 
5.15C). However, it was observed that by increasing the fibre diameter resulted in a change 
in patterns of protein adsorption to substrates; both PCL-A (521 nm) and PCL-R (660 nm) 
predominantly absorbed Ln only, mostly to their surface whereas in the lower fibre 
diameter substrates (PCL-A, 280 nm; PCL-R, 318 nm), more than protein was being 
adsorbed. 
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Figure 5.15 Normalised intensity values of negative ion mass peaks of protein fragments 
from conditioned media (CM) and all pure protein solutions (Coll I, Fn, Ln and Vn) on: 
(A) controls (glass coverslips), (B) PCL-A (280 nm), (C) PCL-R (318 nm), (D) PCL-A 
(521 nm) and (E) PCL-R (660 nm). 
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Table 5.8 Negative ion mass peaks detected at a higher normalised intensity value on each 
substrate type from each pure protein solution relative to conditioned media. 
Substrate Type Pure protein 
solution 
Positive ion fragments detected at a higher 
normalised intensity from pure protein 
solutions in comparison to conditioned 
media 
Glass (control) Coll I 34.9712 
Fn 34.9712, 74.9971, 83.9729, 90.9943 and 
90.9992 
Ln 34.9712, 62.9658, 74.9971, 83.9729 and 
90.9943 
Vn 74.9971 
PCL-A (280 nm) Coll I 34.9712 
Fn 83.9729 and 90.9943 
Ln 74.9971, 83.9729, 90.9943 and 90.9992 
Vn Normalised intensity for all mass peaks 
equivalent to or less than conditioned media 
PCL-R (318 nm) Coll I 62.9658, 74.9971, 83.9729, 90.9943 and 
90.9992 
Fn 62.9658 and 90.9992 
Ln 74.9971, 83.9729, 90.9943 and 90.9992 
Vn Normalised intensity for all mass peaks 
equivalent to or less than conditioned media 
PCL-A (521 nm) Coll I Normalised intensity for all mass peaks 
equivalent to or less than conditioned media 
Fn 34.9712 
Ln 34.9712, 74.9971, 83.9729, 90.9943 and 
90.9992 
Vn Normalised intensity for all mass peaks 
equivalent to or less than conditioned media 
PCL-R (660 nm) Coll I Normalised intensity for all mass peaks 
equivalent to or less than to conditioned media 
Fn 34.9712 
Ln 34.9712, 62.9658, 90.9943 and 90.9992 
Vn Normalised intensity for all mass peaks 
equivalent to or less than conditioned media 
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5.5 Discussion 
Culture and expansion of undifferentiated hESCs in vitro is commonly performed using 
Matrigel™ and MEF-conditioned hESC media. Matrigel™ is a gel comprised of a 
complex of ECM proteins which provide the optimum composition and concentration 
required for the expansion of pluripotent hESCs. This protein complex acts as pivotal 
points which have suitable recognition sites for corresponding cell surface receptors such 
as integrins that are able to bind to these proteins, triggering a cascade of intracellular 
responses causing subsequent cell attachment and pluripotent expansion. This activity is 
further mediated and supported by the secretion of essential ECM proteins, growth factors 
and cytokines by hESCs themselves, crucial for their proliferation and maintenance of 
pluripotency. In the previous chapter (chapter 4), it was revealed that crucial hESC integrin 
receptors differed in their surface expression levels as a result of oxygen environment. 
Attachment of hESCs to Matrigel
TM
 was reliant on αVβ5, αE and α6 integrins/integrin sub-
units in physiological normoxia (2% O2); suggesting that their corresponding ECM 
proteins (collagen, fibronectin, laminin and vitronectin) must be present and make up the 
majority of the protein complex in Matrigel™. Furthermore, a novel, alternative method to 
culture and expand hESCs using synthetic electrospun nanofibrous substrates has also 
demonstrated the successful expansion of pluripotent hESCs with retention of 
differentiation capacity, but in physiological normoxia (2% O2), only and thus was oxygen 
dependant. It is well accepted that cell attachment to biomaterial substrates usually occurs 
after the adsorption of a dynamic interfacial protein layer that is able to adsorb onto a 
substrate; therefore it can be hypothesised that the protein layer adsorbing onto these 
nanofibrous substrates must include collagen, fibronectin, laminin and vitronectin thus 
permitting hESC attachment and expansion. However, several factors can determine the 
type of protein, quantity, density, conformational state and orientation of the protein on a 
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substrate such as substrate chemistry and topography. This study investigated protein 
adsorption onto optimum electrospun nanofibrous substrates (PCL-A and PCL-R) for 
hESC expansion, from MEF conditioned hESC media and pure protein solutions (Coll I, 
Fn, Ln and Vn), in order to identify key ECM proteins and in detail, the critical amino acid 
fragments that may adsorb onto these substrates which mediate the initial attachment of 
hESCs. These important findings may play a crucial role in the design of novel, smart 
substrates, specifically tailored to increase the attachment and expansion rates of 
undifferentiated hESCs and also eliminating the use of xenogenic materials such as 
Matrigel™, resulting in their potential use for the regenerative medicine industry. 
 
PCL was electrospun to fabricate nanofibres with different fibre diameters (small Ø, 280-
318nm; large Ø, 521-660 nm) in both aligned and random conformations. Previously, it 
was observed that the smaller fibre diameter nanofibrous substrates supported the greatest 
number of hESC CFU formation and therefore these fibres were used to quantify the 
amount of protein adsorption to their surface. Quantification of protein adsorption from 
conditioned media and pure protein solutions (Coll I, Fn, Ln and Vn) onto PCL-A (280 
nm), PCL-R (318 nm) and glass (control), in physiological normoxia (2% O2) was 
determined using Nano Orange™. It was revealed statistically, that there was significantly 
increased adsorption of proteins from conditioned media on PCL-A compared to glass 
(p<0.05) and Vn adsorption on PCL-A compared to glass (p<0.01). Although, not the case 
in this study (demonstrated by Nano Orange™), surface topography at the nanoscale 
increases the surface area to volume ratio resulting in increased protein adsorption in 
comparison to a flat surface such as a glass coverslip. Decreasing substrate size topography 
and increasing surface roughness is known to increase protein adsorption ([Rechendorff et 
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al., 2006; Riedel et al., 2001]. Although, it has been demonstrated that surface chemistry 
can also influence protein adsorption such as enhanced adsorption of albumin to 
hydrophilic substrates compared to hydrophobic surfaces, it has been reported topography 
alone can also enhance protein adsorption. For example, bovine serum albumin (BSA; a 
globular protein in shape) and fibrinogen (Fg; a larger protein with a rod-like shape) 
adsorbed in greater quantities on smaller particles (with a high surface curvature) [Roach et 
al., 2006; Scopelliti et al., 2010], also found that nano-scale morphology significantly 
increased adsorption of proteins BSA and fibrinogen on nanostructured TiOx films 
(ranging from 15-30 nm surface morphology).  
  
Protein adsorption ability can be affected by several factors including the characteristics of 
the protein itself (such as size, shape and conformational stability [Cai et al., 2006]as well 
as substrate chemistry and topography[Roach, 2005]. Topography at the nano-scale 
(similar length scale to protein dimensions) can dictate and manipulate the protein shape 
resulting in orientation and conformational changes leading to changes in secondary 
structure and ordered state of the proteins [Roach, 2005]. Furthermore, some proteins may 
have weak internal bonds and hydrophobic interactions and therefore are easy to distort 
and induce conformational changes. However, others have strong internal bonds and 
hydrophobic interactions and are more difficult to distort and induce 
structural/conformational changes. These protein characteristics in combination with 
topography and surface chemistry determine the ability of a protein to unfold and interact 
with a substrate in such a way which can consequently affect the active state of the protein 
and its ability to mediate cell attachment. 
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In this chapter, the effect of fibre diameter (small Ø 280-318 nm; large Ø 521-660 nm) of 
PCL-A and PCL-R nanofibrous substrates was investigated in terms of protein adsorption 
from MEF-conditioned hESC media and pure protein solutions (Coll I, Fn, Ln and Vn). 
Score plots from PCA of both positive and negative ion Tof-SIMS data sets revealed that 
fibre diameter influenced protein adsorption; positive ion data set showed clustering for 
large diameter fibres (521-660 nm) and even greater clustering and overlapping of various 
samples on small diameter fibres (Ø 280-318 nm) suggesting spectral similarities between 
various substrates and conditioned media samples (Table 5.3). Whereas, negative ion data 
set revealed clustering and overlapping of samples amongst small fibre diameter substrates 
and no clustering of samples amongst large fibre diameter samples (Table 5.6). 
Interpretation of Tof-SIMS data revealed that proteins from various pure proteins solutions 
(Coll I, Fn, Ln and Vn) and conditioned media were able to adsorb to nanofibrous 
substrates, as demonstrated by spectral similarities in patterns of protein adsorption. To pin 
point and identify the exact amino acid fragments within those adsorbed proteins on 
substrates which were being exposed, loading plots were formulated. This further 
identified the ion intensity of amino acid fragments (positive and negative) on the various 
substrates and fragmentation patterns of these proteins in comparison to protein adsorption 
patterns to conditioned media. Also, the key amino acid fragments detected on the 
substrates were identified.  
 
Loading plots (for positive ion data) revealed a fragmentation pattern of mass peaks for ion 
fragments to be the following: 41.0139 (C3H5
+
), 42.9994 (CNO
-
, peptide backbone), 
43.0241 (C2H5N), 43.0421 (C2H5N), 44.0371 (C2H6N
+
; alanine, lysine or aspargine), 
55.0208 (C4H7
+
), 56.0233 (C3H6N
+
), 59.0496 (CH5N3; arginine), 69.0374 (C4H5O; 
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threonine), 70.0375 (C4H8N
+
; arginine) and 124.9131 (C5H11N4; arginine) all had higher 
intensity peaks on various nanofibrous substrates (of different fibre diameter and 
orientation) adsorbed from pure protein solutions (Coll I, Fn, Ln and Vn) than proteins 
adsorbed from conditioned media onto substrates. Similarly, loading plots (for negative ion 
data) revealed that mass peaks for ion fragments: 31.9712 (SH
-
; cysteine), 62.9658 (C2H5S, 
methionine), 74.9971 (C3H3NO; threonine), 83.9729 (C4H6NO; glutamine), 90.9943 
(C7H7; phenylalanine/tyrosine) and 90.9992 (C7H7; phenylalanine/tyrosine) all had higher 
intensity peaks on various nanofibrous substrates (of different fibre diameter) adsorbed 
from pure protein solutions (Coll I, Fn, Ln and Vn) than from proteins adsorbed from 
conditioned media onto substrates. This suggests that not only are these pure proteins 
present in conditioned media but infact these identified amino acid fragments are exposed 
on the substrate which may facilitate hESC attachment by providing recognisable 
attachment sites. However, limitations of this data are that no control substrates 
(nanofibrous substrates without any protein/media adsorption) were analysed which could 
have eliminated CH populations containing ion mass peaks that could be arising from the 
polymer material itself rather than proteins. 
 
A similar study performed by [Mahlstedt et al., 2010] also identified a significant increase 
in 14 ions (including m/z 41.0397, 55.0217, 69.0007, 83.061 and 123.0505), using Tof-
SIMS, on plasma treated PE-TCPS (oxygen plasma etched tissue culture polystyrene) in 
comparison to TCPS. Radio frequency plasma etching alone displayed an increase in 14 
ions on the substrate in comparison to standard TCPS;  molecular species on PE-TCPS, 
played an important role in the pluripotent expansion of hESCs with consistent 
proliferation during continuous passage whilst retaining their differentiation capacity 
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[Mahlstedt et al., 2010]. Five of these molecular species were also identified by the data in 
this thesis on the nanofibrous substrates which were: 41.0139, 43.0421, 55.0208, 69.0374 
and 70.0375. 
 
The data in this chapter has suggested obvious clustering and overlapping of various 
samples in PCA score plots, in terms of fibre diameter size and proteins adsorbed from 
pure protein solutions and conditioned media. These highlighted, spectral similarities 
between various samples, giving an indication of similarities in fragmentation patterns 
between samples as well as identifying key protein fragments exposed on each substrate 
type. This protein adsorption behaviour may be a result of a multiple number of reasons. 
Proteins differ in terms of size and shape. Protein adsorption can increase with an increase 
in surface area by increasing surface curvature/roughness (when normalised to surface 
area). In this case, surface roughness was introduced by nanofibrous features (changing 
fibre diameter also) in comparison to a flat glass coverslip. Furthermore, proteins are 
flexible chains that have been coiled, folded and bent to form a particular conformation; 
however, this can be modified upon interaction with a substrate. Substrate chemistry (is the 
same, as PCL was used for all nanofibrous substrates) and topography can influence the 
way a protein unfolds onto a substrate and effects  its orientation Furthermore, PCL is a 
hydrophobic material; hydrophobic materials bind more proteins as they are more 
energetically favourable and also bind them tightly by causing greater distortion of the 
protein in order to maximise surface interactions [Roach et al., 2005; Roach et al., 2006]; 
this is further maximised with increasing surface area (decreasing fibre diameter). Hence, it 
can be hypothesised that each protein has individual characteristics and thus interacts 
differently with substrates (in terms of fibre diameter) as a result of orientation and 
unfolding which reveals different amino acid fragments due to difference in 
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conformational changes. On smaller fibre diameters, positive ion data revealed amino acid 
fragmentation patterns being similar to a range of proteins (Coll I, Fn, Ln and Vn), whereas 
negative ion data indicated fragmentation patterns similar to Fn and Ln but not from Vn. 
On larger fibre diameter substrates, positive ion data revealed amino acid fragmentation 
patterns predominantly similar to Fn and Ln and this was also witnessed in negative ion 
data. Difference in the orientation of PCL nanofibres (aligned and random) demonstrated 
to show a difference in colony forming unit number, where PCL-A substrates provided a 
greater number of CFUs relative to PCL-R. Cell attachment occurs after the adsorption of 
proteins to biomaterials, which then provides recognisable attachment sites for hESC 
attachment. Nano Orange™ demonstrated significant increase in conditioned media and 
Vn adsorption to PCL-A nanofibrous substrates in comparison to glass coverslips 
(control); however, score plots of PCA, of aligned and random substrates separately, 
demonstrated no real clustering between samples of proteins adsorbed from pure protein 
solutions and conditioned media, with no spectral similarities. This suggests that generally 
topography at the nano-scale enhances protein adsorption but the conformation of the 
fibres i.e. aligned or random, causes no difference in protein adsorption or the intensity of 
key amino acid fragments presented on the substrates for hESC attachment. However, the 
difference in hESC CFU formation between aligned and random nanofibrous substrates 
may be a result of, changes in the orientation of the protein and the way the proteins adsorb 
onto the substrates (aligned or random), which could encourage the unfolding of proteins 
and conformational changes on aligned nanofibrous substrates in such a way, which is 
favourable and better for hESC attachment in comparison to random fibre orientation. 
Therefore, it may be that the aligned nanofibrous substrates cause a specific change in the 
secondary structure of certain proteins which either exposes a certain amino acid fragment 
which hESCs prefer on a multiple number of proteins, or that the specific amino acid 
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fragments are arising from a specific protein which could be Vn (suggested by Nano 
Orange™ due to the greatest abundance of Vn witnessed on aligned nanofibres). However, 
this would have to be confirmed by further experimental investigations such as infrared 
spectroscopy for an in depth view of the secondary structure of adsorbed proteins. It can 
also be hypothesised that there may be a threshold in the quantity of each of the proteins 
adsorbed onto the nanofibrous substrates and that, as shown by Nano Orange™, the 
increased adsorption (substrate concentration) of Vn on aligned nanofibrous substratres 
causes a greater number of specific amino acid fragments to be exposed, which are 
essentially relevant for mediating hESC attachment and proliferation.  
 
The use of Tof-SIMS has allowed the investigation of protein adsorption from pure protein 
solutions and conditioned media to electrospun nanofibrous substrates. Specifically, score 
plots of PCA (positive and negative ion data) demonstrated spectral similarities between 
adsorption of proteins from pure protein solutions to nanofibrous substrates and proteins 
adsorbing from conditioned media onto nanofibrous substrates thus confirming the 
presence on Coll I, Fn, Ln and Vn in conditioned media. Furthermore, smaller diameter 
fibres (280-318 nm) displayed a closer clustering and overlapping of numerous samples in 
comparison to larger fibre diameter substrates (521-660 nm). Loading plots identified the 
exact ion mass fragments where differences were observed in terms of peak intensity 
which not only confirmed their existence in conditioned media but also stated the fact that 
these may be critical mediators involved in hESC attachment and proliferation. However, 
Nano Orange™ suggested that only a significant increase in adsorption of Vn and 
conditioned media on PCL-A compared to glass coverslip controls. Coll I, Fn, Ln and Vn 
all share various similarities in their primary structure and thus the exact origin of the 
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identified key amino acid fragment mediators is still unknown. Future work would include 
investigating the secondary structure of the proteins adsorbed onto the nanofibrous 
substrates in order to confirm the exact protein from which it has originated and also to 
determine its conformational state and orientation.  
 
The overall findings in this chapter have demonstrated the successful conditioning of 
electrospun nanofibrous substrates by conditioned media which supports the adsorption of 
critical proteins and the exposure of key amino acid fragments as well as the effect of fibre 
diameter on fragmentation patterns which all influence and mediate the attachment of 
hESCs. Furthermore, fibre diameter also influenced adsorption of proteins from 
conditioned media and pure protein solutions. The discovery of critical amino acid 
fragments detected on the nanofibrous substrates provides exciting opportunities for the 
design and tailoring of novel substrates to enhance the characteristics of synthetic 
substrates such as nanofibres for hESC culture. 
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5.6 Conclusion 
Electrospun PCL nanofibrous substrates (aligned and random) have successfully supported 
undifferentiated hESC CFU expansion, in 2% O2. This is mediated by conditioning of 
nanofibre substrates by proteins present in conditioned media which adsorb from 
conditioning media. Nano Orange™ quantified the adsorption of proteins from pure 
protein solutions (Coll I, Fn, Ln and Vn) and total protein from MEF-conditioned hESC 
media; a significant increase in conditioned media and Vn was apparent on PCL-A 
substrates in comparison to glass coverslips (control). Identification of the characteristics 
of the nanofibrous substrates was performed using Tof-SIMS. Score plots of PCA (positive 
and negative ion data), revealed clustering and thus spectral similarities between various 
nanofibrous substrates to conditioned media samples confirming the presence of the pure 
proteins (Coll I, Fn, Ln and Vn) in MEF-conditioned hESC media. Furthermore, a 
difference in protein adsorption was also detected with varying fibre diameter, where 
smaller fibre diameter substrates (280-318 nm) demonstrated a closer clustering of various 
samples in comparison to larger fibre diameter substrates (521-660 nm). Loading plots 
(PC1 and PC2) identified the exact ion mass peaks which had a higher normalised intensity 
peak than conditioned media, on various substrates. These ion mass fragments appear to be 
the key mediators for hESC attachment and many of them suggested have adsorbing from 
either a predominant protein or from a range of proteins adsorbing onto substrates, which 
was also different depending on fibre diameter. Identification of characteristics of 
nanofibrous substrates provides the opportunity to further modify and enhance electrospun 
nanofibrous substrate biocompatibility to increase hESC attachment, increase proliferation, 
maintain pluripotency, and retain differentiation capacity which would drive the use of 
hESCs towards stem cell therapies and regenerative medicine. 
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6 General Discussion, Future Work and Conclusions 
 
6.1 Discussion  
Limitations associated with current techniques used to culture and expand hESCs in vitro 
have encouraged research towards alternative substrates and techniques. In this thesis, a 
novel substrate in the form of electrospun nanofibrous substrates has been developed and 
investigated for the appropriate use in hESC expansion. This substrate provides the 
opportunity to elimination the use of Matrigel™ and feeder layers which have limitations 
including direct xenogenic exposure to hESCs, poor attachment resulting in low expansion 
rates and scale-up issues, difficulty in controlling and maintaining hESC behaviour and 
finally a substrate which only limits expansion to a 2D in vitro environment and resulting 
in difficulty to transport and translate towards a clinical setting. Furthermore, this thesis is 
the first to report the use of purely synthetic FDA approved polymers to expand 
undifferentiated hESCs without the use of natural polymers and the co-culture of feeder 
layers, whilst also investigating the synergistic effects of oxygen and nanofibre technology. 
 
Various polymers (PCL, PLGA and PLLA) were investigated in both aligned and random 
nanofibre conformations; the optimal performance was witnessed by PCL-aligned 
substrates. Furthermore, it was apparent that the synergistic effect of oxygen environment 
and nanofibre technology had dictated the expansion of hESCs. It was revealed that hESCs 
cultured under hyperoxic conditions (21% O2), were unable to adhere to substrates 
resulting in the formation of EBL features, after 21 days of culture despite using hESC 
conditioned media. However, in physiological normoxia (2% O2) hESCs cultured on 
electrospun nanofibrous substrates (in combination with hESC conditioned media) 
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demonstrated the ability to attach and expand, to form typical undifferentiated CFUs as 
would be expected on Matrigel™. Further evaluation revealed that recovered hESCs on 
nanofibrous substrates maintained pluripotency and their differentiation capacity when 
cultured under 2% O2. Furthermore, it is reported in literature that physiological normoxic 
conditions enhance clonogenicity, decrease in vitro spontaneous differentiation and 
maintain greater pluripotency of hESCs on Matrigel™ in comparison to hESCs cultured in 
21% O2 [Forsyth et al., 2006; Westfall et al., 2008]. This is a result of mimicking the in 
vivo oxygen environment of hESCs to which they are exposed. Furthermore, this thesis 
revealed increased clonogenicity with decreasing fibre diameter of nanofibrous substrates 
(fabricated from PCL; aligned and random) in combination with physiological normoxic 
culture conditions. This lies in agreement with a previous study where HUVECs also 
demonstrated the same observations [Keun Kwon, 2005]}. The general dogma is that fibre 
diameters below 500 nm promote cell adhesion and encourage greater cell attachment due 
to mimicking the similar nano-scale features and topography of native ECM [Ma et al., 
2008; Ravichandran et al., 2009]. Hence, by mimicking a combination of both the nano-
scale ECM architecture and the oxygen environment this may further create an 
environment which resembles the in vivo hESC conditions as accurately as possible 
dictating their natural behaviour and function in vitro. 
 
Discovering the change in hESC activity on nanofibrous substrates by altering the oxygen 
environment (2% O2 and 21% O2), encouraged investigations into the integrin expression 
patterns of hESCs (Matrigel™) cultured in 2% or 21% O2 environments. These findings 
contributed to understand and identify the mechanisms of action and critical interactions 
associated with hESCs, which are yet to be fully elucidated. Microarrays have previously 
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been used to investigate changes in pluripotent and differentiation markers within various 
hESC lines [Cai et al., 2006; Lee et al., 2010] as well as the alterations in integrin 
expression for hMSCs as a result of changing the oxygen environment when cultured on 
various substrates (polystyrene, collagen I, fibronectin and laminin) [Saller et al., 2012]. In 
this thesis, analysis of microarray data revealed for the first time that integrin expression 
levels and patterns changed in hESCs as a result in the change of oxygen environment. It 
was found that β3 binding protein, β1 binding protein 1, β4 binding protein, α5, α6, α8, α9, 
αD, αE, αV, β1 and β5 were significantly up regulated in hESCs cultured in 2% O2 in 
comparison to 21% O2. Furthermore, many of these subunits corresponded to the integrins 
which have been previously identified in literature to be expressed by hESCs for 
corresponding ECM proteins; laminin (α6β1), vitronectin (αVβ5) and fibronectin (αVβ1, 
α5β1), collagen and laminin (α2β1), nidogen, laminin, collagen I and fibronectin (α3β1), 
collagen (α11β1) [Braam et al., 2008; Lee et al., 2010; Miyazaki et al., 2008]. Therefore 
we selected the following integrins/sub-units to investigate the initial attachment of hESCs 
to Matrigel™ when cultured under 2% or 21% O2: αVβ5, αV, β5, αE, α6 and CD44 
(CD44, a receptor for HA, which is secreted by MEFs in hESC media).  
 
Receptor blocking of these integrin sub-units revealed that inhibition of αE receptor 
significantly reduced hESC attachment in both 2% O2 and 21% O2 on Matrigel™; whereas 
inhibition of α6 and αVβ5 receptors significantly reduced hESC attachment in 2% O2 only. 
Although it has been previously identified that hESCs rely on αVβ5 and α6 on hESC 
attachment [Braam et al., 2008; Meng et al., 2010], this thesis was the first to examine 
attachment in different oxygen environments. In 21% O2, only blockage of CD44 
significantly reduced initial hESC attachment. This provides further validation and 
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extension of previous reports where blocking of CD44 demonstrated reduction in hESC 
clonogenicity; also witnessed in 21% O2 [Bourguignon et al., 2008; Gerecht et al., 2007]. 
Observations from this thesis and from previous reports collated together strongly suggest 
that oxygen-signalling has a role in defining substrate adhesion mechanistic choices where 
a switch from CD44 reliance to αVβ5 and α6 was identified. Oxygen is a bioactive, 
signalling molecule which can influence various cellular activities including cell 
attachment, proliferation and related intracellular pathways for controlling stemness 
[Zachar et al., 2010]. In particular, reduced oxygen concentrations regulate the expression 
of HIFs and it can be speculated that HIFs may be promoting the expression of α6 and 
αVβ5 integrins in hESCs during 2% O2 culture, permitting the attachment of hESCs to 
Matrigel™. 
 
The interlink between HIFs, integrins and growth factors all appear to have an effect on 
activation pathways of maintaining pluripotency of hESCs. Interference with substrate 
adhesion mechanism had an instant role upon the maintenance of pluripotency in hESCs. 
Antibody blocking αVβ5 (2% O2) and CD44 (21% O2), significantly decreased the nuclear 
localisation of pluripotent markers Oct 3/4, Nanog, Alkaline Phosphatase and SSEA-4. 
Specifically, in 2% O2 it was apparent that blocking αVβ5 prevents HIFs to upregulate 
transcriptional factors (NKB, AP-1, p53 and c-Myc) resulting in inactivation of intracellular 
pathways (FGF/Notch signalling) which are known to directly affect expression of 
pluripotent markers [Armstrong et al., 2006; Eiselleova et al., 2009]. Whereas in 21% O2, 
it can be speculated that blocking CD44 caused an interference in FGF-2 signalling 
resulting in inactivation of MAPK, ERK, PI3/AKT kinase and NFKB pathways with 
subsequent effects on pluripotency [Ma et al., 2009; Szablowska-Gadomska et al., 2011]  
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Identification of the critical integrin receptor (αVβ5) which was not only significantly up 
regulated in 2% O2 but also played a vital role in the initial attachment of hESCs to 
Matrigel™, lead to the hypothesis of its potential role and importance in mediating the 
attachment of hESCs to electrospun nanofibrous substrates (PCL aligned and random) 
under 2% O2. It was revealed for the first time that hESCs with blocked αVβ5 receptors 
decreased their clonogenicity ability on electrospun nanofibrous substrates in comparison 
to hESCs without blocked αVβ5 receptors. As integrins interact with corresponding ECM 
proteins which contain peptides such as the RGD sequence, which they are able to bind to; 
it was important to cross-validate the importance of these identified hESC integrins by 
evidently proving the existence of these corresponding proteins (collagen I, IV, fibronectin 
and laminin secreted from MEFs into hESC conditioned media) on electrospun 
nanofibrous substrates.  
 
Interaction of cells with synthetic substrates is a subsequent result of the initial adsorption 
of proteins from media to form an interfacial layer on substrates which provide natural 
recognition sites for corresponding integrins [Ma et al., 2007]. This ultimately dictates the 
biocompatibility of the substrate. Furthermore, the amount and type of protein adsorbed to 
substrates can be determined by various factors including polymer chemistry, topography 
and fibre diameter [Roach, 2005; Stevens and George, 2005]. This thesis was the first to 
investigate protein adsorption behaviour of individual, important ECM proteins (collagen I, 
fibronectin, laminin and vitronectin) identified in hESC conditioned media as well as 
conditioned media as a total protein solution, on electrospun nanofibrous substrates (PCL 
aligned and random) using Tof-SIMS. Furthermore, the effect of changing fibre diameter 
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on protein adsorption was also investigated as earlier; decreasing fibre diameter displayed 
an increase in hESC CFUs when cultured in 2% O2. 
 
NanoOrange was able to quantify the adsorption of proteins from pure protein solutions 
and conditioned media on nanofibrous substrates (PCL aligned and random) and glass 
coverslips; significant increases in conditioned media and vitronectin were apparent on 
PCL aligned substrates in comparison to glass coverslips. Tof-SIMS analysis confirmed 
the adsorption of ECM proteins from conditioned media as well as the existence of 
collagen I, fibronectin, laminin and vitronectin in conditioned media. PCA score plots of 
Tof-SIMS data (positive and negative ions) revealed spectral similarities between proteins 
adsorbed onto substrates from pure protein solutions and conditioned media. Specifically, 
smaller fibre diameter substrates revealed greater overlapping and clustering of samples 
and thus greater spectral similarities in comparison to larger fibre diameter samples. 
Loading plots further revealed fragmentation patterns of adsorbed proteins to substrates 
from pure protein solutions and conditioned media and contributed to identifying the exact 
amino acid fragments present on each substrate type and the intensity of expression on 
each substrate in comparison to conditioned media.  
 
For the first time, the following ion fragments were identified on the nanofibrous substrates 
from pure protein solutions and conditioned media with the highest intensity values: 
(positive ions) 41.0139 (C3H5
+
), 42.9994 (CNO
-
, peptide backbone), 43.0241 (C2H5N), 
43.0421 (C2H5N), 44.0371 (C2H6N
+
; alanine, lysine or aspargine), 55.0208 (C4H7
+
), 
56.0233 (C3H6N
+
), 59.0496 (CH5N3; arginine), 69.0374 (C4H5O; threonine), 70.0375 
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(C4H8N
+
; arginine) and 124.9131 (C5H11N4; arginine); (negative ions) 31.9712 (SH
-
; 
cysteine), 62.9658 (C2H5S, methionine), 74.9971 (C3H3NO; threonine), 83.9729 (C4H6NO; 
glutamine), 90.9943 (C7H7; phenylalanine/tyrosine) and 90.9992 (C7H7; 
phenylalanine/tyrosine). However, the intensity of these ion fragments differed depending 
on substrate type, in the context of fibre diameter which could be a result of the way in 
which the protein interacts, unfolds and changes it conformational state causing changes in 
secondary structure with subsequent exposure of specific amino acid fragments. However, 
it is yet to be fully elucidated the exact origin of the identified amino acid fragments as all 
proteins used in this investigation (Coll I, Fn, Ln and vn) share similarities in their primary 
structure; hence future work would include unveiling the secondary structure and locating 
the origin of the protein from which it has occurred from as well as the conformational 
state and orientation of the protein. This would have to be further investigated in detail 
using infrared spectroscopy. 
 
Nonetheless, the ion fragments detected had all adsorbed from proteins (Coll I, Fn, Ln and 
Vn) which appear to be present in conditioned media. Furthermore, this confirmed the 
adsorption of corresponding ECM proteins for critical integrins expressed in hESCs 
(cultured in 2% O2) identified, to play a critical role in initial attachment. αVβ5 is the 
corresponding and preferred integrin receptor for vitronectin; which was confirmed to 
adsorb to nanofibrous substrates. However, the two individual sub-units αV and β5 
including α6 are all also able to adhere to a range of ECM proteins, as many of these 
proteins (Coll I, Fn, Ln and Vn) share similarities in their primary structure (such as the 
RGD peptide). 
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So why were hESCs able to adhere to electrospun nanofibrous substrates in 2% O2 and 
form pluripotent CFUs whereas in 21% O2 embryoid body like features were formed 
instead; whilst maintaining all other parameters consistent? It appears that this is a result of 
integrin expression levels and the availability of critical hESC integrins which are required 
to be at a specific threshold, relevant for permitting and mediating hESC attachment. In 
combination to this, the relative concentration and availability of corresponding ion 
fragments exposed (further determined by how the protein unfolds with conformational 
changes) and available on a substrate determine the chances of interaction and connection 
between the integrin and adsorbed ECM protein on the nanofibrous substrates. Therefore, 
there also maybe a threshold in the quantity of each of the proteins adsorbed onto the 
nanofibrous substrates relevant for hESC attachment and their maintenance in 
pluripotency. Furthermore, it appears the relative ratio of ion fragments may also play an 
important factor in determining the exposure and availability of critical amino acid 
fragments to corresponding integrins, as it was witnessed that the ratio in the intensity of 
each of the ion peaks changed depending on the substrate and fibre diameter. This was 
particularly found on PCL aligned nanofibrous substrates (smaller fibre diameter) where 
the ratio between certain ion fragments was far less in comparison to larger fibre diameter 
substrates (PCL aligned or random) and conditioned media. This may therefore expose the 
critical ion fragments on which are perhaps overpowered by the high expression of 
fragments which perhaps are not as critical or important in mediating the initial attachment 
of hESCs. However, further investigations would be required to further narrow down and 
pin point the exact ion fragments which are crucial for mediating hESC attachment. 
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Anyhow, the identification of these ion fragments provides an opportunity to further 
explore these mass fragments and their importance in hESC attachment in greater detail, as 
well as tailor and modify the electrospun nanofibrous substrates with these identified ion 
fragments in order to further enhance and improve the attachment and expansion efficiency 
of hESCs whilst retaining their pluripotency. However, optimisation of various parameters 
would be required such as the exact ion fragments; their concentration and whether a 
combination of ion fragments tailored onto the substrates would enhance attachment, 
expansion rates as well as hESC stemness.  
 
This thesis has developed and investigated the applicability of a novel application of 
electrospun nanofibrous substate for the use in the expansion of undifferentiated hESCs. 
The beauty of this substrate is the elimination of limitations currently associated with the 
expansion and culture of hESCs in vitro. The novel substrate has the potential to replace 
Matrigel™ and the use of feeder layers which excludes xenogenic contact. This novel 
substrate is FDA approved and can act as a 3D carrier substrate for the delivery of 
differentiated hESCs into various tissue specific sites in vivo and thus encourages their 
drive towards a clinical setting without the need to remove the substrate due to its 
biodegradability, which would be the ultimate purpose. This thesis has set the fundamental 
foundations for expanding pluripotent hESCs which provides the opportunity to 
differentiate them towards countless lineages of the three germ layers, which in theory they 
are able to produce. The key findings of this thesis are summarised in Figure 6.1. 
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Figure 6.1 An overriding schematic which describes the key, novel findings identified in this thesis, collating together the results from Chapter 3, 
4 (Integrin mechanisms) and 5 (Protein adsorption to nanofibrous substrates). 
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6.2 Future Work 
This thesis has laid down the foundation of a suitable substrate which eliminates the use of 
Matrigel™ which currently limits the use of hESCs to 2D structures only. Due to poor 
attachment and expansion rates of hESCs to Matrigel™, this has prevented and hindered 
the use of hESCs in tissue engineering and regenerative medicine applications to the best 
of their ability. These electrospun nanofibrous substrates can be further improved by 
further tailoring and modification with identified amino acid fragments in this thesis. It 
would be hoped that these improvements would further enhance the biocompatibility of 
these substrates resulting in improved attachment, expansion rates, enhanced scale-up 
whilst maintaining their stemness. Additional improvements could also include the 
incorporation of growth factors into the electrospun nanofibrous substrates, required for 
specific lineage differentiation which would be released over time as the fibres degraded in 
order to continually provide the relevant chemical cues to differentiate hESCs. 
 
These substrates provide the opportunity to act as a 3D substrate which then allows the all 
tissue engineering principles to be applied such as 3D spatial environment, substrate 
topography, chemical environment and mechanical stimulation. The combinatory effects 
all these optimised parameters allows the opportunity to mimic and create countless in vivo 
environments encouraging their differentiation into many different cell types of interest of 
all three germ layers (mesoderm, endoderm and ectoderm). Therefore, future work could 
include the use of bioreactors to create this multi-environment and attempt to differentiate 
hESCs towards lineages such as bone, cartilage and tendon tissue. Differentiated hESCs 
and secreted matrix on substrates then have the potential to be implanted into in vivo 
models to investigate their ability to repair and regenerate tissue-specific defect sites. 
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6.3 Concluding Remarks 
This thesis has shown that electrospun nanofibrous substrates have the potential to function 
as an appropriate, alternative substrate for the culture and expansion of hESCs in vitro, 
thus potentially eliminating the use of Matrigel™ and xenogenic contaminations. From the 
investigations reported in this thesis, this was dependant upon the synergistic effect 
between electrospun nanofibrous substrates and oxygen environment, where hESC CFU 
expansion with maintenance of pluripotency and retention of differentiation capacity was 
only possible in 2% O2. The key issues highlighted here were that oxygen environment 
changes expression levels of key hESC integrins which mediate attachment to Matrigel™ 
and influence their pluripotency. Furthermore, it has been demonstrated that corresponding 
ECM proteins for those crucial hESC integrins adsorb to electrospun nanofibrous 
substrates and that this adsorption activity can be influenced by fibre diameter resulting in 
fragmentation patterns; as well as the exposure and intensity of critical ion fragments at 
significantly higher levels with the appropriate conformation facilitating hESC attachment. 
Armed with this knowledge this allows further modification and tailoring of the substrates 
with critical amino acid fragments in order to enhance the biocompatibility of these 
substrates to ensure maximum hESC attachment and enhance expansion rates whilst 
maintaining pluripotency. 
 
References 
Chapter 7 
 
 
251 
 
7. References 
 
Abeyta MJ, Clark AT, Rodriguez RT, Bodnar MS, Pera RAR and Firpo MT. Unique gene 
expression signatures of independently-derived human embryonic stem cell lines. Human 
Molecular Genetics 2004;13(6):601-608. 
 
Agarwal S, Wendorff JH and Greiner A. Use of electrospinning technique for biomedical 
applications. Polymer 2008;49(26):5603-5621. 
 
Amit M, Carpenter MK, Inokuma MS, Chiu C-P, Harris CP, Waknitz MA, Itskovitz-Eldor 
J and Thomson JA. Clonally Derived Human Embryonic Stem Cell Lines Maintain 
Pluripotency and Proliferative Potential for Prolonged Periods of Culture. Developmental 
Biology 2000;227(2):271-278. 
 
Amit M, Chebath J, Margulets V, Laevsky I, Miropolsky Y, Shariki K, Peri M, Blais I, 
Slutsky G, Revel M and Itskovitz-Eldor J. Suspension Culture of Undifferentiated Human 
Embryonic and Induced Pluripotent Stem Cells. Stem Cell Reviews and Reports 
2010;6(2):248-259. 
 
Amit M, Margulets V, Segev H, Shariki K, Laevsky I, Coleman R and Itskovitz-Eldor J. 
Human Feeder Layers for Human Embryonic Stem Cells. Biology of Reproduction 
2003;68(6):2150-2156. 
 
Amit M, Shariki C, Margulets V and Itskovitz-Eldor J. Feeder Layer and Serum-Free 
Culture of Human Embryonic Stem Cells. Biology of Reproduction 2004;70(3):837-845. 
 
Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, Wappler I, Peters H, Walter T, 
Stojkovic P, Evans J, Stojkovic M and Lako M. The role of PI3K/AKT, MAPK/ERK and 
NFkb signalling in the maintenance of human embryonic stem cell pluripotency and 
viability highlighted by transcriptional profiling and functional analysis. Human Molecular 
Genetics 2006;15(11):1894-1913. 
 
Ashammakhi N, Wimpenny I, Nikkola L and Yang Y. Electrospinning: methods and 
development of biodegradable nanofibers for drug release. Journal of Biomedical 
Nanotechnology 2009;5(1):1-19. 
 
Axelrod HR. Embryonic stem cell lines derived from blastocysts by a simplified technique. 
Developmental Biology 1984;101(1):225-228. 
 
Azarin SM and Palecek SP. Matrix Revolutions: A Trinity of Defined Substrates for Long-
Term Expansion of Human ESCs. Cell Stem Cell 2010;7(1):7-8. 
 
Badami AS, Kreke MR, Thompson MS, Riffle JS and Goldstein AS. Effect of fiber 
diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun 
poly(lactic acid) substrates. Biomaterials 2006;27(4):596-606. 
 
Bajada S, Mazakova I, Ashton BA, Richardson JB and Ashammakhi N. Stem Cells in 
Regenerative Medicine. In: Ashammakhi N, Reis R and Chiellini F, editors. Topics in 
Tissue Engineering. Volume 4; 2008a. 
References 
Chapter 7 
 
 
252 
 
 
Bajada S, Mazakova I, Richardson JB and Ashammakhi N. Updates on stem cells and their 
applications in regenerative medicine. Journal of Tissue Engineering and Regenerative 
Medicine 2008b;2(4):169-183. 
 
Baksh D, Song L and Tuan RS. Adult mesenchymal stem cells: characterization, 
differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular 
Medicine 2004;8(3):301-316. 
 
Barber RD, Harmer DW, Coleman RA and Clark BJ. GAPDH as a housekeeping gene: 
analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol. Genomics 
2005;21(3):389-395. 
 
Barnes CP, Sell SA, Boland ED, Simpson DG and Bowlin GL. Nanofiber technology: 
Designing the next generation of tissue engineering scaffolds. Advanced Drug Delivery 
Reviews 2007;59(14):1413-1433. 
 
Bauwens C, Yin T, Dang S, Peerani R and Zandstra PW. Development of a perfusion fed 
bioreactor for embryonic stem cell-derived cardiomyocyte generation: Oxygen-mediated 
enhancement of cardiomyocyte output. Biotechnology and Bioengineering 
2005;90(4):452-461. 
 
Beachley V and Wen X. Effect of electrospinning parameters on the nanofiber diameter 
and length. Materials Science and Engineering: C 2009;29(3):663-668. 
 
Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota 
M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B and Anversa P. Adult 
Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration. Cell 
2003;114(6):763-776. 
 
Benoit DSW, Schwartz MP, Durney AR and Anseth KS. Small functional groups for 
controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat 
Mater 2008;7(10):816-823. 
 
Bianco A, Di Federico E, Moscatelli I, Camaioni A, Armentano I, Campagnolo L, Dottori 
M, Kenny JM, Siracusa G and Gusmano G. Electrospun poly(e-caprolactone)/Ca-deficient 
hydroxyapatite nanohybrids: Microstructure, mechanical properties and cell response by 
murine embryonic stem cells. Materials Science and Engineering: C 2009;29(6):2063-
2071. 
 
Bielby RC, Boccaccini AR, Polak JM and Buttery LD. In vitro differentiation and in vivo 
mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 
2004;10(9-10):1518-1525. 
 
Biggs MJP, Richards RG and Dalby MJ. Nanotopographical modification: a regulator of 
cellular function through focal adhesions. Nanomedicine: Nanotechnology, Biology and 
Medicine 2010;6(5):619-633. 
 
References 
Chapter 7 
 
 
253 
 
Bini TB, Gao S, Wang S and Ramakrishna S. Poly(l-lactide-co-glycolide) biodegradable 
microfibers and electrospun nanofibers for nerve tissue engineering: an in vitro study  
J Mater Sci Mater Med 2006;41:6453-6459. 
 
Boland E, Telemeco T, DG S, Wnek G and Bowlin G. Utilizing acid pretreatment and 
electrospinning to improve biocompatibility of poly(glycolic acid) for tissue engineering. 
Journal of Biomedical Materials Research Part B: Applied Biomaterials 2004;71B(1):144-
152. 
 
Bourguignon LYW, Peyrollier K, Xia W and Gilad E. Hyaluronan-CD44 Interaction 
Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and 
Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells. Journal of 
Biological Chemistry 2008;283(25):17635-17651. 
 
Braam SR, Zeinstra L, Litjens S, Ward-van Oostwaard D, van den Brink S, van Laake L, 
Lebrin F, Kats P, Hochstenbach R, Passier R, Sonnenberg A and Mummery CL. 
Recombinant Vitronectin Is a Functionally Defined Substrate That Supports Human 
Embryonic Stem Cell Self-Renewal via αVβ5 Integrin. STEM CELLS 2008;26(9):2257-
2265. 
 
Brafman DA, Chang CW, Fernandez A, Willert K, Varghese S and Chien S. Long-term 
human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials 
2010;31(34):9135-9144. 
 
Brännvall K, Bergman K, Wallenquist U, Svahn S, Bowden T, Hilborn J and Forsberg-
Nilsson K. Enhanced neuronal differentiation in a three-dimensional collagen-hyaluronan 
matrix. Journal of Neuroscience Research 2007;85(10):2138-2146. 
 
Cai J, Chen J, Liu Y, Miura T, Luo Y, Loring JF, Freed WJ, Rao MS and Zeng X. 
Assessing Self-Renewal and Differentiation in Human Embryonic Stem Cell Lines. STEM 
CELLS 2006;24(3):516-530. 
 
Canavan HE, Graham DJ, Cheng X, Ratner BD and Castner DG. Comparison of Native 
Extracellular Matrix with Adsorbed Protein Films Using Secondary Ion Mass 
Spectrometryâ€ Langmuir 2006;23(1):50-56. 
 
Carlberg B, Axell MZ, Nannmark U, Liu J and Kuhn HG. Electrospun polyurethane 
scaffolds for proliferation and neuronal differentiation of human embryonic stem cells. 
Biomedical Materials 2009;4(4):7. 
 
Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A and Bhatia M. 
Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem 
cells. Blood 2003;102(3):906-915. 
 
Chan CK, Liao S, Li B, Lareu RR, Larrick JW, Ramakrishna S and Raghunath M. Early 
adhesive behavior of bone-marrow-derived mesenchymal stem cells on collagen 
electrospun fibers. Biomedical Materials 2009;4(3):035006. 
 
References 
Chapter 7 
 
 
254 
 
Chen HF, Kuo HC, Lin SP, Chien CL, Chiang MS and Ho HN. Hypoxic culture maintains 
self-renewal and enhances embryoid body formation of human embryonic stem cells. 
Tissue Eng Part A 2010;16(9):2901-2913. 
 
Choi JS, Lee SJ, Christ GJ, Atala A and Yoo JJ. The influence of electrospun aligned 
poly(e-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal 
muscle myotubes. Biomaterials 2008;29(19):2899-2906. 
 
Chong EJ, Phan TT, Lim IJ, Zhang YZ, Bay BH, Ramakrishna S and Lim CT. Evaluation 
of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal 
reconstitution. Acta Biomaterialia 2007;3(3):321-330. 
 
Conley BJ, Young JC, Trounson AO and Mollard R. Derivation, propagation and 
differentiation of human embryonic stem cells. The International Journal of Biochemistry 
& Cell Biology 2004;36(4):555-567. 
 
Cooper HM, Tamura RN and Quaranta V. The major laminin receptor of mouse embryonic 
stem cells is a novel isoform of the alpha 6 beta 1 integrin. The Journal of Cell Biology 
1991;115(3):843-850. 
 
Coppolino MG and Dedhar S. Bi-directional signal transduction by integrin receptors. The 
international journal of biochemistry & cell biology 2000;32(2):171-188. 
 
Csete M. Oxygen in the Cultivation of Stem Cells. Annals of the New York Academy of 
Sciences 2005;1049(1):1-8. 
 
D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA and Schiller PC. Marrow-isolated 
adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and 
old human cells with extensive expansion and differentiation potential. Journal of Cell 
Science 2004;117(14):2971-2981. 
 
Danen EHJ, Sonneveld P, Brakebusch C, Fassler R and Sonnenberg A. The fibronectin-
binding integrins a5b1 and avb3 differentially modulate RhoA-GTP loading, organization 
of cell matrix adhesions, and fibronectin fibrillogenesis. The Journal of Cell Biology 
2002;159(6):1071-1086. 
 
De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre 
AC, Snyder EY, Yoo JJ, Furth ME, Soker S and Atala A. Isolation of amniotic stem cell 
lines with potential for therapy. Nat Biotech 2007;25(1):100-106. 
 
De Filippis L and Delia D. Hypoxia in the regulation of neural stem cells. Cellular and 
Molecular Life Sciences 2011;68(17):2831-2844. 
 
Dee KC, Puleo DA and Bizios R. Protein-Surface Interactions. An Introduction To Tissue-
Biomaterial Interactions. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2003. p 37-52. 
 
Derda R, Li L, Orner BP, Lewis RL, Thomson JA and Kiessling LL. Defined Substrates 
for Human Embryonic Stem Cell Growth Identified from Surface Arrays. ACS Chemical 
Biology 2007;2(5):347-355. 
References 
Chapter 7 
 
 
255 
 
Dhandayuthapani B, Yoshida Y, Maekawa T and Kumar DS. Polymeric Scaffolds in 
Tissue Engineering Application: A Review. International Journal of Polymer Science 
2011;2011:1-19. 
 
Doran MR, Frith JE, Prowse ABJ, Fitzpatrick J, Wolvetang EJ, Munro TP, Gray PP and 
Cooper-White JJ. Defined high protein content surfaces for stem cell culture. Biomaterials 
2010;31(19):5137-5142. 
 
Dua HS and Azuara-Blanco A. Limbal Stem Cells of the Corneal Epithelium. Survey of 
Ophthalmology 2000;44(5):415-425. 
 
Eiselleova L, Matulka K, Kriz V, Kunova M, Schmidtova Z, Neradil J, Tichy B, 
Dvorakova D, Pospisilova S, Hampl A and Dvorak P. A Complex Role for FGF-2 in Self-
Renewal, Survival, and Adhesion of Human Embryonic Stem Cells. STEM CELLS 
2009;27(8):1847-1857. 
 
Ellis S and Tanentzapf G. Integrin-mediated adhesion and stem-cell-niche interactions. 
Cell and Tissue Research 2010;339(1):121-130. 
 
Engler AJ, Sen S, Sweeney HL and Discher DE. Matrix Elasticity Directs Stem Cell 
Lineage Specification. Cell 2006;126(4):677-689. 
 
Erickson GR, Gimble JM, Franklin DM, Rice HE, Awad H and Guilak F. Chondrogenic 
Potential of Adipose Tissue-Derived Stromal Cells in Vitro and in Vivo. Biochemical and 
Biophysical Research Communications 2002;290(2):763-769. 
 
Evans ND, Minelli C, Gentleman E, LaPointe V, Patankar SN, Kallivretaki M, Chen X, 
Roberts CJ and Stevens MM. Substrate stiffness affects early differentiation events in 
embryonic stem cells. Eur Cell Mater 2009;18:1-13; discussion 13-14. 
 
Ezashi T, Das P and Roberts RM. Low O2 tensions and the prevention of differentiation of 
hES cells. Proceedings of the National Academy of Sciences of the United States of 
America 2005;102(13):4783-4788. 
 
Fadeev AG and Melkoumian Z. Synthetic Surfaces for Human Embryonic Stem Cell 
Culture: InTech; 2011. 
 
Feng L, Li S, Li H, Zhai J, Song Y, Jiang L and Zhu D. Super-hydrophobic surface of 
aligned polyacrylonitrile nanofibers. Angewandte Chemie International Edition 
2002;41(7):1221-1223. 
 
Finkemeier CG. Bone-grafting and bone-graft substitutes. Journal of Bone and Joint 
Surgery - Series A 2002;84(3):454-464 
 
 
Fong H, Chun I and Reneker DH. Beaded nanofibers formed during electrospinning. 
Polymer 1999;40:4585-4592. 
 
References 
Chapter 7 
 
 
256 
 
Forristal CE, Wright KL, Hanley NA, Oreffo ROC and Houghton FD. Hypoxia inducible 
factors regulate pluripotency and proliferation in human embryonic stem cells cultured at 
reduced oxygen tensions. Reproduction 2010;139(1):85-97. 
 
Forsyth NR, Kay A, Hampson K, Downing A, Talbot R and McWhir J. Transcriptome 
alterations due to physiological normoxic (2% O2) culture of human embryonic stem cells. 
Regenerative Medicine 2008;3(6):817-833. 
 
Forsyth NR and McWhir J. Human embryonic stem cell telomere length impacts directly 
on clonal progenitor isolation frequency. Rejuvenation Res 2008;11(1):5-17. 
 
Forsyth NR, Musio A, Vezzoni P, Simpson AH, Noble BS and McWhir J. Physiologic 
oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal 
abnormalities. Cloning Stem Cells 2006;8(1):16-23. 
 
Franco SJ, Rodgers MA, Perrin BJ, Han J, Bennin DA, Critchley DR and Huttenlocher A. 
Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol 
2004;6(10):977-983. 
 
Friedenstein AJ, Chailakhyan RK and Gerasimov UV. Bone marrow osteogenic stem cells: 
in vitro cultivation and transplantation in diffusion chambers. Cell Proliferation 
1987;20(3):263-272. 
 
Furue MK, Na J, Jackson JP, Okamoto T, Jones M, Baker D, Hata R-I, Moore HD, Sato 
JD and Andrews PW. Heparin promotes the growth of human embryonic stem cells in a 
defined serum-free medium. Proceedings of the National Academy of Sciences 
2008;105(36):13409-13414. 
 
Galbraith CG and Sheetz MP. Forces on adhesive contacts affect cell function. Current 
Opinion in Cell Biology 1998;10(5):566-571. 
 
Galli R, Pagano SF, Gritti A and Vescovi AL. Regulation of Neuronal Differentiation in 
Human CNS Stem Cell Progeny by Leukemia Inhibitory Factor. Developmental 
Neuroscience 2000;22(1-2):86-95. 
 
Gao SY, Lees JG, Wong JCY, Croll TI, George P, Cooper-White JJ and Tuch BE. 
Modeling the adhesion of human embryonic stem cells to poly(lactic-co-glycolic acid) 
surfaces in a 3D environment. Journal of Biomedical Materials Research Part A 
2010;92A(2):683-692. 
 
Gauthaman K, Venugopal JR, Yee FC, Peh GSL, Ramakrishna S and Bongso A. 
Nanofibrous substrates support colony formation and maintain stemness of human 
embryonic stem cells. Journal of Cellular and Molecular Medicine 2009;13(9B):3475-
3484. 
 
Gearhart JD and Mintz B. Contact-mediated myogenesis and increased 
acetylcholinesterase activity  in primary cultures of mouse teratocarcinoma cells. 
Proceedings of the National Academy of Sciences 1974; 71: 1734-1738.  
 
References 
Chapter 7 
 
 
257 
 
Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R and Vunjak-Novakovic G. 
Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human 
embryonic stem cells. Proceedings of the National Academy of Sciences 
2007;104(27):11298-11303. 
 
Godier AFG, Marolt D, Gerecht S, Tajnsek U, Martens TP and Vunjak-Novakovic G. 
Engineered microenvironments for human stem cells. Birth Defects Research Part C: 
Embryo Today: Reviews 2008;84(4):335-347. 
 
Goldmann WH. Kinetic Determination of Focal Adhesion Protein Formation. Biochemical 
and Biophysical Research Communications 2000;271(2):553-557. 
 
Grayson WL, Zhao F, Izadpanah R, Bunnell B and Ma T. Effects of hypoxia on human 
mesenchymal stem cell expansion and plasticity in 3D constructs. Journal of Cellular 
Physiology 2006;207(2):331-339. 
 
Greiner A and Wendorff JH. Electrospinning: A Fascinating Method for the Preparation of 
Ultrathin Fibers. Angewandte Chemie International Edition 2007;46(30):5670-5703. 
 
Griffith LG and Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev 
Mol Cell Biol 2006;7(3):211-224. 
 
Gunatillake PA and Adhikari R. Biodegradable synthetic polymers for tissue engineering. 
Eur Cell Mater 2003;5:1-16; discussion 16. 
 
Halvorsen YD, Franklin D, Bond AL, Hitt DC, Auchter C, Boskey AL, Paschalis EP, 
Wilkison WO and Gimble JM. Extracellular matrix mineralization and osteoblast gene 
expression by human adipose tissue-derived stromal cells. Tissue Eng 2001;7(6):729-741. 
 
Hashemi SM, Soleimani M, Zargarian SS, Haddadi-Asl V, Ahmadbeigi N, Soudi S, 
Gheisari Y, Hajarizadeh A and Mohammadi Y. In vitro Differentiation of Human Cord 
Blood-Derived Unrestricted Somatic Stem Cells into Hepatocyte-Like Cells on Poly(e-
Caprolactone) Nanofiber Scaffolds. Cells Tissues Organs 2009;190(3):135-149. 
 
Hewitt Z, Forsyth NR, Waterfall M, Wojtacha D, Thomson AJ and McWhir J. 
Fluorescence-activated single cell sorting of human embryonic stem cells. Cloning Stem 
Cells 2006;8(3):225-234. 
 
Higuchi O, Okabe M, Yoshida T, Fathy M, Saito S, Miyawaki T and Nikaido T. Stemness 
of Human Wharton's Jelly Mesenchymal Cells Is Maintained by Floating Cultivation. Cell 
Reprogram 2012:In press. 
 
Horbett TA, Schway MB and Ratner BD. Hydrophilic-hydrophobic copolymers as cell 
substrates: Effect on 3T3 cell growth rates. Journal of Colloid and Interface Science 
1985;104(1):28-39. 
 
Horwitz A, Duggan K, Buck C, Beckerle MC and Burridge K. Interaction of plasma 
membrane fibronectin receptor with talin - a transmembrane linkage. Nature 
1986;320(6062):531-533. 
References 
Chapter 7 
 
 
258 
 
Howard D, Buttery LD, Shakesheff KM and Roberts SJ. Tissue engineering: strategies, 
stem cells and scaffolds. Journal of Anatomy 2008;213(1):66-72. 
 
Howell JC and Yoder MC. Adult Stem Cell Plasticity Defined. NeoReviews 
2003;4(7):e181-e186. 
 
Humphries JD, Byron A and Humphries MJ. Integrin ligands at a glance. Journal of Cell 
Science 2006;119(19):3901-3903. 
 
Hynes RO. Integrins: Bidirectional, Allosteric Signaling Machines. Cell 2002;110(6):673-
687. 
 
Irwin EF, Gupta R, Dashti DC and Healy KE. Engineered polymer-media interfaces for the 
long-term self-renewal of human embryonic stem cells. Biomaterials 2011;32(29):6912-
6919. 
 
Ivanović, Bartolozzi, Bernabei, Cipolleschi, Rovida, Milenković, Praloran and Sbarba. 
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-
repopulating ability together with the expansion of committed progenitors. British Journal 
of Haematology 2000;108(2):424-429. 
 
Jacobson L, Kahan B, Djamali A, Thomson J and Odorico JS. Differentiation of endoderm 
derivatives, pancreas and intestine, from rhesus embryonic stem cells. Transplantation 
Proceedings 2001;33(1â€“2):674. 
 
Jaiswal N, Haynesworth SE, Caplan AI and Bruder SP. Osteogenic differentiation of 
purified, culture-expanded human mesenchymal stem cells in vitro. Journal of Cellular 
Biochemistry 1997;64(2):295-312. 
 
Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, 
Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, 
Largaespada DA and Verfaillie C. Pluripotency of mesenchymal stem cells derived from 
adult marrow. 2002 
 
Jin H-J, Chen J, Karageorgiou V, Altman GH and Kaplan DL. Human bone marrow 
stromal cell responses on electrospun silk fibroin mats. Biomaterials 2004;25(6):1039-
1047. 
 
Jones LJ, Haugland RP and Singer VL. Development and characterization of the 
NanoOrange protein quantitation assay: a fluorescence-based assay of proteins in solution. 
Biotechniques 2003;34(4):850-854, 856, 858 passim. 
 
Jones MB, Chu CH, Pendleton JC, Betenbaugh MJ, Shiloach J, Baljinnyam B, Rubin JS 
and Shamblott MJ. Proliferation and pluripotency of human embryonic stem cells 
maintained on type I collagen. Stem Cells Dev 2010;19(12):1923-1935. 
 
Kang X, Xie Y, Powell HM, James Lee L, Belury MA, Lannutti JJ and Kniss DA. 
Adipogenesis of murine embryonic stem cells in a three-dimensional culture system using 
electrospun polymer scaffolds. Biomaterials 2007;28(3):450-458. 
References 
Chapter 7 
 
 
259 
 
Karner E, Unger C, Sloan AJ, Ahrlund-Richter L, Sugars RV and Wendel M. Bone matrix 
formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem 
Cells Dev 2007;16(1):39-52. 
 
Kasemo B. Biological surface science. Current Opinion in Solid State & Materials Science 
1998;3(5):451-459. 
 
Kasemo B. Biological surface science. Surface Science 2002;500(1-3):656-677. 
 
Keun Kwon I, Kidoaki S and Matsuda T. Electrospun nano- to microfiber fabrics made of 
biodegradable copolyesters: structural characteristics, mechanical properties and cell 
adhesion potential. Biomaterials 2005;26(18):3929-3939. 
 
Khademhosseini A, Ling Y, Karp JM and Langer R. Micro- and Nanoscale Control of 
Cellular Environment for Tissue Engineering. Nanobiotechnology II: Wiley-VCH Verlag 
GmbH & Co. KGaA; 2007. p 347-364. 
 
Kim S, Ahn SE, Lee JH, Lim D-S, Kim K-S, Chung H-M and Lee S-H. A Novel Culture 
Technique for Human Embryonic Stem Cells Using Porous Membranes. STEM CELLS 
2007;25(10):2601-2609. 
 
Koay EJ, Hoben GMB and Athanasiou KA. Tissue Engineering with Chondrogenically 
Differentiated Human Embryonic Stem Cells. STEM CELLS 2007;25(9):2183-2190. 
 
Kogler G, Radke TF, Lefort Al, Sensken S, Fischer J, Sorg RdV and Wernet P. Cytokine 
production and hematopoiesis supporting activity of cord blood-derived unrestricted 
somatic stem cells. Experimental Hematology 2005;33(5):573-583. 
 
Kothapalli R, Yoder S, Mane S and Loughran T. Microarray results: how accurate are 
they? BMC Bioinformatics 2002;3(1):1-10. 
 
Krampera M, Pizzolo G, Aprili G and Franchini M. Mesenchymal stem cells for bone, 
cartilage, tendon and skeletal muscle repair. Bone 2006;39(4):678-683. 
 
Kruegel J and Miosge N. Basement membrane components are key players in specialized 
extracellular matrices. Cellular and Molecular Life Sciences 2010;67(17):2879-2895. 
 
Kumar D, Gittings JP, Turner IG, Bowen CR, Bastida-Hidalgo A and Cartmell SH. 
Polarization of hydroxyapatite: Influence on osteoblast cell proliferation. Acta 
Biomaterialia 2010;6(4):1549-1554. 
 
Kweon H, Yoo MK, Park IK, Kim TH, Lee HC, Lee H-S, Oh J-S, Akaike T and Cho C-S. 
A novel degradable polycaprolactone networks for tissue engineering. Biomaterials 
2003;24(5):801-808. 
 
Labat-Robert J. Cell-Matrix interactions, the role of fibronectin and integrins. A survey. 
Pathologie Biologie 2012;60(1):15-19. 
 
Lakshmipathy U and Verfaillie C. Stem cell plasticity. Blood reviews 2005;19(1):29-38. 
References 
Chapter 7 
 
 
260 
 
Le Clainche C and Carlier M-F. Regulation of Actin Assembly Associated With Protrusion 
and Adhesion in Cell Migration. Physiological Reviews 2008;88(2):489-513. 
 
Lee C-K, Wang Y-M, Huang L-S and Lin S. Atomic force microscopy: Determination of 
unbinding force, off rate and energy barrier for protein-ligand interaction. Micron 
2007;38(5):446-461. 
 
Lee KH, Kim HY, Khil MS, Ra YM and Lee DR. Characterization of nano-structured 
poly(Îµ-caprolactone) nonwoven mats via electrospinning. Polymer 2003;44(4):1287-
1294. 
 
Lee S, Kim J, Park TJ, Shin Y, Lee SY, Han Y-M, Kang S and Park H-S. The effects of 
the physical properties of culture substrates on the growth and differentiation of human 
embryonic stem cells. Biomaterials 2011;32(34):8816-8829. 
 
Lee ST, Yun JI, Jo YS, Mochizuki M, van der Vlies AJ, Kontos S, Ihm JE, Lim JM and 
Hubbell JA. Engineering integrin signaling for promoting embryonic stem cell self-
renewal in a precisely defined niche. Biomaterials 2010;31(6):1219-1226. 
 
Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J and Langer R. 
Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. 
Proceedings of the National Academy of Sciences 2003;100(22):12741-12746. 
 
Li HY, Liao CY, Lee KH, Chang HC, Chen YJ, Chao KC, Chang SP, Cheng HY, Chang 
CM, Chang YL, Hung SC, Sung YJ and Chiou SH. Collagen IV significantly enhances 
migration and transplantation of embryonic stem cells: involvement of alpha2beta1 
integrin-mediated actin remodeling. Cell Transplant 2011;20(6):893-907. 
 
Li J, Bardy Ja, Yap L, Chen A, Victor N, Cool S, Oh S and Birch W. Impact of vitronectin 
concentration and surface properties on the stable propagation of human embryonic stem 
cells. Biointerphases 2010;5(3):FA132-FA142. 
 
Li L, Wang S, Jezierski A, Moalim-Nour L, Mohib K, Parks RJ, Francesco Retta S and 
Wang L. A Unique Interplay Between Rap1 and E-Cadherin in the Endocytic Pathway 
Regulates Self-Renewal of Human Embryonic Stem Cells. STEM CELLS 2009;28(2):247-
257. 
 
Li W-J, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ and Tuan RS. A three-
dimensional nanofibrous scaffold for cartilage tissue engineering using human 
mesenchymal stem cells. Biomaterials 2005;26(6):599-609. 
 
Li WJ, Laurencin CT, Caterson EJ, Tuan RS and Ko FK. Electrospun nanofibrous 
structure: a novel scaffold for tissue engineering. J Biomed Mater Res 2002;60(4):613-621. 
 
Liao S, Chan CK and Ramakrishna S. Stem cells and biomimetic materials strategies for 
tissue engineering. Materials Science and Engineering: C 2008;28(8):1189-1202. 
 
Lim SH and Mao H-Q. Electrospun scaffolds for stem cell engineering. Advanced Drug 
Delivery Reviews 2009;61(12):1084-1096. 
References 
Chapter 7 
 
 
261 
 
Lin X. Functions of heparan sulfate proteoglycans in cell signaling during development. 
Development 2004;131(24):6009-6021. 
 
Liu S, Calderwood DA and Ginsberg MH. Integrin cytoplasmic domain-binding proteins. 
Journal of Cell Science 2000;113(20):3563-3571. 
 
Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, 
Daigh CA, Conard KR, Piekarczyk MS, Llanas RA and Thomson JA. Derivation of human 
embryonic stem cells in defined conditions. Nat Biotech 2006;24(2):185-187. 
 
Ma K, Chan CK, Liao S, Hwang WYK, Feng Q and Ramakrishna S. Electrospun nanofiber 
scaffolds for rapid and rich capture of bone marrow-derived hematopoietic stem cells. 
Biomaterials 2008;29(13):2096-2103. 
 
Ma PX and Zhang R. Synthetic nano-scale fibrous extracellular matrix. Journal of 
Biomedical Materials Research Part A 1999;46(1):60-72. 
 
Ma T, Grayson WL, Fröhlich M and Vunjak-Novakovic G. Hypoxia and stem cell-based 
engineering of mesenchymal tissues. Biotechnology Progress 2009;25(1):32-42. 
 
Ma Z, Mao Z and Gao C. Surface modification and property analysis of biomedical 
polymers used for tissue engineering. Colloids and Surfaces B: Biointerfaces 
2007;60(2):137-157. 
 
Ma ZW. Modiﬁcation and cytocompatibility of poly-l-lactic acid (PLLA) scaffold for 
cartilage tissue engineering. Hangzhou: Zhejiang University, China; 2003. 
 
Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO and Pittenger MF. 
Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. 
Tissue Eng 1998;4(4):415-428. 
 
Mahlstedt MM, Anderson D, Sharp JS, McGilvray R, Barbadillo Muñoz MD, Buttery LD, 
Alexander MR, Rose FRAJ and Denning C. Maintenance of pluripotency in human 
embryonic stem cells cultured on a synthetic substrate in conditioned medium. 
Biotechnology and Bioengineering 2010;105(1):130-140. 
 
Mallon BS, Park K-Y, Chen KG, Hamilton RS and McKay RDG. Toward xeno-free 
culture of human embryonic stem cells. The International Journal of Biochemistry &amp; 
Cell Biology 2006;38(7):1063-1075. 
 
Mano JoF, Sousa RA, Boesel LF, Neves NM and Reis RL. Bioinert, biodegradable and 
injectable polymeric matrix composites for hard tissue replacement: state of the art and 
recent developments. Composites Science and Technology 2004;64(6):789-817. 
 
Martin MJ, Muotri A, Gage F and Varki A. Human embryonic stem cells express an 
immunogenic nonhuman sialic acid. Nat Med 2005;11(2):228-232. 
 
Mason C and Dunnill P. A brief definition of regenerative medicine. Regenerative 
Medicine 2008;3(1):1-5. 
References 
Chapter 7 
 
 
262 
 
Matthews JA, Wnek GE, Simpson DG and Bowlin GL. Electrospinning of Collagen 
Nanofibers. Biomacromolecules 2002;3(2):232-238. 
 
McHale G, Shirtcliffe NJ and Newton MI. Contact-Angle Hysteresis on Super-
Hydrophobic Surfaces. Langmuir 2004;20(23):10146-10149. 
 
Meng Y, Eshghi S, Li YJ, Schmidt R, Schaffer DV and Healy KE. Characterization of 
integrin engagement during defined human embryonic stem cell culture. The FASEB 
Journal 2010;24(4):1056-1065. 
 
Millward-Sadler SJ and Salter DM. Integrin-Dependent Signal Cascades in Chondrocyte 
Mechanotransduction. Annals of Biomedical Engineering 2004;32(3):435-446. 
 
Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, 
Beerenstrauch M, Abou-Easa K, Hildreth T and Troyer D. Matrix Cells from Wharton's 
Jelly Form Neurons and Glia. STEM CELLS 2003;21(1):50-60. 
 
Miyazaki T, Futaki S, Hasegawa K, Kawasaki M, Sanzen N, Hayashi M, Kawase E, 
Sekiguchi K, Nakatsuji N and Suemori H. Recombinant human laminin isoforms can 
support the undifferentiated growth of human embryonic stem cells. Biochemical and 
Biophysical Research Communications 2008;375(1):27-32. 
 
Mohyeldin A, Garzon-Muvdi T and Quinones-Hinojosa A. Oxygen in Stem Cell Biology: 
A Critical Component of the Stem Cell Niche. Cell Stem Cell 2010;7(2):150-161. 
 
Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L, Tarone G and Defilippi 
P. Integrins induce activation of EGF receptor: role in MAP kinase induction and 
adhesion-dependent cell survival. EMBO J 1998;17(22):6622-6632. 
 
Mostafavi-Pour Z, Keihani S, Talaei-Khozani T, Mokaram P, Fardaei M, Rohani L, Ebadat 
S and Sardarian A. Expression of α2, α5 and α6 subunits of integrin in de-differentiated 
NIH3T3 cells by cell-free extract of embryonic stem cells. Molecular Biology Reports 
2012;39(7):7339-7346. 
 
Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink 
R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R and Tertoolen L. 
Differentiation of Human Embryonic Stem Cells to Cardiomyocytes. Circulation 
2003;107(21):2733-2740. 
 
Nagaoka M, Si-Tayeb K, Akaike T and Duncan S. Culture of human pluripotent stem cells 
using completely defined conditions on a recombinant E-cadherin substratum. BMC 
Developmental Biology 2010;10(1):60. 
Nain A, Wong J, Amon C and Sitti M. Drawing suspended polymer micro/nanofibers 
using glass micropipettes. Applied Physics Letters 2006;89(18):183105-183107. 
 
Nath N, Hyun J, Ma H and Chilkoti A. Surface engineering strategies for control of protein 
and cell interactions. Surface Science 2004;570(1-2):98-110. 
 
References 
Chapter 7 
 
 
263 
 
Nistor GI, Totoiu MO, Haque N, Carpenter MK and Keirstead HS. Human embryonic 
stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord 
transplantation. Glia 2005;49(3):385-396. 
 
Nur-E-Kamal A, Ahmed I, Kamal J, Schindler M and Meiners S. Three-dimensional 
nanofibrillar surfaces promote self-renewal in mouse embryonic stem cells. Stem Cells 
2006;24(2):426-433. 
 
Odorico JS, Kaufman DS and Thomson JA. Multilineage Differentiation from Human 
Embryonic Stem Cell Lines. STEM CELLS 2001;19(3):193-204. 
 
Olivier EN, Rybicki AC and Bouhassira EE. Differentiation of Human Embryonic Stem 
Cells into Bipotent Mesenchymal Stem Cells. STEM CELLS 2006;24(8):1914-1922. 
 
Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, 
Chien KR and Melton DA. Marked differences in differentiation propensity among human 
embryonic stem cell lines. Nat Biotech 2008;26(3):313-315. 
 
Ostuni E, Yan L and Whitesides GM. The interaction of proteins and cells with self-
assembled monolayers of alkanethiolates on gold and silver. Colloids and Surfaces B: 
Biointerfaces 1999;15(1):3-30. 
 
Otey CA, Pavalko FM and Burridge K. An interaction between alpha-actinin and the beta 1 
integrin subunit in vitro. The Journal of Cell Biology 1990;111(2):721-729. 
 
Paikal D, Zhang G, Cheng QI and Lee DA. The Effect of Integrin Antibodies on the 
Attachment and Proliferation of Human Tenon's Capsule Fibroblasts. Experimental Eye 
Research 2000;70(4):393-400. 
 
Parsons JT. Focal adhesion kinase: the first ten years. Journal of Cell Science 
2003;116(8):1409-1416. 
 
Patthy L. Protein Evolution. Oxford, UK: Blackwell Science Ltd; 1999. 228 p. 
 
Phanstiel DH, Brumbaugh J, Wenger CD, Tian S, Probasco MD, Bailey DJ, Swaney DL, 
Tervo MA, Bolin JM, Ruotti V, Stewart R, Thomson JA and Coon JJ. Proteomic and 
phosphoproteomic comparison of human ES and iPS cells. Nature Methods 2012; 8(10): 
821-827. 
 
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, 
Simonetti DW, Craig S and Marshak DR. Multilineage Potential of Adult Human 
Mesenchymal Stem Cells. Science 1999;284(5411):143-147. 
 
Polak JM and Bishop AE. Stem Cells and Tissue Engineering: Past, Present, and Future. 
Annals of the New York Academy of Sciences 2006;1068(1):352-366. 
 
Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y and Mayer U. 
Collagen IV is essential for basement membrane stability but dispensable for initiation of 
its assembly during early development. Development 2004;131(7):1619-1628. 
References 
Chapter 7 
 
 
264 
 
Prabhakaran M, Venugopal J, Ghasemi-Mobarakeh L, Kai D, Jin G, Ramakrishna S, 
Jayakumar R and Nair S. Stem Cells and Nanostructures for Advanced Tissue 
Regeneration Biomedical Applications of Polymeric Nanofibers. Advances in Polymer 
Science: Springer Berlin / Heidelberg; 2012. p 21-62. 
 
Price PJ, Goldborough MD and Tilkins ML; Embryonic Stem Cell Serum Replacement. 
US. 1998. 
 
Prowse ABJ, Chong F, Gray PP and Munro TP. Stem cell integrins: Implications for ex-
vivo culture and cellular therapies. Stem Cell Research 2011;6(1):1-12. 
 
Ramakrishna S, Fujihara K, Teo W, Lim T and Ma Z. An Introduction to Electrospinning 
and Nanofibers. Singapore: World Scientific Publishing Co.; 2005. 1-380. 
 
Ramakrishna S, Fujihara K, Teo W, Yong T, Ma Z and Ramaseshan R. Electrospun 
nanofibers: solving global issues. Materials Today 2006;9(3):40-50. 
 
Ravichandran R, Liao S, Ng C, Chan CK, Raghunath M and Ramakrishna S. Effects of 
nanotopography on stem cell phenotypes. World J Stem Cells 2009;1(1):55-66. 
 
Rechendorff K, Hovgaard MB, Foss M, Zhdanov VP and Besenbacher F. Enhancement of 
Protein Adsorption Induced by Surface Roughness. Langmuir 2006;22(26):10885-10888. 
 
Ren H, Cao Y, Zhao Q, Li J, Zhou C, Liao L, Jia M, Zhao Q, Cai H, Han ZC, Yang R, 
Chen G and Zhao RC. Proliferation and differentiation of bone marrow stromal cells under 
hypoxic conditions. Biochemical and Biophysical Research Communications 
2006;347(1):12-21. 
 
Richards M, Fong C-Y, Chan W-K, Wong P-C and Bongso A. Human feeders support 
prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. 
Nat Biotech 2002;20(9):933-936. 
 
Riedel M, MÃ¼ller B and Wintermantel E. Protein adsorption and monocyte activation on 
germanium nanopyramids. Biomaterials 2001;22(16):2307-2316. 
 
Roach P. Measurement of Surface-Protein Interactions on Novel Surfaces. Nottingham: 
Nottingham Trent University; 2005. 142 p. 
 
Roach P, Farrar D and Perry CC. Interpretation of Protein Adsorption: Surface-Induced 
Conformational Changes. Journal of the American Chemical Society 2005;127(22):8168-
8173. 
 
Roach P, Farrar D and Perry CC. Surface Tailoring for Controlled Protein Adsorption: 
Effect of Topography at the Nanometer Scale and Chemistry. Journal of the American 
Chemical Society 2006;128(12):3939-3945. 
Rodesch F, Simon P, Donner C and Jauniaux E. Oxygen Measurements in Endometrial and 
Trophoblastic Tissues During Early Pregnancy. Obstetrics & Gynecology 1992;80(2) 
 
References 
Chapter 7 
 
 
265 
 
Rodin S, Domogatskaya A, Strom S, Hansson EM, Chien KR, Inzunza J, Hovatta O and 
Tryggvason K. Long-term self-renewal of human pluripotent stem cells on human 
recombinant laminin-511. Nat Biotech 2012;28(6):611-615. 
 
Rose FRAJ and Oreffo ROC. Bone Tissue Engineering: Hope vs Hype. Biochemical and 
Biophysical Research Communications 2002;292(1):1-7. 
 
Ross AM, Nandivada H, Ryan AL and Lahann J. Synthetic substrates for long-term stem 
cell culture. Polymer 2012;53(13):2533-2539. 
 
Rowland TJ, Miller LM, Blaschke AJ, Doss EL, Bonham AJ, Hikita ST, Johnson LV and 
Clegg DO. Roles of integrins in human induced pluripotent stem cell growth on Matrigel 
and vitronectin. Stem Cells Dev 2010;19(8):1231-1240. 
 
Rozen S and Skaletsky H. Primer3 on the WWW for General Users and for Biologist 
Programmers In: Misener S and Krawetz SA, editors. Bioinformatics Methods and 
Protocols. Totowa, New Jersey: Humana Press Inc.; 1999. p 365-386. 
 
Safford KM, Hicok KC, Safford SD, Halvorsen Y-DC, Wilkison WO, Gimble JM and 
Rice HE. Neurogenic differentiation of murine and human adipose-derived stromal cells. 
Biochemical and Biophysical Research Communications 2002;294(2):371-379. 
 
Saller MM, Prall WC, Docheva D, Schonitzer V, Popov T, Anz D, Clausen-Schaumann H, 
Mutschler W, Volkmer E, Schieker M and Polzer H. Increased stemness and migration of 
human mesenchymal stem cells in hypoxia is associated with altered integrin expression. 
Biochemical and Biophysical Research Communications 2012;423(2):379-385. 
 
Schaller MD, Otey CA, Hildebrand JD and Parsons JT. Focal adhesion kinase and paxillin 
bind to peptides mimicking beta integrin cytoplasmic domains. The Journal of Cell 
Biology 1995;130(5):1181-1187. 
 
Schindler M, Ahmed I, Kamal J, Nur-E-Kamal A, Grafe TH, Young Chung H and Meiners 
S. A synthetic nanofibrillar matrix promotes in vivo-like organization and morphogenesis 
for cells in culture. Biomaterials 2005;26(28):5624-5631. 
 
Schlaepfer DD and Hunter T. Evidence for in vivo phosphorylation of the Grb2 SH2-
domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. 
Molecular and Cellular Biology 1996;16(10):5623-5633. 
 
Schnell E, Klinkhammer K, Balzer S, Brook G, Klee D, Dalton P and Mey J. Guidance of 
glial cell migration and axonal growth on electrospun nanofibers of poly-e-caprolactone 
and a collagen/poly-e-caprolactone blend. Biomaterials 2007;28(19):3012-3025. 
 
Schoenwaelder SM and Burridge K. Bidirectional signaling between the cytoskeleton and 
integrins. Current Opinion in Cell Biology 1999;11(2):274-286. 
 
Schvartz I, Seger D and Shaltiel S. Vitronectin. The International Journal of Biochemistry 
&amp; Cell Biology 1999;31(5):539-544. 
 
References 
Chapter 7 
 
 
266 
 
Schwartz MA. Integrin signaling revisited. Trends in Cell Biology 2001;11(12):466-470. 
 
Scopelliti PE, Borgonovo A, Indrieri M, Giorgetti L, Bongiorno G, Carbone R, PodestÃ  A 
and Milani P. The Effect of Surface Nanometre-Scale Morphology on Protein Adsorption. 
PLoS ONE 2010;5(7):e11862. 
 
Seo MJ, Suh SY, Bae YC and Jung JS. Differentiation of human adipose stromal cells into 
hepatic lineage in vitro and in vivo. Biochemical and Biophysical Research 
Communications 2005;328(1):258-264. 
 
Shabani I, Haddadi-Asl V, Seyedjafari E, Babaeijandaghi F and Soleimani M. Improved 
infiltration of stem cells on electrospun nanofibers. Biochemical and Biophysical Research 
Communications 2009;382(1):129-133. 
 
Shih YR, Chen CN, Tsai SW, Wang YJ and Lee OK. Growth of mesenchymal stem cells 
on electrospun type I collagen nanofibers. Stem Cells 2006;24(11):2391-2397. 
 
Sill TJ and von Recum HA. Electrospinning: Applications in drug delivery and tissue 
engineering. Biomaterials 2008;29(13):1989-2006. 
 
Silva MMCG, Cyster LA, Barry JJA, Yang XB, Oreffo ROC, Grant DM, Scotchford CA, 
Howdle SM, Shakesheff KM and Rose FRAJ. The effect of anisotropic architecture on cell 
and tissue infiltration into tissue engineering scaffolds. Biomaterials 2006;27(35):5909-
5917. 
 
Siti-Ismail N, Bishop AE, Polak JM and Mantalaris A. The benefit of human embryonic 
stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 
2008;29(29):3946-3952. 
 
Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A and Peppas NA. Hydrogels in 
Regenerative Medicine. Advanced Materials 2009;21(32-33):3307-3329. 
 
Smith LA, Liu X, Hu J and Ma PX. The influence of three-dimensional nanofibrous 
scaffolds on the osteogenic differentiation of embryonic stem cells. Biomaterials 
2009;30(13):2516-2522. 
 
Spangrude GJ, Heimfeld S and Weissman IL. Purification and characterization of mouse 
hematopoietic stem cells. Science 1988;241(4861):58-62. 
 
Stalder AF, Kulik G, Sage D, Barbieri L and Hoffmann P. A snake-based approach to 
accurate determination of both contact points and contact angles. Colloids and Surfaces A: 
Physicochemical and Engineering Aspects 2006;286(1-3):92-103. 
 
Stevens MM. Biomaterials for bone tissue engineering. Materials Today 2008;11(5):18-25. 
 
Stevens MM and George JH. Exploring and Engineering the Cell Surface Interface. 
Science 2005;310(5751):1135-1138. 
 
References 
Chapter 7 
 
 
267 
 
Streuli CH and Akhtar N. Signal co-operation between integrins and other receptor 
systems. Biochemical Journal 2009;418(3):491-506. 
 
Sundberg C and Rubin K. Stimulation of beta(1) integrins on fibroblasts induces PDGF 
independent tyrosine phosphorylation of PDGF beta-receptors. Journal of Cell Biology 
1996;132(4):741-752. 
 
Symes K, Smith EM, Mitsi M and Nugent MA. Sweet cues: How heparan sulfate 
modification of fibronectin enables growth factor guided migration of embryonic cells. 
Cell Adhesion & Migration 2010;4(4):507-510. 
 
Szablowska-Gadomska I, Zayat V and Buzanska L. Influence of low oxygen tensions on 
expression of pluripotency genes in stem cells. Acta Neurobiol Exp (Wars) 2011;71(1):86-
93. 
 
Taborelli M, Eng L, Descouts P, Ranieri JP, Bellamkonda R and Aebischer P. Bovine 
serum albumin conformation on methyl and amine functionalized surfaces compared by 
scanning force microscopy. Journal of Biomedical Materials Research 1995;29(6):707-
714. 
 
Taylor G. Disintegration of water drops in an electric field Proceedings of the Royal 
Society of London 1964;A A280:383-397. 
 
Teo W and Ramakrishna S. Electrospun fibre bundle made of aligned nanofibres over two 
fixed points. Nanotechnology 2005;16:1878-1884. 
 
Teo WE and Ramakrishna S. A review on electrospinning design and nanofibre 
assemblies. Nanotechnology 2006;17(14):R89. 
 
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS and 
Jones JM. Embryonic Stem Cell Lines Derived from Human Blastocysts. Science 
1998;282(5391):1145-1147. 
 
Toh Y-C, Ng S, Khong YM, Zhang X, Zhu Y, Lin P-C, Te C-M, Sun W and Yu H. 
Cellular responses to a nanofibrous environment. Nano Today 2006;1(3):34-43. 
 
Trounson A. The Production and Directed Differentiation of Human Embryonic Stem 
Cells. Endocrine Reviews 2006;27(2):208-219. 
 
van der Flier A and Sonnenberg A. Function and interactions of integrins. Cell and Tissue 
Research 2001;305(3):285-298. 
 
van Wachem PB, Hogt AH, Beugeling T, Feijen J, Bantjes A, Detmers JP and van Aken 
WG. Adhesion of cultured human endothelial cells onto methacrylate polymers with 
varying surface wettability and charge. Biomaterials 1987;8(5):323-328. 
 
Vasita R and Katti DS. Nanofibers and their applications in tissue engineering. Int J 
Nanomedicine 2006;1(1):15-30. 
 
References 
Chapter 7 
 
 
268 
 
Vogler EA. Structure and reactivity of water at biomaterial surfaces. Advances in Colloid 
and Interface Science 1998;74(1-3):69-117. 
 
Vroman L. Effect of Adsorbed Proteins on the Wettability of Hydrophilic and 
Hydrophobic Solids. Nature 1962;196(4853):476-477. 
 
Wagers AJ and Weissman IL. Plasticity of Adult Stem Cells. Cell 2004;116(5):639-648. 
 
Wagner MS and Castner DG. Characterization of Adsorbed Protein Films by Time-of-
Flight Secondary Ion Mass Spectrometry with Principal Component Analysis. Langmuir 
2001;17(15):4649-4660. 
 
Wagner MS, Tyler BJ and Castner DG. Interpretation of Static Time-of-Flight Secondary 
Ion Mass Spectra of Adsorbed Protein Films by Multivariate Pattern Recognition. 
Analytical Chemistry 2002;74(8):1824-1835. 
 
Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW and Orkin SH. A protein 
interaction network for pluripotency of embryonic stem cells. Nature 2006;444(7117):364-
368. 
 
Watt FM and Hogan BL. Out of Eden: stem cells and their niches. Science 
2000;287(5457):1427-1430. 
 
Westfall SD, Sachdev S, Das P, Hearne LB, Hannink M, Roberts RM and Ezashi T. 
Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. 
Stem Cells Dev 2008;17(5):869-881. 
 
Wiesner S, Legate KR and Fässler R. Integrin-actin interactions. Cellular and Molecular 
Life Sciences 2005;62(10):1081-1099. 
 
Wimpenny I, Hampson K, Yang Y, Ashammakhi N and Forsyth NR. One-step recovery of 
marrow stromal cells on nanofibers. Tissue Eng Part C Methods 2010;16(3):503-509. 
 
Wobus AM and Boheler KR. Embryonic Stem Cells: Prospects for Developmental Biology 
and Cell Therapy. Physiological Reviews 2005;85(2):635-678. 
 
Wong SSY and Bernstein HS. Cardiac regeneration using human embryonic stem cells: 
producing cells for future therapy. Regenerative Medicine 2010;5(5):763-775. 
 
Woo KM, Chen VJ and Ma PX. Nano-fibrous scaffolding architecture selectively enhances 
protein adsorption contributing to cell attachment. Journal of Biomedical Materials 
Research Part A 2003;67A(2):531-537. 
 
Xie J, Willerth SM, Li X, Macewan MR, Rader A, Sakiyama-Elbert SE and Xia Y. The 
differentiation of embryonic stem cells seeded on electrospun nanofibers into neural 
lineages. Biomaterials 2009;30(3):354-362. 
 
References 
Chapter 7 
 
 
269 
 
Xu CH, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD and Carpenter MK. Feeder-
free growth of undifferentiated human embryonic stem cells. Nature Biotechnology 
2001;19(10):971-974. 
 
Xu R-H, Peck RM, Li DS, Feng X, Ludwig T and Thomson JA. Basic FGF and 
suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat 
Meth 2005;2(3):185-190. 
 
Yang F, Murugan R, Wang S and Ramakrishna S. Electrospinning of nano/micro scale 
poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. 
Biomaterials 2005;26(15):2603-2610. 
 
Yang J, Rose FRAJ, Gadegaard N and Alexander MR. A High-Throughput Assay of Cell-
Surface Interactions using Topographical and Chemical Gradients. Advanced Materials 
2009;21(3):300-304. 
 
Yla-Outinen L, Mariani C, Skottman H, Suuronen R, Harlin A and Narkilahti S. 
Electrospun poly (L, D-lactide) scaffolds support the growth of human embryonic stem 
cell-derived neuronal cells. The Open Tissue Engineering and Regenerative Medicine 
Journal 2010;3:1-9. 
 
Young H and Carpentar MK. Characterisation of human embryonic stem cells. In: Atala A 
and Lanza RP, editors. Methods of tissue engineering: Essentials of Stem Cell Biology. 
London: Elsevier Academic Press; 2002. p 265-268. 
 
Young HE and Black AC. Adult stem cells. The Anatomical Record Part A: Discoveries in 
Molecular, Cellular, and Evolutionary Biology 2004;276A(1):75-102. 
 
Zachar V, Prasad S, Weli S, Gabrielsen A, Petersen K, Petersen M and Fink T. The effect 
of human embryonic stem cells (hESCs) long-term normoxic and hypoxic cultures on the 
maintenance of pluripotency. In Vitro Cellular & Developmental Biology - Animal 
2010;46(3):276-283. 
 
Zhang Y, Ouyang H, Lim CT, Ramakrishna S and Huang Z-M. Electrospinning of gelatin 
fibers and gelatin/PCL composite fibrous scaffolds. Journal of Biomedical Materials 
Research Part B: Applied Biomaterials 2005;72B(1):156-165. 
 
Zhang Z, Vuori K, Reed JC and Ruoslahti E. The alpha 5 beta 1 integrin supports survival 
of cells on fibronectin and up-regulates Bcl-2 expression. Proceedings of the National 
Academy of Sciences 1995;92(13):6161-6165. 
 
Zhu Y, Gao C, Liu X and Shen J. Surface Modification of Polycaprolactone Membrane via 
Aminolysis and Biomacromolecule Immobilization for Promoting Cytocompatibility of 
Human Endothelial Cells. Biomacromolecules 2002;3(6):1312-1319. 
 
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, 
Benhaim P and Hedrick MH. Human Adipose Tissue Is a Source of Multipotent Stem 
Cells. Molecular Biology of the Cell 2002;13(12):4279-4295. 
 
References 
Chapter 7 
 
 
270 
 
Zuo WW, Zhu MF, Yang W, Yu H, Chen YM and Zhang Y. Experimental study on 
relationship between jet instability and formation of beaded fibers during electrospinning. 
Polymer Engineering and Science 2005;45(5):704-709. 
 
Zussman E, Theron A and Yarin AL. Formation of nanofiber crossbars in electrospinning. 
Applied Physics Letters 2003;82(6):973-975. 
 
 
 
Appendix 
 
 
 
 
271 
 
Appendix  
Table A1 Normalised intensity values of positive ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in conditioned media. 
m/z Potential Assignment CM+ CTL CM+ A (280 nm) CM+ A (521 nm) CM+ R (318nm) CM+R (660 nm) 
22,9718 Na (Wagner et al., 2001) 1,23E-04 8,74E-05 8,74E-05 1,08E-04 1,25E-04 
25,9929 C2H
-
 (Wagner et al., 2001) 2,40E-05 1,83E-05 1,83E-05 1,88E-05 1,98E-05 
26.995 
CN
- 
(peptide backbone) 
(Wagner et al., 2001) 1,59E-04 1,41E-04 1,41E-04 1,60E-04 1,11E-04 
27,9917 
C2H3
+
 (Wagner et al 2002) 
(Mahlstedt et al., 2009) 7,18E-05 4,32E-05 4,32E-05 5,23E-05 3,49E-05 
29,0254 C2H5 (Mahlstedt et al., 2009) 7,92E-04 6,72E-04 6,72E-04 7,47E-04 4,26E-04 
30,0112 
CH4N
+
: Glycine (Wagner et 
al.,2001).  8,64E-05 7,38E-05 7,38E-05 8,51E-05 5,22E-05 
37,9999 No assignment identified 3,82E-05 2,87E-05 2,87E-05 2,39E-05 1,75E-05 
39,7221 C3H3
+
 (Wagner et al., 2002) 1,47E-04 1,13E-04 1,13E-04 1,31E-04 1,73E-04 
40,0167 No assignment identified 3,10E-04 2,46E-04 2,46E-04 2,49E-04 1,87E-04 
40,9458 No assignment identified 1,03E-04 1,21E-04 1,21E-04 1,18E-04 9,73E-05 
41,0139 
C3H5
+
 (Wagner et al., 2002) 
(Mahlstedt et al., 2009) 2,03E-03 2,02E-03 2,02E-03 2,34E-03 1,77E-03 
41,7003 
C3H5
+
 (Wagner et al., 2002) 
2,85E-04 3,19E-04 3,19E-04 3,64E-04 1,91E-04 
41,9932 
C3H5
+
 (Wagner et al., 2002) 
2,27E-04 2,25E-04 2,25E-04 3,02E-04 1,06E-04 
42,9994 
CNO
-
: peptide backbone 
(Wagner et al., 2001) 5,92E-04 6,20E-04 6,20E-04 1,18E-03 2,50E-04 
43,0241 
CH3N2
+
 (Argenine: laminin 
(Wagner et al., 2002) .  6,29E-03 5,59E-03 5,59E-03 6,98E-03 3,08E-03 
43,0421 C2H5N (Hazen et al., 2006) 2,60E-03 1,86E-03 1,86E-03 2,29E-03 1,21E-03 
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44,0371 
C2H6N
+
 (Wagner et al., 
2002) 1,40E-03 9,95E-04 9,95E-04 1,23E-03 5,45E-04 
54,9998 No assignment identified 2,49E-04 2,33E-04 2,33E-04 3,37E-04 1,49E-04 
55,0208 C4H7
+
 (Wagner et al., 2002) 1,05E-02 8,17E-03 8,17E-03 1,16E-02 4,60E-03 
56,0233 
C3H6N
+
 (Wagner et al., 
2002) 1,64E-03 1,16E-03 1,16E-03 1,53E-03 7,17E-04 
56,6144 
C3H6N
+
 (Wagner et al., 
2002) 2,18E-04 2,11E-04 2,11E-04 2,42E-04 1,11E-04 
58,0392 
C2H4NO: Glycine; collagen 
(Cannnan et al., 2007) 8,52E-04 1,03E-03 1,03E-03 8,73E-04 5,12E-04 
59,0118 
C3H7O
+
 (Wagner et al., 
2002) 2,12E-04 1,50E-04 1,50E-04 2,30E-04 8,14E-05 
59,0496 
CH5N3: Arginine; laminin 
(Cannnan et al., 2007) 7,36E-03 5,09E-03 5,09E-03 6,76E-03 2,20E-03 
68,0263 
C4H6N
+
 (Wagner et al., 
2002) 1,28E-03 9,28E-04 9,28E-04 1,23E-03 5,84E-04 
69,0374 
C4H5O: threonine; 
fibronectin 
(Cannnan et al., 2007) 3,26E-03 2,37E-03 2,37E-03 3,14E-03 1,36E-03 
70,0375 
C4H8N
+
 (Wagner et al., 
2002) 1,56E-03 1,08E-03 1,08E-03 1,41E-03 6,05E-04 
78,0441 C6H6
+
 Toporski et al., 2002 9,61E-04 1,03E-03 1,03E-03 1,04E-03 5,33E-04 
87,9004 C4H9O2
+
 Cheng et al., 2008  6,68E-05 8,51E-05 8,51E-05 5,25E-05 1,10E-04 
96,8582 
SO4
-
 (Alexander & Jones et 
al., 1995) 2,65E-05 2,39E-05 2,39E-05 2,59E-05 4,91E-05 
98,1067 
C4H4NO2
+
: asparagine 
(Wagner et al., 2001) 4,74E-04 3,82E-04 3,82E-04 5,15E-04 3,51E-04 
103,9236 No assignment identified 1,70E-04 1,32E-04 1,32E-04 1,22E-04 3,13E-03 
124,9131 
C8H9NO
4
 (125 m/z) 
(Mahlstedt et al., 2009) 8,45E-04 1,35E-03 1,35E-03 5,63E-04 5,41E-04 
164.857 C13H9
+
 (165 m/z) (Delcorte 1,34E-04 2,67E-04 2,67E-04 1,31E-04 1,60E-04 
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et al., 1997) 
180,0851 No assignment identified 1,22E-04 1,12E-04 1,12E-04 1,17E-04 9,01E-05 
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Table A2 Normalised intensity values of positive ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure collagen I protein solution (50 
µg/ml). 
m/z Potential Assignment 
Coll I CTL Coll I +A (280nm) Coll I +A (521nm) Coll I +R (318nm) Coll I +R (660nm) 
22,9718 
Na (Wagner et al., 
2001) 
8,37E-05 5,45E-05 3,10E-05 1,30E-04 8,90E-06 
25,9929 
C2H
-
 (Wagner et al., 
2001) 
2,25E-05 2,15E-05 7,46E-05 2,25E-05 2,16E-05 
26.995 
CN
- 
(peptide backbone) 
(Wagner et al., 2001) 
1,68E-04 1,87E-04 4,99E-04 2,18E-04 2,41E-04 
27,9917 
C2H3
+
 (Wagner et al 
2002) (Mahlstedt et al., 
2009) 
1,03E-04 7,41E-05 1,49E-04 5,67E-05 7,73E-05 
29,0254 
C2H5 (Mahlstedt et al., 
2009) 
1,16E-03 9,22E-04 6,08E-04 7,39E-04 1,10E-03 
30,0112 
CH4N
+
: Glycine 
(Wagner et al.,2001).  
1,41E-04 1,02E-04 4,36E-05 7,59E-05 1,29E-04 
37,9999 
No assignment 
identified 
3,18E-05 2,64E-05 3,09E-05 2,78E-05 1,54E-05 
39,7221 
C3H3
+
 (Wagner et al., 
2002) 
1,16E-04 1,39E-04 4,70E-04 1,46E-04 1,58E-04 
40,0167 
No assignment 
identified 
4,12E-04 3,31E-04 2,85E-04 2,78E-04 3,01E-04 
40,9458 
No assignment 
identified 
9,77E-05 1,12E-04 2,97E-04 1,42E-04 1,70E-04 
41,0139 
C3H5
+
 (Wagner et al., 
2002) (Mahlstedt et al., 
2,17E-03 2,48E-03 3,76E-03 2,72E-03 3,28E-03 
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2009) 
41,7003 
C3H5
+
 (Wagner et al., 
2002) 2,92E-04 4,32E-04 1,03E-03 4,78E-04 6,62E-04 
41,9932 
C3H5
+
 (Wagner et al., 
2002) 3,15E-04 2,95E-04 6,44E-04 2,42E-04 3,27E-04 
42,9994 
CNO
-
: peptide 
backbone (Wagner et 
al., 2001) 
9,00E-04 9,99E-04 1,84E-03 7,25E-04 8,09E-04 
43,0241 
CH3N2
+
 (Argenine: 
laminin (Wagner et al., 
2002) .  
1,05E-02 1,18E-02 5,93E-03 7,53E-03 1,07E-02 
43,0421 
C2H5N (Hazen et al., 
2006) 
4,32E-03 2,95E-03 9,14E-04 1,96E-03 3,24E-03 
44,0371 
C2H6N
+
 (Wagner et al., 
2002) 
1,79E-03 1,58E-03 2,04E-04 1,14E-03 1,63E-03 
54,9998 
No assignment 
identified 
3,33E-04 3,61E-04 9,45E-04 2,79E-04 4,75E-04 
55,0208 
C4H7
+
 (Wagner et al., 
2002) 
1,68E-02 1,34E-02 5,64E-03 8,63E-03 2,07E-02 
56,0233 
C3H6N
+
 (Wagner et al., 
2002) 
3,05E-03 2,44E-03 4,50E-04 1,57E-03 2,79E-03 
56,6144 
C3H6N
+
 (Wagner et al., 
2002) 
3,01E-04 2,94E-04 5,22E-04 2,62E-04 5,30E-04 
58,0392 
C2H4NO: Glycine; 
collagen 
(Cannnan et al., 2007) 
8,55E-04 6,73E-04 2,13E-04 4,96E-04 8,28E-04 
59,0118 
C3H7O
+
 (Wagner et al., 
2002) 
3,53E-04 2,82E-04 9,41E-05 1,80E-04 3,22E-04 
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59,0496 
CH5N3: Arginine; 
laminin 
(Cannnan et al., 2007) 
1,22E-02 9,53E-03 2,81E-03 5,95E-03 9,68E-03 
68,0263 
C4H6N
+
 (Wagner et al., 
2002) 
2,28E-03 1,89E-03 4,30E-04 1,27E-03 2,33E-03 
69,0374 
C4H5O: threonine; 
fibronectin 
(Cannnan et al., 2007) 
5,12E-03 3,26E-03 1,13E-03 1,91E-03 5,45E-03 
70,0375 
C4H8N
+
 (Wagner et al., 
2002) 
2,41E-03 1,64E-03 2,64E-04 1,10E-03 2,42E-03 
78,0441 
C6H6
+
 Toporski et al., 
2002 
1,23E-03 1,25E-03 2,08E-03 1,03E-03 1,69E-03 
87,9004 
C4H9O2
+
 Cheng et al., 
2008  
4,35E-05 3,68E-05 3,14E-05 6,38E-05 3,55E-05 
96,8582 
SO4
-
 (Alexander & 
Jones et al., 1995) 
3,64E-05 2,80E-05 2,25E-05 2,33E-05 3,73E-05 
98,1067 
C4H4NO2
+
: asparagine 
(Wagner et al., 2001) 
8,05E-04 8,72E-04 7,16E-04 8,68E-04 8,37E-04 
103,9236 
No assignment 
identified 
6,91E-05 6,93E-05 1,54E-04 1,24E-04 4,43E-05 
124,9131 
C8H9NO
4
 (125 m/z) 
(Mahlstedt et al., 2009) 
2,43E-04 3,22E-04 1,14E-04 8,85E-04 1,12E-04 
164.857 
C13H9
+
 (165 m/z) 
(Delcorte et al., 1997) 
8,05E-05 9,67E-05 2,36E-04 2,19E-04 9,70E-05 
180,0851 
No assignment 
identified 
1,43E-04 1,29E-04 1,30E-04 1,18E-04 1,29E-04 
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Table A3 Normalised intensity values of positive ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure fibronectin protein solution (50 
µg/ml). 
m/z Potential Assignment 
Fn CTL Fn +A (280nm) Fn +A (521nm) Fn +R (318nm) Fn +R (660nm) 
22,9718 
Na (Wagner et al., 2001) 
7,58E-05 1,07E-04 7,49E-05 7,43E-05 1,35E-04 
25,9929 
C2H
-
 (Wagner et al., 
2001) 
1,92E-05 2,25E-05 1,52E-05 2,30E-05 2,53E-05 
26.995 
CN
- 
(peptide backbone) 
(Wagner et al., 2001) 
9,71E-05 1,62E-04 2,06E-04 1,71E-04 1,79E-04 
27,9917 
C2H3
+
 (Wagner et al 
2002) (Mahlstedt et al., 
2009) 
5,35E-05 5,16E-05 3,39E-05 4,06E-05 7,87E-05 
29,0254 
C2H5 (Mahlstedt et al., 
2009) 
7,72E-04 6,93E-04 5,93E-04 6,23E-04 9,33E-04 
30,0112 
CH4N
+
: Glycine 
(Wagner et al.,2001).  
7,92E-05 6,10E-05 3,89E-05 5,49E-05 9,77E-05 
37,9999 
No assignment identified 
3,50E-05 3,43E-05 1,16E-05 2,56E-05 3,06E-05 
39,7221 
C3H3
+
 (Wagner et al., 
2002) 
1,66E-04 1,17E-04 1,64E-04 1,35E-04 1,19E-04 
40,0167 
No assignment identified 
3,44E-04 3,12E-04 1,67E-04 2,57E-04 3,39E-04 
40,9458 
No assignment identified 
7,45E-05 8,68E-05 2,26E-04 1,10E-04 8,05E-05 
41,0139 
C3H5
+
 (Wagner et al., 
2002) (Mahlstedt et al., 
1,65E-03 2,03E-03 3,12E-03 2,14E-03 2,20E-03 
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2009) 
41,7003 
C3H5
+
 (Wagner et al., 
2002) 1,41E-04 3,38E-04 8,43E-04 3,54E-04 3,07E-04 
41,9932 
C3H5
+
 (Wagner et al., 
2002) 1,53E-04 1,82E-04 2,83E-04 1,77E-04 2,13E-04 
42,9994 
CNO
-
: peptide backbone 
(Wagner et al., 2001) 
4,88E-04 6,47E-04 1,01E-03 6,26E-04 7,11E-04 
43,0241 
CH3N2
+
 (Argenine: 
laminin (Wagner et al., 
2002) .  
6,06E-03 7,06E-03 7,34E-03 6,43E-03 9,36E-03 
43,0421 
C2H5N (Hazen et al., 
2006) 
2,05E-03 1,87E-03 1,25E-03 1,60E-03 2,70E-03 
44,0371 
C2H6N
+
 (Wagner et al., 
2002) 
1,35E-03 1,31E-03 6,42E-04 1,08E-03 1,68E-03 
54,9998 
No assignment identified 
2,14E-04 2,31E-04 3,81E-04 2,16E-04 3,23E-04 
55,0208 
C4H7
+
 (Wagner et al., 
2002) 
8,03E-03 7,96E-03 1,06E-02 6,92E-03 1,26E-02 
56,0233 
C3H6N
+
 (Wagner et al., 
2002) 
1,36E-03 1,24E-03 1,14E-03 1,02E-03 1,94E-03 
56,6144 
C3H6N
+
 (Wagner et al., 
2002) 
1,95E-04 2,66E-04 6,37E-04 2,43E-04 2,83E-04 
58,0392 
C2H4NO: Glycine; 
collagen 
(Cannnan et al., 2007) 
3,53E-04 3,43E-04 4,54E-04 3,30E-04 4,64E-04 
59,0118 
C3H7O
+
 (Wagner et al., 
2002) 
2,09E-04 2,07E-04 1,63E-04 1,78E-04 2,57E-04 
59,0496 
CH5N3: Arginine; 
laminin 
7,47E-03 7,14E-03 4,58E-03 5,68E-03 8,53E-03 
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(Cannnan et al., 2007) 
68,0263 
C4H6N
+
 (Wagner et al., 
2002) 
1,16E-03 1,13E-03 1,05E-03 9,80E-04 1,71E-03 
69,0374 
C4H5O: threonine; 
fibronectin 
(Cannnan et al., 2007) 
3,65E-03 3,36E-03 2,89E-03 2,68E-03 4,87E-03 
70,0375 
C4H8N
+
 (Wagner et al., 
2002) 
1,41E-03 1,28E-03 1,03E-03 1,06E-03 1,91E-03 
78,0441 
C6H6
+
 Toporski et al., 
2002 
5,97E-04 8,77E-04 1,48E-03 8,15E-04 1,14E-03 
87,9004 
C4H9O2
+
 Cheng et al., 
2008  
9,06E-05 8,29E-05 4,50E-05 7,20E-05 5,37E-05 
96,8582 
SO4
-
 (Alexander & Jones 
et al., 1995) 
3,22E-05 2,30E-05 2,82E-05 2,23E-05 2,96E-05 
98,1067 
C4H4NO2
+
: asparagine 
(Wagner et al., 2001) 
3,30E-04 3,97E-04 7,36E-04 4,07E-04 6,17E-04 
103,9236 
No assignment identified 
1,00E-03 1,32E-04 7,72E-05 2,27E-04 8,90E-05 
124,9131 
C8H9NO
4
 (125 m/z) 
(Mahlstedt et al., 2009) 
1,87E-03 1,02E-03 1,82E-04 1,23E-03 2,37E-04 
164.857 
C13H9
+
 (165 m/z) 
(Delcorte et al., 1997) 
2,49E-04 2,27E-04 9,67E-05 2,68E-04 9,48E-05 
180,0851 
No assignment identified 
9,10E-05 1,19E-04 1,07E-04 1,13E-04 1,81E-04 
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Table A4 Normalised intensity values of positive ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure laminin protein solution (50 
µg/ml). 
m/z Potential Assignment 
Ln CTL Ln +A (280nm) Ln +A (521nm) Ln +R (318nm) Ln +R (660nm) 
22,9718 
Na (Wagner et al., 
2001) 
8,91E-05 1,06E-04 1,32E-04 1,26E-04 1,98E-04 
25,9929 
C2H
-
 (Wagner et al., 
2001) 
1,84E-05 2,29E-05 2,03E-05 2,12E-05 2,14E-05 
26.995 
CN
- 
(peptide backbone) 
(Wagner et al., 2001) 
1,08E-04 1,59E-04 1,82E-04 1,19E-04 1,65E-04 
27,9917 
C2H3
+
 (Wagner et al 
2002) (Mahlstedt et al., 
2009) 
4,96E-05 4,70E-05 4,02E-05 3,69E-05 4,69E-05 
29,0254 
C2H5 (Mahlstedt et al., 
2009) 
6,79E-04 6,70E-04 7,35E-04 5,80E-04 7,08E-04 
30,0112 
CH4N
+
: Glycine 
(Wagner et al.,2001).  
7,39E-05 6,42E-05 6,95E-05 5,10E-05 7,41E-05 
37,9999 
No assignment 
identified 
3,94E-05 3,26E-05 2,23E-05 2,67E-05 2,30E-05 
39,7221 
C3H3
+
 (Wagner et al., 
2002) 
9,98E-05 1,09E-04 1,29E-04 9,01E-05 1,05E-04 
40,0167 
No assignment 
identified 
3,04E-04 3,11E-04 2,77E-04 2,69E-04 2,75E-04 
40,9458 
No assignment 
identified 
7,79E-05 8,69E-05 1,24E-04 6,25E-05 8,28E-05 
41,0139 
C3H5
+
 (Wagner et al., 
2002) (Mahlstedt et al., 
1,54E-03 1,98E-03 2,53E-03 1,62E-03 2,06E-03 
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2009) 
41,7003 
C3H5
+
 (Wagner et al., 
2002) 1,34E-04 3,11E-04 4,88E-04 1,87E-04 3,70E-04 
41,9932 
C3H5
+
 (Wagner et al., 
2002) 1,56E-04 1,94E-04 2,05E-04 1,25E-04 1,89E-04 
42,9994 
CNO
-
: peptide 
backbone (Wagner et 
al., 2001) 
4,64E-04 6,81E-04 6,67E-04 4,88E-04 7,18E-04 
43,0241 
CH3N2
+
 (Argenine: 
laminin (Wagner et al., 
2002) .  
5,71E-03 6,57E-03 7,80E-03 5,50E-03 7,61E-03 
43,0421 
C2H5N (Hazen et al., 
2006) 
1,87E-03 1,94E-03 1,98E-03 1,81E-03 2,16E-03 
44,0371 
C2H6N
+
 (Wagner et al., 
2002) 
1,19E-03 1,21E-03 1,20E-03 1,12E-03 1,29E-03 
54,9998 
No assignment 
identified 
1,87E-04 2,23E-04 2,69E-04 1,85E-04 2,49E-04 
55,0208 
C4H7
+
 (Wagner et al., 
2002) 
7,19E-03 7,98E-03 1,01E-02 7,19E-03 9,39E-03 
56,0233 
C3H6N
+
 (Wagner et al., 
2002) 
1,15E-03 1,23E-03 1,33E-03 1,11E-03 1,35E-03 
56,6144 
C3H6N
+
 (Wagner et al., 
2002) 
1,17E-04 2,01E-04 3,42E-04 1,43E-04 2,46E-04 
58,0392 
C2H4NO: Glycine; 
collagen 
(Cannnan et al., 2007) 
3,43E-04 3,97E-04 4,25E-04 3,26E-04 4,69E-04 
59,0118 
C3H7O
+
 (Wagner et al., 
2002) 
1,58E-04 1,88E-04 2,08E-04 1,51E-04 2,11E-04 
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59,0496 
CH5N3: Arginine; 
laminin 
(Cannnan et al., 2007) 
5,80E-03 6,27E-03 6,50E-03 5,24E-03 6,47E-03 
68,0263 
C4H6N
+
 (Wagner et al., 
2002) 
8,97E-04 1,02E-03 1,13E-03 9,25E-04 1,11E-03 
69,0374 
C4H5O: threonine; 
fibronectin 
(Cannnan et al., 2007) 
2,51E-03 2,72E-03 3,02E-03 2,49E-03 2,92E-03 
70,0375 
C4H8N
+
 (Wagner et al., 
2002) 
1,12E-03 1,25E-03 1,40E-03 1,16E-03 1,41E-03 
78,0441 
C6H6
+
 Toporski et al., 
2002 
5,64E-04 8,09E-04 1,18E-03 6,68E-04 8,73E-04 
87,9004 
C4H9O2
+
 Cheng et al., 
2008  
1,01E-04 1,18E-04 9,69E-05 8,26E-05 8,60E-05 
96,8582 
SO4
-
 (Alexander & 
Jones et al., 1995) 
3,06E-05 2,48E-05 2,46E-05 2,03E-05 2,61E-05 
98,1067 
C4H4NO2
+
: asparagine 
(Wagner et al., 2001) 
2,80E-04 3,74E-04 4,54E-04 3,13E-04 4,40E-04 
103,9236 
No assignment 
identified 
5,07E-04 2,26E-04 1,21E-04 4,92E-04 1,63E-04 
124,9131 
C8H9NO
4
 (125 m/z) 
(Mahlstedt et al., 2009) 
2,05E-03 1,09E-03 3,77E-04 7,25E-04 4,45E-04 
164.857 
C13H9
+
 (165 m/z) 
(Delcorte et al., 1997) 
4,29E-04 2,67E-04 1,15E-04 1,45E-04 1,33E-04 
180,0851 
No assignment 
identified 
7,72E-05 1,09E-04 1,21E-04 1,01E-04 1,18E-04 
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Table A5 Normalised intensity values of positive ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure vitronectin protein solution (50 
µg/ml). 
m/z Potential Assignment 
Vn CTL Vn +A (280nm) Vn +A (521nm) Vn +R (318nm) Vn +R (660nm) 
22,9718 
Na (Wagner et al., 
2001) 
3,59E-04 9,07E-05 1,68E-04 2,93E-04 1,01E-04 
25,9929 
C2H
-
 (Wagner et al., 
2001) 
1,76E-05 2,37E-05 2,05E-05 1,91E-05 2,06E-05 
26.995 
CN
- 
(peptide backbone) 
(Wagner et al., 2001) 
1,49E-04 2,29E-04 2,01E-04 1,80E-04 2,01E-04 
27,9917 
C2H3
+
 (Wagner et al 
2002) (Mahlstedt et al., 
2009) 
9,01E-05 7,06E-05 5,88E-05 7,59E-05 5,88E-05 
29,0254 
C2H5 (Mahlstedt et al., 
2009) 
6,10E-04 1,08E-04 2,77E-04 6,83E-04 2,76E-04 
30,0112 
CH4N
+
: Glycine 
(Wagner et al.,2001).  
9,10E-05 1,33E-05 3,09E-05 8,03E-05 3,05E-05 
37,9999 
No assignment 
identified 
2,53E-05 1,39E-03 3,41E-05 2,13E-05 9,95E-06 
39,7221 
C3H3
+
 (Wagner et al., 
2002) 
9,61E-05 2,06E-03 2,17E-04 1,08E-04 5,03E-04 
40,0167 
No assignment 
identified 
2,37E-04 9,80E-05 1,20E-03 2,42E-04 1,49E-04 
40,9458 
No assignment 
identified 
7,80E-05 9,62E-05 3,19E-04 9,13E-05 1,40E-04 
41,0139 
C3H5
+
 (Wagner et al., 
2002) (Mahlstedt et al., 
1,69E-03 1,57E-03 1,79E-03 2,23E-03 1,75E-03 
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2009) 
41,7003 
C3H5
+
 (Wagner et al., 
2002) 2,19E-04 3,36E-04 4,21E-04 3,14E-04 4,40E-04 
41,9932 
C3H5
+
 (Wagner et al., 
2002) 5,37E-04 3,31E-04 1,22E-03 4,97E-04 2,86E-04 
42,9994 
CNO
-
: peptide 
backbone (Wagner et 
al., 2001) 
2,99E-03 1,52E-03 8,91E-04 2,65E-03 8,58E-04 
43,0241 
CH3N2
+
 (Argenine: 
laminin (Wagner et al., 
2002) .  
1,11E-02 2,79E-03 4,00E-03 1,02E-02 3,98E-03 
43,0421 
C2H5N (Hazen et al., 
2006) 
2,32E-03 5,62E-04 6,19E-04 2,42E-03 6,15E-04 
44,0371 
C2H6N
+
 (Wagner et al., 
2002) 
1,50E-03 7,58E-05 1,01E-04 1,43E-03 1,01E-04 
54,9998 
No assignment 
identified 
3,65E-04 3,55E-04 3,48E-04 4,29E-04 3,24E-04 
55,0208 
C4H7
+
 (Wagner et al., 
2002) 
9,42E-03 2,47E-03 5,85E-03 1,04E-02 5,81E-03 
56,0233 
C3H6N
+
 (Wagner et al., 
2002) 
1,40E-03 1,88E-04 4,26E-04 1,43E-03 4,29E-04 
56,6144 
C3H6N
+
 (Wagner et al., 
2002) 
1,62E-04 1,30E-04 2,17E-04 1,99E-04 2,71E-03 
58,0392 
C2H4NO: Glycine; 
collagen 
(Cannnan et al., 2007) 
5,62E-04 2,89E-04 1,64E-04 5,58E-04 1,68E-04 
59,0118 
C3H7O
+
 (Wagner et al., 
2002) 
3,09E-04 6,82E-05 6,69E-05 2,66E-04 7,25E-05 
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59,0496 
CH5N3: Arginine; 
laminin 
(Cannnan et al., 2007) 
1,06E-02 1,57E-03 1,03E-03 8,42E-03 1,05E-03 
68,0263 
C4H6N
+
 (Wagner et al., 
2002) 
1,23E-03 1,88E-04 4,85E-04 1,25E-03 4,56E-04 
69,0374 
C4H5O: threonine; 
fibronectin 
(Cannnan et al., 2007) 
2,92E-03 4,80E-04 1,03E-03 2,98E-03 1,05E-03 
70,0375 
C4H8N
+
 (Wagner et al., 
2002) 
1,54E-03 1,65E-04 2,71E-04 1,47E-03 2,74E-04 
78,0441 
C6H6
+
 Toporski et al., 
2002 
1,07E-03 7,48E-04 6,90E-04 1,56E-03 7,28E-04 
87,9004 
C4H9O2
+
 Cheng et al., 
2008  
1,31E-04 1,60E-05 1,42E-04 7,73E-05 2,70E-04 
96,8582 
SO4
-
 (Alexander & 
Jones et al., 1995) 
2,62E-05 3,52E-04 1,66E-05 2,42E-05 3,86E-05 
98,1067 
C4H4NO2
+
: asparagine 
(Wagner et al., 2001) 
3,64E-04 1,09E-04 1,41E-04 4,48E-04 5,61E-04 
103,9236 
No assignment 
identified 
1,77E-04 1,11E-04 4,11E-04 1,30E-04 1,46E-04 
124,9131 
C8H9NO
4
 (125 m/z) 
(Mahlstedt et al., 2009) 
7,25E-04 1,48E-04 1,54E-04 3,42E-04 4,98E-05 
164.857 
C13H9
+
 (165 m/z) 
(Delcorte et al., 1997) 
1,85E-04 7,37E-05 9,65E-05 1,79E-04 6,66E-05 
180,0851 
No assignment 
identified 
1,19E-04 5,62E-05 7,40E-05 1,71E-04 4,13E-05 
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Table A6 Normalised intensity values of negative ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure collagen I protein solution. 
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m/z Potential Assignment 
CM+ 
CTL CM+ A (280 nm) CM+ A (521 nm) CM+ R (318nm) CM+R (660 nm) 
13.0086 
No assignment identified 
1,06E-02 1,01E-02 1,33E-02 1,30E-02 9,75E-03 
15.9954 
No assignment identified 
1,59E-02 1,12E-02 8,24E-03 1,52E-02 1,13E-02 
17.0034 
No assignment identified 
1,47E-02 1,17E-02 1,01E-02 1,38E-02 1,27E-02 
25.0094 
CN
- 
(m/z of 26) peptide 
backbone 
(Wagner et al., 2001) 
2,24E-06 2,36E-06 3,10E-06 3,04E-06 2,14E-06 
34.9712 
SH
-
 (m/z of 33) cysteine  
(Wagner et al., 2001) 
1,40E-02 1,14E-02 8,17E-03 1,37E-02 1,35E-02 
41.0453 
C3H5
+
 (m/z of 41) 
(Wagner et al., 2002) 
7,32E-04 7,74E-04 1,03E-03 9,94E-04 9,63E-04 
43.0017 
CH3N2 (m/z of 43.0296) 
Glycine most prevalent in 
coll (Canavan et al., 
2007) 
4,34E-03 3,19E-03 2,59E-03 3,00E-03 1,85E-03 
59.9676 
C2H6NO (m/z of 
60.0449) 
L-serine most prevalent 
in Fn (Canavan et al., 
2007) 
1,50E-03 9,70E-04 9,62E-04 1,58E-03 6,15E-04 
60.9755 
C2H5S (m/z of 61.011) 
methionine most 
prevalent in Coll 
(Canavan et al., 2007) 
1,56E-03 1,05E-03 1,08E-03 1,58E-03 4,87E-04 
62.9658 
No assignment identified 
2,74E-02 3,36E-02 1,42E-02 1,18E-02 4,89E-03 
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74.9971 
C3H8NO (m/z of 74.061) 
threonine most prevalent 
in Fn 
(Canavan et al., 2007) 
8,43E-03 1,12E-02 1,18E-02 8,95E-03 1,19E-02 
75.9611 
C2H6NS (76.022) 
cysteine most prevalent 
in Fn (Canavan et al., 
2007) 7,68E-04 3,48E-04 2,60E-04 3,98E-04 9,49E-05 
76.9699 
C2H6NS
+
 (m/z of 76) 
cysteine  
(Wagner et al., 2001) 4,36E-03 2,26E-03 2,16E-03 2,84E-03 8,26E-04 
78.9615 
No assignment identified 
7,17E-02 8,21E-02 4,50E-02 3,58E-02 1,55E-02 
79.9609 
No assignment identified 
4,92E-03 4,81E-03 5,44E-03 5,62E-03 2,30E-03 
83.9729 
C4H6NO (m/z of 
84.0449) glutamine; most 
prevalent in Fn (Canavan 
et al., 2007) 
5,97E-03 6,63E-03 5,73E-03 5,78E-03 1,08E-02 
90.9943 
No assignment identified 
7,68E-03 9,74E-03 1,04E-02 6,60E-03 8,58E-03 
90.9992 
C7H7
+
 (m/z of 91) 
(Wagner et al., 2002) 
7,84E-03 9,92E-03 1,07E-02 6,81E-03 8,97E-03 
92.944 
No assignment identified 
3,80E-03 2,96E-03 1,99E-03 3,31E-03 5,28E-03 
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99.9847 
C4H10N3(m/z of 
100.0875) arginine; most 
prevalent in Ln (Canavan 
et al., 2007) 
2,97E-03 5,98E-03 2,71E-03 2,14E-03 1,31E-03 
127.9609 
C5H11N4 (m/z of 
127.0984) arginine; most 
prevalent in Ln (Canavan 
et al., 2007) 
3,60E-04 4,52E-04 4,59E-04 3,91E-04 6,17E-04 
136.9337 
C8H10NO (m/z of 
136.076) tyrosine; most 
prevalent in Fn (Canavan 
et al., 2007) 
9,58E-04 2,27E-03 6,63E-04 6,96E-04 3,26E-04 
164.9226 
No assignment identified 
1,44E-03 3,19E-03 8,48E-04 9,25E-04 2,51E-04 
180.904 
No assignment identified 
1,06E-02 1,01E-02 1,33E-02 1,30E-02 9,75E-03 
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Table A7 Normalised intensity values of negative ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure collagen I protein solution. 
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m/z 
Potential 
Assignment 
Coll I 
CTL 
Coll I +A 
(280nm) 
Coll I +A 
(521nm) 
Coll I +R 
(318nm) 
Coll I +R 
(660nm) 
13.0086 
No assignment 
identified 
1,29E-02 1,50E-02 3,35E-02 1,29E-02 2,16E-02 
15.9954 
No assignment 
identified 
2,27E-02 1,88E-02 4,61E-02 1,03E-02 1,82E-02 
17.0034 
No assignment 
identified 
1,84E-02 1,87E-02 6,35E-02 1,33E-02 1,90E-02 
25.0094 
CN
-
(26) peptide 
backbone 
(Wagner et al., 
2001) 
2,27E-06 2,48E-06 7,57E-06 2,98E-06 2,67E-06 
34.9712 
SH
-
 (33) cysteine  
(Wagner et al., 
2001) 
2,01E-02 1,64E-02 4,58E-03 1,47E-02 6,55E-03 
41.0453 
C3H5
+
 (41) 
(Wagner et al., 
2002) 
6,32E-04 6,79E-04 4,71E-04 7,64E-04 1,13E-03 
43.0017 
CH3N2 (43.0296) 
Glycine most 
prevalent in coll 
(Canavan et al., 
2007) 
3,15E-03 2,25E-03 1,56E-02 2,31E-03 1,96E-03 
59.9676 
C2H6NO (60.0449) 
L-serine most 
prevalent in Fn 
(Canavan et al., 
2007) 
1,80E-03 2,14E-03 1,51E-02 1,36E-03 1,34E-03 
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60.9755 
C2H5S (61.011) 
methionine most 
prevalent in Coll 
(Canavan et al., 
2007) 
1,99E-03 2,26E-03 1,26E-02 1,41E-03 1,72E-03 
62.9658 
No assignment 
identified 
9,09E-03 1,53E-02 1,31E-03 3,19E-02 1,60E-03 
74.9971 
C3H8NO (74.061) 
threonine most 
prevalent in Fn 
(Canavan et al., 
2007) 
4,54E-03 5,64E-03 3,10E-03 1,15E-02 1,37E-03 
75.9611 
C2H6NS (76.022) 
cysteine most 
prevalent in Fn 
(Canavan et al., 
2007) 7,90E-04 9,16E-04 1,22E-02 5,93E-04 4,44E-04 
76.9699 
C2H6NS
+
 (76) 
cysteine  
(Wagner et al., 
2001) 5,43E-03 5,95E-03 3,78E-02 3,38E-03 4,34E-03 
78.9615 
No assignment 
identified 
2,15E-02 4,44E-02 2,94E-03 9,30E-02 6,33E-03 
79.9609 
No assignment 
identified 
5,59E-03 1,45E-02 1,81E-03 7,59E-03 4,53E-03 
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83.9729 
C4H6NO (84.0449) 
glutamine; most 
prevalent in Fn 
(Canavan et al., 
2007) 
3,82E-03 3,97E-03 3,31E-04 8,67E-03 2,80E-04 
90.9943 
No assignment 
identified 
3,27E-03 3,56E-03 1,95E-04 9,27E-03 2,43E-04 
90.9992 
C7H7
+
 (91) 
(Wagner et al., 
2002) 
3,35E-03 3,68E-03 2,76E-04 9,47E-03 3,06E-04 
92.944 
No assignment 
identified 
2,33E-03 3,72E-03 1,37E-04 4,81E-03 9,94E-05 
99.9847 
C4H10N3(100.0875) 
arginine; most 
prevalent in Ln 
(Canavan et al., 
2007) 
1,10E-03 1,28E-03 1,69E-04 4,33E-03 1,29E-04 
127.9609 
C5H11N4 
(127.0984) 
arginine; most 
prevalent in Ln 
(Canavan et al., 
2007) 
2,25E-04 2,17E-04 2,10E-04 2,63E-04 2,24E-04 
136.9337 
C8H10NO 
(136.076) tyrosine; 
most prevalent in 
Fn (Canavan et al., 
2007) 
6,56E-04 5,93E-04 3,28E-04 2,31E-03 2,32E-04 
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164.9226 
No assignment 
identified 
1,20E-03 1,07E-03 8,43E-04 3,71E-03 3,57E-04 
180.904 
No assignment 
identified 
1,29E-02 1,50E-02 3,35E-02 1,29E-02 2,16E-02 
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Table A8 Normalised intensity values of negative ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure fibronectin protein solution. 
m/z Potential Assignment 
Fn CTL Fn +A (280nm) Fn +A (521nm) Fn +R (318nm) Fn +R (660nm) 
13.0086 
No assignment identified 
7,64E-03 9,27E-03 1,58E-02 1,08E-02 1,43E-02 
15.9954 
No assignment identified 
1,46E-02 1,10E-02 7,89E-03 9,56E-03 1,89E-02 
17.0034 
No assignment identified 
1,23E-02 1,14E-02 9,76E-03 1,14E-02 1,66E-02 
25.0094 
CN
-
(26) peptide backbone 
(Wagner et al., 2001) 
1,90E-06 2,43E-06 5,81E-06 3,32E-06 2,33E-06 
34.9712 
SH
-
 (33) cysteine  
(Wagner et al., 2001) 
1,83E-02 1,32E-02 1,12E-02 1,22E-02 1,78E-02 
41.0453 
C3H5
+
 (41) 
(Wagner et al., 2002) 
6,58E-04 7,45E-04 1,19E-03 7,78E-04 8,97E-04 
43.0017 
CH3N2 (43.0296) 
Glycine most prevalent in 
coll (Canavan et al., 
2007) 
2,80E-03 2,64E-03 2,22E-03 2,17E-03 2,61E-03 
59.9676 
C2H6NO (60.0449) 
L-serine most prevalent in 
Fn (Canavan et al., 2007) 
8,31E-04 9,34E-04 1,67E-03 9,28E-04 1,12E-03 
60.9755 
C2H5S (61.011) 
methionine most 
prevalent in Coll 
(Canavan et al., 2007) 
8,22E-04 9,05E-04 1,86E-03 9,24E-04 1,11E-03 
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62.9658 
No assignment identified 
2,82E-02 2,51E-02 6,73E-03 3,03E-02 5,14E-03 
74.9971 
C3H8NO (74.061) 
threonine most prevalent 
in Fn 
(Canavan et al., 2007) 
1,07E-02 1,26E-02 9,77E-03 1,10E-02 7,54E-03 
75.9611 
C2H6NS (76.022) cysteine 
most prevalent in Fn 
(Canavan et al., 2007) 2,68E-04 3,22E-04 3,36E-04 3,11E-04 4,30E-04 
76.9699 
C2H6NS
+
 (76) cysteine  
(Wagner et al., 2001) 1,79E-03 1,87E-03 2,81E-03 1,86E-03 2,58E-03 
78.9615 
No assignment identified 
7,66E-02 7,77E-02 1,32E-02 8,30E-02 1,42E-02 
79.9609 
No assignment identified 
2,91E-03 4,72E-03 6,40E-03 5,43E-03 2,67E-03 
83.9729 
C4H6NO (84.0449) 
glutamine; most prevalent 
in Fn (Canavan et al., 
2007) 
1,15E-02 1,00E-02 5,93E-03 8,29E-03 7,62E-03 
90.9943 
No assignment identified 
9,50E-03 1,13E-02 6,43E-03 9,48E-03 6,53E-03 
90.9992 
C7H7
+
 (91) 
(Wagner et al., 2002) 
9,70E-03 1,15E-02 6,67E-03 9,72E-03 6,71E-03 
92.944 
No assignment identified 
7,79E-03 4,59E-03 2,37E-03 4,34E-03 4,34E-03 
99.9847 
C4H10N3(100.0875) 
arginine; most prevalent 
7,17E-03 5,76E-03 1,15E-03 5,81E-03 1,46E-03 
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in Ln (Canavan et al., 
2007) 
127.9609 
C5H11N4 (127.0984) 
arginine; most prevalent 
in Ln (Canavan et al., 
2007) 
2,81E-04 2,73E-04 2,51E-04 2,64E-04 2,74E-04 
136.9337 
C8H10NO (136.076) 
tyrosine; most prevalent 
in Fn (Canavan et al., 
2007) 
3,15E-03 2,19E-03 5,96E-04 2,86E-03 5,86E-04 
164.9226 
No assignment identified 
4,57E-03 3,19E-03 7,07E-04 4,01E-03 8,09E-04 
180.904 
No assignment identified 
7,64E-03 9,27E-03 1,58E-02 1,08E-02 1,43E-02 
 
 
  
Appendix 
 
 
 
 
298 
 
Table A9 Normalised intensity values of negative ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure laminin protein solution. 
m/z Potential Assignment 
Ln CTL Ln +A (280nm) Ln +A (521nm) Ln +R (318nm) Ln +R (660nm) 
13.0086 
No assignment identified 
8,45E-03 9,05E-03 1,15E-02 8,90E-03 9,86E-03 
15.9954 
No assignment identified 
1,38E-02 1,01E-02 7,90E-03 1,10E-02 9,62E-03 
17.0034 
No assignment identified 
1,30E-02 1,05E-02 9,21E-03 1,03E-02 9,71E-03 
25.0094 
CN
-
(26) peptide backbone 
(Wagner et al., 2001) 
1,82E-06 2,53E-06 2,56E-06 2,09E-06 2,10E-06 
34.9712 
SH
-
 (33) cysteine  
(Wagner et al., 2001) 
1,82E-02 1,35E-02 1,42E-02 1,10E-02 1,52E-02 
41.0453 
C3H5
+
 (41) 
(Wagner et al., 2002) 
6,71E-04 7,84E-04 9,22E-04 8,13E-04 8,33E-04 
43.0017 
CH3N2 (43.0296) 
Glycine most prevalent in coll 
(Canavan et al., 2007) 
2,26E-03 2,15E-03 1,93E-03 1,86E-03 2,08E-03 
59.9676 
C2H6NO (60.0449) 
L-serine most prevalent in Fn 
(Canavan et al., 2007) 
7,10E-04 8,69E-04 7,47E-04 5,62E-04 7,82E-04 
60.9755 
C2H5S (61.011) methionine 
most prevalent in Coll 
(Canavan et al., 2007) 
7,20E-04 8,12E-04 6,31E-04 4,85E-04 6,93E-04 
62.9658 
No assignment identified 
4,29E-02 1,99E-02 6,38E-03 7,88E-03 6,48E-03 
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74.9971 
C3H8NO (74.061) threonine 
most prevalent in Fn 
(Canavan et al., 2007) 
1,09E-02 1,50E-02 1,35E-02 1,42E-02 1,17E-02 
75.9611 
C2H6NS (76.022) cysteine 
most prevalent in Fn (Canavan 
et al., 2007) 1,62E-04 2,21E-04 1,12E-04 9,18E-05 1,14E-04 
76.9699 
C2H6NS
+
 (76) cysteine  
(Wagner et al., 2001) 1,02E-03 1,24E-03 7,41E-04 5,84E-04 8,03E-04 
78.9615 
No assignment identified 
7,41E-02 6,48E-02 2,01E-02 2,85E-02 2,17E-02 
79.9609 
No assignment identified 
3,45E-03 4,80E-03 5,35E-03 3,62E-03 5,76E-03 
83.9729 
C4H6NO (84.0449) glutamine; 
most prevalent in Fn (Canavan 
et al., 2007) 
1,03E-02 1,19E-02 1,23E-02 1,04E-02 1,06E-02 
90.9943 
No assignment identified 
1,01E-02 1,40E-02 1,23E-02 1,34E-02 1,04E-02 
90.9992 
C7H7
+
 (91) 
(Wagner et al., 2002) 
1,03E-02 1,43E-02 1,26E-02 1,37E-02 1,07E-02 
92.944 
No assignment identified 
8,41E-03 5,08E-03 5,62E-03 3,88E-03 5,36E-03 
99.9847 
C4H10N3(100.0875) arginine; 
most prevalent in Ln 
(Canavan et al., 2007) 
9,57E-03 6,25E-03 2,22E-03 3,63E-03 2,68E-03 
127.9609 
C5H11N4 (127.0984) arginine; 
most prevalent in Ln 
(Canavan et al., 2007) 
2,83E-04 3,45E-04 3,47E-04 3,48E-04 3,14E-04 
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136.9337 
C8H10NO (136.076) tyrosine; 
most prevalent in Fn (Canavan 
et al., 2007) 
5,20E-03 2,28E-03 5,82E-04 8,74E-04 8,28E-04 
164.9226 
No assignment identified 
7,93E-03 2,91E-03 6,13E-04 1,03E-03 9,64E-04 
180.904 
No assignment identified 
8,45E-03 9,05E-03 1,15E-02 8,90E-03 9,86E-03 
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Table A10 Normalised intensity values of negative ion amino acid fragments identified by Tof-SIMS on PCL electrospun nanofibrous 
substrates, in both aligned (280 ± 122 nm) and random (318 ± 151 nm) conformations when incubated in pure vitronectin protein solution. 
m/z Potential Assignment 
Vn CTL Vn +A (280nm) Vn +A (521nm) Vn +R (318nm) Vn +R (660nm) 
13.0086 
No assignment identified 
1,02E-02 2,50E-02 1,29E-02 1,39E-02 2,28E-02 
15.9954 
No assignment identified 
1,76E-02 3,05E-02 8,97E-03 1,62E-02 3,13E-02 
17.0034 
No assignment identified 
1,31E-02 3,79E-02 1,02E-02 1,29E-02 3,71E-02 
25.0094 
CN
-
(26) peptide backbone 
(Wagner et al., 2001) 
2,69E-06 9,60E-06 4,77E-06 3,70E-06 6,05E-06 
34.9712 
SH
-
 (33) cysteine  
(Wagner et al., 2001) 
7,70E-03 9,34E-03 8,65E-03 9,67E-03 1,29E-02 
41.0453 
C3H5
+
 (41) 
(Wagner et al., 2002) 
6,40E-04 1,11E-03 9,94E-04 8,34E-04 1,46E-03 
43.0017 
CH3N2 (43.0296) 
Glycine most prevalent in 
coll (Canavan et al., 2007) 
3,53E-03 1,06E-02 2,72E-03 2,72E-03 8,72E-03 
59.9676 
C2H6NO (60.0449) 
L-serine most prevalent in 
Fn (Canavan et al., 2007) 
2,54E-03 9,81E-03 1,76E-03 2,37E-03 7,98E-03 
60.9755 
C2H5S (61.011) methionine 
most prevalent in Coll 
(Canavan et al., 2007) 
2,26E-03 8,25E-03 1,86E-03 2,13E-03 6,54E-03 
62.9658 
No assignment identified 
1,38E-02 9,00E-04 3,93E-03 8,70E-03 1,12E-03 
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74.9971 
C3H8NO (74.061) threonine 
most prevalent in Fn 
(Canavan et al., 2007) 
1,05E-02 4,89E-03 9,71E-03 9,76E-03 3,08E-03 
75.9611 
C2H6NS (76.022) cysteine 
most prevalent in Fn 
(Canavan et al., 2007) 6,15E-04 7,85E-03 3,59E-04 2,87E-04 6,86E-03 
76.9699 
C2H6NS
+
 (76) cysteine  
(Wagner et al., 2001) 3,33E-03 2,36E-02 2,56E-03 2,05E-03 1,99E-02 
78.9615 
No assignment identified 
4,26E-02 2,35E-03 7,11E-03 2,21E-02 2,94E-03 
79.9609 
No assignment identified 
1,84E-02 9,80E-03 2,02E-02 1,75E-02 1,36E-02 
83.9729 
C4H6NO (84.0449) 
glutamine; most prevalent in 
Fn (Canavan et al., 2007) 
3,30E-03 3,62E-04 4,41E-03 3,66E-03 5,00E-04 
90.9943 
No assignment identified 
6,34E-03 3,36E-04 6,35E-03 5,28E-03 3,47E-04 
90.9992 
C7H7
+
 (91) 
(Wagner et al., 2002) 
6,51E-03 4,78E-04 6,55E-03 5,47E-03 4,39E-04 
92.944 
No assignment identified 
1,26E-03 3,13E-04 1,20E-03 1,57E-03 4,10E-04 
99.9847 
C4H10N3(100.0875) arginine; 
most prevalent in Ln 
(Canavan et al., 2007) 
1,68E-03 1,37E-04 4,95E-04 9,13E-04 1,64E-04 
127.9609 
C5H11N4 (127.0984) 
arginine; most prevalent in 
Ln (Canavan et al., 2007) 
3,06E-04 3,03E-04 4,08E-04 3,29E-04 3,50E-04 
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136.9337 
C8H10NO (136.076) tyrosine; 
most prevalent in Fn 
(Canavan et al., 2007) 
7,95E-04 4,71E-04 4,66E-04 4,68E-04 4,33E-04 
164.9226 
No assignment identified 
9,05E-04 8,81E-04 3,96E-04 4,96E-04 7,99E-04 
180.904 
No assignment identified 
1,02E-02 2,50E-02 1,29E-02 1,39E-02 2,28E-02 
 
